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Preface
The DNA in a eukaryotic cell is the primary vehicle for transmitting traits to the 
progeny. DNA is, however, intimately connected to a number of factors controlling 
the expression of the genetic information. This partnership, termed chromatin, not 
only has a strong influence on how genes are expressed but can build additional lay-
ers of information, which can be inherited in parallel to the genetic information. 
Epigenetics studies the processes behind the inheritance of traits that cannot be 
attributed to changes in the DNA sequence.
The epigenetic landscape of a cell contributes to its fate and diversity by “remem-
bering” developmental decisions and by maintaining a stable and faithful memory 
over many cell divisions. The composition and structure of chromatin can mark and 
silence a single gene or even an entire chromosome while its allele or sister chromatid 
in the same nucleus remains active. These chromatin marks can be erased if  required 
and new marks reestablished to adapt the cell to changing developmental or environ-
mental conditions. Epigenetics attempts to understand what these marks are; how 
they are established, if  required reversed; and, above all, how they are inherited to the 
next cell generation. DNA in itself, by marking bases with a chemical signal, adding 
a methyl-moiety on cytosine, can generate additional information beyond the genetic 
context. Notably, this methyl-moiety can be removed again without changing the 
sequence content but altering epigenetic pathways. DNA is packaged into a regular 
array of nucleosomes. These are composed of histones and their variants, which can 
as well be chemically modified in a very intricate pattern. The histone marks are the 
result of a complex cellular machinery generating local signatures on the DNA 
sequence they package, thereby establishing an epigenetically transmissible state. 
Also, in this case, the marks can be eliminated or replaced by others, emphasizing the 
reversibility and flexibility of epigenetic control. A third component, regulatory 
RNA, plays an ever-increasing yet less well-understood role in epigenetic control, 
providing an important link between genetic and epigenetic information.
The interplay between these three major players generates a much more complex 
layering of transmissible information than the sequence of the bases alone could 
provide. Unlike the sequence information of DNA, the reversibility and flexibility of 
particular epigenetic marks ensures that genetic information can be interpreted in a 
much more context-dependent manner. For example, the process of organ and tissue 
regeneration requires substantial reprogramming of epigenetic control by changing 
and adapting cellular identities for tasks of repair and homeostasis. Most chromatin- 
modifying enzymes use metabolites as co-factors, intimately connecting the control 
of epigenetic mechanisms to the changing physiological needs of a cell. Eventually, 
if  not appropriately maintained, epigenetic signatures can lead to malfunctions rang-
ing from cancer development to neuronal disorders. Epigenetics plays a complemen-
tary role to genetics, touching many aspects of medicine, biotechnology, and plant 
biology.
This book is intended as an accompanying reading to the lecture “Epigenetics” 
taught by the authors at the ETH Zurich, Switzerland. The first chapters provide an 
introduction to the biology of chromatin with all the components and cellular pro-
cesses that establish the toolbox of epigenetic mechanisms. In the following chapters, 
VI
complex epigenetic phenomena are illustrated by explaining the structures and prin-
ciples of the underlying molecular mechanisms. Towards the end of the book, two 
chapters examine environmental influences on epigenetic control and epigenetic mis-
regulation in human disease.
I am very grateful to the authors of this book for their effort and commitment to 
realize this teaching support for the students. All of us highly appreciate the strong 
support and patience of Amrei Strehl and Bibhuti Sharma at Springer Nature’s edi-
torial office. We apologize to many of our colleagues for the limited referencing of 
their cited work caused by space restrains. We hope this book will stimulate students 
and readers and further their interest and curiosity for the fascinating biology of 
epigenetics. Indeed, many fundamental questions and applications in epigenetics 
remain to be discovered and their mechanisms resolved in the future. This perspec-
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What You Will Learn in This Chapter
This chapter provides an introduction to chromatin. We will examine the organization of 
the genome into a nucleosomal structure. DNA is wrapped around a globular complex of 
8 core histone proteins, two of each histone H2A, H2B, H3, and H4. This nucleosomal 
arrangement is the context in which information can be established along the sequence of 
the DNA for regulating different aspects of the chromosome, including transcription, 
DNA replication and repair processes, recombination, kinetochore function, and telomere 
function. Posttranslational modifications of histone proteins and modifications of DNA 
bases underlie chromatin-based epigenetic regulation. Enzymes that catalyze histone mod-
ifications are considered writers. Conceptually, erasers remove these modifications, and 
readers are proteins binding these modifications and can target specific functions. On a 
larger scale, the 3-dimensional (3D) organization of chromatin in the nucleus also contrib-
utes to gene regulation. Whereas chromosomes are condensed during mitosis and segre-
gated during cell division, they occupy discrete volumes called chromosome territories 
during interphase. Looping or folding of DNA can bring regulatory elements including 
enhancers close to gene promoters. Recent techniques facilitate understanding of 3D con-
tacts at high resolution. Lastly, chromatin is dynamic and changes in histone occupancy, 
histone modifications, and accessibility of DNA contribute to epigenetic regulation.
1.1  Introduction: Epigenetic Regulation in the Context 
of the Genome
1.1.1  Background: Gene Expression and Chromatin
All organisms inherit traits from their parents, which are encoded in the succession 
of four bases in nucleic acids. All eukaryotic organisms possess deoxyribonucleic 
acid (DNA)-based genomes, whereby DNA comprises of antiparallel strands wound 
in a right-handed double helix. Although the sequence of bases as well as the 3D 
structure of the DNA helix contribute to the expression of traits, it is thought that 
the DNA sequence facilitates trait generation by the regulated expression of genes. 
Gene expression is not the only function of the genome, but replication and faithful 
inheritance of the genome to descendant somatic cells and the next generation, and 
evolutionary modifications of the genome are principal functions of the heritable 
material. Importantly, a genome is not sufficient for generating an organism; this 
requires a suitable reader that can be represented by a cell or, in the case of higher 
organisms, an oocyte or zygote that must be from the same species as the genome. 
The reader implements molecular processes in the cell’s nucleus that lead to the pro-
duction of biomolecules – ribonucleic acids and other biosynthetically active mole-
cules – that replenish the cells and maintain organismal tissues. Through feedback by 
transcription factors that are encoded in the genome and typically bind to specific 
DNA sequences, complex regulatory circuits are established. In addition, the DNA 
itself  is organized in a chromatin fiber that facilitates the imposition of information 
along the DNA sequence. Chromatin also supports the transduction of this epigen-
etic information into regulatory processes that, in turn, affect transcription, replica-
tion, repair, and, in specialized cases, even changes of the DNA sequence. Reciprocal 
feedback of transcription, combinatorial activity of regulators, genome size, and 
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temporal dynamics contribute to the complexity of gene regulatory networks. On the 
one hand, this has led to the evolution of developmental programs for complex body 
plans and, on the other hand, often makes the understanding of individual processes 
difficult. Therefore, exploration of mechanism of chromatin regulation relies on well 
suited model systems that disambiguate the function of the components involved. 
Genomic imprinting and X chromosome inactivation are phenomena where 
expressed and repressed copies of individual genes are present in the same nucleo-
plasm and facilitate the study of chromatin-based regulation of transcription factor 
activity. In addition, ingenious approaches have been designed to analyze chromatin- 
based heritable expression states controlled by Polycomb (PcG) and Trithorax group 
(TrxG) complexes. This chapter contains an introduction to the organization and 
function of chromatin and provides a basis for understanding its role in regulating 
the cellular function of DNA sequences.
1.1.2  Discovery of the Nucleosomal Structure of the Genome
Linear arrays of spherical particles of about 70 Ångström in diameter were initially 
observed by electron microscopy of chromatin released from animal cells (. Fig. 1.1) 
(Olins and Olins 1974). The regular spacing of the spherical units and the fact that 
similar arrangements were found in many eukaryotes suggested a basic form of orga-
nization of the genome. Consistent with a regular structure, experiments using lim-
ited digestion of chromatin with nucleases and gel electrophoresis analysis revealed 
DNA fragments at regular intervals at multiples of 150 base pairs (bp). This is con-
sistent with protection of around 150 bp of DNA from nuclease digestion, whereby 
nuclease cleavage occurs on the stretch of DNA that lies between spherical particles. 
Based on these studies, it has become clear that an understanding of the genome 
needs to consider the molecular components of nucleosomal structure.
1.2  The Structure of the Nucleosome
A nucleosome represents a single repeat unit for organizing the majority of the DNA 
of a cell.1 A nucleosome consists of 8 histone proteins and 146 bp of DNA, which is 
wrapped around them in two left-handed turns2 (. Fig. 1.2a–c). Histone proteins 
form an octamer complex that comprises positively charged surfaces formed by basic 
amino acid side chains, which interact with the negatively charged phosphate groups 
of the DNA backbone. The octamer is assembled from two of each histone H3/H4 
and histone H2A/H2B dimers (. Fig. 1.2d). The histone H3/H4 dimers occupy the 
core of the nucleosome and the H2A/H2B dimers are more loosely associated 
1 An exception to nucleosomal organization of  eukaryotic genomes is found in male gametes of  ani-
mals, where histones are largely replaced with protamine facilitating a distinct and highly com-
pacted genome configuration.
2 Although it is clear that the large majority of  DNA in cells is arranged in left-handed turns around 
the histone octamer, it has been suggested that right-handed DNA looping can be accommodated 
by the nucleosomal structure and has experimentally been produced in vitro.
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(. Fig. 1.3). Histone proteins form a globular domain with a characteristic alpha- 
helical arrangement called the histone fold (Luger et al. 1997). Flexible N-terminal 
regions of histone proteins, the so-called histone tails, associate more loosely with the 
 nucleosome and are accessible for posttranslational modifications.
1.2.1  Histone Variants
Although the nucleosomal structure appears homogenous, variation in histone com-
position can introduce different functionalities. Different variants of histones can be 
incorporated, whereby variations of histone H3 and histone H2A are common, and 
histones H2B and H4 appear to be predominantly canonical.
a b c
  . Fig. 1.1 Electronmicrographs of  eukaryotic chromatin. Rat thymus chromatin a positive and 
b negative staining, and c chicken erythrocyte chromatin. (From Olins and Olins (1974))
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Histone variants are encoded by a different set of genes and show slight varia-
tions in the amino acid sequence. In mammals, histone H3.1 and H3.2 are deposited 
during DNA replication in S-phase, whereas histone H3.3 is involved in histone 
exchange at active transcription units and at pericentric and telomeric heterochroma-
tin. Incorporation of histone H3.3 outside of S-phase can be explained as it is the 
only histone H3 gene whose expression is not restricted to S-phase. Histones are very 
basic proteins and are associated with chaperones, or loaders, in the cell when they 
are not in a chromatin context (see book 7 Chap. 2 of Paro). Different histone load-
ers are involved in deposition of histone H3 variants. During S-phase, chromatin 
assembly factor 1 (CAF-1) incorporates histones H3.1 and H3.2 into DNA, whereas 

































  . Fig. 1.2 Scheme representing biologically relevant aspects of  the nucleosome structure. a DNA 
forms a right-handed double helix with two strands aligned in opposite (antiparallel) orientation. The 
helix forms a major and minor groove, whereby DNA bases are more accessible from the major groove. 
b Winding of  the DNA in left-handed turns over the histone octamere. c At a distance of  approximately 
70 bp, the two DNA loops face the same surface of  the nucleosome. Two hypothetical factor binding-
sites are indicated by the boxed “A”. As one turn of  the DNA is completed every 10 bp, both “A” boxes 
can be facing the surface through the major grove, depending on the position of  the nucleosome. 
Nucleosome positioning along the DNA thereby allows for changes in binding-site geometry that can 
have a regulatory function. d A model for assembly of  nucleosomes from histone dimers. DNA assem-
bled into a nucleosomal structure is depicted at the bottom
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genes. At pericentric3 and telomeric heterochromatin, ATRX/DAXX is required for 
histone H3.3 incorporation. At the centromere of mammalian cells, canonical his-
tone H3 is replaced by CENP-A, which contains a number of amino acid differences 
and adopts a more compact structure. It is thought that CENP-A contributes to the 
mechanical rigidity of centromeric chromatin that forms the basis of the kineto-
chore, where spindle microtubules attach for chromosome segregation in mitosis. The 
specific loader JHURP is involved in CENP-A incorporation into centromeres.
Among histone H2A genes in mammals, the incorporation of the H2A.z variant 
is restricted to promoters of active genes. This is somehow surprising as H2A.z 
appears to represent the ancestral form of H2A and is the mammalian H2A gene 
that is most similar to the H2A gene of Saccharomyces cerevisiae. Therefore, the 
canonical H2A, which is found in the majority of mammalian chromatin, has a 
slightly different amino acid sequence to the ancestral histone. Additional variants of 
histone H2A have been correlated with gene activity. Whereas H2A.B is incorporated 
into chromatin over the transcription unit of active genes, macroH2A accumulates in 




11 nm 5 nm 
  . Fig. 1.3 A model-based on X-ray crystallographic structure determination reveals details of  a 
nucleosome. DNA is wrapped around a protein core of  8 histone proteins (histone H3/H4 dimers, green 
and blue; histone H2AH2B dimers, red and yellow). Globular domains of  histone proteins show helical 
folds and long, unstructured N-terminal peptides are pasted into the model as protruding from the core. 
(From Luger et al. (1997))
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silent chromatin. MacroH2A is a vertebrate-specific histone H2A variant that con-
tains a large C-terminal extension, which is commonly referred to as a macro-domain. 
MacroH2A is enriched at the inactive X chromosome of female mammals, consistent 
with its association with transcriptionally repressed chromatin (see book 7 Chap. 4 
of Wutz). Through variation of the composition of histone proteins, the function of 
nucleosomes can be changed, which affects the function of the 146 bp long DNA 
associated with the nucleosome.
1.3  Histone Modifications
Changes in histone composition are not the only way by which information can be 
added to nucleosomes. Histone proteins are the subject to posttranslational modifi-
cations. In particular, the unstructured N-termini of histones can be modified in a 
variety of ways, whereby the chemical spectrum of modifications and the combinato-
rial complexity is high. Phosphorylation of serine, acetylation and methylation of 
lysine, and methylation of arginine residues are the most prominent histone modifi-
cations. Notably, multiple methyl-groups can be added to lysines and arginines, 
thereby increasing the complexity. Transfer of a ubiquitin to lysines in histone H2A 
and H2B has also been described. Improvements of analytical techniques have 
revealed an increasing number of histone modifications and it is likely that this trend 
will continue in the future. Posttranslational modifications of histones and their 
functions are incompletely understood at present. However, the development of spe-
cific antisera to detect modified histones has provided key insights.
1.3.1  Nomenclature for Histone Modifications
The chemical diversity of modifications and the large number of acceptor sites on 
histone proteins makes it difficult to describe the modification state of nucleosomes. 
To facilitate the precise and comprehensive documentation of experimental results 
and further theoretical elaborations, the scientific community has adopted guidelines 
for a systematic nomenclature. The class of the histone protein is prefixed to the 
single character code and position4 of the amino acid carrying the modification, fol-
lowed by an abbreviation of the chemical nature of the modification (. Fig. 1.4). 
For example, the short form for histone H3 carrying di-methylation of lysine 27 is 
H3K27me2. Similarly, H2AK119ub identifies histone H2A carrying a mono- 
ubiquitin modification on lysine 119. If  the precise histone subtype is known this can 
also be incorporated, for example H3.3K4ac stands for histone H3.3 that is acety-
lated on lysine at position 4. This versatile nomenclature can easily be extended for 
multiple modifications: H3K9me3S10p specifies a doubly modified histone H3 with 
tri-methylation on lysine 9 and phosphorylation on serine 10.
4 Numbering of  amino acids starts at the biochemical N-terminus, which is different from the methi-
onine encoded by the start ATG of  the histone gene due to the activity of  methionine aminopeti-
dase.
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1.3.2  Combinatorial Modifications at Pericentric 
Heterochromatin
Histone modifications can be detected by suitable antibodies either using biochemi-
cal methods or by staining techniques followed by microscopy. The latter has been 
used in combination with fluorescence-labeled secondary antibody detection to ana-
lyze different histone modification states within the nucleus. Microscopy techniques 
for dual- or multi-color labeling have further facilitated the observation of co- 
localization of specific protein complexes with histone modifications. These 
approaches have been important to characterize different types of chromatin in the 
nucleus. When combined with fluorescent probes that hybridize with specific DNA 
sequences, an assessment of the genomic context can be made, albeit at a modest 
resolution of several thousand bp and, hence, tens or hundreds of nucleosomes.
The pericentric repeats in mouse cells are observed as DNA-dense clusters that 
are brightly stained with DNA binding dyes such as DAPI.5 Association of H3K9me3 
with this DAPI-dense region suggested a correlation of a specific histone methylation 
mark with pericentric heterochromatin. Binding of H3K9me3 by the chromo-domain 
of heterochromatin protein 1 (HP1) leads to HP1 accumulation at the pericentric 
5 DAPI (4′,6-diamidino-2-phenylindole) is a fluorescent dye that binds to DNA, allowing the detec-



























Nomenclatur of Histone modications
  . Fig. 1.4 A schematic of  short-form nomenclature for posttranslational histone modifications
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heterochromatin. The assay of co-localization with pericentric heterochromatin has 
been exploited to identify additional components. The curious and instructive anec-
dote of the human autoimmune serum MCA1 provides a concise understanding. 
Initial interest in the MCA1 antiserum was raised when it seemed to recognize cen-
tromeres in mitosis and, thus, suggested specificity for a potential component of the 
kinetochore. Since MCA1 did not identify any know kinetochore-associated pro-
teins, mass spectrometry was performed, leading to identification of none but his-
tone proteins. Finally, the mystery was resolved when the specificity of MCA1 was 
investigated on a panel of doubly modified histone H3 peptides (Hirota et al. 2005). 
It turned out that MCA1 specifically recognizes H3K9me3S10p, which occurs exclu-
sively at pericentric heterochromatin in mitosis, when serine 10 is phosphorylated by 
cell cycle kinases, including polo-like kinase (PLK). The physiological effect of serine 
10 phosphorylation is to displace HP1 from pericentric heterochromatin in mitosis. 
This shows that the interaction between HP1 and histone H3 is specific for the 
H3K9me3 state and is disrupted by doubly modified H3K9me3S10p. This result is 
important for two reasons. Firstly, it clearly demonstrates that combinations of his-
tone modifications can act in cellular regulation. Secondly, in hindsight, it became 
clear that antisera for specific histone modifications are sensitive to modifications on 
neighboring amino acids. This has implications for the interpretation of results 
obtained with such immunoreagents as a failure to detect a signal does not always 
correlate with the absence of the modification but can also be caused by interference 
with a neighboring modification. Although it is assumed that in the majority of cases 
interference from neighboring modifications can be neglected, there is no systematic 
study to ascertain the validity of this assumption.
Research on pericentric heterochromatin has also led to the identification of his-
tone methyltransferases. Suppressor of position variegation 3-9 homologues 1 and 2 
(Suvar3-9h1 and Suvar3-9h2) associate with pericentric chromatin and catalyze 
H3K9me3 (. Fig. 1.5). H3K9me3 acts as a binding site for HP1 and mediates the 
recruitment of the additional histone methyltransferases Suvar4-20h1 and Suvar4- 
20h2 which, in turn, catalyze H4K20me3 at pericentric regions (Schotta et al. 2004). 
This example shows that modifications from histone H3 can be propagated onto 
histone H4 within the same chromatin context. The observation that multiple his-
tones and modifications contribute to pericentric chromatin suggests a mechanism 
for the stability of heterochromatin.
1.3.3  Histone Modifications at High Resolution
Practically, it is of interest to investigate which modifications are present on nucleo-
somes at a given gene promoter. Knowing of the activity of genes, this can further 
identify correlations with histone modifications that are generally associated with 
active or repressed chromatin. For this analysis, two prerequisites need to be fulfilled. 
Firstly, suitable and specific reagents are required to detect a particular modification 
of a histone. This has been facilitated by the development of a large array of anti-
bodies that specifically recognize histone modifications. Secondly, the methodology 
needs to establish a link between modified histones and the DNA sequence, with 
which these are associated. Chromatin immunoprecipitation (ChIP) does exactly 
allow for such an analysis (7 Method Box 1.1). Chromatin enriched for a defined 
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Combinatorial interaction of histone modications
The HMTs Suvar3-9h1 and Suvar3-9h2 catalyse
tri-methylation of histone H3 lysine 9 in pericentric heterochromatin
tri-methylation of histone H3 lysine 9 is a signal for recruiting
HP1 through its chromo-domain in pericentric heterochromatin
Interplay between two dierent
histone methylase complexes
The HMTs Suvar4-20h1 and Suvar4-20h2 are recruited
















  . Fig. 1.5 A schematic of  histone marks at pericentric heterochromatin. The histone methyl- 
transferases Suv3-9h1 and Suv3-9h2 establish H3K9me3. The tri-methylated lysine 9 serves as a binding 
signal for HP1 to histone H3. HP1 binding and recruitment of  the histone-methyltransferases Suv4-
20h1 and Suv4-20h2 leads to establishment of  H4K20me1 (Schotta et al. 2004)
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Method Box 1.1: Chromatin Immunoprecipitation
Histone modifications, and transcription factor binding, can be analysed at high 
resolution by chromatin immunoprecipitation (ChIP). For ChIP analysis, the DNA 
is cross-linked to histone proteins using formaldehyde, when chromatin is in its 
native form within cells. Subsequently, cells are lysed and chromatin is sheared either 
by ultrasound treatment or partial digestion with nucleases. Chromatin that is asso-
ciated with a specific histone modification or protein is enriched by immunoprecipi-
tation with a specific antibody. After purification, the chromatin associated DNA 
can be analysed by dot blot, gene specific PCR, and next generation sequencing 
(. Box Fig. 1.1).
histone modification is isolated through immunoprecipitation using antibodies that 
recognize specific histone modifications. The DNA can then be purified and analyzed 
by a variety of methods including hybridization to microarrays (ChIP-array), adapter 
ligation and sequencing (ChIPseq), PCR with gene-specific primers, or by hybridiza-
tion on dot blots. The latter has originally been used to investigate highly repeated 
parts of the genome, such as the pericentric repeats, whilst the former can provide 
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  . Box Fig. 1.1 Analysis of  chromatin modifications by ChIP. A schematic shows an overview 
of  the ChIP analysis (left) and an example view from a genome browser of  a histone modifica-
tion map obtained by next generation sequencing (right)
1.3 · Histone Modifications
12
1
1.3.4  Chromatin Modifications Associated  
with Transcription Units
From analyses in multiple cell types, correlation of gene activity and histone modifi-
cations along transcription units has been performed. Some general rules can be 
deduced. Gene promoters are frequently marked by H3K4me3 and carry acetylated 
lysines on histone H4 and H3. The gene body of active genes is often marked by 
H3K36me3. The occurrence of H3K4me3 at the promoter and H3K36me3 over the 
gene body is a reliable indicator for transcription and has been used to identify new 
genes (. Fig. 1.6) whose transcripts would have been difficult to detect due to their 
low abundance (Guttman et al. 2009).
In contrast, genes that are characterized by H3K9me2 or H3K9me3 tend to be 
transcriptionally inactive. Similarly, H3K27me3 and H2AK119ub are associated 
with the activity of PcG complexes that are well-known repressors of developmen-
tally regulated genes (see book 7 Chap. 3 of Paro). In progenitor cells and embry-
onic stem cells (see book 7 Chap. 7 of Paro), these marks can also co-occur with the 
active mark H3K4me3. This observation has led to the discovery of bivalent chro-
matin at promoters with apparently active H3K4me3 and repressive H3K27me3 
modifications. It appears that this configuration is resolved when cells differentiate 
and yields active H4K4me3 or repressed H3K27me3 configurations in separate cell 




at very high resolution the lack of a nucleosome
at the transcription start site can be observed

















  . Fig. 1.6 Illustration of  ChIPseq analysis of  the transcription unit of  a hypothetical active gene. A 
peak of  H4K4me3 enrichment overlaps the gene promoter whereas the transcription unit shows increas-
ing H3K36me3 towards the 3′ end of  the gene. If  data is obtained at very high resolution, a gap in the 
H4K4me3 peak can be observed at the position of  the transcription start site (TSS). At TSS one nucleo-
some is displaced and the DNA is bound by general transcription factors
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lineages. Therefore, PcG complexes might pre-mark certain developmentally regu-
lated genes before an expression state is committed, which is consistent with the 
developmental plasticity of progenitor cells (see book 7 Chaps. 3 and 7 of Paro).
1.3.5  A Concept of Writers, Readers, and Erasers  
of Histone Modifications
Chemical reactions that lead to posttranslational modifications of proteins use co- 
factors from metabolic pathways. Acetyl-Co-enzyme A, S-adenosyl-methionine, and 
ATP are used for the acetylation, methylation, and phosphorylation of histones, 
respectively (see book 7 Chap. 9 of Santoro). The corresponding enzymatic activities 
are referred to as histone acetyltransferases (HATs), histone methylases (HMTs), and 
histone kinases. Analogously, histone ubiquitin-transferases catalyze mono- 
ubiquitinylation. Posttranslational modifications of proteins are frequent and can 
have different functions. Not all modifications do possess an apparent physiological 
function and might be observed, to varying extents, as likely bystander reactions that 
the cell could not prevent. In a number of cases, highly specific modifications have 
been selected during evolution as signals that can have profound effects on the func-
tion of chromatin. Several histone modifications have been implicated in the tran-
scription of genes. Other modifications act to establish a heritable signal for repression. 
Highly specific functions have been identified for particular methylation states of 
lysines in the N-termini of histone H3, whereas acetylation can be less specific. 
Acetylation of lysines of histones is part of the chromatin assembly process and is 
thought to remove the positive charge from lysines, thereby preventing strong interac-
tions with negatively charged phosphate groups of the DNA. Acetylation of lysines 
of histone H3 and H4 is also associated with active promoters and could similarly 
loosen the association of histones with DNA to facilitate accessibility. These observa-
tions suggest a charge effect of acetylation and biophysical mechanisms involved in 
regulating local chromatin accessibility. However, this is not the entire story.
Bromodomain6-containing proteins can bind to acetylated lysines and attract 
other regulators. Proteins that specifically bind modified histones are considered 
readers of histone modifications. This group of proteins is particularly important for 
recognizing specific methylations states of lysines in the N-terminus of histone H3. 
HP1 protein can associate with H3K9me3 through a chromodomain. A single inter-
action provides only little binding energy given the small size of the tri-methyl- 
modification. However, HP1 can bind through a cooperative binding mechanism 
that enhances the binding of several HP1 proteins to longer stretches of H3K9me3 
modified chromatin. This explains the enrichment of HP1 on the pericentric regions 
of mouse chromosomes, where H3K9me3 is abundant. Similar to HP1, the Polycomb 
(Pc) protein contains a chromodomain which is specific for H3K27me3 (see book 
7 Chap. 3 of Paro). The relevance of chromodomains in cells has been confirmed by 
replacing the chromodomain of Pc by the one from HP1, whereby the protein was 
6 Bromo- and chromodomains are defined based on sequence homology in a number of  chromatin-
associated proteins. They recognize posttranslational modifications and sequence variation of  his-
tones in the context of  the nucleosome.
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redirected to pericentric chromatin. Similar protein domains exist for reading phos-
phorylated serines on histones. Importantly, 14-3-3 proteins have high specificity for 
the doubly modified histone H3S10pK14ac. This specificity plays a role in gene acti-
vation. A switch from an inactive H3K9me3 and HP1-bound state to an active 
H3K9me3S10pK14ac state has been described during the activation of the cell cycle 
inhibitor p21, which is an important tumor suppressor gene (see 7 Chap. 8 of 
Santoro). Histone H3 serine 10 phosphorylation by ERK kinase activity interferes 
with HP1 binding to H3K9me3 and simultaneously facilitates the association of 
14-3-3 proteins if  lysine 14 is acetylated. This mechanism demonstrates how cell sig-
naling, in combination with combinatorial histone modifications, can contribute to 
complex gene regulatory mechanisms.
A last aspect of histone modifications is their stability. Depending on their chem-
ical nature, histone modifications possess different lifetimes. Whereas phosphoryla-
tion is readily reversible through phosphatases, tri-methylated lysine modifications 
can persist for extended periods. Histone deacetylases (HDACs) and histone demeth-
ylases (HDMs, or KDMs for lysine demethylases) remove acetyl- and methyl-groups 
from lysines, respectively. In addition, deubiquitinating enzymes contribute to the 
turnover of ubiquitin moieties. To date, mechanisms for the enzymatic removal of all 
histone modifications have been described, suggesting that posttranslational modifi-
cations of chromatin are dynamic and actively regulated by the cell. Proteins or com-
plexes that remove histone modifications are considered erasers of epigenetic 
information. Whereas some histone modifications have been selected by evolution 
for a regulatory function other may be less important. Examples for the function of 
histone modifications will be discussed in their physiological context in the following 
chapters of this book.
1.4  DNA Modifications
Modifications of histones illustrate how information can be added to the genome 
without changing the sequence of the DNA. This is exactly how we defined “epi-
genetics” in the opening of the book. Enzymatic activities for establishing and remov-
ing modifications also illustrate how this information can be dynamically regulated 
during development or in response to external stimuli. However, we also had one 
expectation that is less easily explained: How can the potentially complex patterns of 
histone modifications be transmitted through cell division? Upon replication of the 
DNA, twice the number of nucleosomes will need to be assembled and this necessi-
tates that half  of the histones are freshly produced whereas the other half  keeps the 
previously established modification patterns (see book 7 Chap. 2 of Paro). How can 
the information be reestablished on the new histones? Or is it not restored but lost? 
There are good indications that epigenetic modifications are maintained but the 
mechanisms appear to be complex and are poorly understood. To understand the 
problem of epigenetic heritability, we turn to a much simpler system where mainte-
nance is mediated by a concise mechanism.
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1.4.1  DNA Cytosine Methylation
The cytosine base of DNA in animal and plant genomes can be chemically modified 
to 5-methyl-cytosine (5mC). This modification is observed in the majority of animals 
but is conspicuously absent from some popular laboratory model organisms includ-
ing the nematode Caenorhabditis elegans, the fly Drosophila melanogaster, and the 
yeasts S. cerevisiae and Schizosaccharomyces pombe. Although 5mC is not ubiqui-
tous, it is widely distributed among animals7 and plants. In particular, DNA meth-
ylation is essential for mammalian development and has been extensively studied for 
its role in silencing tumor suppressor genes in certain types of human cancer (see 
book 7 Chap. 8 by Santoro).
5mC is catalyzed by the activity of DNA methyltransferases (DNMTs) that use 
S-adenosyl-methionine (SAM) as a methyl-donor. The catalytic center of mammalian 
DNMTs resembles the one of DNA methylases that are components of bacterial 
restriction systems. The reaction involves an attack at the 6 position of the cytosine ring 
by the thiol group of a cysteine, leading to the formation of a covalent bond between 
the cytosine and the DNMT. The reaction mechanism of DNMTs thereby comprises 
an intermediate that links DNMTs temporarily to DNA (. Fig. 1.7). This intermedi-
ate is subsequently resolved by transfer of a methyl-group from SAM to the 5 position 
of the cytosine ring, abstraction of a proton, and release of the DNMT enzyme. After 
release, DNMT enzymes are available for another reaction cycle. Derivatization of the 
ring system of a DNA base requires that the base is accessible. From structural analysis 
of bacterial DNA methylases, it has been proposed that the cytosine is flipped out from 
the DNA double helix by rotation of the phospho- deoxyribose backbone. In this way, 
the base can be inserted into a deep pocket where SAM and catalytic residues are in 
close contact to the 5 and 6 positions of the cytosine ring.
A variety of methods has been developed to analyze DNA methylation at specific 
genes and genome-wide (7 Method Box 1.2). 5mC in mammalian genomes is pref-
erentially found in the context of CG dinucleotides, but not on cytosines in other 
sequence contexts like CC, CA, and CT.  The reason for this becomes clear when 
replication of the DNA and the maintenance of methylation patterns are considered. 
CG dinucleotides represent a symmetric configuration on the antiparallel DNA 
strand as C pairs with G and DNA strands have opposite polarity in the double helix. 
7 DNA methylation has been observed in honey bees and ants suggesting that it is present in insects. 

























  . Fig. 1.7 Schematic of  the catalytic mechanism of  DNA methylation. DNMTs attach to the 6 posi-
tion of  the pyrimidine ring of  the cytosine and enter a covalent intermediate. Methylation of  the 5 
position induces a shift of  electrons and releases the enzyme
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If  DNA with symmetrically methylated CG dinucleotides on both strands is repli-
cated, two copies result, each having a methylated and an unmethylated (the newly 
synthesized) strand. Maintenance DNMT enzymes are recruited to hemi-methylated 
DNA to restore a fully symmetric methylation pattern (. Fig. 1.8). This mechanism 
requires the recognition of hemi-methylated CG dinucleotides and the activation of 
methylation activity to restore the pattern on the newly synthesized strand for a faith-
ful maintenance of the epigenetic marks. This conceptually simple mechanism can 
explain the heritability of this particular epigenetic information through cell divi-
sion. We will see shortly that the molecular details are not quite as simple but the 


































2nd round DNA replication
Passive DNA demethylation
  . Fig. 1.8 A model for maintaining CpG methylation patterns in mammalian genomes. After a single 
round of  DNA replication, hemi-methylated DNA is generated. Restoration of  DNA methylation on 
the newly synthesized DNA strand leads to a heritable pattern of  DNA methylation. DNMT1 is an 
enzyme that is targeted to hemi-methylated substrates and has maintenance DNMT activity. The origi-
nal 5mC is not lost but unmethylated C is present in newly synthesized DNA. Hence, if  CpG methyla-
tion patterns are not restored after 2 rounds of  DNA replication, fully unmethylated (newly synthesized) 
DNA is expected (bottom). This leads to a loss of  epigenetic information by passive, replication-depen-
dent demethylation
Method Box 1.2: Analysis of DNA Modifications
DNA methylation can be detected by different methods. Bacterial restriction endo-
nucleases that are inhibited by cytosine methylation can be used to digest genomic 
DNA. Electrophoretic size separation and hybridization with complementary probes 
(Southern blot) reveals unmethylated DNA at a lower molecular weight than the 
methylated DNA, which remains undigested. PCR with gene-specific primers can 
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What would happen if  methylation does not take place, possibly because the 
DNMT enzyme is inactive or unavailable? Well, after another round of  cell divi-
sion, genomes would emerge that have completely lost DNA methylation from 
both strands and, hence, the corresponding epigenetic information (. Fig.  1.8). 
also be used to detect methylated DNA. When the endonuclease cuts the unmethyl-
ated template, no PCR product is obtained. Suitable controls are required as inter-
pretation relies on the completeness of  the enzymatic reaction. By using restriction 
enzymes that recognize the same sequence but are not inhibited by cytosine methyla-
tion, the digestibility of  the DNA can be confirmed. HpaII and MspI recognize 
CCGG, but only HpaII is inhibited by C5mCGG.
5mC can also be detected by antibodies. Similar to ChIP, methylated DNA is 
precipitated using 5mC-specific antibodies and can then be studied by a range of 
techniques including dot blots, PCR, and sequencing. Similar antisera have been 
developed for 5hmC. These antisera have further been used for immunofluorescence 
staining to observe the distribution of  DNA modifications in tissues and cells by 
microscopy techniques.
Bisulfite conversion allows to examine DNA methylation at single base resolu-
tion. Heating DNA in the presence of  bisulfite leads to deamination of  cytosine to 
uracil (. Box Fig. 1.2). Under suitable reaction conditions, the conversion of  5mC 
is not observed and, thus, cytosine remains unchanged. Sequencing of  the converted 
DNA shows unmethylated cytosines as thymines, so that methylation can be identi-
fied by comparison to a reference sequence.
Recently, nanopore sequencing and mass spectrometry have also been applied to 
detect and quantify DNA modifications.
Reaction conditions
do not allow the





















































  . Box Fig.  1.2 Analysis of  5mC by bisulfite conversion. a The reaction mechanism for the 
conversion of  cytosine to uracil in the presence of  bisulfite. b The conversion of  5mC to thymine 
is blocked under suitably chosen reaction conditions
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We would expect this to happen to half  of  all cells that have descended from the 
last ancestor with fully symmetric methylation. Further divisions would lead to 
increased loss as methylation patterns would not be restored and the only remain-
ing hemi-methylated DNA strands are the ones inherited from the last ancestral 
cell that was fully  methylated.
In mammalian genomes, CG nucleotides are observed in less than the expected 
frequency.8 As a consequence, long stretches of DNA contain 5mC at a relatively low 
density. To explain this observation, evolutionary erosion of methylated CG dinucle-
otides has been suggested. Deamination of cytosine leads to uracil that is recognized 
as an illicit base in DNA and is efficiently replaced. The deamination product of 
5mC is thymine, which is a valid base in DNA and might not be repaired and, thus, 
can become fixed. If  C to T mutations occur in the germline they can accumulate 
over evolutionary time and could explain the overall deficiency of CG dinucleotides 
in the genome of species with DNA methylation. This view is further supported by 
the observation that the unmethylated genome of D. melanogaster does not show a 
deficiency in CG dinucleotides.
Also in mammalian genomes, there are regions with the expected number of CG 
dinucleotides. These regions appear as islands of about 500–1000 bp of locally ele-
vated CG density compared to the majority of the genome. These CpG islands9 have 
been associated with gene promoters and are normally devoid of any 5mC. However, 
methylation of cytosines in CpG islands does occur in specific physiological contexts. 
CpG islands are methylated on the inactive X chromosome in female mammalian 
cells as a consequence of transcriptional repression (see book 7 Chap. 4 of Wutz). 
In addition, methylation of CpG island promoters of tumor suppressor genes is 
important in human tumors (see book 7 Chap. 8 of Santoro). It has been shown that 
loss of DNA methylation from the promoters of tumor suppressor genes can lead to 
their reactivation and cause cell cycle arrest and death of tumor cells. Therefore, 
DNMTs have been pursued as potential targets for treating human tumors (see book 
7 Chap. 8 by Santoro).
The physiological function of DNA methylation has been explored by reverse 
genetic analysis in mice. Mice possess three genes with catalytic DNMT activity. 
DNMT1 is considered the maintenance DNMT and catalyzes most of the replication- 
coupled cytosine methylation. This is the enzyme that we invoked in the simple mech-
anism for inheriting DNA methylation patterns earlier in this chapter. In addition, 
there are two enzymes, DNMT3A and DNMT3B, that are considered de novo 
DNMTs. These DNMTs are thought to newly establish DNA methylation patterns 
and are targeted by other factors to chromatin. All DNMTs possess characteristic 
sequence homology in their catalytic domains. In mice, DNMT1 and DNMT3B are 
essential for embryo development. Mutations of DNMT3B are also associated with 
the immunodeficiency, chromosomal instability, and facial abnormalities (ICF) syn-
drome in humans, suggesting a contribution of DNMT3 to centromere function and 
8 In a stretch of  mammalian DNA, fewer CGs occur than any of  the other possible dinucleotide 
combinations GC, AT, TA, AC, CA, AG, GA, CT, TC, GT, TG, AA, CC, GG, TT. In plants, CNG 
appears the sequence motif  instead of  CG. Like CG, CNG is symmetric on both DNA strands.
9 The term CpG islands, the “p” representing the phosphor-ribose linkage, is often used instead of 
CG islands to indicate that CpG dinucleotides and not CG base pairs are meant.
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genomic stability. Part of the defects caused by loss of DNMT1 are derepression of 
retrovirus-like genomic elements, so called intra-cisternal A-particles (IAPs). Loss of 
DNMT1 also causes cell death of differentiated cells but might be tolerated in trans-
formed cells to some extent. Surprisingly, early embryonic cells appear to tolerate a 
loss of DNA methylation. Studies have shown that DNA methylation is critical for 
gene regulation. In particular, gene regulation by genomic imprinting is intimately 
linked to cytosine methylation (see book 7 Chap. 5 of Grossniklaus).
Analyses of the effects of mutations on DNA methylation led to the identification 
of factors that are involved in the mammalian DNA methylation system. These 
include structural maintenance of chromosomes hinge domain 1 (SmcHD1), which 
contributes to DNA methylation and gene repression at promoters on the inactive X 
chromosome, the non-catalytic DNMT3L that acts together with DNMT3A in 
establishing DNA methylation patterns in the germline, and UHRF1 (also called 
NP95). UHRF1 is required for association of DNMT1 with the replication machin-
ery. UHRF1 contains a domain with specificity for hemi-methylated DNA. Further 
studies have led to the discovery that UHRF1 possesses catalytic activity and medi-
ates ubiquitinylation of histone H3 lysines 23 and 18. H3K23ub and/or H3K18ub 
recruit DNMT1 to DNA where it changes the hemi-methylated to a fully methylated 
pattern. It is interesting to note that histone modifications are an integral part of the 
maintenance pathway of DNA methylation patterns. We will see more overlap and 
crosstalk between DNA and histone modifications in the chapters throughout this 
book.
The methyl-group of 5mC is located in the major groove of the DNA double 
helix where it can be accessed by readers of DNA methylation. Protein domains have 
been identified that mediate specific binding to methylated or unmethylated 
DNA. UHRF1 contains such a domain for recognizing hemi-methylated DNA. A 
family of DNA-binding proteins contains a methyl-DNA binding (MDB) domain. 
In this family of proteins, methyl-cytosine binding protein 2 (MeCP2) specifically 
recognizes 5mC. The function of MeCP2 is not entirely clear but it appears to affect 
gene expression in a subtle way. Mutations affecting MeCP2 have been shown to 
cause RETT-syndrome in humans (. Table 1.1). RETT syndrome is named after its 
discoverer and characterizes a neurodevelopmental disorder. It mainly affects girls 
who initially appear to develop normally but, at about 1 year of age, regress and 
display neurologic symptoms that overlap with symptoms of autism. The mutation is 
in a heterozygous state and MeCP2 is located on the X chromosome. Due to random 
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X inactivation, only about half  of the patients’ cells lack MeCP2 expression whereas 
the other half  is phenotypically normal. It has been suggested that the presence of 
MeCP2-deficient cells might have a dominant effect disrupting brain functions, 
which is likely due to subtle changes in gene expression in neurons and glia cells. A 
mouse model has been established that recapitulates some neurological defects to 
study the disease mechanism. Experiments that allow the restoration of MeCP2 
function after symptoms have developed, suggest that neurologic phenotypes can be 
reversed (Guy et al. 2007). This finding has spurred efforts to reactivate the intact 
copy of MeCP2 in human patients where an intact copy of the gene resides on the 
inactive X chromosome. If  these approaches were successful and MeCP2 could be 
reactivated, possibly by removing DNA methylation, a treatment of this devastating 
disease could be found. However, caution is needed as the mouse model on which 
these hopes were based does not fully recapitulate all phenotypes that are observed 
in humans. Mice that lack MeCP2 completely are viable and show neurologic symp-
toms, whereas absence of MeCP2 in all cells is lethal in humans. Therefore, MeCP2 
mutations are generally not observed in males.
A second way how DNA methylation can affect gene expression is by preventing 
the recognition of binding sites by transcription factors. One might think of a steric 
hindrance by methyl groups that stick out into the major grove of a DNA segment 
containing a binding motif. The transcription factor CCCTC-binding factor (CTCF) 
recognizes a motif  containing cytosines that can be methylated. CTCF plays a role in 
chromatin organization and has been associated with the formation of chromatin 
boundaries and insulator function (see 7 Sect. 1.7.3 of this Chap., and book 
7 Chap. 5 of Grossniklaus). CTCF binding is blocked by DNA methylation, which 
can have profound consequences for the genomic region.
Studies of DNA methylation in mouse development have revealed that early 
embryos lose most of their DNA methylation at the blastocyst stage (see book 
7 Chap. 5 of Grossniklaus). Initially, the genomes of the gametes are characterized 
by substantial methylation, which is removed during the cleavage stages of preim-
plantation mouse development. Both active and passive (through DNA replication) 
demethylation mechanisms have been considered. It is interesting to note that the 
precise mechanism of enzymatic removal of 5mC from DNA has not yet been estab-
lished. It is thought that DNA repair pathways play a role as it appears impossible to 
chemically remove the methyl-group from 5mC without opening the pyrimidine ring 
system. This eraser mechanism is therefore different from mechanisms of erasing 
histone modifications and, thus, DNA methylation is considered a relatively stable 
epigenetic mark.
1.4.2  DNA Cytosine Hydroxymethylation
A fundamental advance in understanding DNA methylation in animal genomes has 
come from the discovery of a family of enzymes that convert 5mC in DNA. The ten 
eleven translocation (TET) family of proteins has three members in mice, TET1, 
TET2, and TET3. These are iron- and α-ketoglutarate-dependent dioxygenases that 
use molecular oxygen to oxidize the methyl-group of 5mC (. Fig.  1.9). The first 
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product of this oxidation is 5-hydroxy-methyl-cytosine (5hmC). Further oxidation 
converts 5hmC to 5-formyl-cytosine (5fC), and 5-carboxy-cytosine (5caC). It has 
been suggested that recognition and removal of these oxidation products by the base 
excision DNA repair machinery could be a mechanism for active demethylation of 
DNA. Additional roles for different cytosine modifications have been proposed in 
gene regulation, organization of nucleosomes, and the regulation of histone modifi-
cations. It is important to recognize that the substrate for generating any of these 
modifications is 5mC and, therefore, DNMTs are required. The dependence of some 
modifications on a preceding reaction is interesting as a more complex regulation of 
epigenetic information might be established similar to an “AND” gate in Boolean 
logic. However, whether this aspect is used by cells is presently unclear. Also, con-
straints for the system of DNA modifications come from the observation that DNA 
methylation is dispensable in some organisms (D. melanogaster and C. elegans), sug-
gesting that evolutionary important processes are not strongly dependent on it.
TET1 was initially discovered at the breakpoint of chromosomal translocations 
associated with leukemia and gave the family its name: ten-eleven-translocation. 
Mutation of Tet2 in mice leads to aberrant blood cell differentiation and leukemia- 
like phenotypes (see book 7 Chap. 8 of Santoro). These observations suggest a role 
of TET dioxygenases in the regulation of gene expression during cell differentiation. 
The function of Tet3 has been associated with the demethylation of the genome in 
mouse preimplantation embryos. TET3 is present in the oocyte as a maternally sup-
plied protein. After fertilization TET3 converts 5mC on the paternal, i.e., sperm- 
derived, genome to 5hmC.  In contrast, the maternal genome is protected and 
maintains 5mC in the zygote. This leads to a differential marking of maternal and 
paternal chromosomes by 5mC and 5hmC, respectively. Although, the differences are 
removed through the subsequent passive demethylation process during embryonic 
cleavage, it is important to note that parent-of-origin marking is initially genome- 
wide. This is surprising considering that only a small number of imprinted genes 















  . Fig. 1.9 Conversion of  5mC to 5hmC by TET dioxygenases. TET enzymes use oxygen to hydroxyl-
ate the methyl-group of  5mC. The reaction requires iron in oxidation state 2 [Fe(II)] and leads to the 
decarboxylation of  α-ketoglutarate to succinate
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1.4.3  Interaction of DNA and Histone Modifications
At first sight, the large number of chromatin modifications might appear daunting to 
comprehend. Conceptually, it can be helpful to see different modifications in the 
context of their biological functions. Thereby, the same chromatin modifications 
might be established by different enzymes and contribute to different molecular path-
ways. Biochemical studies have identified domains that recognize specific chromatin 
modifications and, thus, allow the prediction of successive modifications if  binding 
domains are part of enzymes. A number of rules can be considered to predict and 
describe the makeup and function of different states of chromatin.
CG-rich DNA appears to be recognized by the PcG complexes that establish 
H3K27me3 and H2AK119ub. Cytosine methylation of CpG islands prevents recruit-
ment, suggesting an antagonism between DNA methylation and PcG proteins, at 
least in CG-rich DNA. H3K27me3 has been shown to coexist with H3K4me3 that 
marks promoters. Such H3K27me3 and H3K4me3 doubly marked chromatin is con-
sidered to carry a “bivalent” mark, indicating that it has an ambivalent state between 
active and inactive. Yet, active promoters are acetylated on H3K27 and H3K27ac 
and H3K27me3 cannot coexist on the very same lysine. This logic suggests a  potential 
step for activation by blocking PcG activity through H3K27ac (see book 7 Chap. 3 
of Paro). Notably, H3K9me3 does not appear to occur together with H3K4me3, 
such that a strong anti-correlation is observed. At pericentric heterochromatin, 
H3K9me3 is paired with H4K20me3 as we have seen earlier in this chapter. In addi-
tion, it is correlated with H3K4me1. Preventing methylation of histone H3 lysine 4 
causes DNA de novo methylation. It has been shown that all mammalian DNMTs 
bind to H3K4 when it is unmodified. Binding leads to structural changes that acti-
vate de novo DNMT activity. In addition, DNMT3A and DNMT3B bind to 
H3K36me2 and H3K36me3 that are associated with the gene body of active genes. It 
is thought that DNA methylation within the transcription unit helps to prevent spu-
rious transcription initiation, thereby reducing transcriptional noise. Undoubtedly, 
future studies have to extend our understanding of functional pathways in chromatin 
but keeping a few general rules in mind is helpful to evaluate epigenomic data and to 
decipher its biological relevance.
1.5  Chromatin Organization and Compartmentalization 
in the Cell Nucleus
We have now taken a look at chromatin and identified molecular characteristics that 
can carry epigenetic information along the DNA sequence. This has led to the view 
of a highly functional structure of chromatin. We end this chapter with a brief  anal-
ysis of how chromatin is arranged in the cell nucleus. This aspect becomes important 
when one considers the large number of nucleosomes encompassing an animal 
genome. In the case of the diploid human genome, over 40 million nucleosomes will 
need to be assembled. This has implications of how genes can be identified and how 
transcription factors can bind to their recognition sites. Transport is not the only 
issue. The RNA polymerase II complex that transcribes most messenger RNAs exerts 
force on the DNA fiber. Transcribing in the order of 10,000 genes in a cell would lead 
to excessive movement within the nucleus. Observations from microscopy suggest 
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that chromatin maintains a relatively stable distribution. Discrete foci are observed 
from pericentric heterochromatin, with similar chromatin appearing to cluster 
together. Also, chromosomes appear to occupy discrete volumes within the cell 
nucleus, referred to as chromosome territories (CTs). Although different CTs are in 
close contact, there is very little mixing of the majority of the DNA from different 
chromosomes. These observations constitute evidence that the chromatin fiber is 
constrained and mechanisms exist that compartmentalize the nucleus.
Microscopy images of DNA-stained nuclei show the nucleoli as prominent struc-
tures (. Fig. 1.10). These are the locations where ribosomal RNA is transcribed by 
RNA polymerase I and the assembly of ribosomal subunits takes place. Nucleoli con-
tain RNA and ribosomes at different stages of assembly. As they contain little DNA, 
they stain weakly with DNA dyes and appear dark under the microscope. Nucleoli are 
bordered by a rim of heterochromatin called perinucleolar heterochromatin. 
Throughout the nucleus, DNA staining is distributed with different brightness corre-
sponding to nucleosome density. Notably, small holes appear throughout the DNA 
staining. These are channels within chromatin, which are thought to allow genes to be 
accessed by factors and transcripts to be transported (Markaki et  al. 2012). 
Connections of these channels to nuclear pores have been observed in super- resolution 
images, illustrating how mRNAs might be exported from the interior of the nucleus. 
Channels and gaps within chromatin are referred to as interchromatin compartment 
(IC). Collectively, these observations suggest that processes might take place on the 
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  . Fig. 1.10 Organization of  the cell nucleus. Super-resolution microscopy images of  the cell nucleus 
have been annotated with prominent structures and compartments. (Adapted from Markaki et  al. 
(2012))
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1.5.1  Replication of Pericentric Heterochromatin Domains
The use of 3D fluorescent in situ hybridization (FISH) with complementary DNA 
probes makes it possible to correlate nuclear sub-domains with repetitive sequences. 
Fluorescently labeled DNA probes can be used to detect minor and major satellite 
repeat DNA of the pericentric regions in fixed nuclei. These preparations can be 
further stained using antibodies for histone modifications. From such experiments, it 
could be concluded that the pericentric repeats are organized into chromatin domains 
that are stained homogenously by H3K9me3 antisera. Thus, microscopy showed that 
pericentric heterochromatin is indeed marked with certain histone modifications and 
associates with specific proteins as we discussed earlier in this chapter. Microscopy 
can also be useful to gain insights into how heterochromatin behaves during DNA 
replication. Newly synthesized DNA can be marked by incorporation of modified 
nucleotides such as bromo-deoxyuridine (BrdU), which can be visualized by specific 
antisera. Replication of pericentric repeats appears to take place at the outer border 
of the heterochromatin domain. The replicated DNA then associates again with the 
domain of heterochromatin. As we have seen earlier, pericentric heterochromatin 
recruits enzymes that catalyze histone modifications. It is, therefore, reasonable to 
predict that newly deposited histones on the replicated DNA will be targeted by his-
tone modifying activities that are resident in pericentric heterochromatin. Restoration 
of the characteristic chromatin marks is accomplished during S-phase and chromo-
somes with faithfully marked pericentric repeats can then be segregated in mitosis. 
Therefore, self-association of pericentric heterochromatin can be regarded as a 
mechanistic basis for the heritability of histone modifications. Although this is a 
plausible model, it is likely that the situation is more complex. Firstly, pericentric 
repeats are also subject to DNA methylation and, therefore, additional interactions 
might have to be taken into account to understand the mechanism. Secondly, it is 
presently not clear how self-association of pericentric chromatin is mediated and 
how it can be segregated from neighboring chromatin. Could it be an intrinsic prop-
erty of chromatin modifications? Are specific H3K9me3 binding proteins mediating 
self-association by cooperative binding mechanisms? Potentially, additional factors 
could be involved in this process (see book 7 Chap. 3 of Paro). Anchoring of chro-
matin at non-chromatin structures has been proposed, including a nuclear matrix or 
nuclear scaffold. However, the components of these conceptually plausible structures 
remain to be revealed.
1.5.2  Topologically Associating Domains
Even in images from super-resolution microscopy, which can resolve details of 
30–100 nm, a single voxel10 represents between 30 and 100 nucleosomes. Microscopy 
analysis is, therefore, on a different scale than our molecular understanding of  reg-
10 A voxel represents the smallest volume that can be resolved in a 3D image. It is defined in analogy 
to a pixel, which represents a dot of  a 2D picture.
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ulatory elements. A typical 1 kb long promoter would be assembled into 7 nucleo-
somes. To bridge this gap, new methods have been developed. Chromatin 
conformation capture techniques (3C to HiC) aim to identify DNA fragments that 
are in close proximity of  each other in the nucleus but might be far apart in the 
linear DNA sequence. The method preserves DNA contacts by cross-linking chro-
matin when it is in its native state in the cell (7 Method Box 1.3). Thereafter, chro-
matin is digested with restriction enzymes. Ligation of  the ends of  the cut DNA in 
very dilute conditions yields chimeric DNA fragments. DNA fragments that are 
frequently in close proximity in the nucleus have a higher probability to be cross-
linked in the same chromatin particle and, hence, show an elevated number of  chi-
meric fragments. Sequence determination of  the ligation products and plotting the 
number of  chimeric DNA fragments against their distance in the linear DNA 
sequence yields a contact frequency estimate. Using this approach, the in vivo 3D 
topology of  chromosomes has been investigated. From these studies it has become 
apparent that chromosomes are made up of  domains of  interacting chromatin that 
are partitioned by boundaries between them. Intervals with high internal contact 
frequencies are termed topologically associating domains (TADs, 7 Method 
Box 1.3). Although TADs might share regulatory elements and be co-regulated, it 
is important to realize that 3C and related techniques usually investigate a large 
number – several thousands to millions – of  cells and, therefore, only averages are 
observed. It is not always clear whether, in a given cell at a given time, all contacts 
take place. 3C techniques have been very successful in identifying gene regulatory 
elements such as enhancers that are located at a distance from their promoters but 
show a high contact frequency. Chromatin conformation data is, therefore, useful 
to determine regulatory interactions and possibly to identify genes that are coregu-
lated by certain cis-regulatory elements. Recently, chromatin conformation cap-
ture-based techniques have been extended to single cell analysis. This has further 
contributed to our understanding of  chromatin organization. From a study that 
used haploid G1 phase cells to make unambiguous assignments of  DNA sequence 
contacts, it has become clear that a general subnuclear arrangement is adopted in 
all cells (Stevens et al. 2017). A-compartments predominantly consist of  sequences 
that are correlated with active chromatin marks. These can be distinguished from 
B-compartments that contain largely inactive chromatin and frequently locate to 
the nuclear periphery. The precise winding and geometry of  the chromatin fiber is 
different in each cell. Therefore, chromatin in the nucleus is stochastically distrib-
uted at the smallest scale but becomes more deterministic as the scale increases. A 
potential mechanism for such a topology has been proposed as local self-organiza-
tion of  chromatin, whereby locally acting elements would affect chromatin struc-
ture in their proximity. The combined activity of  many elements would then result 
in the overall observed topology.
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1.5.3  Structural Maintenance of Chromosomes Complexes
The association of enhancers with gene promoters and the organization of TADs 
raises the expectation for mechanisms that facilitate the winding and bending of the 
chromatin fiber to achieve the observed topology. This aspect has been a long- standing 
question, which appeared difficult to answer for many years. Recent evidence illus-
trates a surprising and very powerful mechanism involving protein complexes of the 
structural maintenance of chromosomes (SMC) family. SMC proteins associate with 
chromatin and have important roles in chromosome condensation and segregation 
during mitosis. Two distinct SMC complexes have been identified, referred to as cohe-
sin and condensin complexes in anticipation of their function in mediating sister chro-
matid cohesion and condensation of mitotic chromosomes, respectively. SMC proteins 
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  . Box Fig. 1.3 Chromatin conformation capture. a The 3D organization of  chromatin is pre-
served by crosslinking protein complexes and DNA with formaldehyde. The DNA is then 
digested with nucleases into short fragments. Subsequent ligation of  DNA ends from fragments 
that are crosslinked facilitates the capture of  interactions between sequences that are distant in 
the linear sequence of  the genome but have been in close proximity in the nucleus. Sequencing 
of  the ligation products and analysis of  the frequency of  chimeric DNA can be used to calculate 
the frequency of  interaction between distant genomic regions. b Organization of  chromatin 
compartments in the nucleus (left) can be deduced from interaction frequencies. A matrix of 
color-coded interaction frequencies (middle) can visualize the interaction of  sequences in the 
genome. The diagonal line that runs from top left to right bottom represents interactions of 
regions that are in close proximity in the DNA sequence and are, thus, closely linked by the 
DNA backbone. Topological associated domains (TADs) (right) are confined by borders that 
limit interactions. High frequencies of  interactions are observed within TADs and little interac-
tions are observed outside. Cohesin complexes have been associated with TAD borders. Sche-
matic representation of  A and B compartments is also shown
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contain ATPase head domains that can hydrolyze ATP to exert motor function. 
Reconstituted recombinant condensin complexes (containing SMC1 and SMC3) have 
the ability to induce changes in the topology of fluorescently marked DNA molecules. 
This observation has been made in sophisticated microscopy-based biochemical assays 
(Ganji et al. 2018). DNA loops were formed when DNA fragments were incubated 
with condensin complexes and ATP. A similar function has subsequently been observed 
for a recombinant human cohesin complex (containing SMC2 and SMC4), when 
additional cohesin-associated factors were present (Kim et  al. 2019). These experi-
ments suggest the SMC family as important regulators of chromatin topology.
Cohesins have a role in the cell cycle where they mediate the cohesion of sister 
chromatids after replication of the chromosomal DNA until segregation at mitosis. 
In addition, cohesins have been found to be involved in gene regulation. Cohesins are 
loaded on chromatin in interphase and likely can slide along the chromatin fiber, 
mediating loop formation. Some chromatin loops correlate with the presence of 
CTCF sites at the loop base (7 Method Box 1.3). CTCF binds sequences that are 
asymmetric and, therefore, have an orientation. CTCF sites at the base of chromatin 
loops are oriented towards each other, suggesting that CTCF might act in a direc-
tional manner to block cohesin sliding. A number of TAD boundaries can be 
correlated with CTCF binding sites. In addition, other molecules can also contribute 
to the localization of cohesins and possibly other SMC complexes. Therefore, the 
recent discovery of the DNA motor function of SMC complexes suggests a funda-
mental mechanism for establishing DNA topology at a larger scale that will certainly 
continue to attract attention in the future (Banigan and Mirny 2020).
Take-Home Message
 5 Chromatin organizes the genome of eukaryotic cells into a nucleosomal structure 
that facilitates the imposition of epigenetic information and assists in regulating 
the DNA sequence.
 5 The nucleosomal structure can be modified through histone variants, posttransla-
tional histone modifications, and DNA modifications that act combinatorically 
and synergistically.
 5 Specific enzymes that establish histone modifications can be considered writers of 
epigenetic information. Conversely, readers are proteins with affinity for histone 
marks that can recruit protein complexes with additional functions to chromatin. 
Erasers are enzymes that remove chromatin marks and, thus, ensure that epigene-
tic information is reversible.
 5 Folding of the linear DNA in the nucleus facilitates the compartmentalization of 
chromatin into domains with different functional properties.
 5 Chromosomes are not randomly distributed but are organized into discrete vol-
umes called chromosome territories, whereby separation of active A and repressed 
B compartments can be observed.
 5 Modifications of chromatin structure and chromatin topology both contribute to 
establishing information along the sequence of the DNA that regulates the func-
tion of distinct genomic regions.
 5 The understanding of nuclear pathways for chromatin regulation is a basis for the 
consideration of epigenetic mechanisms that will further be discussed in following 
chapters.
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What You Will Learn in This Chapter
The nucleus of a eukaryotic cell is a very busy place. Not only during replication of the 
DNA, but at any time in the cell cycle specific enzymes need access to genetic information 
to process reactions such as transcription and DNA repair. Yet, the nucleosomal structure 
of chromatin is primarily inhibitory to these processes and needs to be resolved in a highly 
orchestrated manner to allow developmental, organismal, and cell type-specific nuclear 
activities. This chapter explains how nucleosomes organize and structure the genome by 
interacting with specific DNA sequences. Variants of canonical histones can change the 
stability of the nucleosomal structure and also provide additional epigenetic layers of 
information. Chromatin remodeling complexes work locally to alter the regular beads-on- 
a-string organization and provide access to transcription and other DNA processing fac-
tors. Conversely, factors like histone chaperones and highly precise templating and copying 
mechanisms are required for the reassembly of nucleosomes and reestablishment of the 
epigenetic landscape after passage of activities processing DNA sequence information. A 
very intricate molecular machinery ensures a highly dynamic yet heritable chromatin tem-
plate.
2.1  Basic Nuclear Activities
The eukaryotic genome is packaged into a nucleosomal beads-on-a-string architec-
ture (see book 7 Chap. 1 of Wutz). This allows the long but thin DNA fiber to be 
protected, condensed, and organized in the cell nucleus. For example, tight packag-
ing of the genome is used actively to suppress deleterious sequences to become mobi-
lized, like transposable or retroviral elements. However, DNA acts as a template for 
a number of nuclear processes which require access to the genetic information and, 
thus, an open chromatin conformation. Some of the associated enzymes use, for 
example, the sequence of a DNA strand to accomplish their work. However, nucleo-
somal DNA is double-stranded requiring that the DNA fiber be freed from histone 
packaging before these nuclear activities can be carried out. A number of mecha-
nisms evolved to counter the primarily repressive nature of the nucleosome, permit-
ting flexible and responsive nuclear activities.
A prime example in this respect is the process of transcription. The eukaryotic cell 
has three RNA polymerases, which are distinguished by the RNA products they pro-
duce. Their mode of action is similar, though, requiring the sequence information 
provided by an open DNA strand to synthesize the complementary RNA molecule 
(Cramer 2019). Before this process can start, gene activation mechanisms ensure that 
particular transcription factors (TFs) can access their specific target sequences, fur-
ther requiring a remodeling of the protective nucleosomal structure at their sites of 
action, like enhancers. Similarly, during the process of elongation, the RNA poly-
merase complex encounters a nucleosomal structure, which needs not only to be 
removed for the synthesis of the transcript but also reassembled in an epigenetically 
conform manner after passage. All these steps are in conflict with the primarily static 
interaction of DNA and histones and require a dynamic chromatin structure 
responding to external signals, enzymatic processing, and mechanical forces.
The process of DNA replication uses the activity of DNA polymerases templating 
on single-stranded DNA the production of an exact copy of the genetic material 
(Hammond et al. 2017). As such, sites of origins, where replication starts, have to be 
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freed of nucleosomes to allow the factors to bind DNA and assemble the replication 
machinery. Nucleosomes are removed ahead of the advancing replication fork and 
reassembled behind the site of replication. In addition, histone modifications, DNA 
methylation, and other chromatin associated factors are reestablished to maintain 
the epigenetic landscape. Indeed, at the replication site, two distinct mechanisms of 
epigenetic inheritance are taking place, of which we do understand one very well. 
The beauty of the complementary DNA structure revealed immediately how this 
molecule can self-template its own copy. Conversely, we know much less about how 
heritable epigenetic information is duplicated and faithfully replaced after passage of 
the replication fork. While we understand comparatively well the duplication of 
DNA methylation patterns on newly synthesized DNA (see book 7 Chap. 1 of 
Wutz), we still lack a similarly comprehensive understanding of how protein-encoded 
information, including histone marks and histone variants is maintained in a herita-
ble manner.
Other nuclear processes like DNA repair or recombination require the alignment 
of DNA sequences and, hence, a local removal of nucleosomal structures. Dedicated 
processes ensure fast repair of open damaged sites and the search factors required to 
align complementary genome sections for sequence exchange (Papamichos- 
Chronakis and Peterson 2013; Misteli and Soutoglou 2009).
Still other nuclear processes like the addition of telomere sequences to the end of 
chromosomes, the generation of anchoring points for the segregation of chromo-
somes, or the silencing of transposable or repeat elements in heterochromatic 
sequences are dependent on specific chromatin structures for their functional perfor-
mance. This shows that chromatin needs to be dynamically regulated to support 
nuclear processes during the cell cycle in a predictable and reliable manner. The 
dampening nature of nucleosomes has also a positive effect, however. Transcription 
factors have many more presumptive binding sites in the genome than are observed 
in vivo. In combination with highly processive enzymes like RNA polymerase II, this 
can result in spurious and unwanted genome transcription. Such “expression noise” 
is kept in check by the nucleosomal packaging and only regulated chromatin acces-
sibility will allow the basic nuclear processes to trigger their activities at the specific 
and required sites in the genome.
2.2  Connecting Nucleosomes to DNA Sequence
As packaging entities for an entire genome, it is clear that histones cannot rely on a 
similar DNA sequence-specificity as transcription factors. Nevertheless, as a nucleo-
somal unit, histone proteins are intimately interacting with the DNA that bends 
around the histone core. This can only be achieved through distinctive chemical 
interactions between the nucleic acid and the histones. As such, nucleosome assembly 
is thermodynamically preferred for some sequences in comparison to others, suggest-
ing that chromatin architecture is governed by the sequence of the genome (Parmar 
and Padinhateeri 2020; Hughes and Rando 2014; Struhl and Segal 2013). Certain 
sequence determinants, like particular dinucleotides, affect DNA bending and, in 
consequence, nucleosome formation. Optimal nucleosome formation occurs when 
bendable dinucleotides (AT and TA) occur on the face of the helical repeat (approxi-
mately every 10 bp) that directly interacts with histones (. Fig. 2.1).
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The exact position of the histone octamer with respect to the 10-bp helical repeat 
of the DNA double helix is termed ‘rotational positioning’ and, thus, sequence is a 
critical determinant for the assembly of the nucleosome. However, protein-DNA 
interactions are not only recognizing base readout but are also dependent on the 
local shape structure of the DNA fiber, which is determined by the local sequence of 
bases (Rohs et al. 2010). Local kinks in the DNA fiber or variable width of the minor 
groove influence the efficiency of nucleosome build-up. Conversely, some homopoly-
meric sequences like poly(dA:dT) and poly(dG:dC) are rather stiff  and are strongly 
inhibitory to nucleosome formation. Such sequences are often found at positions 
where nucleosome presence is reduced to allow transcription factors or polymerases 
access to enhancers or promoters, respectively. Hence, a combination of positively 
and negatively acting DNA sequences has a strong impact on the positioning of 
nucleosomes in the genome. Indeed, this information allowed predicting fairly accu-
rately the position of nucleosomes in the yeast genome by computational methods. 
Similar attempts for more complex genomes have failed, probably because other fac-
tors might strongly influence the assembly and positioning of nucleosomes (see 
below). This indicates that sequence-dependent effects might be less important for 
nucleosome positioning in higher organisms.
In addition to a local interdependence between DNA sequence and nucleosome 
position, a number of DNA regulatory elements with a strong impact on large-scale 
a b
  . Fig. 2.1 Sequence determining nucleosomal position. a Nucleosome sequence preferences. Within 
the 147 bp that are wrapped around the histone octamer, there is a preference for distinctive dinucleo-
tides that recur periodically at the DNA helical repeat and are known to facilitate the sharp bending of 
DNA around the nucleosome. These include ~10-bp periodic AA, TT, or TA dinucleotides that oscillate 
in phase with each other and out of  phase with ~10-bp periodic GC dinucleotides. The linker regions 
exhibit a strong preference for sequences that resist DNA bending and, thus, disfavor nucleosome for-
mation. Among these, poly(dA:dT) tracts and their variants are the most dominant and highly enriched 
in eukaryotic promoters. b Determinants of  nucleosome positioning. (top) Nucleosome- depleted 
regions (NDRs) are generated either by poly(dA:dT) tracts and/or by transcription factors and the 
nucleosome remodeling complexes they recruit (see below). Gray circles indicate nucleosomes. (middle) 
Nucleosomes located at highly preferred positions (black circles) flanking the NDR are generated by 
nucleosome-remodeling complexes (for example, Isw2 and RSC, likely in a transcription- independent 
manner), and fine-tuned by the Pol II preinitiation complex (PIC) and associated factors. (bottom) 
Positioning of  the more downstream nucleosomes depends on transcriptional elongation as well as the 
recruitment of  nucleosome-remodeling activities (for example, Chd1 and Isw1) and histone chaperones 
by the elongating Pol II machinery. (From Struhl and Segal (2013))
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chromatin conformations have evolved. Highly repressed chromatin, like heterochro-
matin, is built by multiprotein complexes with a strong polymerization activity. They 
package the nucleosomal fiber over an extended chromosomal region into a condensed 
and regular arrangement (see book 7 Chap. 1 of Wutz). Heterochromatic regions do 
not only show a local regular array of condensed nucleosomes but also a clustering in 
the 3D space of the nucleus. This highly repressive structure can potentially immerse 
nearby active genes. The propensity of heterochromatin to spread along the chromo-
some can be observed in position effect variegation (PEV). After chromosomal trans-
locations, repressive heterochromatin can “spread” into regions with euchromatic 
genes inhibiting their normal regulated activity. Normally, the presence of regulatory 
elements, termed boundary elements or insulators, restrains this expansive behavior of 
heterochromatin (Valenzuela and Kamakaka 2006). In cases where these insulators 
are lost, a stochastic spreading of heterochromatin in neighboring euchromatic genes 
can be observed, resulting in a variable expression of these genes.
However, also at the local level, different chromatin domains and gene regulatory 
units need to be appropriately controlled such that they can exert their function not 
over the linear dimension of the DNA fiber but in the true 3D space of the nucleus. 
At complex genetic loci, such insulator elements regulate the tissue-specific and 
developmental-specific interaction of distant enhancer elements with their corre-
sponding promoter region. Additionally, such elements prevent the spreading of 
repressive chromatin, like PcG-chromatin (see 7 Chap. 3 of Paro), into neighboring 
active expression domains. Technically, this knowledge can be used by flanking a 
transgene with insulator elements generating a functionally independent domain 
protected from position effects at the insertion site of the transgene. Appropriate 
regulatory signaling can occur within the insulated-flanked domain as the insulators 
prevent accidental external chromatin interactions.
Factors like sequence-specific CTCF bound to insulators do not only organize the 
local chromatin interactions, but, in conjunction with other chromatin-associated 
elements like cohesins, are also involved in large-scale chromatin loop formation or 
coordination of topologically associated domains (TADs; see book 7 Chap. 1 of 
Wutz)(Chen and Lei 2019; Pisignano et  al. 2019). Hence, at many points in the 
genome the DNA sequence plays, through specific DNA-protein interactions, an 
important structuring role in organizing chromatin and, consequently, contribute to 
the epigenetic landscape. Since every cell of a defined organism contains the same 
DNA, the question is how this apparent rigid structure of chromatin, nevertheless, 
permits a highly dynamic environment for the regulation of basic nuclear activities in 
a cell-type specific manner. In the next section of this Chapter, we will discuss how 
nucleosome positioning is regulated.
2.3  Nucleosome Remodeling
2.3.1  A Template for Transcription
This nuclear process transcribes RNAs from genes that are located in different 
regions of the genomic templates. These transcription units range from ribosomal 
RNAs, tRNAs, and mRNAs to the newly discovered miRNAs and long non-coding 
RNAs that are involved in distinct biological processes. In all cases, the process of 
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transcription is tightly controlled in a temporal and spatial manner. RNA polymer-
ases have to pass through three phases: initiation, elongation, and termination 
(Cramer 2019). The initiation phase involves recognition of a promoter DNA 
sequence, opening of DNA strands, and synthesis of a short initial RNA oligomer 
(Cairns 2009). During the elongation phase, the polymerase uses the DNA template 
to synthesize the growing RNA chain in a processive manner. Finally, DNA and 
RNA are released during termination, and the polymerase can then be recycled and 
re-initiate transcription. This entire process is reflected in a characteristic arrange-
ment of nucleosomes and accompanying histone modifications at the transcription 
unit. The promoter region is devoid of nucleosomes while the downstream region 
exerts  regularly phased nucleosomes as a consequence of the repeated passage of the 
polymerase complex (. Fig. 2.1c, d).
Biochemically, the sequence of events can be ideally studied at an inducible gene, 
for example, a target gene activated by a nuclear hormone receptor (. Fig.  2.2). 
Under such conditions, the process can be started and analyzed in a synchronous 
manner by the addition of a hormone to a tissue culture. After hormone binding, the 
nuclear receptor dimerizes and enters the nucleus. With the help of accessory factors, 
it can bind to its DNA recognition site even in a nucleosomal context. To open chro-
matin structures, in a next step, remodeling factors are attracted (see book 7 Chap. 1 
of Wutz and below). The unwound DNA can be bound by general TFs and, conse-
quently, the transcriptional preinitiation complex can be loaded onto the promoter.
In many instances the cofactor SAGA is a multifunctional complex that facili-
tates transcription initiation in the context of chromatin. The TFIID complex also 
acts as a cofactor that is involved in promoter recognition. Both SAGA and TFIID 
can deliver the TATA box-binding protein (TBP) to promoters and stimulate assem-
bly of the preinitiation complex. Eukaryotic RNA polymerases require a number of 
general transcription factors for initiation. Assembly of the polymerase on promot-
ers to form a pre-initiation complex, for example, requires the general transcription 
factors TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH. In the case of Pol II, TFs 
do not target the polymerase directly but, rather, through interactions with cofactors, 
like the multiprotein complex Mediator. After DNA opening, the DNA template 
strand transitions into the active center of the polymerase. The template strand then 
directs de novo RNA chain initiation without the use of a priming oligonucleotide. 
Extension of the RNA to a critical length eventually triggers disassembly of the pre- 
initiation complex, escape of the polymerase from the promoter, and formation of a 
stable elongation complex.
The Pol II elongation complex often pauses downstream of the transcription 
start site (Gaertner and Zeitlinger 2014; Adelman and Lis 2012). Paused Pol II can 
be stabilized by the elongation factors DSIF and NELF but may also terminate 
(. Fig. 2.3). Upon an additional positive signal, Pol II is released from pausing into 
active elongation by the kinase positive transcription elongation factor, (P-TEFb). 
P-TEFb phosphorylates Pol II, DRB sensitivity-inducing factor (DSIF), and nega-
tive elongation factor (NELF), and this leads to dissociation of NELF and recruit-
ment of elongation factors that stimulate Pol II progression. A number of epigenetic 
processes control transcription directly at the site of paused Pol II. Silencing by the 
Polycomb group (PcG) proteins (see book 7 Chap. 3 of Paro) is the result of an inhi-
bition of elongation by repressory PcG complexes. Transcriptional elongation is 
coupled to the processing of nascent RNA.  This coupling requires the so-called 
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  . Fig. 2.2 Key transition points during hormone signaling. After ligand binding, glucocorticoid 
receptor (GR) dimerizes, enters the nucleus, and binds target sequences such as the Glucocorticoid 
Response Element (GRE) within chromatin. The receptor binds co-regulators, such as NcoA1/SRC-1, 
NCoA2/TIF-2/GRP-1, and CBP/p300, which do not require remodeling to engage the receptor at the 
promoter. In the following step, these factors attract directly the BRG1 nucleosome remodeling complex 
SWI/SNF to the promoter leading to the formation of  a nucleosome free region. This allows transcrip-
tion factors such as NF1 and the octamer transcription factors (OTFs) as well as the TATA-binding 
protein (TBP) to engage with the promoter. Finally, mediator proteins are recruited and the preinitia-
tion complex forms, leading to transcription by RNA Pol II. (From King et al. (2012))
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C-terminal repeat domain (CTD). During elongation, the CTD is highly phosphory-
lated and recruits factors for post-transcriptional processing, like pre-mRNA 
 capping, splicing, and also enzymes that modify histones. Indeed, the chromatin 
landscape at a gene appears to have a profound impact on post-transcriptional events 
and influences for example the specificity of splicing events. At the end of the tran-
scribed region, Pol II transcribes the poly-adenylation site, which results in cleavage 
of the nascent RNA transcript and maturation of the mRNA.
At every point of the transcription cycle, the factors described above interact with 
a chromatin template and, therefore, require additional activities of partners to make 
DNA more accessible. Pioneer TFs can recognize their cognate DNA binding 
sequence in a nucleosomal context and open up chromatin by attracting histone acet-
ylase complexes like SAGA that locally destabilize repressive nucleosomal structures. 
However, to make DNA accessible over an extended region, as required for example 
for the assembly of the large transcriptional pre-initiation complex, an energy depen-
dent machinery in the form of ATP-dependent chromatin remodeling complexes is 
necessary.
2.3.2  Chromatin Remodeling Complexes
The process of remodeling involves reconfiguring the histone-DNA interactions 
either by disrupting, reassembling, or moving nucleosomes (Sundaramoorthy 2019). 
Enzymes known as ATP-dependent chromatin remodeling complexes are capable of 
generating changes by binding to a single nucleosome and reconfiguring it through 
utilizing the energy obtained from hydrolyzing ATP.  Remodelers can (i) mediate 
nucleosome sliding in which the nucleosome position on DNA moves in either direc-
tion, (ii) generate access for TFs whereby histones remain bound but DNA becomes 
  . Fig. 2.3 Establishment and release of paused RNA polymerase II. The promoter region is shown with 
the transcription start site (TSS). Factors that are involved in the establishment or release of paused Pol 
II, such as DRB sensitivity-inducing factor (DSIF; purple pentagon), negative elongation factor (NELF; 
orange oval), and positive transcription elongation factor b (P-TEFb; green diamond), are indicated. a 
Promoter opening often involves binding a sequence-specific transcription factor (shown here as TF1) that 
brings in chromatin remodelers to remove nucleosomes from around the TSS and to render the promoter 
accessible for recruitment of the transcription machinery. b Pre-initiation complex formation involves the 
recruitment of a set of general transcription factors (GTFs) and Pol II, which is also facilitated by binding 
specific transcription factors (also shown as TF1 for simplicity). This step precedes the initiation of RNA 
synthesis. c Pol II pausing occurs shortly after transcription initiation and involves the association of 
pausing factors DRB sensitivity-inducing factor (DSIF) and negative elongation factor (NELF). The 
paused Pol II is phosphorylated on its carboxy-terminal heptapeptide repeat domain (CTD). The region 
in which pausing takes place is indicated in the figure. d Pause release is triggered by the recruitment of the 
positive transcription elongation factor b (P-TEFb kinase), either directly or indirectly by a transcription 
factor (shown here as TF2). P-TEFb kinase phosphorylates the DSIF–NELF complex to release paused 
Pol II and also targets the CTD. Phosphorylation of DSIF–NELF dissociates NELF from the elongation 
complex and transforms DSIF into a positive elongation factor that associates with Pol II throughout the 
gene. e In the presence of both TF1 and TF2, escape of the paused Pol II into productive elongation is 
rapidly followed by entry of another Pol II into the pause site, allowing for efficient RNA production. 
When the gene is activated, some nucleosome disruption is likely, as depicted by the lighter coloring of the 
downstream nucleosome. (From Adelman and Lis (2012))
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more accessible, (iii) induce eviction of the histone octamer, and (iv) replace a core 
histone with a variant histone (. Fig. 2.4) (Lorch and Kornberg 2017; Clapier and 
Cairns 2009). The general importance of these processes is also evident by the fact 
that components of chromatin remodeling complexes are found to be frequently 
mutated in cancers (see book 7 Chap. 8 of Santoro).
A shared property of this wide variety of effects rests on a common enzymatic 
function; an ATP-dependent DNA translocase activity that is utilized to break the 
histone- DNA contacts. This activity is carried out by an evolutionarily conserved 
catalytic core ATPase subunit. This remodeler ATPase subunit adopts a fold typical 
of the much larger superfamily 2 (SF2) DNA/RNA helicases and translocases. 
Analogous to SF2 family DNA translocases, the remodeler ATPase contains several 
highly conserved motifs, including WALKER A/B motifs, a DNA-binding cleft, and 
a site of ATP-binding that are all important for the DNA translocation activity. The 
ATPase of the remodeler differs from the SF2 DNA translocases in that they have 
much higher affinity for nucleosomes compared to naked DNA.  An interesting 
aspect that emerged from the recently resolved CryoEM structures of various 
remodeler- nucleosome complexes is that remodelers unwrap outer turns of DNA 
from the nucleosome. This is a key step to minimize the number of histone-DNA 
contacts and maximize the output from ATP hydrolysis (. Fig. 2.5). Based on the 

















  . Fig. 2.4 The activities of  chromatin remodeling complexes. Remodelers support assembly of  a regu-
lar chromatin template by sliding deposited nucleosome and thereby providing space for new nucleo-
somes. Remodelers can make a binding site for a TF accessible by moving nucleosomes to the side 
(repositioning), by ejecting a complete nucleosome (eviction) or by partially freeing the DNA (unwrap-
ping). In addition, remodelers can change the local composition of  nucleosomes by ejecting a dimer or 
replacing histone dimers with corresponding variant forms (dimer exchange)
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ATPase function and defining its selectivity for nucleosomal substrates, the family of 
Snf2 ATPases is grouped into four different classes: SWI/SNF, ISWI, CHD/Mi-2, 
and INO80-SWR1.
SWI/SNF remodelers are regulators involved in a wide range of gene control pro-
cesses in all cell types. Composed typically of 9–14 subunits, at least two forms of 
SWI/SNF-specific Snf2 ATPases are present in most cell types with well- conserved 
signature domains: an acetyl lysine-binding bromo domain, a helicase- related SANT 
domain that binds actin-related protein (ARP), and the SF2 family helicase domain. 
In Saccharomyces cerevisiae, these two forms are termed as SWI- SNF (contains 
ATPase Swi2, also called Snf2) and RSC (contains ATPase Sth1). SWI/SNF com-
plexes can oppose epigenetic silencing by PcG proteins (see book 7 Chap. 3 of Paro). 
In Drosophila melanogaster, PcG proteins were shown to maintain repression of Hox 
genes during embryogenesis, while the SWI/SNF complex promotes Hox gene acti-
vation. In mammalian cells, the SWI/SNF complexes are generally grouped into two 
types of complexes: hBAF complexes containing ATPase BRG1 or BRM and several 
alternate core subunits such as ARID1A or ARID1B and hPBAF (polybromo-asso-
ciated BAF) complexes containing the BRG1 ATPase associated with factors such as 
PBRM1 and ARID2. Both are essential for cell survival and involved in a number of 
transcriptional processes.
The ISWI (imitation switch) remodelers were initially identified in Drosophila and 
then subsequently observed in other species like yeast, Xenopus, and human. In 
Drosophila, the complex exists in at least four forms: ACF, NURF, CHRAC, and 
RSF. All four of these complexes possess the same ATPase protein ISWI but contain 
different associated subunits, which are likely important for specialized remodeler 
functions. In yeast S. cerevisiae, there are two distinct ISWI complexes, ISW1 and 
  . Fig. 2.5 Model of  INO80 nucleosome remodeling. The functional architecture of  INO80 with 
motor (ATPase, red), grip (Arp complex, green) and grappler (orange) suggests that processive nucleo-
some sliding proceeds via a ratchet mechanism. Transient generation of  loops between the motor and 
the grip could expose H2A–H2B for editing. Direct binding of  H2A–H2B by the grappler sensorfoot 
could regulate variant- or modification-specific editing. (From Eustermann et al. (2018))
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ISW2. Mammals have two homologs of ISWI, SNF2L (encoded by the SMARCA1 
gene) and SNF2H (encoded by the SMARCA5 gene). In mammals, five ISWI com-
plexes have been identified: ACF, CHRAC, WICH, RSF, and NoRC.  ISWI com-
plexes are typically heterodimers and composed of an ISWI protein (SNF2H or 
SNF2L) and another subunit that provides specific biological processes. The ISWI 
remodelers generate regularly spaced nucleosomal arrays, facilitating the deposition 
of histones onto DNA and participating in replication progression and transcrip-
tional repression.
The members of  the chromodomain-helicase-DNA-binding domain (CHD) fam-
ily are characterized by the presence of  tandem chromodomains in the N-terminal 
region of  the ATPase and a C-terminal DNA-binding domain. This highly con-
served family is divided into three subfamilies based on the presence of  additional 
protein domains. The first subfamily is defined by an additional DNA-binding 
domain located in the C-terminal region. This subfamily consists of  the S. cerevisiae 
Chd1, the only CHD family member in yeast, as well as Chd1 and Chd2 in higher 
eukaryotes. The second subfamily includes the proteins Chd3 and Chd4 as well as 
Drosophila Mi-2, which are characterized by the presence of  an additional 
N-terminal PHD domain. Members of  the second subfamily are typically part of 
large multi- subunit complexes having besides chromatin remodeling functions, also 
histone deacetylation activities. The third subfamily contains the proteins Chd5–
Chd9 and is characterized by additional functional motives in the C-terminal 
region, including paired BRK domains, a SANT-like domain, chromo domains, 
and a DNA-binding domain.
The remodelers of the INO80 family are the most recently identified remodeling 
complexes. The multi-subunit INO80 (Inositol 80) and SWR1 (Sick with Rat8) are 
the subfamily members of the INO80 family. INO80 regulates gene expression, DNA 
repair and replication by sliding nucleosomes, the exchange of histone H2A.Z with 
H2A, and the positioning of + 1 and −1 nucleosomes at promoter DNA.  Recent 
cryo-EM studies resolved the interaction sites of INO80 with a nucleosome (see 
. Fig. 2.5) (Eustermann et al. 2018). Their analyses suggest a ratchet-like mecha-
nism for how INO80 slides and possibly edits nucleosomes. INO80 unwraps and 
grips DNA and histones by multivalent interactions. The motor is positioned to 
pump DNA into the nucleosome against the Arp complex, which could hold onto 
DNA until a sufficient force is generated by multiple small steps of the motor. Such 
a tracking mechanism might create a DNA loop between the motor and the Arp 
complex. As a result, INO80 would move nucleosomes in larger steps of 10–20 bp. 
The proposed ratchet mechanism explains DNA loop formation that results in large 
translocation steps, as well as the means for ATP-dependent H2A.Z → H2A exchange. 
The motor, stator and multivalent grip of INO80 enable highly processive sliding 
without release and large-scale reconfigurations such as editing while keeping the 
remainder of the nucleosome intact.
Central to each of these remodeler families is the ATPase domain that conducts 
DNA translocase activity through ATP hydrolysis. Accessory domains within the 
ATPase and auxiliary subunits in a multi-subunit remodeler finetune the ATPase 
activity to the desired outcome of nucleosome remodeling. Hence, not only 
 transcriptional processes require the moving capacity of the remodelers but all basic 
nuclear processes depend in one form or the other on this powerful competence to 
free DNA.
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Methods Box 2.1: Determining DNA Accessibility in a Chromatin Template
As described in this chapter, the regulated access to the DNA template is a prerequi-
site for many nuclear enzymatic processes. In reverse, the appearance of  accessible 
sites in chromatin could pinpoint to regions of  regulation or active genomic process-
ing. To this purpose, nuclei are treated with limited concentrations of  nucleases like 
DNase I or micrococcal nuclease. Given the appropriate conditions, these enzymes 
will only cut exposed DNA but not DNA wrapped around histones or packaged in 
condensed or silenced nucleosomal structures like heterochromatin. Originally, open 
chromatin regions, termed DNase hypersensitive sites, could be determined at single 
genes. For example, after hormone induction, the chromatin rearrangements at the 
nuclear hormone binding sites and the accompanying changes at the promoter could 
be visualized by the appearance, over time, of  DNase hypersensitive sites. 
Experimentally, after hormone induction of  the cells in culture, the nuclei would be 
isolated and treated with nucleases under limiting conditions. The reaction would be 
stopped, the DNA isolated, its size further reduced with specific restriction enzymes, 
and eventually separated on an agarose gel. Hybridization with probes encompass-
ing the boundaries of  the gene would reveal the sites at which the nuclease attack had 
reduced the original size of  the restriction fragment. Comparison of  hypersensitive 
sites from uninduced and induced cells could provide not only information about the 
potential location of  regulatory sites and produce co-called “DNase footprints” but 
also give clues about how fast chromatin is opening to permit the associated nuclear 
process (. Box Fig. 2.1).
In the meantime, recognition of  hypersensitive sites can be achieved on a genome- 
wide scale. While the initial steps of  limited nuclease attack to open chromatin con-
formations remains principally the same, the subsequent site recognition utilizes new 
high-throughput sequencing technologies. After nuclease digestion, fragments of  dif-
ferent sizes appear; while nucleosome-packaged DNA, in general, produces larger 
fragments, regions with open chromatin or nucleosome depleted regions are cut more 
often, resulting in smaller fragments. Hence, a local high frequency of  smaller frag-
ments is an indication for a hypersensitive site in the genome.
A further improvement was achieved with ATAC-Seq (Assay for Transposase- 
Accessible Chromatin using Sequencing). Instead of  DNase I, a mutated form of  a 
transposase, Tn5, is used to fragment the chromatin. This enzyme not only cleaves 
DNA but also tags the resulting double-stranded DNA fragment with sequencing 
adaptors, which can be amplified by PCR and subjected to high-throughput sequenc-
ing. Also in this case, the number of  reads for a region correlates with how open that 
chromatin region is. The method has the advantage that much less starting material, 
compared to the other described methods, is required. Overall, the method needs less 
time as fewer steps are required and tricky enzyme titrations are not necessary.
These methods have provided substantial insight into how chromatin “breathes” 
under specific physiological conditions, presenting a direct readout for chromatin 
dynamics. In all cases, however, the approach is dependent on nucleases which have an 
inherent albeit low DNA sequence specificity. This could result in preferential site 
cleavage, which is not solely governed by the chromatin structure. These caveats have 
to be considered when generating and interpreting results measuring chromatin 
dynamics.
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2.4  Nucleosome Assembly
The above section discussed processes evicting, moving, or replacing histones in nucleo-
somes and, thereby, liberating DNA for access to processing enzymes. However, the 
reverse process is as important in order to reconstitute the native nucleosomal template 
and the correct epigenetic landscape. This need is most evident at the time of DNA 
replication. The newly synthesized DNA has to be packaged and epigenetically marked 
in a regular and complementary manner. At the replication fork, a highly orchestrated 
mechanism not only templates and produces an identical copy of the DNA but also 
removes nucleosomes in front and reassembles histones into nucleosomes behind, now 
on two DNA fibers in an epigenetically impeccable state (Hammond et al. 2017).
2.4.1  Histone Variants and Histone Chaperones
Most histones are produced during the S-phase of the cell cycle. These DNA 
synthesis- coupled canonical histones provide the source for the repackaging of the 
two new chromatids. However, a number of DNA synthesis-independent histone 
  . Box Fig. 2.1 DNase I-hypersensitivity (DH) analysis at an inducible gene. The chromatin 
organization at the glucocorticoid-responsive enhancer element, 2.5 kb upstream of  the pro-
moter of  the tyrosine aminotransferase gene, was probed in rat liver cells. Isolated nuclei of 
cells are digested with increasing amounts of  DNase I. Digested genomic DNA is purified, 
cleaved with a restriction enzyme, resolved by agarose gel electrophoresis, and subjected to 
Southern blotting. The DH sites are revealed by indirect end-labeling of  restriction frag-
ments through hybridization of  a small radioactive probe (marked with arrows). In the unin-
duced state there are two DH sites at the promoter and one at 21 kb upstream. After hormone 
induction with corticosterone, nucleosomes are remodeled at the enhancer within 15 min. A 
new DH site appears 2.5 kb upstream of  the transcriptional start site. This correlates with the 
binding of  glucocorticoid receptors and a complex set of  remodeling factors. On removal of 
the hormone (“washout”), the factors dissociate and canonical nucleosomes reform within 
15 min and the 22.5-kb enhancer DH disappears. (From Becker and Workman (2013))
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variants are produced at any time in the cell cycle, with variable tasks in structuring 
the chromatin landscape (see also book 7 Chap. 1 of Wutz) (Talbert and Henikoff 
2017). The incorporation of the centromeric H3 variant (known as CENPA in verte-
brates or CENH3 in plants) instead of the canonical H3 into a nucleosome forms the 
foundational structure of centromeric chromatin. The replacement of human canon-
ical H3.1 by the highly similar variant H3.3 has few apparent consequences. This 
variant has a primary role in repairing gaps in the chromatin landscape that result 
from nucleosome disruption occurring during basic nuclear processes. Several H2A 
variants affect gene expression: H2A.Z and H2A.B are implicated in transcription 
initiation whereas macroH2A in animals and H2A.W in plants seem to be  associated 
with nucleosome immobility and transcriptional silencing. Hence, like DNA con-
taining base variants like methyl-cytosine, also nucleosomes can alter their informa-
tion surface by incorporating variants of the canonical histones. This provides an 
additional layer of flexibility and complexity for epigenetic processing as the variants 
can have an influence on nucleosome stability and marking by chromatin modifiers.
For the assembly of histones into nucleosomes histone chaperones are required 
(De Koning et al. 2007). Indeed, when histones are mixed with DNA in solution at 
physiological ionic strength, they precipitate unless chaperones help histones to fold 
properly, preventing their positive charges from engaging in nonspecific interactions. 
The highly conserved histone chaperones are also necessary for escorting and depos-
iting histones into chromatin and for histone storage. There are a number of different 
chaperones for cellular processes and pathways of histone assembly. Newly synthe-
sized histones are bound by a series of chaperones in the cytosol before entering the 
nucleus. Once soluble histone complexes enter the nucleus, chromatin assembly fac-
tor 1 (CAF1) directs histone assembly behind the replication fork, whereas the his-
tone regulator A (HIRA) complex directs assembly into chromatin independent of 
DNA synthesis (see below). In humans, CAF1 deposits canonical H3.1 and H3.2 
during replication, whereas HIRA deposits the H3.3 variant throughout the cell 
cycle. Hence, any process in the cell requiring histone assembly utilizes the chaperon-
ing capability of specific complexes. . Figure 2.6 summarizes the identity and sites 
of action of these important factors in chromatin dynamics.
2.4.2  The Replication Fork: Still the Major Enigma in Epigenetics
The most outstanding cooperation between DNA, histones, histone chaperones, chro-
matin modifiers, and the replication machinery is exemplified at the replication fork 
(. Fig. 2.7) (Bellush and Whitehouse 2017; Hammond et al. 2017). The passage of 
genomic DNA through the small hole in the replicative helicase must result in the 
transient release of all DNA-binding proteins, including the disassembly of nucleo-
somes and, hence, the uncoupling of histone- and nucleosome-based epigenetic infor-
mation from the DNA.  Eventually, old nucleosomes, including many with histone 
variants and modifications, are rapidly reassembled on the newly synthesized leading 
and lagging strands. Gaps between old nucleosomes are filled with nucleosomes com-
prising newly synthesized canonical histones. Histone chaperones support this dynamic 
process. Behind the replication fork deposition of new nucleosomes is mediated by the 
histone chaperone CAF1, which teams with the replication clamp proliferating cell 
nuclear antigen (PCNA) and travels with the replisome. CAF1 is a trimeric complex 
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  . Fig. 2.6 Overview of  histone deposition mechanisms. Newly synthesized histones are incorporated 
into chromatin via globally and locally acting mechanisms. A network of  specialized histone chaper-
ones controls histone delivery and deposition. The figure provides an overview of  replication-coupled 
and replication-independent pathways that require the incorporation of  newly synthesized canonical 
histones and replacement variants, together with parental histone recycling. The histone chaperones 
that are implicated in each process are listed at the bottom. (From (Hammond et al. (2017))
  . Fig. 2.7 Parental histone recycling during DNA replication. Evicted parental histones are randomly 
segregated to daughter DNA strands. It remains unknown whether other components of  the DNA 
replication machinery have histone chaperone activity and whether deposition of  old and new histones 
occurs by separate pathways (for details see text). (From Hammond et al. (2017))
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responsible for assembling new canonical H3 nucleosomes behind the fork (see 
. Fig. 2.7). ASF1 interacts with H3-H4 by binding the homodimerization interface 
of H3 and can only present dimers, not tetramers, to CAF1. A single CAF1 molecule 
can bind two H3-H4 dimers or a crosslinked (H3-H4)2 tetramer, suggesting that CAF1 
is capable of assembling and depositing (H3-H4)2 tetramers onto DNA. Hence, old 
nucleosomes might be randomly disassembled and reassembled from their dimer com-
ponents behind the fork, resulting in histone octamers containing both new and old 
histones. However, new Histones H3 and H4 may have epigenetic marks added before 
chromatin assembly at the fork. It is thought that H3K9 monomethylation and H4K5 
and H4K12 acetylation are commonly added moieties by modifying enzymes SetDBl 
and HAT1, respectively, in complex with histone chaperones (e.g., CAF1 or ASF1). 
Once chromatin has been assembled these acetylation marks might become removed 
by deacetylases and replaced by corresponding opposing marks like H3K9me3 in the 
case of heterochromatin. However, in animals, canonical H3.1- containing nucleo-
somes consist of nearly all old or all new (H3.1-H4)2 tetramers. This suggests that 
either old tetramers are transferred intact behind the fork or they are transiently disas-
sembled and reassembled in a way that excludes the incorporation of new dimers. 
Transfer of tetramers or dimers occurs across the fork either to CAF1 via ASF1 or, 
perhaps with the assistance of FACT (Facilitates Chromatin Transcription), directly 
onto DNA. FACT may contribute to nucleosome disruption and histone recycling 
through interaction with the replicative helicase CMG complex (which includes 
CDC45-MCM2-7-GINS), polymerase α (Polα), and the single- strand binding replica-
tion protein A (RPA). MCM2 provides a binding platform for evicted H3-H4 tetra-
mers and may facilitate their recycling directly, in collaboration with FACT, or as 
dimers with ASF1, which splits H3-H4 tetramers and forms a co- chaperone complex 
with MCM2.
The big question still is how, after the passage of the replication fork and the 
assembly of new and old nucleosomes, the local epigenetic landscape is reestablished 
(Singh 2014). A templating mechanism has to duplicate and appropriately pattern the 
new histones with the necessary modifications. Given the vicinity to the parental his-
tones, these could act as anchors and templates for readers, writers and erasers to 
appropriately tag the new histones (see book 7 Chap. 1 of Wutz). In light of the intri-
cate patterns of modifications observed at certain functional chromatin locations, this 
certainly begs the question which and how precisely a biochemical mechanism is capa-
ble to faithfully reproduce these instructions. A better understanding of this process 
represents certainly a major and ambitious challenge in epigenetic research.
Take-Home Message
 5 The assembly of histones into nucleosomes is influenced by the DNA sequences 
wrapped around the protein core. Certain sequences favor bending of DNA 
whereas others disfavor the assembly of a nucleosome. Hence, the chromatin land-
scape is to a large part also determined by the genome sequence.
 5 DNA elements organize the chromatin in the 3D space of the nucleus. Insulator/
boundary elements prevent long-range effects of repressive heterochromatin but 
can also locally control the interaction of cis-regulatory elements.
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What You Will Learn in This Chapter
The identity of cells in an organism is largely defined by their specific transcriptional pro-
file. During cell division, these profiles need to be faithfully inherited to the daughter cells 
to ensure the maintenance of cell structure and function in a cell lineage. Here, you will 
learn how two groups of chromatin regulators, the Polycomb group (PcG) and the Trithorax 
group (TrxG), act in an antagonistic manner to maintain differential gene expression 
states. Members of the PcG cooperate in large multiprotein complexes to modify histones 
with repressive marks, resulting in condensed chromatin domains. Conversely, the TrxG 
proteins counteract the repressed domains by opening nucleosomal structures and estab-
lishing activating histone modifications. PcG and TrxG proteins are evolutionary highly 
conserved and control diverse processes, such as the identity of stem cells in mammalian 
development to the process of vernalization in plants.
3.1  Maintaining Cellular Fates
Metazoan organisms reach their size and body complexity through a sequential 
series of cellular specifications intermingled with phases of growth. During early 
embryonic stages, the body pattern is defined, the germ layers established, and the 
primordia for the organs delineated. Subsequently, during the process of differentia-
tion the developmental fates are implemented to produce morphological features, 
organ structures, and functions fulfilling the needs of survival and reproduction of 
the specific organism. During all these development processes, cells also undergo a 
large number of divisions, with the requirement to retain the once established devel-
opmental fates1. To a large part, the fates and identities of cells are written in their 
differential patterns of gene expression. Hence, after each cell division, these unique 
transcriptional networks have to be reestablished to maintain cellular identities. This 
is not a trivial task given the extensive molecular and cellular rearrangements 
observed during the processes of genome replication and cellular division, where 
most regulatory proteins and chromatin factors are stripped from the DNA. However, 
complex mechanisms evolved to retain cellular identities in the wake of these pro-
cesses, which ensure that developmental decisions are faithfully maintained. In other 
words, cells seem to have a “cellular memory”.
How can the “memory” of cells be revealed? Transplantation experiments have 
demonstrated that cells and tissues react differently when moved to a foreign neigh-
borhood, depending on their programmed state. Before being determined for a par-
ticular identity, transplanted cells often adapt to the identity of their new foreign 
neighbors. Conversely, when transplanted after having been determined, they retain 
their original identity even when exposed to a new developmental environment. This 
shows that there is a specific period in the development of an organism in which cel-
lular programs become fixed and irreversible (Wolpert et al. 2015).
1 Developmental fates are built through consecutive developmental restrictions. Among the first are 
the allocations to the germ layers (ecdoderm, endoderm and mesoderm). Subsequently, cells receive 
information to be part of  a specific organ or tissue and fulfill a particular structural or functional 
role. Every step of  these decisions have to be memorized and faithfully maintained.
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In Drosophila melanogaster, at metamorphosis, larval cell are eliminated and 
adult precursor cells become differentiated during the subsequent pupal stage, giv-
ing rise to the organs and appendages of  the adult fly. This process is triggered by 
the hormone 20-hydroxyecdysone (ecdysone). The burst of  hormone induces a well- 
orchestrated cascade of  transcriptional and post-transcriptional events leading to 
the differentiation of  adult precursor (imaginal) cells. An example being the 
 transformation of  the morphologically inert imaginal disc cells which give rise to 
the highly specialized external cuticular structures, like wings, legs, or eyes. 
Concomitantly, larval cells and tissues which do not form part of  the adult fly 
become marked for death and are histolyzed during metamorphosis. A classical 
experiment by Hadorn and collaborators demonstrated that imaginal discs main-
tain and remember their determined program (Hadorn 1968). Clusters of  cells rep-
resenting the primordia of  imaginal discs are defined at early stages of 
embryogenesis. During subsequent embryonic and larval stages, theses clusters 
grow in size but do not differentiate. Only at metamorphosis, the cells implement 
their early defined transcriptional programs and differentiate into the structures 
and appendages that give rise to the external cuticle of  the fly. Fragments of  imagi-
nal discs can be transplanted into the fluid of  the abdomen of  adult flies (hemo-
lymph), which acts like an incubator, allowing the discs to grow in size but not to 
differentiate. This process can be repeated over many weeks and months, forcing the 
imaginal disc cells to undergo more cell divisions than they would have done during 
normal development of  a fly. To observe whether the cells also retained their iden-
tity under these circumstances, they are transplanted back into a larva prior to 
metamorphosis. After undergoing metamorphosis, the hatched adult fly contains, in 
its hemolymph, differentiated cuticular tissue of  the same identity as the original 
imaginal disc. This clearly demonstrates that cells can retain a memory of  their 
programmed state even when placed in a foreign environment and undergoing many 
cell divisions.
Interestingly, Hadorn and collaborators observed rare cases where the trans-
planted imaginal disc fragments, after differentiation, produced cuticular structures 
other than those originally determined. Hence, cells can also “forget” and change 
fate. They termed this phenomenon “transdetermination”. These changes of fate 
often mimicked phenotypes which had been observed in homeotic mutants. These 
are mutations in master regulatory genes required to establish the appropriate seg-
mental identities in the fly (Lewis 1978). As such, it was argued that the maintenance 
of cellular memory is inherently connected to the faithful conservation of the specific 
expression patterns of master developmental regulators.
3.2  PcG/TrxG System Maintaining Cellular Memory
Parallel to the studies of Hadorn, geneticists identified fly mutations displaying mul-
tiple homeotic phenotypes. Among these, Ed Lewis and his wife Pam characterized a 
mutation they named “Polycomb”, which they demonstrated to control the homeotic 
master regulators in the Bithorax Complex (BX-C) (Lewis 1978). In this mutant, the 
cuticular structures of the second and third leg were transformed towards the iden-
tity of the first leg. Given that normally, in males, only the first leg pair depicts so- 
called sex combs, the fact that in the mutant all legs developed this morphological 
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marker pointed to a deregulation of the underlying segmental identity imposed by 
the homeotic master regulators. Over time, a number of other genes with a similar 
phenotype were isolated and classified as “Polycomb group (PcG)” genes. Their phe-
notype indicated that they all act as repressors of homeotic master regulators. 
Interestingly, early patterns of homeotic gene expression were not disturbed but they 
were only at later stages (Struhl and Akam 1985). This suggested that the products of 
the PcG were not responsible for establishing the segment-specific expression pat-
terns of master regulators, but for maintaining them appropriately expressed for the 
rest of development. Additionally, mutations in PcG genes also increased the rate of 
transdetermination events observed in transplantation experiments, suggesting that 
this group is part of the system maintaining cellular identities (Grossniklaus and 
Paro 2014).
In Drosophila, mutations like Trithorax, which mimic loss-of-function homeotic 
mutations, were identified. Further genetic analyses also revealed the existence of an 
entire group of genes acting as repressors of the additional sex combs phenotype 
found in PcG mutants. Mutations in these genes reversed or redirected the pheno-
typic transformations of segmental structures in an opposite manner compared to 
the homeotic transformations observed in PcG mutants. The genes belonging to this 
class were termed “Trithorax group (TrxG)” and their products seemed to act as anti- 
repressors that ensure a faithful expression activity of the master regulators (Kingston 
and Tamkun 2014).
While originally identified as regulators of  homeotic genes in Drosophila, both 
genes of  the PcG as well TrxG were subsequently found to be evolutionary highly 
conserved in plants and animals. Primarily by molecular homology, members of 
the two groups were identified in the genomes of  a number of  model organisms. In 
some way, this is not surprising as cellular memory is an inherent requirement for 
a multicellular organism. However, subsequent analyses found a much broader 
regulatory regimen for PcG.  They not only required to maintain developmental 
fates, but also used in a large number of  other transcriptional control processes 
requiring maintenance of  stable and heritable gene repression. The representatives 
of  the TrxG are molecularly and functionally a rather diverse group and were 
found to be not only needed for many active transcriptional processes but also 
other nuclear processes requiring chromatin decompaction or activation. PcG and 
TrxG factors do not shape decisions for gene regulation, which is rather imple-
mented by transcription factors (TFs) acting as master regulators. However, in 
many cases these TFs are switched off  or take-up new tasks after their initiating 
signal. The further maintenance of  the active or repressed state and the transmis-
sion of  this information to the next cell generation is achieved by the combined 
action of  PcG and TrxG.  Hence, “cellular memory” could be understood as a 
mechanism for maintaining “transcriptional memory”. Maintaining a transcrip-
tional state in the absence of  the initial trigger is a classical epigenetic task fulfilled 
by these factors. Indeed, subsequent studies using the corresponding technical 
advantages of  the different model organisms under analysis, revealed a class of 
gene products with major activities in shaping and modulating chromatin structure 
and function in the nucleus.
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3.3  Biochemical Characterization and Molecular 
Function of PcG/TrxG Proteins
The molecular characterization of the genes and products of the PcG and TrxG pro-
vided deep insights into their specific role in the nucleus. General chromatin research 
had identified the important role of histones not only as packing material for the 
genome but as an additional carrier of information (see book 7 Chap. 1 of Wutz). 
Histones depict an elaborate pattern of covalent modifications of their amino acids. 
Specific histone modifications were found to be correlated with defined transcrip-
tional states, providing a platform for a gene-specific control and, therefore, produc-
ing an apparent code in addition to the genetic information encoded in the sequence 
of the DNA. An elaborate machinery consisting of chromatin factors writing, read-
ing, and, if  necessary, erasing the histone marks was revealed over the years (see 
book 7 Chap. 1 of Wutz). Strikingly, among these so-called writers, readers, and 
erasers of epigenetic information, many were found to be encoded by PcG and TrxG 
genes.
Another interesting result was the discovery that PcG genes and to some degree 
also TrxG genes were genetically interacting. Subsequent molecular characterization 
revealed an interaction and cooperation of the proteins encoded by these groups in 
large and biochemically defined multimeric complexes. PcG proteins form two major 
types of complexes, Polycomb Repressive Complex 1 (PRC1) and 2 (PRC2) (Kuroda 
et al. 2020). Four PcG members constitute the core PRC1 complex in Drosophila: 
Polycomb (Pc), Polyhomeotic (Ph), Posterior sex combs (Psc), and Sex combs extra 
(Sce), also known as dRing1. PRC2 comprises four core proteins: Enhancer of zeste 
(E(z)), Suppressor of zeste 12 (Su(z)12), Extra sex combs (Esc), and Chromatin 
assembly factor 1, p55 subunit (Caf1-55), also known as p55 or Nurf55.
PRC1 recognizes and binds to the repressive H3K27me3 mark via the chromodo-
main of Polycomb and blocks chromatin remodeling and transcription. PRC1 has 
also E3 ubiquitin ligase activity mediated by Sce/dRING1, which monoubiquitylates 
H2AK119 (in Drosophila the corresponding K118 is ubiquitylated). Through E(z)’s 
methyltransferase activity, PRC2 trimethylates lysine 27 on histone H3 (H3K27me3) 
at genes targeted for silencing, thus being responsible for this distinctive histone mark 
of PcG system-mediated repression. The Su(z)12 and Esc subunits enhance this 
histone- modifying activity. The composition of the core complexes is conserved also 
in mammals (. Fig. 3.1). There, to deal with the higher regulatory complexity of the 
organism, a number of additional orthologs and factors cooperate with the core 
subunits to execute cell type- and tissue-specific functions. The concerted action of 
these protein complexes results in the stable and heritable transcriptional repression 
of PcG target genes.
The genetically defined group of TrxG proteins on the other hand was found to 
comprise a large and more divergent family of protein functions and complexes 
involved in the activation of transcription. They counteract PcG-mediated silencing 
by utilizing different mechanisms including the posttranslational modifications of 
histones, chromatin remodeling, recruitment of the transcriptional machinery, and 







































































Chapter 3 · Cellular Memory
55 3
chromosome cohesion (Kingston and Tamkun 2014). The TrxG complexes TAC1, 
dCOMPASS, and dCOMPASS-like methylate H3K4, the modification that marks 
actively transcribed genes and active promoters. TrxG members also assemble into 
large SWI/SNF or BRG ATP-dependent chromatin remodeling complexes that can 
mobilize nucleosomes and promote chromatin accessibility (see book 7 Chap. 2 by 
Paro).
Developmentally relevant TFs are often expressed in a tissue- and stage-specific 
manner. To a large degree, the activity of these TFs is controlled through their expres-
sion in the cell of action. Conversely, most of the core PcG and TrxG proteins are 
present in all cell types at all the time. Hence, the question is how these ubiquitously 
expressed factors, controlling transcriptional processes in a cell type specific manner, 
can maintain such an apparent specificity for their respective target genes.
3.4  Targeting and Propagation of PcG/TrxG-Controlled 
Chromatin Domains
In the Drosophila homeobox gene (HOX) clusters, the Antennapedia Complex 
(ANT-C) and BX-C, cis-regulatory elements attracting PcG proteins were identified. 
These so-called PcG Response Elements (PREs) can act in isolation by binding PcG 
proteins that silence adjacent reporter genes (Simon et al. 1993). Deletions of PREs 
result in ectopic mis-expression of the corresponding homeotic genes. Sequence- 
specific and globally expressed PcG factors like Pleiohomeotic (Pho) and GAGA 
factor (GAF) were found, among others, to provide the bridge between the DNA 
and PRC1 and PRC2, generating target specificity (Kuroda et al. 2020) (. Fig. 3.2). 
In the mammalian genome, targeting appears to use similar principles, albeit the 
exact nature and combination of TFs has not yet been determined. PcG complexes 
are enriched at unmethylated CpG islands. Various components, like KDM2, SUZ12 
and JARID2, have affinity for GC-rich DNA sequences which may help to drive 
assembly of the complexes at nucleation sites. In addition, DNA methylation plays 
an important role in anchoring PRC2 to particular sites in mammals. Additionally, 
long non-coding RNAs have been suggested to anchor PcG complexes to target sites 
(see 7 Chap. 4 of Wutz).
A major hallmark of PcG silencing is the H3K27me3 histone modification 
observed primarily at PREs and connected promoters but also extending largely over 
the body of the repressed gene. This “spreading” effect can be visualized using meth-
ods of chromatin immunoprecipitation (ChIP, see Methods Box 1 in book 7 Chap. 
1 of Wutz). The placement of the H3K27me3 mark over extended nucleosome 
regions can be explained by the combined and cooperative activities of individual 
  . Fig. 3.1 Polycomb Repressive Complex 1 and 2  in flies and mammals. PRC1 and PRC2 are bio-
chemically identifiable multiprotein complexes. The core factors are color coded to show the respective 
counterparts in flies and mammals. The two complexes have a distinctive enzymatic activity; dRING or 
RING1A/B in PRC1 places a monoubiquitin at H2AK118 (Drosophila) and H2AK118 (mammals) and 
E(z) or EZH1/2 place a methyl moiety on H3K27. Some of  the core proteins are found in variant com-
plexes (vPRC1.1-6), especially in mammals. In combination with additional accessory factors these 
complexes fulfill specific tasks in a tissue-specific manner
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members of PRC1 and PRC2. The activity of the H3K27 histone methyltransferase 
E(z)/Ezh in PRC2 is stimulated by the other PRC2 component Esc/Eed that binds to 
H3K27me3, suggesting a feed-forward mechanism that could progress along the 
chromatin fiber. The Polycomb protein of PRC1 acts as a reader by binding the 
H3K27me3 mark through its chromodomain. In combination with other components 
of PRC1, like Polyhomeotic (Ph) containing multimerization modules (SAM 
domain), extended local clustering of chromatin sections are established. This leads 
to local nucleosomal condensation at regulatory sites and, in consequence, reduced 
DNA accessibility for TFs. Interestingly, such locally condensed regions can also 
interact with similar silenced regions in other parts of the genome, producing large, 
microscopically visible domains (Entrevan et al. 2016). An example for such long-
range interactions can be found at the two Drosophila HOX clusters, normally sepa-
rated by megabases on the linear chromosome, but colocalizing in the nucleus of cells 
where the Hox genes are repressed. The chemical property of certain components of 
the PcG induce the complexes to produce so-called phase-separated droplets, which 
have been termed PcG bodies. Such sub-nuclear compartments are not defined by 
molecular boundaries like membranes but, like oil and water, are separated by their 
disparate chemical properties. Recently, it was shown that the mammalian Polycomb 































  . Fig. 3.2 Anchoring of  PcG complexes to silencing elements. (top) In Drosophila PcG repressive 
elements (PREs) are recognized and bound by a combination of  sequence-specific TFs (Spps, Pho/Phol, 
GAF and CG). They interact with PRC2 complexes which produce the H3K27me3 signal, attracting 
PRC1. ESC/EED of  PRC2 and PC/CBX of  cPRC1 bind H3K27me3 to drive self-propagation or 
spreading of  the repressive mark. As a result, PREs can induce nucleosome compaction and inhibition 
of  transcription by interaction with paused pol II. (bottom) In mammals the sequence requirement of 
PREs and corresponding TFs are less well understood. Unmethylated CpG islands attract PcG com-
plexes through factors like KDM2, SUZ12 and JARID2 that have an affinity for CG-rich DNA.  In 
contrast to Drosophila, where the role of  H2Aub is not well understood, in mammals this mark facili-
tates recruitment of  PRC2 via JARID2. PREs can also be used as platform for factors of  the TrxG 
thereby acting as a switch for gene modulation
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dynamic bodies in cells (Plys et al. 2019). The same mutations in CBX2 identified 
previously to impair nucleosome compaction and resulting in axial defects in mice 
were found to disrupt phase separation in vitro and the formation of bodies in cells. 
This brings together the ability to bind H3K27me3, compact nucleosomes, and 
phase-separate into a single component of PRC1. These data support the hypothesis 
that phase separation and compaction by PRC1 are generated by linked mechanisms. 
The authors therefore speculate that the high concentration of PRC1 within phase- 
separated bodies could facilitate maintenance of a repressive chromatin state during 
development.
Multiplication of chromatin marks, multimerization of complexes, and clustering 
in the 3D space of the nucleus appear to be central requirements for generating stably 
and heritably repressed genomic domains. Indeed, the regulation of Hox genes, 
defining long-lasting cellular identities, nicely supports this restricted view of PcG 
function. However, most of the other PcG target genes identified change expression 
over time, the cell cycle or are even subjected to short-term environmental control. 
Here comes the family of TrxG factors into play. A surprising finding was that PREs 
do not only attract PRC1/2 proteins but also a number of TrxG proteins, suggesting 
they are switchable elements (PRE/TRE). While silencing by PcG components to 
gene-specific PREs represents the default state, a competitive off/on switch and fine- 
tuning is imposed by particular combinations of TrxG proteins and transcription 
factors that react to developmental or environmental cues (. Fig. 3.3).
An interesting case in this respect are so-called bivalent domains. Originally dis-
covered in mammalian embryonic stem cells, they recently were also identified in the 
Drosophila embryonic genome (Akmammedov et  al. 2019). Bivalent domains are 
characterized by the concomitant presence, over an extended genomic region, of the 
characteristic PcG histone mark H3K27me3 and the typical TrxG mark H3K4me3 
(see also Methods Box 1 in book 7 Chap. 1 of Wutz). In early embryonic stages, this 
dual marking at genes appears to signal a transcriptionally poised condition. Hence, a 
gene “waits” for the appropriate developmental signals to drive its expression into an 
active or repressed state, depending on the fate of the cell lineage. With ongoing devel-
opmental time and programming, the signals are resolved into either a complete 
H3K27me3 pattern (and/or in the case of mammals with additional DNA methyla-
tion signals) when the gene is repressed or a complete H3K4me3 (and accompanying 
H3/H4 acetylation) when the gene is active (Voigt et al. 2013). This site-specific anti- 
repressor capability of members of the TrxG provides a means for how localized com-
petition can switch the expression state from silenced to activated, also known as the 
“bivalent master switch” model (Kuroda et al. 2020). A central aspect is a shift of the 
balance by the addition of acetylation moieties, opening up nucleosomal condensa-
tion and allowing transcriptional activation. Indeed, PRC1 proteins have been found 
complexed with acetyltransferases and acetyl-binding bromo domain- containing pro-
teins. Hence, the local balance between PcG and TrxG proteins defines the state of 
histone modifications and, consequently, the accessibility and processability of the 
chromatin template. However, based on theoretical considerations, it was suggested 
that poised chromatin is produced by a bistable state imposed by the PcG/TrxG com-
petition rather than through a true bivalent marking of nucleosomes (Sneppen and 
Ringrose 2019). In their model, poised chromatin is bistable and not bivalent. They 
suggest that bivalent chromatin containing H3K4me3 and H3K27me3 is present as an 
unstable background population in all system states, and different subtypes co-occur 
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with active and silent chromatin. In contrast, bistability, in which the system switches 
frequently between stable active and silent states, occurs under a wide range of condi-
tions at the transition between monostable active and silent system states. The ques-
tion whether bistability and not bivalency is associated with poised chromatin has 




  . Fig. 3.3 Antagonistic functions between TrxG and PcG factors. Both TrxG and PcG families 
include proteins that covalently modify histones and those that non-covalently modify chromatin. 
Covalent modifications on histones can promote or block the binding or activity of  TrxG complexes 
(e.g., SWI/SNF and KIS), PcG complexes (e.g., PRC1 and PRC2), or other factors involved in the main-
tenance of  active or repressed states. Binding by these latter complexes has the potential to lead to fur-
ther covalent modifications, thus leading to iterative cycles of  covalent modification and recognition of 
the covalent marks. a TrxG factors are attracted to PREs at promoter regions and mark histones for 
activity. b In a different cell type the same gene is marked by negative histone modifications by PcG 
complexes bound at PREs. c Nucleosome remodeling complexes recognize the active histone marks and 
open nucleosomal packaging for access to the transcriptional machinery. d Modification of  histones by 
PcG complexes result in compaction of  nucleosomes and in gene repression. Depending on local con-
stitution and concentration of  the antagonistic factors, genes are either kept in an active or permanently 
repressed form. (from (Kingston and Tamkun (2014))
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memory. To resolve this important issue super resolution chromatin dissection analy-
ses (single cell ChIP, single nucleosome analyses, etc.) will eventually be required.
A major interaction platform for both activities is the promoter of target genes. 
In particular, PcG proteins were found to act primarily at promoters with a paused 
Pol II. Pol II pausing is found at many protein-coding genes (see book 7 Chap. 2 of 
Paro). Genome-wide ChIP analyses as well as Global Run-On sequencing (GRO- 
seq) studies indicated that the distribution of the PcG complexes PRC1 and PRC2 
correlates significantly with genes exhibiting stalled polymerases, suggesting a com-
mon mechanistic basis. In murine ES cells, genes with bivalent domains and binding 
both PRC1 and PRC2 show substantially reduced levels of paused Poll II at the 
promoter region. This supports the view that nucleosomal compaction is part of the 
PcG-mediated silencing process. Conversely, many bivalent promoters with only 
PRC2 bound exhibit strong Pol II pausing at the 5′-end, suggesting that the PcG 
system overall controls important rate-limiting steps in assembly and transcriptional 
elongation at target genes. In Drosophila, many members of the TrxG are co- localized 
with PcG complexes at promoters, including those with paused promoters. Indeed, 
the occurrence of bivalent domains at particular mammalian genes and the co- 
occupancy of PRC1/2 components with TrxG proteins at many Drosophila target 
genes suggest a strong molecular interface between these opposing activities.
A still unresolved question in this respect is how this complex layering of regula-
tory levels, from local amplification of histone modifications, multimerization of 
protein complexes, to clustering in the 3D nuclear space, is reproduced after DNA 
replication and cell division. However, also in this case, the complexity might become 
reduced to the maintenance of a few relevant molecular marks, which subsequently 
act as entry sites to reconstruct the full epigenetic landscape. It has been suggested 
that TrxG proteins (and/or local histone marks or activity) tag an active gene and still 
remain associated during S-phase where general chromatin remodeling is observed. 
Hence, they act as “bookmark” to keep the genes active which are necessary for the 
specific identity of the cell (Blobel et al. 2009). Conversely, in the ensuing G1 phase, 
all genes without a bookmark become silenced again by default and by the tagging 
through a PRE(s). This would ensure that only one part of the complex transcrip-
tional memory machinery is required to be faithfully duplicated and actively trans-
ported through DNA replication and mitosis.
3.5  Switching Memory and the Role of Non-coding RNAs
The example of bivalent chromatin domains showed how PcG/TrxG competitive 
interactions lead to permanent opposing expression states necessary for developmen-
tal stability. However, many repressed genes need to become activated or active genes 
repressed at later developmental times or when required by physiological or environ-
mental conditions. An example for the latter is the process of vernalization in plants 
(Costa and Dean 2019). Since plants are sessile, they need to adjust their growth, 
development, and physiology to the changing environment. To ensure that reproduc-
tive development only starts after the winter period and, therefore, during more 
favorable environmental conditions, plants developed mechanisms to “remember” 
that they experienced prolonged periods of cold. Central to this process is the epigen-
etic silencing of a floral repressor during cold periods. In Arabidopsis thaliana, the 
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FLOWERING LOCUS C (FLC) transcription factor acts as a break to flowering. 
The expression of this repressor is gradually reduced during long periods of cold, so 
that, once plants detect inductive photoperiods and warm temperatures, the switch 
to flowering can be activated. The repression of FLC is stable and maintained for 
many months after cold exposure until embryogenesis in the seed producing the next 
generation, leading to reactivation of FLC (. Fig. 3.4).
The discovery of a pair of long non-coding RNAs (lncRNAs) transcribed at the 
FLC locus revealed a novel role for such transcripts in an epigenetic switch mecha-
nism. Cold induces the local accumulation of both lncRNAs: COLDAIR, which is 
transcribed inside an intron of FLC, and COOLAIR, which is transcribed antisense 
to the FLC mRNA. COLDAIR recruits plant PRC2 containing the E(z) homologs 
CURLY LEAF (CLF) and SWINGER (SWN). This results in enrichment of 






























































































  . Fig. 3.4 Model for a lncRNA inducing an epigenetic switch at FLC. a Before cold exposure during 
winter time the FLC locus is expressed and the histones marked with H3K4me2/3, H3K36me3 and 
acetylation. At the start of  cold exposure, the expression of  the internal lncRNA Coldair attracts PcG 
complexes to the gene. Additionally, the anti-sense lncRNA Coolair becomes transiently expressed at 
high levels inducing the down-regulation of  FLC transcription. Near the nucleation region VAL1/2 
attract the histone deacetylase HDA19, the transcriptional regulator complex ASAP and PRC1, linking 
transcriptional repression to PcG silencing. b Nucleation start by ASAP associating with PRC2 acces-
sory proteins VIN3 and VRN5 and with the PRC2-SWN complex. This generates a metastable silenced 
state of  FLC starting accumulation of  H3K27me3 signals at the nucleation region. c After exposure to 
warm temperatures, this signal together with PRC2-CLF and LHP1 spreads over the entire locus estab-
lishing a long-term epigenetically silenced state. This condition is maintained across multiple cell divi-
sion until reset in the next generation during embryogenesis
Chapter 3 · Cellular Memory
61 3
the FLC gene and promotes removal of the activating H3K4me and H3K36me 
marks. The lncRNAs trigger the repression of FLC, which is subsequently stabilized 
by PcG silencing. Like at PREs, PRC2 complexes are concentrated at a single site 
inside the FLC gene which acts as a nucleation site for H3K27me3 spreading. 
Eventually, the entire FLC chromatin is covered by PRC2 and the accompanying 
histone methylation mark. Interestingly, the degree of methylation at the nucleation 
site as well as the extent of the silenced domain correlate with the length of the cold 
period, providing a rheostat for the vernalization process.
The role of lncRNAs play an ever-increasing importance in epigenetic processes 
and, in particular, interactions with the PcG silencing complexes have been exten-
sively documented. One such example is XIST involved in mammalian X chromo-
some inactivation (see book 7 Chap. 4 of Wutz). Other examples include the 
HOTAIR lncRNA involved in silencing Hox genes in the mammalian genome 
(Achour and Aguilo 2018). HOTAIR acts in trans to repress expression. The lncRNA 
is transcribed from the HOXC locus on chromosome 12 but recruits PRC2 and the 
LSD1- containing coREST/REST complex to HOXD on chromosome 2. Recruitment 
leads to deposition of H3K27me by PRC2 and removal of activating H3K4me marks 
by LSD1. In these cases, the RNAs appear to act as scaffolds either in cis or in trans 
for the silencing activity. However, regulatory modules have been described where the 
transcription of a lncRNA through a PRE leads to the displacement of the silencing 
complexes and in consequence to the activation of a target gene (Ringrose 2017). In 
animals, reports where the sequence of a lncRNA, by its complementarity to DNA, 
is used to target epigenetic complexes to specific genomic sites are not well validated 
and still controversial. This is in contrast to small RNAs in plants that can clearly 
recruit chromatin and DNA modifying complexes to target sites in a sequence- 
specific manner (see book 7 Chap. 6 of Grossniklaus).
In summary, there are several cases where the act of transcribing a lncRNA (or 
any other transcript) can displace a PcG silencing complex. In parallel, transcripts 
exist which could locally attract PcG complexes in cis and induce the silencing of a 
gene. This offers the potential of a switch mechanism, based on the activity of RNAs. 
Indeed, the role of lncRNAs acting in cis in switching PcG/TrxG transcriptional 
states has been modelled based on published criteria (Ringrose 2017). Depending on 
the kinetic parameters, lncRNAs can act to recruit PRC2 to target chromatin or can 
be induced to evict PRC2 from silenced chromatin (see . Fig. 3.5).
3.6  Losing Memory
A natural form of cellular memory loss is required during the transmission of genetic 
information by the germ cells for fertilization and generation of progeny. Germ cells 
need to strap any epigenetically encoded information covered by tissue-specific chro-
matin domains or epigenetically imprinted marks caused by environmental cues 
(Reik and Surani 2015). Indeed, development of germ cells encompasses several 
bottlenecks where chromatin information is apparently erased to ensure a faithful 
re-start of transcriptional programming at fertilization. These range from the replace-
ment of histones with protamines, followed by a strong compaction of the genome in 
sperm cells, to the complete genome-wide DNA demethylation observed in early 
mammalian preimplantation embryos (see book 7 Chap. 6 of Grossniklaus). 
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Interestingly, exceptions have been observed in both animal and plant reproduction 
where not all epigenetic information is erased, influencing the normal growth and 
physiology of the progeny. A first case was described in Drosophila with a PRE con-
trolling a white reporter gene (responsible for the red eye color in flies) (Ciabrelli et al. 
2017; Cavalli and Paro 1998). Normally, the PRE would silence the reporter resulting 
in white-eyed flies, given that the endogenous white locus was mutant. Through a 
single transcriptional switch, the reporter gene could become activated and stay on 
through the entire development of the fly. Surprisingly, the activated form was not 
erased in the germ line but transmitted to the progeny, which also displayed red eye 
color. The effect could be maintained over several generations, demonstrating that, 











Slow RNA release: PRC2 recruitment and silencing
Total RNA molecules = 57
kr = 1



















Fast RNA release: PRC2 eviction and activation
Total RNA molecules = 878
kr = 1,000











  . Fig. 3.5 Simple kinetic model for interaction of  PRC2 with RNA and chromatin. a The model is 
based on ordinary differential equations and contains three components: chromatin (gray), PRC2 (red), 
and RNA (dark blue). (Left) Chromatin binding: PRC2 can bind directly to chromatin. The dissocia-
tion constant (Kd) for this interaction is 86 nM, measured for PRC2 binding to H3K27me3 modified 
histone tails. (Middle) RNA binding: PRC2 can also bind to RNA. The Kd used for this interaction in 
the simulations shown is 30 nM. RNA is produced with rate kt, released from chromatin with rate kr, 
and degraded with rate kd (not shown). (Right) RNA is released from chromatin after transcription, 
either unbound (top) or bound (bottom) by PRC2. b, c The system was simulated over a time course, 
and RNA transcription was initiated after 8 min. The input quantities for these simulations were set to 
reflect average molecule numbers in a 0.1 μm3 volume in a Drosophila embryo nucleus at cycle 12, based 
on total nuclear concentrations (approximately the confocal volume used for fluorescence correlation 
spectroscopy experiments. The quantities were PRC2 = 5 molecules; H3K27me3 = 52 molecules, assum-
ing 6% of  tails modified; kt = 0.2 s−1; and kd = 0.01 s−1. kr was varied as shown in panels b and c. RNA 
molecules were assumed to be localized in the volume of  the simulation. (From Ringrose (2017))
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PREs, can propagate epigenetically encoded information over a number of genera-
tions. Instances of transgenerational inheritance have now been observed also in 
mammals (Boskovic and Rando 2018). One of the most influential examples is the 
transgenerational inheritance of the expression state of the agouti gene, responsible 
for coat color, in mice (see also Book 7 Chap. 9 of Santoro). Specific diets of parents 
can change the DNA methylation pattern at the locus which, in the germline, is not 
always erased and thus propagated to the offspring. The transferred epigenetic mark 
controls the expression of the agouti gene and, hence, the coat color in the next gen-
erations. While transmission through meiosis, gametogenesis, and early embryogen-
esis based on DNA methylation marks are well documented, in many other cases the 
underlying epigenetic signal that is transmitted and causes an effect in the progeny is 
not always clear (Grossniklaus et al. 2013). Conversely, in plants, transgenerational 
epigenetic regulation in response to environmental stress is well described both at the 
physiological and molecular level.
Cancer is largely considered a genetic disease. With accumulating mutations in 
oncogenes or tumor suppressor genes, the cells lose their contacts with the neighbors, 
start to over-proliferate, change metabolic behavior, and eventually migrate to create 
the deadly metastases. Cancer is also a disease of transcriptional mis-regulation and, 
given the role of chromatin in this process, it is not surprising to realize that many 
mutations in chromatin-controlling factors have been observed in human cancers. 
Mutations ensure the long-term phenotypic change of cancer cells. However, epigen-
etic marks like DNA methylation or histone modifications can also be long-lasting, 
maintaining gene expression states over many cell generations. In consequence, 
deregulated expression in cancer cells need not only have a mutational basis but is 
often driven by epigenetic mis-regulation. In 7 Chap. 9 cancer epigenetics is described 
in great detail. Here, two examples for mutations in components of the cellular mem-
ory system will be outlined, illustrating how the loss of cellular identity during 
ontogeny can lead to the development of a tumorigenic state.
The human TrxG gene Mixed Lineage Leukemia (MLL1) was initially identified 
as a chromosomal translocation found in blood cells and causing acute lymphoblas-
tic or myeloid leukemia. MLL1 codes, as its Drosophila ortholog trithorax (trx), for 
a histone 3 lysine 4 methyltransferase (KMT), catalyzing the addition of the positive 
histone mark H3K4me3. The translocation brakes inside the gene, often fusing the 
N-terminal part of the MLL1 protein with other transcriptional control factors. The 
C-terminal part containing the KMT activity (SET domain) is removed, depriving 
MLL1 from its normal activating function. Depending on the fusion partner, MLL1 
can repress or activate target genes in an aberrant manner and thereby induce cancer- 
typical expression profiles. Since the KMT activity normally repels the DNA meth-
ylation machinery, the MLL1 fusions, where this part is often absent, are often found 
at hypermethylated promoters. This results in the down-regulation of many target 
genes. Conversely, the N-terminal part of MLL1 contains a DNA-binding affinity. 
The recruitment of co-activators through the fused partner protein can result in the 
hyperactivation of target genes. The result is a highly deregulated gene expression 
profile found in leukemic cells. By studying the molecular partnerships of MLL1 
fused, for example, to the AF9 activator, specific small molecule inhibitors could be 
identified. In one case, MLL1 interacts with the histone demethylase LSD1. When 
blocked by a small inhibitor (LSD1i) the aberrant activating function of the fusion 
MLL1 is reduced. Similarly, preventing another interaction partner, BRD4, to bind 
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via its bromo domain to acetylated histones by blocking the reader function (BETi) 
also reduces the transcriptional hyperactivity (see also book 7 Chap. 8 of Santoro). 
Hence, the detailed knowledge of the molecular processes encompassing TrxG- 
driven anti-repressor activity allowed the development of highly specific inhibitors, 
which are currently in clinical trials as anti-cancer drugs.
Mutations in PcG genes are often associated with a variety of human cancers of 
a large range of cell types and tissues. Similarly, down-regulation of members of the 
PcG protein complex in Drosophila can lead to neoplastic growth in imaginal discs 
(Beira et al. 2018). The role of the PRC1 component polyhomeotic (ph) has been 
studied in substantial detail, revealing how loss of cellular identity can drive cells to 
an over-proliferative behavior. Interestingly, no genetic instability is observed in these 
tumor cells. Epigenetic dysregulation reprograms the cells to an embryonic state and 
blocks them from entering differentiation. However, by enforcing development 
through the overexpression of a differentiation factor, tumorigenic competence is 
restrained (Torres et al. 2018). Not only in fly cancers but also in many human can-
cers, cells with overproliferative traits often depict a de-differentiated state. This 
reflects the characteristics and need of these cells to divide out of control, indepen-
dent of the neighboring environment and developmental cues. Interestingly, novel 
approaches, termed “differentiation therapy”, attempt to force cancer cells into the 
differentiation path again, eventually removing them from the pool of overproliferat-
ing cells. Indeed, a large number of new cancer drugs that are currently in clinical 
trials target epigenetic factors, attempting to reverse aberrant transcriptional profiles 
(see also book 7 Chap. 8 of Santoro) (Audia and Campbell 2016).
In summary, the chromatin factors encoded by the PcG and TrxG are required for 
maintaining developmental and other transcriptional states. While decisions to acti-
Take-Home Message
 5 The PcG/TrxG system, including the chromatin modifying and remodeling activi-
ties, is evolutionary highly conserved and is involved in many basic cellular processes 
like maintenance of developmentally controlled gene expression states (cellular 
memory), mammalian X chromosome inactivation, and vernalization in plants.
 5 PcG multiprotein complexes are involved in long-term silencing of genes. 
H3K27me3 is a hallmark of PcG repression, correlated with condensed nucleoso-
mal structures. PcG repressed domains cluster in the 3D space of the nucleus to 
produce stable silencing.
 5 TrxG complexes counteract PcG repression and are required for maintaining gene 
activity stable and heritable. H3K4me3 is the hallmark of the TrxG, which encodes 
writers and readers of histone modifications but also components of the nucleo-
some remodeling complexes involved in opening chromatin structures.
 5 Long non-coding RNAs play an important role in the silencing mechanism of the 
PcG. It has been suggested that lncRNAs interact with PcG protein complexes to 
add structural features, evict PRCs from PREs, or target the complexes to specific 
genomic sites.
 5 Deregulation of components of the PcG/TrxG system often results in cancer 
development. Epigenetic cancers are not dependent on the accumulation of genetic 
aberrations. Many new drugs against chromatin regulators are currently being 
tested in the clinic.
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vate or silence a gene are made by master regulators, the resulting expression state 
can be maintained and faithfully inherited from one cell generation to the next by the 
epigenetic landscape imposed by either PcG- or TrxG-driven marks. The competitive 
and bistable nature of PcG and TrxG allows, however, the reversion of expression 
states if  required, producing a highly versatile and adaptive regulatory network.
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What You Will Learn in this Chapter
This chapter provides an introduction to chromosome-wide dosage compensation systems. 
We will examine the evolution of dosage compensation, which is thought to be driven by 
the appearance of differentiated sex chromosomes. In a subset of species with X chromo-
somal sex determination or XY sex chromosome systems, expression of X-linked genes is 
regulated by chromosome-wide modifications that equalize gene expression differences 
between males and females. The molecular mechanisms of X chromosome-wide dosage 
compensation have been studied in flies, worms, and mammals. Each of these species uses 
a distinct dosage compensation strategy with a different molecular mechanism. In the 
worm Caenorhabditis elegans, gene expression on the two X chromosomes of hermaphro-
dites is reduced to a level that approximates a single X chromosome in males. The fruit fly 
Drosophila melanogaster achieves dosage compensation by increased transcription of the 
single X chromosome in males to a level that is similar to the two X chromosomes in 
females. Lastly, in mammals, one of the two X chromosomes in female cells is transcrip-
tionally inactive and a single X chromosome is transcribed in both sexes. Studies of dosage 
compensation systems provide insights into how epigenetic regulation controls gene 
expression and chromatin organization differentially within a cell.
4.1  Introduction: Evolution of Chromosome-Wide Dosage 
Compensation
Sexual reproduction can be observed in nearly all animal phyla. Different sex deter-
mination strategies have evolved, ranging from determination by environmental 
conditions including temperature to genetic sex determination with specific sex deter-
mination genes (Bachtrog et al. 2014). Sex determination systems allow the develop-
ment of dimorphic phenotypes of males and females in a species. For this chapter, 
chromosomal sex determination is of primary interest as structural differences of sex 
chromosomes provide the context for the evolution of dosage compensation systems. 
In birds, males carry two Z chromosomes and females possess heteromorphic Z and 
W chromosomes. In mammals, males have an XY and females an XX sex chromo-
some constitution (Graves 2015). A wide range of XY, XO, and ZW sex chromo-
some systems have been documented in reptiles, amphibians, fish, and insects (Kaiser 
and Bachtrog 2010). The gene content of the sex chromosomes is different, though. 
For example, the snake and bird ZW systems are different and, hence, have evolved 
independently. Sex chromosomes in one species can correspond to autosomes in a 
different species, suggesting that sex chromosomes originate through modification 
of autosome pairs. How autosomes are selected to become sex chromosomes is just 
beginning to be understood. Evolution acts on sex chromosomes in a variety of ways 
that are species-, chromosome-, and context-dependent (Bellott et al. 2010). The gen-
eral idea is that a sex determining locus arises on an ancestral autosome forming 
a proto-sex chromosome. Subsequent loss of sequences (erosion) on the proto-sex 
chromosome converts the ancestral autosome pair into a dimorphic sex chromosome 
pair (. Fig. 4.1).
The erosion of sex chromosomes has been explained as a consequence of recom-
bination suppression. This could likely be facilitated by large inversions in the vicin-
ity of the sex-determining region. Suppressed recombination facilitates the genetic 
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linkage between the sex-determining gene and genes that are beneficial for one sex 
but detrimental to the other. For example, genes that are required for testis develop-
ment reside on the mammalian Y chromosome together with the sex determining 
region Y (SRY) gene, which specifies male sex. Since females do not inherit a Y chro-
mosome, there are no detrimental consequences from Y-linked genes to them. The 
XY sex chromosome system of placental mammals including humans is estimated to 
have evolved about 210 million years ago (mya) (Marshall Graves 2008). The mouse 
Y chromosome has lost all but a few genes that act in determining male sex and testis 
development whereas in other mammals, repeated addition of autosomal fragments 
to the XY chromosome pair has generated different and larger Y chromosomes. The 
evolution of different clades of mammals has led to divergent sex chromosome struc-
tures. Placental and marsupial mammals possess XY chromosomes that originate 
from the same ancestral autosome pair. The more distantly related monotremes are 
examples of species with multiple sex chromosomes (. Fig. 4.1). Platypus and sev-
eral species of echidna possess 5 X and 5 Y chromosomes, which are not homologous 















pair X Y X Y X Y X Y






  . Fig. 4.1 Evolution of  sex chromosomes in mammals. Placental and marsupial mammals possess 
XY sex chromosomes that have arisen from an ancestral autosome pair about 210 mya. These sex chro-
mosomes correspond to autosomes in monotremes that possess a system of  5 X and 5 Y chromosomes. 
Evolution has shaped sex chromosomes by erosion and the addition of  autosomal fragments to the sex 
chromosomes, leading to divergent chromosome structures between marsupials and placental mammals 
but also within placental mammals. Sequences lost due to erosion are marked in black along the evolv-
ing Y chromosome. As a consequence of  the erosion of  the Y chromosome, dosage compensation sys-
tems have arisen. Although placental and marsupial mammals inactivate the second X chromosome in 
female cells, the molecular details of  the underlying mechanisms differ. In placental mammals, the Xist 
gene initiates X chromosome inactivation. In marsupials, the Rsx gene has emerged as the trigger by 
convergent evolution
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homology to the Z chromosome of birds (Graves 2015; Veyrunes et al. 2008). The 
human X chromosome is homologous to an autosomal region in monotremes. 
Further information on the evolution of mammalian sex chromosome systems can 
be found in a specialized review (Marshall Graves 2008).
4.1.1  Consequences of Gene Dosage Differences Arising from Sex 
Chromosome Erosion
Loss of genes on the sex-limited chromosome (the Y in mammals) and the evolution 
of dimorphic sex chromosomes can have two consequences. Firstly, a divergence 
from the ancestral gene dosage through erosion of the proto-sex chromosome rela-
tive to the ancestral autosomes is incurred. Whether an associated reduction of fit-
ness1 is tolerated or can be compensated for, remains to be resolved for each 
particular system. Secondly, a gene dosage difference between the two sexes arises as 
one of the sex chromosomes progressively shrinks in size and its gene content dimin-
ishes. It is likely that the process of erosion is constrained by deleterious effects 
caused by these gene dosage changes. Therefore, not all autosomes might be suitable 
for forming small sex chromosomes. In some instances, sex chromosomes appear to 
avoid erosion (Bachtrog et al. 2014), which might reflect a requirement to maintain 
ancestral gene dosage and prevents dosage compensation systems from arising.
Chromosome-wide dosage compensation systems have been discovered in worms, 
flies, and mammals (. Fig. 4.2). In some species, distinct processes are involved in 
adjusting dosage difference between the sexes and dosage differences between sex 
chromosomes and the ancestral autosome pair. This is the case in mammals, which 
possess a single active X chromosome in both sexes. Transcriptional silencing of one 
of the two X chromosomes in female mammals by the process of X chromosome 
inactivation approximates gene expression of the single male X chromosome. In this 
case, a reduction in fitness due to emerging differences in gene dosage between the 
sexes appears to have driven the evolution of dosage compensation. The mechanism 
of X to autosome (X:A) compensation remains to be resolved in mammals. In con-
trast, in the fruit fly D. melanogaster the regulation of the sex chromosomes is accom-
plished in a manner that balances gene dosage between the sexes and restores the 
level of X chromosome expression in males relative to the ancestral autosome pair. 
This is facilitated through the transcriptional hyperactivation of genes on the single 
X chromosome in males, such that an expression level is achieved that corresponds to 
two X chromosomes in females. Thus, the evolution of the dosage compensation 
system in flies appears to be driven by the adjustment of X-linked expression, such 
that it maintains gene expression levels between the sexes as well as the expression 
level of the ancestral autosome pair. In the worm C. elegans, the two X chromosomes 
1 Reduction of  fitness caused by shifts in sex chromosomal to autosomal gene dosage is consistent 
with studies on human monosomies, which show that inheritance of  a single autosome in an other-
wise diploid genome has high fitness costs. Human monosomies are generally detrimental and only 
monosomy X, and monosomies of  smaller parts of  chromosomes 5 and 1 are viable. Trisomies are 
also detrimental and only trisomy 13, 18, and 21 are viable in humans leading to Patau, Edwards, 
and Down syndrome, respectively.
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in hermaphrodites are partially repressed to approximate the gene expression level of 
the single X chromosome in males, which are XO. In C. elegans, it is again the dosage 
difference between the sexes that appears to drive the evolution of the dosage com-
pensation mechanism. All studied dosage compensation systems to date have arisen 
within the context of an XY or XO sex chromosome system where the males carry 
the heteromorphic sex chromosome pair. Thus far, no chromosome-wide dosage 
compensation systems have been identified in ZW systems with heteromorphic 
female sex chromosomes. Consistent with the idea that X chromosomal dosage com-
pensation in flies, worms, and mammals have evolved independently, these processes 
adopt molecularly distinct strategies and possess distinct genetic requirements.
4.2  The Dosage Compensation Complex of the Fruit Fly 
Drosophila melanogaster
The dosage compensation system of the fruit fly D. melanogaster has been extensively 














female male  . Fig. 4.2 Overview of  dosage 
compensation in mammals, flies, 
and worms. X-linked gene 
expression differences between 
the sexes are compensated by 
different strategies. Mammals 
inactivate one of  the two X 
chromosomes in female cells. In 
D. melanogaster the single male 
X chromosome is hyperacti-
vated, and in C. elegans both X 
chromosomes are partially 
repressed in hermaphrodites
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chromosome system where a single X chromosome is present in male flies.2 The sin-
gle male X chromosome is the target of a dosage compensation complex (DCC) 
which acts to enhance transcription and, thereby, approximates the expression from 
two X chromosomes in female flies. In this manner, not only the difference in X-linked 
gene expression between the sexes but also the ancestral X:A ratio is restored. Thus, 
the single male X chromosome emulates an ancestral pair of two X chromosomes. 
Conceptually, the single X chromosome needs to be identified to target  transcriptional 
upregulation. In addition, dosage compensation needs to be regulated to prevent 
aberrant hyper-transcription of the two X chromosomes in females. In D. melanogas-
ter, dosage compensation and sex determination are regulated by a common upstream 
pathway that senses the number of X chromosomes. If  a single X chromosome is 
present, this pathway diverges to regulate male sex differentiation and independently 
induces to the formation of the DCC.
The components of the DCC have been identified in genetic screens for mutations 
that prevent the development of male flies. The Male specific lethal (Msl) factors 
Msl1, Msl2, and Msl2 as well as Male lethal (Mle) and Males absent on the first 
(Mof) are proteins that contribute to the formation of the DCC. The respective genes 
are genetically required for male but not female development. Notably, the Msl2 
protein is only present in males but not in females. Msl2 is regulated by the sex deter-
mination cascade and is essential for DCC assembly. Its absence in females prevents 
erroneous dosage compensation of both X chromosomes. Thus, Msl2 presents a 
molecular link between sensing the presence of a single X chromosome and assembly 
of the DCC. Once the DCC is assembled in male embryos, it is targeted to multiple 
sites on the single X chromosome. These sites have been referred to as chromosome 
entry sites as they appear to confer independent affinity for the binding of the 
DCC.  These sites have further been associated with the DNA-binding protein 
CLAMP. CLAMP appears to be required for association of the DCC with chromo-
some entry sites and has also other functions in addition to its role in dosage com-
pensation. Because mutations affecting CLAMP are detrimental to both male and 
female development, it could not be identified as a component of the DCC in the 
original genetic screens.
The DCC spreads out from chromosome entry sites over the entire X chromo-
some. DCC spreading is dependent on non-coding RNAs and the RNA helicase Mle. 
The discovery that functional RNAs are essential components of the Drosophila dos-
age compensation system was made serendipitously. Two genes encoding RNA on the 
X 1 (roX1) and rox2 were isolated as transcripts that are specifically expressed in 
males but not females. Their discovery was made considerably later than the identifi-
cation of the protein components of the dosage compensation system. A likely rea-
son why roX1 and roX2 were not discovered in genetic screens is that both RNAs are 
functionally redundant. Male development requires either roX1 or roX2. Only com-
bined mutations of roX1 and roX2 lead to a failure of dosage compensation and 
male lethality. It is thought that Mle, which encodes an RNA helicase, mediates the 
association of roX1 and roX2 with the Msl complex. Association of Mle and roX 
2 Drosophila males do possess a Y chromosome that contains a small number of  genes but it does not 
specify male sex. Therefore, the Y chromosome is not relevant for sex determination in flies.
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RNA thereby facilitates the spreading of dosage compensation from chromosome 
entry sites over the entire X chromosome.
Recruitment of the DCC to the X chromosome induces changes to chromatin 
and facilitates elevated transcription. An important component of the DCC that has 
been implicated in transcriptional regulation is the histone acetyltransferase Mof. 
Mof catalyzes the acetylation of histone H4 lysine 16 on the X chromosome in males 
(. Fig. 4.3). The activity of Mof thereby contributes to the transcriptional activa-
tion of the single male X chromosome, consistent with the idea that acetylation of 
lysines in histone tails has an activating role for gene expression and facilitates acces-
sibility of the DNA (see book 7 Chap. 1 of Wutz, and 7 Chap. 2 of Paro). The rel-
evance of the observation that lysine 16 is specifically targeted by Mof for dosage 
compensation remains to be further explored. Furthermore, it appears that histone 
acetylation on the X chromosome is not stable or heritable by itself  but depends on 
the continued recruitment of the DCC (see 7 Box 4.1). Depletion of Mof or Msl2 
by RNA interference in cultured male D. melanogaster S2 cells was shown to cause a 
loss of histone H4 lysine 16 hyper-acetylation on the X chromosome (Zhang et al. 
2010). Although, the mechanism of dosage compensation in flies has been well char-
acterized, our understanding is far from complete and, certainly, additional compo-
nents of the dosage compensation pathway will be identified in the future. In this 
context, it is interesting to note that the kinase JIL1 was found associated with the 
DCC but its role in dosage compensation remains unclear.
  . Fig. 4.3 Enrichment of 
H4K16ac on the X chromo-
some in D. melanogaster males. 
Immunostaining of  a polytene 
chromosome spread with an 
antiserum specific for H4K16ac 
identifies the X chromosome in 
males. Polytene chromosomes 
are obtained from salivary 
glands and contain many 
strands of  DNA due to 
endoreduplication of  the 
genome in this polyploid tissue. 
This makes them well-suited 
for microscopy studies. (From 
Bone et al. (1994))
Depletion of  MSL2 or MOF by RNA 
interference in S2 cells leads to loss of 
H4K16ac on X-linked gene promoters. a 
A Western analysis shows MSL2 and 
MOF protein abundance following 
RNAi-mediated depletion (msl2 and mof 
RNAi) and control (Mock) transfected 
S2 cells. b A schematic representation of 
H4K16ac enrichment over genes from 
the X chromosome and the right arm of 
Box 4.1: A Conceptual Experiment: Testing the Heritability of Chromatin Marks 
on the D. melanogaster Male X Chromosome (. Box Fig. 4.1)
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chromosome 3 as an autosomal control. 
H4K16ac enrichment was determined by 
ChIPseq (see book 7 Chap. 1 of  Wutz). 
The data are represented relative to 
DNA in the chromatin preparation to 
normalize for different sequence counts 
in different genomic regions. Each line 
represents a gene, the columns corre-
spond to S2 cells as indicated on top of 
panel a.  Genes enriched (yellow) and 
depleted (blue) for H4K16ac are indi-
cated.
S2 cells were derived from male fly 
embryos and possess a single X chromo-
some that is subject to dosage compensa-
tion. Conversely, the X chromosome is 
a
b
  . Box Fig. 4.1 Depletion of  msl2 and 
mof in S2 cells
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The components of the D. melanogaster DCC have been investigated in distantly 
related insects to study the evolution of dosage compensation. An Msl complex is 
present in the distantly related insect Sciara (Ruiz et  al. 2000) but localizes to all 
chromosomes in both sexes. The absence of sex-specific differences suggests that the 
Sciara Msl complex is not involved in dosage compensation and might have other 
functions. This points to a diversity of molecular mechanisms for dosage compensa-
tion among different insects. Interestingly, an independent chromosome-wide mark-
ing system has been observed on the fourth chromosome in D. melanogaster. The 
Painting of fourth (POF) protein associates with the fourth chromosome (. Fig. 4.4) 
where it enhances gene expression (Johansson et al. 2007). Initially, POF appeared to 
be unrelated to dosage compensation. However, a link between POF and an ancestral 
sex chromosome and dosage compensation system has recently been uncovered 
(Vicoso and Bachtrog 2013). The fourth chromosome of D. melanogaster is part of 
the sex chromosome in other fly species. POF is targeted to the male X chromosome 
in D. busckii and D. ananassae (Stenberg and Larsson 2011). In the latter, POF is 
recruited together with H4K16ac and the Msl complex. Overlap of chromatin marks 
of the X and fourth chromosome can be observed to varying degrees in different fly 
species. These observations could suggest a common origin of both pathways in an 
ancestral dosage compensation system and a potential separation of the X and forth 
chromosome in the lineage that led to the evolution of D. melanogaster. It is interest-
ing to speculate that chromosome-wide modifications might be more common than 
would appear from the limited number of examples that are known today.
4.3  X Chromosome Inactivation in Mammals
In mammals, dosage compensation of X-linked genes is achieved by repression of 
one of the two X chromosomes in female cells. X chromosome inactivation ensures 
that, in both sexes, a single X chromosome remains active. This mode of dosage com-
pensation might appear less intuitive than the D. melanogaster system as the ances-
  . Fig. 4.4 Chromosome-wide 
marking of  D. melanogaster X 
and fourth chromosomes. 
Immunostaining of  POF (red) 
and Msl3 (green) of  polytene 
chromosomes from D. melano-
gaster male salivary glands. 
(From Stenberg and Larsson 
(2011))
highly enriched for H4K16ac in control 
S2 cells. After depletion of  MSL2 or 
MOF, this enrichment is lost and the X 
chromosome appears similar to chromo-
some 3R. This shows that the continuous 
activity of  the DCC is required to main-
tain dosage compensation in S2 cells. 
(From Zhang et al. (2010))
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tral X:A gene expression ratio is changed from 2X:2A to 1X:2A. The relative X:A 
dosage shift associated with the evolution of the mammalian XY chromosome sys-
tem could reduce fitness. In addition, mutations on the single X chromosome that is 
transcribed in both sexes are functionally hemizygous and cause phenotypes at a 
higher rate than recessive mutations on autosomes where complementation by the 
homolog is possible. Notably, random choice of which X chromosome is inactivated 
in placental mammals protects females from X-linked hemizygosity to some extent. 
Females comprise of a genetic mosaic of cells expressing either X-chromosome. 
Hence, in case of a heterozygous mutation, half  of the cells will express the intact 
gene. However, it remains unknown to what extent the fitness costs arising from the 
evolution of the mammalian sex chromosome and dosage compensation systems 
have been absorbed. Although the evolution of X chromosome inactivation remains 
largely unclear, one potential scenario might be that it was derived from an extension 
of meiotic inactivation of unpaired chromosomes. Meiotic sex chromatin inactiva-
tion (MSCI) is a process that results in the transcriptional inactivation of unpaired 
chromosomes in meiosis during germ cell development. This process has been 
observed in a wide range of animal species. Inactivation is thought to allow unpaired 
chromosomes to be passed through meiosis. Reactivation of MSCI normally occurs 
after fertilization when embryo development starts. One might speculate that a per-
petuation of MSCI of the paternal X chromosome might have evolved in mammals. 
As the paternal X chromosome is largely unpaired in male (XY) meiosis, silencing 
would be initiated by MSCI. In marsupial mammals, transcriptional inactivation of 
the paternally inherited X chromosome is observed, suggesting that imprinted X 
chromosome inactivation in marsupials might be based on mechanisms that extend 
silencing of MSCI. The process of random X chromosome inactivation in placental 
mammals poses a greater challenge to explain. Each female cell nucleus possesses 
two potentially genetically identical X chromosomes, whereby one is inactivated and 
the other remains active. Hence, both chromosomes assume divergent fates in the 
same nucleus. Therefore, a novel and complex mechanism had to be established at the 
split of placental and marsupial mammals.
4.3.1  The Mammalian Dosage Compensation Mechanism
The inactive X chromosome (Xi) was discovered serendipitously when a dark stained 
dot was observed in the nucleus of neurons from female cat brains (. Fig. 4.5). This 
dot was not present in male cat neurons (. Fig. 4.5). From this study, the Xi acquired 
its colloquial name “Barr body” in recognition of its discoverer (Barr and Bertram 
1949). Subsequent studies revealed the identity of the Barr body as the Xi and the 
process of random X inactivation. A key insight into the mechanism was the identi-
fication of a transcript that is expressed only in female cells and encoded on the X 
chromosome. The X inactive specific transcript (XIST) gene was initially identified in 
humans and shown to produce a functional RNA that associates with the Xi. XIST 
is located within a region of the X chromosome that contains additional regulators 
of dosage compensation which together make up the X inactivation center (XIC). 
The XIC encompasses elements that signal the presence of an X chromosome and 
regulate XIST expression if  more than one is present. XIST expression precedes the 
transcriptional repression of genes on the Xi. Therefore, XIST is an appealing solu-
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tion to restrict dosage compensation to one of the two X chromosomes in female 
cells. XIST specifically associates with the chromosome from which it is produced. 
The X chromosome that does not express XIST remains active. Since male cells con-
tain only a single active X chromosome, they do not express XIST in general. 
Conceptually, the issue arises as to how XIST prevents its own repression on the Xi, 
when the majority of gene promoters are inactivated. Actually, a number of genes 
are known that escape X inactivation and remain expressed from the Xi. This obser-
vation points to the existence of specific expression control elements in the promoters 
of XIST and genes that escape X inactivation, but this aspect remains incompletely 
understood.
XIST localization to the Xi induces modifications of chromatin and gene repres-
sion. The formation of a fully inactivated X chromosome then occurs through 
sequential changes to Xi. Studies in mouse embryonic stem cells (ESCs), which reca-
pitulate the process of X chromosome inactivation, have led to the view of a multi-
step process. Xist RNA recruits chromatin modifiers including Polycomb group 
(PcG) proteins and the mammalian homologue of Split ends (SPEN), an RNA-
binding protein. Initially, repression and chromatin changes are dependent on XIST 
expression. Reactivation and complete reversion to an active X chromosome is 
observed when Xist is lost at this stage. This phase of X inactivation is referred to as 
the initiation phase, when Xist-dependent gene repression and chromatin changes are 
established that are reversible (. Fig.  4.6a). The initiation phase is distinguished 
from the maintenance of gene repression on Xi in differentiated somatic cells. During 
development, the Xi acquires a series of chromatin modifications as cells differenti-
ate into mature cell types of the tissues. Chromatin changes on the Xi include the 
deposition of the histone H2A variant macroH2A, the loss of acetylation of histone 
H4, and the acquisition of DNA methylation at promoters of repressed genes. At 
this stage, Xist becomes dispensable for maintaining gene repression on the Xi. 
Therefore, the repressed state is perpetuated in a heritable manner without Xist. 
Stable maintenance of gene repression that is independent of XIST characterizes the 
maintenance phase of X chromosome inactivation (. Fig. 4.6a). The fact that Xist, 
  . Fig. 4.5 The inactive X chromosome observed in neurons of  female cats. Microscopy images of 
stained cat neurons show the cell darkly and the nucleus lightly stained. Within the nucleus, the large 
dark round spot is the nucleolus. Near the nucleolus, a smaller dark spot (arrow) can be observed in 
female neurons (left and right) but not in those of  males (center). This is the inactive X chromosome 
which, in recognition of  its discoverer, is also referred to as Barr body. (From Barr and Bertram (1949))





















































  . Fig. 4.6 Chromosome-wide gene silencing during X chromosome inactivation. a Developmental 
changes of  chromatin on the Xi are aligned with the initiation and maintenance phase of  X chromo-
some inactivation. b Molecular interaction of  Xist A-, B-, and E-repeats are indicated. c Recruitment of 
PRC1 and PRC2 in X chromosome inactivation is shown. These pathways lead to chromosome- wide 
modification of  the Xi with H3K27me3 and H2AK119ub
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which is the initial trigger of repression, is no longer needed for the maintenance 
phase, illustrates the characteristics of epigenetic memory (see book 7 Chap. 3 of 
Paro).
XIST is a long RNA that lacks a reading frame encoding proteins. This observa-
tion, together with its localization over the Xi, indicate that the functional product of 
the Xist gene is a transcript rather than a protein. A number of elements with repeated 
sequence motifs have been identified along Xist RNA.  Deletion of one of these 
repeated elements at the 5′ end of Xist, which is referred to as Xist A-repeat, abolishes 
the function of Xist for gene repression (. Fig. 4.6b). In this case, many modifica-
tions of chromatin can be observed on the Xist-coated X chromosome independent 
of gene repression (7 Box 4.2). This introduces a conceptual problem: how can 
genes remain active on a chromosome that carries chromatin modifications associ-
ated with heterochromatin? A potential explanation is the spatial separation of het-
erochromatin and genes. Genes appear to be positioned in the periphery of the X 
chromosome territory (CT), where they do not overlap with the domain of Xist 
RNA. Xist RNA establishes a domain enriched in heterochromatic modifications 
and forms a repressive compartment in the core of the CT (see book 7 Chap. 1 of 
Wutz). Xist repeat-A is required for the repression of genes but not for the formation 
of the repressive compartment. Once genes are repressed, they associate with Xi het-
erochromatin. However, if  repeat-A is deleted from Xist, repression of genes and 
association with the repressive compartment are not observed. These studies suggest 
that two types of chromatin are initially distinguished on the Xi and spatial organiza-
tion of chromatin might play an important role during the initiation of X chromo-
some inactivation.
Expression of Xist RNA without the 
A-repeat leads to chromosome-wide chro-
matin changes but prevents the repres-
sion of X-linked genes. A heterologous 
expression system has been engineered 
in male ESCs to force expression of Xist 
without the A-repeat. a Staining with an 
antiserum specific for acetylated histone 
H4 (green) reveals a single hypoacety-
lated chromosome, which is identified as 
the X chromosome by DNA FISH using 
an X chromosome paint (red). b Histone 
H4 hypoacetylation is observed even 
after 9 days of differentiation, consistent 
with the observation that X-linked genes 
are expressed. A novel chromosome con-
figuration that carries chromatin modifi-
cations associated with the Xi and active 
genes is displayed in this experiment. 
A magnified view of this Xiag (for Xi 
with active genes) is shown on the right. 
Notably, stripes of chromatin containing 
acetylated histone H4 can be discerned 
that would be missing from a silent Xi. 
These stripes of active chromatin might 
represent clusters of active genes that are 
spatially separated from heterochroma-
tin. (From Pullirsch et al. (2010))
Box 4.2: A  Conceptual Experiment: Separation of  Gene Repression and 
Chromatin Modifications on the Mouse X Chromosome (. Box Fig. 4.2)
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The mechanism of gene repression by Xist has been investigated. The RNA- binding 
protein SPEN binds to the Xist A-repeat (. Fig. 4.6b) and is required for the func-
tion of Xist in gene repression. Mutations affecting SPEN phenocopy the deletion of 
Xist repeat-A in cultured mouse ESCs. SPEN associates with NCoR/SMRT co-
repressor complexes, which contain the histone deacetylase HDAC3. The latter sug-
gests that histone deacetylation contributes to the gene silencing pathway of Xist. A 
conceptually important question is how Xist function in repressing genes can be 
localized to the X chromosome from which it is expressed. The RNA binding protein 
hnRNPU is required for localizing Xist RNA to Xi in specific cellular contexts. 
Notably, hnRNPU is a protein that associates with the nuclear scaffold and is also 
referred to as Scaffold attachment factor A (SAF-A). Interactions with non- 
chromatin nuclear organization seems to contribute to the specific localization of 
Xist to the Xi. Recently, the cyclin binding protein CIZ1 has also been shown to be 
required for Xist localization in differentiated somatic cells but not in embryonic 
cells. CIZ1 is enriched at the Xi, apparently mediated by the Xist repeat-E 
(. Fig. 4.6b).
During the initiation phase of X chromosome inactivation, PcG proteins (see 
book 7 Chap. 3 of Paro) are recruited to the Xi. This Xist RNA-dependent recruit-
ment mechanism has been analyzed in detail. The RNA-binding protein hnRNPK is 





  . Box Fig. 4.2 Chromosome-wide histone H4 hypoacetylation is triggered by Xist indepen-
dent of  gene silencing
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to represent binding sites for hnRNPK. Initially, a complex containing the PcG pro-
teins PCGF3 or PCGF5 and the catalytic subunit of Polycomb Repressive Complex 
1 (PRC1), RING1B (. Fig. 4.6b), is recruited by hnRNPK to Xist. This atypical 
PRC1 complex mediates ubiquitinylation of histone H2A lysine 119 (H2AK119ub). 
This modification has two functions. Firstly, it can recruit additional PRC1 com-
plexes that contain RyBb which has affinity for H2AK119ub. Secondly, Jarid2 binds 
H2AK119ub and activates PRC2. PRC2 contains the histone methyltransferase 
EZH2 and catalyzes tri-methylation of histone H3 lysine 27 (H3K27me3) on the Xi. 
H3K27me3 can, in turn, enhance the recruitment of PRC2 through the EED protein, 
which has affinity for H3K27me3. In addition, recruitment of canonical PRC1 com-
plexes is mediated through the CBX7 subunit, which contains a chromodomain with 
affinity for H3K27me3. Multiple interactions between PcG proteins and histone 
modifications generate a feed-forward loop that results in a strong enrichment of 
PcG proteins over Xi (. Fig. 4.6b). Spreading of PcG complexes leads to a high 
amount of histone modifying activity and, therefore, nearly all histone H3 on the Xi 
carry the H3K27me3 modification. Multiple interactions between PcG complexes 
endow this chromatin modification system with a substantial robustness. Random X 
chromosome inactivation appears not materially affected when individual PcG pro-
teins are mutated. A mutation in the EED gene diminishes PRC2 activity and blocks 
the establishment of H3K27me3 on Xi but not the recruitment of PRC1 complexes, 
establishment of H2AK119ub, and gene repression. Furthermore, additional require-
ments for the recruitment of PcG proteins to Xi appear to exist. For example, a 
depletion of SPEN has been shown to reduce the amount of PcG complexes that are 
recruited by Xist. However, it is not clear whether SPEN directly interacts with PcG 
complexes or indirectly causes an effect on PcG recruitment by influencing gene 
repression or Xist RNA modification. It is noteworthy that a deletion of Xist repeat-
 A appears to have less effect on PcG recruitment by Xist than the mutation of 
SPEN. Future studies will be required to explain these observations.
Additional factors that contribute to the initiation of X chromosome inactivation 
include lamin B receptor (LBR) and a complex that mediates methylation of ade-
nines on RNA. It is likely that several of these molecular pathways act in parallel 
and, through their combination, bring about the remarkable localization and repres-
sive function of Xist RNA. Conceptually, it is tempting to speculate that Xist RNA 
might contain multiple binding sites for different complexes, repeat-A, -B and –C, 
and –E are examples in support of this view (. Fig.  4.6b). Thus, X inactivation 
might instantiate novel combinatorial functions of molecular components that have 
other roles in distinct biological processes.
The maintenance of X chromosome inactivation involves other factors than its 
initiation. The atypical structural maintenance of chromosomes (SMC) protein 
SMC hinge domain 1 (SmcHD1) has been identified in a genetic screen in mice. A 
mutation in SmcHD1 causes female-specific lethality, suggesting a role in dosage 
compensation (Blewitt et al. 2008). Subsequent studies could show that SmcHD1 is 
required for the maintenance of gene repression and promoter DNA methylation in 
somatic cells. In contrast, the initiation of X chromosome inactivation is largely 
unaffected by a mutation in SmcHD1. SmcHD1 is conceptually important as it is a 
rare example of a gene whose mutation causes sex-specific lethality in mammals 
(another one being Xist). Many components of the dosage compensation system 
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have additional functions that are also required in males. For example, the hnRNPK 
mutation is embryonic lethal in mice of both sexes (Gallardo et al. 2015).
Although most of the genes on the Xi are transcriptionally silenced, certain genes 
remain active on the Xi. Some of these genes are located in regions of the X chromo-
some that are homologous with the Y chromosome and exchange genetic informa-
tion through recombination during meiosis in male germ cells through X-Y pairing. 
Genes within these pseudoautosomal regions (PARs) of the X chromosome are pres-
ent in two copies in both sexes, similar to autosomal genes. Therefore, these genes do 
not require dosage compensation and remain transcriptionally active on the Xi. In 
addition, several genes that do not possess homologues on the Y chromosome are 
expressed from the Xi. These genes are referred to as escape genes and the phenom-
enon is called “escape from X inactivation”. Escape genes are important for under-
standing phenotypes that arise from numerical aberrations of sex chromosomes 
including the human Klinefelter (XXY) and Turner (XO) syndromes. The level of 
expression of escape genes from the Xi often does not reach that of the X chromo-
some that remains active (Xa). Furthermore, for some genes, tissue-specific escape or 
polymorphic escape among individuals has been observed (Carrel and Willard 1999, 
2005). The molecular features that determine whether a gene is repressed or remains 
active on the Xi remain to be explored further. Notably, it appears that a higher fre-
quency of escape genes can be observed in regions of the X chromosome that were 
recently acquired from autosomal fusions. This correlation could indicate that chro-
mosomal features change in evolution to accommodate dosage compensation.
4.3.2  Regulation of XCI in Different Mammals
The Xist gene originated before the radiation of placental mammals3 (. Fig. 4.1). 
However, mammalian sex chromosomes and dosage compensation systems have 
continued to evolve after the dosage compensation system was established. Even 
today, evolution continues to introduce changes into sex chromosome and dosage 
compensation systems among placental mammals, which can be illustrated by strik-
ing examples. Dominant mutations that specify female fate have arisen on the X 
chromosomes of lemmings and African pygmy mice (Veyrunes et  al. 2010). As a 
consequence, females that possess one X chromosome carrying a dominant modifier 
and a Y chromosome (X*Y females) can be observed along with XX and XX* 
females, and XY males. Possibly, the increased ratio of females over males was 
favored in these species. In contrast, novel autosomal male sex determining factors 
can be observed in specific vole species (Mulugeta et al. 2016). A novel autosomal sex 
determination mechanism has led to the loss of the second sex chromosome in voles 
of the species Ellobius lutescens. A single X chromosome is present in both males and 
females and likely X chromosome inactivation is no longer initiated. E. talpinus and 
E. tancrei possess two X chromosomes in both sexes and have lost their Y chromo-
somes entirely. It is likely that X chromosome inactivation occurs in both sexes of 
3 Evolutionary radiation of  placental mammals followed the extinction of  the dinosaurs 65 million 
years ago. In the late Cretaceous, placental mammals were mostly represented by small shrew-like 
animals from which such diverse species as mice, bats, dolfins, cows, dogs, and humans evolved.
 Chapter 4 · Dosage Compensation Systems
83 4
these species. These examples illustrate dramatic changes in sex determination strate-
gies between closely related species. They are accompanied by a gain or loss of het-
eromorphic sex chromosomes and dosage compensation processes. The presence of 
an inactive X chromosome in E. talpinus males and females bears some reminiscence 
of the modified fourth chromosome in D. melanogaster as an evolutionary relict of a 
past sex chromosome system.
In placental mammals, chromosome-wide silencing is a consequence of Xist 
expression. The regulation of Xist is, therefore, important for correct dosage com-
pensation whereby, in males, a single X chromosome remains active and, in females, 
one of the two X chromosomes is inactivated. Conceptually, it has been proposed 
that blocking factors would prevent Xist activation in male cells. In female cells, 
X-linked activation factors would be produced from two X chromosomes in sufficient 
amounts to counteract the blocking factors and lead to Xist expression. Blocking 
factors are expected to be encoded on autosomes and to set a threshold in male and 
female cells for X-linked activation factors to induce Xist expression. The identity 
of these blocking factors and X-linked activators remains to be fully understood 
but several genes with predicted properties have been identified (. Fig. 4.7a). These 
genes appear to be species-specific, likely reflecting the evolutionary divergence of 
placental mammals.
In mice, the X-linked gene Rnf12/RLim can trigger Xist expression in male ESCs 
when it is expressed from transgenes. This observation suggests that Rnf12/RLim is 
an X-linked activator of X chromosome inactivation. The function of Rnf12/RLim 
in female mouse embryos appears to be restricted to the initiation of imprinted X 
inactivation in early embryos (. Fig.  4.7b). Therefore, it has been proposed that 
other activators might act in the regulation of random X chromosome inactivation 
in mice.
Also, the mechanism of blocking factor function has been studied. A potential 
gene that likely acts downstream of blocking factors and negatively regulates Xist 
expression is the non-coding RNA gene Tsix, whose name is derived from the reverse 
spelling of Xist because it is transcribed in antisense orientation to Xist (. Fig. 4.7a). 
Tsix represses the promoter of Xist on the same chromosome from which it is 
expressed and, therefore, can be considered a cis-acting repressor. Tsix is the target of 
autosomal factors that enhance Tsix transcription and can be considered as blocking 
factors (. Fig. 4.7a). Among these factors are several transcription factors that are 
expressed in early embryos and repress Xist. These factors are not exclusively func-
tioning in dosage compensation but have also other roles in embryo development.
For understanding the regulation by blocking factors, it is helpful to examine the 
function of the Tsix and XACT genes in mice and humans, respectively. Both genes 
are X-linked and produce non-coding transcripts. They are cis-acting repressors of 
Xist and their expression is associated with Xa. Yet, Tsix and XACT are not con-
served between mouse and human and likely act by different molecular mechanisms. 
XACT encodes a non-coding transcript that associates with the chromosome terri-
tory of the Xa and appears to counteract XIST localization and gene repression. In 
humans, both X chromosomes in female cells initially express XIST but X-linked 
gene silencing appears to be incomplete. The reduced gene expression caused by this 
early wave of XIST expression is referred to as “dampening” instead of silencing of 
X-linked gene expression and is exclusively observed in humans. It is conceivable that 
antagonistic interactions between XACT and XIST contribute to dampening. As 
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embryo development progresses, one X chromosome maintains XIST expression and 
initiates gene silencing whereas the second X chromosome remains active and is cov-
ered by XACT. XACT expression ceases as cell differentiation progresses further, 
suggesting a role for XACT specifically in regulating the initiation phase of X inacti-
vation. The observation that independent cis-acting repressors of Xist have evolved 
in mice and humans suggests a model where blocking factors activate these X-linked 
RNAs, thereby counteracting the initiation of X inactivation. If  this view were cor-
rect, blocking factor abundance or activity would be integrated at the promoters of 
Tsix and XACT.
In marsupials, inactivation of the paternally inherited X chromosome is observed. 
Imprinted X inactivation is distinct from random X inactivation that is exclusive to 
placental mammals (. Fig. 4.1). In the American opossum Monodelphis domestica, 




























  . Fig. 4.7 Regulation of  X chromosome inactivation in mice. a Xist expression is stimulated by 
X-linked activators, including Rnf12. Blocking factors enhance expression of  Tsix that is a cis-acting 
repressor of  Xist. In males, X-linked activators are not abundant enough to overcome the repressive 
effect of  blocking factors and X inactivation is not initiated. b Imprinted (orange) and random (red) X 
chromosome inactivation in mouse embryos. Initially, the paternally inherited X chromosome in inacti-
vated in 4-cell embryos. The Xi is maintained in the extraembryonic membranes and placenta but reac-
tivated in the epiblast. After implantation, random inactivation of  the maternal or paternal X 
chromosome is initialed in the cells of  the developing embryo. Once the Xi is chosen, all descendants of 
the cell maintain this choice, giving rise to a genetic mosaic of  patches of  cells
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Xist encode non-coding RNAs that associate with the Xi chromosome territory. Xist 
has evolved from the Lnx3 gene, which is a protein-coding gene in extant vertebrates 
(Duret et al. 2006). In contrast, Rsx seems to have arisen from a gene in proximity to 
the Hprt gene that is distinct from Lnx3, which remains protein-coding in marsupi-
als. Therefore, Xist and Rsx are likely products of convergent evolution as the dosage 
compensation mechanisms of marsupials and placental mammals share a number of 
similarities. Both mechanisms include non-coding RNAs and involve the acquisition 
of H3K27me3 over repressed X-linked genes (Wang et al. 2014). It could be specu-
lated that the molecular basis for this dosage compensation mechanism existed before 
the split of marsupial and placental mammals and had emerged likely soon after the 
split from monotremes. Divergence might have subsequently led to the origin of Xist 
and Rsx in independent phylogenetic lineages (. Fig. 4.1). In contrast, dosage com-
pensation in platypus appears partial and gene-specific, similar to dosage compensa-
tion in birds.
4.4  X Chromosome Dosage Compensation in Caenorhabditis 
elegans
C. elegans reproduces through hermaphrodites that possess two X chromosomes and 
produce sperm and eggs. Environmental triggers can induce the production of males 
with a single X chromosome but no Y chromosome. Dosage compensation in the 
worm equalizes X-linked gene expression to the single X chromosome in males. For 
this, genes on both X chromosomes are repressed in hermaphrodites. C. elegans pos-
sesses a dosage compensation complex (DCC) that contains structural maintenance 
of chromosomes (SMC) proteins and resembles a condensin-like complex (see book 
7 Chap. 1 of Wutz). Therefore, the composition of the fly and worm DCCs are dif-
ferent and, in the worm, the DCC is recruited to both X chromosomes of hermaph-
rodites. DCC recruitment leads to an impairment of transcription to reduce the gene 
expression level by half  to match that of the single male X.
Components of the C. elegans DCC have been identified by screening for sex- 
specific lethal mutations. Whereas defects in dosage compensation cause male lethal-
ity in D. melanogaster, they lead to lethality of hermaphrodites in C. elegans. The 
SMC protein MIX-1, together with several subunits that are shared with condensin, 
make up the DCC (. Fig. 4.8). The SMC family of proteins has functions in orga-
nizing chromatin during cell division, coordination of gene expression, and DNA 
repair. In the case of the C. elegans DCC, SMC proteins mediate a partial repression 
of transcription on both X chromosomes. As a consequence of DCC localization, 
H4K20me1 is enriched on the two X chromosomes.
In C. elegans, the number of X chromosomes determines sex and initiates dosage 
compensation (. Fig. 4.8). The DCC is engaged by SDC-2, which also functions to 
suppresses male development. SDC-2 localizes to both X chromosomes together 
with the DCC.  The dosage compensated X chromosomes contain low levels of 
H4K16ac. Recent studies provided evidence that deacetylation of H4K16ac can 
already be observed early in worm development before the DCC is recruited. This 
early deacetylation seems to require a PRC2-like complex that contains MES2, a 
homologue of E(z), MES3, and MES6. This suggests the presence of an initiation 





  . Fig. 4.8 Genetic control of  sex determination and dosage compensation in C. elegans. a xol-1 is the 
master sex-determination gene that controls both sex determination and dosage compensation. It is the 
direct molecular target of  the X-chromosome counting mechanism that determines sex. In XX her-
maphrodites, two doses of  the X-signal elements (XSEs) repress xol-1 by overcoming the xol-1 activa-
tion achieved by autosomal signal elements (ASEs). xol-1 repression occurs at the level of  transcription 
and pre-mRNA splicing. When xol-1 is repressed, the XX-specific gene SDC-2 is active and stabilizes 
SDC-3. SDC-2 acts with SDC-3 to target dosage compensation proteins to the X chromosome, thereby 
repressing gene expression by half. SDC-2 plays the lead role in recognizing X-specific sequences. It is 
the only dosage compensation protein expressed solely in XX animals. SDC-2 also activates the her-
maphrodite program of  sexual development by repressing the male-specific sex-determination gene her-
1. SDC-2 acts with SDC-3 to recruit dosage compensation proteins to her-1. In this case, SDC-3 plays 
the lead role in recognizing her-1 DNA targets. The her-1 and X complexes differ by one component: 
DPY-21 is present on the X but not at her-1. b In XO males, the single dose of  XSEs is insufficient to 
overcome the activating influence of  ASEs. xol-1 is active and promotes male fate by repressing the 
activities of  sdc genes. her-1 is transcribed and the single X is not repressed. In xol-1 XO mutants, the 
dosage compensation complex localizes to the single X chromosome, killing XO animals by reducing 
X-linked gene expression. (Copyright: © 2005 Barbara J. Meyer. From Meyer, B.  J. X-Chromosome 
dosage compensation (June 25, 2005), WormBook, ed. The C. elegans Research Community, Worm-
Book, doi/7 https://doi.org/10.1895/wormbook.1.8.1, 7 http://www. wormbook. org., which permits 
unrestricted use, distribution, and reproduction in any medium, provided the original author and source 
are credited)
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and maintenance phase in C. elegans dosage compensation. The DCC is required to 
maintain partial repression and reduced H4K16ac on the X chromosomes. These 
observations suggest some similarities to dosage compensation in mammals, where 
the Xi shares features including H4K20me1 enrichment, histone H4 hypoacetylation, 
as well as PRC2 recruitment. Notably, SmcHD1 is involved in maintenance of the Xi 
and shares the hinge domain of SMC proteins. Although hypo-transcription of X 
chromosomes in C. elegans hermaphrodites is superficially similar to dampening of 
X-linked gene expression in early human embryos, any mechanistic similarity remains 
to be demonstrated. Thus far, no RNAs have been implicated in dosage compensa-
tion in C. elegans, where both X chromosomes in hermaphrodites appear to be rec-
ognized through DNA motifs. Similar to mammals, dosage compensation is initiated 
in C. elegans in a developmentally regulated manner. Thus, repression of both X 
chromosomes is observed in the germline and involves a PRC2-like complex and 
H3K27me3. This initial repressive mechanism could persist to some extent into the 
embryo and mark the early phase of X chromosome modification. Future studies 
will show to what extent mechanisms overlap for X-linked gene repression in C. ele-
gans and mammals.
Take-Home Message
 5 The dosage compensation systems of flies, worms, and mammals engage different 
mechanisms to achieve chromosome-wide adjustments of gene expression between 
the sexes.
 5 In the fruit fly D. melanogaster, a dosage compensation complex mediates the 
upregulation of X-linked genes in males to adjust gene dosage to the level of two 
X chromosomes as is observed in females.
 5 In mammals, the process of X chromosome inactivation silences one of the two X 
chromosomes in female cells, thereby equalizing the gene dose to the single X chro-
mosome of males.
 5 In the nematode C. elegans, the two X chromosomes in hermaphrodites are par-
tially repressed and adjust the gene dose to a level similar to males that possess a 
single X chromosome.
 5 Components of dosage compensation systems have functions in animal develop-
ment in addition to dosage compensation and can, therefore, be considered model 
systems for understanding gene regulation.
 5 The fly and mammalian dosage compensation systems include long non-coding 
RNAs (Xist, Rsx, XACT, roX1, and roX2) as part of the mechanism.
 5 Chromosome-wide dosage compensation mechanisms have, thus far, been discov-
ered in XY systems in a few animal species, although sex chromosome systems are 
widely distributed among animals and in dioecious plants (Vyskot and Hobza 
2015). It is possible that novel molecular reagents facilitate further discoveries. 
Considering past discoveries made in dosage compensation systems, future 
research in this area promises to extend our understanding of the molecular mech-
anisms and the evolution of pathways for gene regulation.




Bachtrog D, Mank JE, Peichel CL, Kirkpatrick M, Otto SP, Ashman TL, Hahn MW, Kitano J, Mayrose 
I, Ming R, Perrin N, Ross L, Valenzuela N, Vamosi JC, Tree of  Sex C (2014) Sex determination: why 
so many ways of  doing it? PLoS Biol 12(7):e1001899. https://doi.org/10.1371/journal.pbio.1001899
Barr ML, Bertram EG (1949) A morphological distinction between neurones of  the male and female, 
and the behaviour of  the nucleolar satellite during accelerated nucleoprotein synthesis. Nature 
163(4148):676
Bellott DW, Skaletsky H, Pyntikova T, Mardis ER, Graves T, Kremitzki C, Brown LG, Rozen S, Warren 
WC, Wilson RK, Page DC (2010) Convergent evolution of  chicken Z and human X chromosomes 
by expansion and gene acquisition. Nature 466(7306):612–616. https://doi.org/10.1038/nature09172
Blewitt ME, Gendrel AV, Pang Z, Sparrow DB, Whitelaw N, Craig JM, Apedaile A, Hilton DJ, 
Dunwoodie SL, Brockdorff  N, Kay GF, Whitelaw E (2008) SmcHD1, containing a structural- 
maintenance- of-chromosomes hinge domain, has a critical role in X inactivation. Nat Genet 
40(5):663–669. https://doi.org/10.1038/ng.142
Bone JR, Lavender J, Richman R, Palmer MJ, Turner BM, Kuroda MI (1994) Acetylated histone H4 on 
the male X chromosome is associated with dosage compensation in Drosophila. Genes Dev 8(1):96–
104
Carrel L, Willard HF (1999) Heterogeneous gene expression from the inactive X chromosome: an 
X-linked gene that escapes X inactivation in some human cell lines but is inactivated in others. Proc 
Natl Acad Sci U S A 96(13):7364–7369
Carrel L, Willard HF (2005) X-inactivation profile reveals extensive variability in X-linked gene expres-
sion in females. Nature 434(7031):400–404. https://doi.org/10.1038/nature03479
Duret L, Chureau C, Samain S, Weissenbach J, Avner P (2006) The Xist RNA gene evolved in eutheri-
ans by pseudogenization of  a protein-coding gene. Science 312(5780):1653–1655. https://doi.
org/10.1126/science.1126316
Gallardo M, Lee HJ, Zhang X, Bueso-Ramos C, Pageon LR, McArthur M, Multani A, Nazha A, 
Manshouri T, Parker-Thornburg J, Rapado I, Quintas-Cardama A, Kornblau SM, Martinez-Lopez 
J, Post SM (2015) hnRNP K is a haploinsufficient tumor suppressor that regulates proliferation and 
differentiation programs in hematologic malignancies. Cancer Cell 28(4):486–499. https://doi.
org/10.1016/j.ccell.2015.09.001
Grant J, Mahadevaiah SK, Khil P, Sangrithi MN, Royo H, Duckworth J, McCarrey JR, VandeBerg JL, 
Renfree MB, Taylor W, Elgar G, Camerini-Otero RD, Gilchrist MJ, Turner JM (2012) Rsx is a 
metatherian RNA with Xist-like properties in X-chromosome inactivation. Nature 487(7406):254–
258. https://doi.org/10.1038/nature11171
Graves JA (2015) Weird mammals provide insights into the evolution of  mammalian sex chromosomes 
and dosage compensation. J Genet 94(4):567–574
Johansson AM, Stenberg P, Bernhardsson C, Larsson J (2007) Painting of  fourth and chromosome- 
wide regulation of  the 4th chromosome in Drosophila melanogaster. EMBO J 26(9):2307–2316. 
https://doi.org/10.1038/sj.emboj.7601604
Kaiser VB, Bachtrog D (2010) Evolution of  sex chromosomes in insects. Annu Rev Genet 44:91–112. 
https://doi.org/10.1146/annurev- genet- 102209- 163600
Marshall Graves JA (2008) Weird animal genomes and the evolution of  vertebrate sex and sex chromo-
somes. Annu Rev Genet 42:565–586. https://doi.org/10.1146/annurev.genet.42.110807.091714
Mulugeta E, Wassenaar E, Sleddens-Linkels E, van IJcken WFJ, Heard E, Grootegoed JA, Just W, 
Gribnau J, Baarends WM (2016) Genomes of  Ellobius species provide insight into the evolutionary 
dynamics of  mammalian sex chromosomes. Genome Res 26(9):1202–1210. https://doi.org/10.1101/
gr.201665.115
Pullirsch D, Hartel R, Kishimoto H, Leeb M, Steiner G, Wutz A (2010) The Trithorax group protein 
Ash2l and Saf-A are recruited to the inactive X chromosome at the onset of  stable X inactivation. 
Development 137(6):935–943. https://doi.org/10.1242/dev.035956
Ruiz MF, Esteban MR, Donoro C, Goday C, Sanchez L (2000) Evolution of  dosage compensation in 
Diptera: the gene maleless implements dosage compensation in Drosophila (Brachycera suborder) 
but its homolog in Sciara (Nematocera suborder) appears to play no role in dosage compensation. 
Genetics 156(4):1853–1865
Stenberg P, Larsson J (2011) Buffering and the evolution of  chromosome-wide gene regulation. 
Chromosoma 120(3):213–225. https://doi.org/10.1007/s00412- 011- 0319- 8
 Chapter 4 · Dosage Compensation Systems
89 4
Veyrunes F, Waters PD, Miethke P, Rens W, McMillan D, Alsop AE, Grutzner F, Deakin JE, 
Whittington CM, Schatzkamer K, Kremitzki CL, Graves T, Ferguson-Smith MA, Warren W, 
Marshall Graves JA (2008) Bird-like sex chromosomes of  platypus imply recent origin of  mammal 
sex chromosomes. Genome Res 18(6):965–973. https://doi.org/10.1101/gr.7101908
Veyrunes F, Chevret P, Catalan J, Castiglia R, Watson J, Dobigny G, Robinson TJ, Britton-Davidian J 
(2010) A novel sex determination system in a close relative of  the house mouse. Proc Biol Sci 
277(1684):1049–1056. https://doi.org/10.1098/rspb.2009.1925
Vicoso B, Bachtrog D (2013) Reversal of  an ancient sex chromosome to an autosome in Drosophila. 
Nature 499(7458):332–335. https://doi.org/10.1038/nature12235
Vyskot B, Hobza R (2015) The genomics of  plant sex chromosomes. Plant Sci 236:126–135. https://doi.
org/10.1016/j.plantsci.2015.03.019
Wang X, Douglas KC, Vandeberg JL, Clark AG, Samollow PB (2014) Chromosome-wide profiling of 
X-chromosome inactivation and epigenetic states in fetal brain and placenta of  the opossum, 
Monodelphis domestica. Genome Res 24(1):70–83. https://doi.org/10.1101/gr.161919.113
Zhang Y, Malone JH, Powell SK, Periwal V, Spana E, Macalpine DM, Oliver B (2010) Expression in 
aneuploid Drosophila S2 cells. PLoS Biol 8(2):e1000320. https://doi.org/10.1371/journal.
pbio.1000320
Open Access This chapter is licensed under the terms of the Creative Commons Attribution 4.0 Inter-
national License (http://creativecommons. org/licenses/by/4. 0/), which permits use, sharing, adaptation, 
distribution and reproduction in any medium or format, as long as you give appropriate credit to the 
original author(s) and the source, provide a link to the Creative Commons license and indicate if  changes 
were made.
The images or other third party material in this chapter are included in the chapter's Creative Commons 
license, unless indicated otherwise in a credit line to the material. If  material is not included in the chapter's 
Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the 
permitted use, you will need to obtain permission directly from the copyright holder.
References
© The Author(s) 2021





5.1  Discovery of the Non-equivalence of Maternal 
and Paternal Genomes – 92
5.1.1  Genome-Wide Imprinting in Insects – 92
5.1.2  Discovery of Genomic Imprinting at an Individual Locus 
in Maize – 93
5.1.3  Demonstrating the Non-equivalence of Parental Genomes 
in Mammals – 96
5.2  Characteristics of Imprinted Genes in Mammals – 98
5.2.1  Molecular Characteristics of Imprinted Gene Clusters – 98
5.2.2  Molecular Mechanisms Leading to Imprinted  
Expression – 99
5.2.3  The Life Cycle of a Genomic Imprint – 101
5.3  Genomic Imprinting and Human Disease – 103
5.4  Genomic Imprinting in Flowering Plants – 105
5.4.1  Genomic Imprinting Occurs Predominantly  
in the Endosperm But Also Exists in the Embryo – 107
5.4.2  Mechanisms Underlying Imprinting Show  
Similarities Between Mammals and Plants – 108
5.5  Evolution of Genomic Imprinting – 111




What You Will Learn in This Chapter
A typical cell contains two sets of chromosomes: one that was inherited from the mother, 
the other from the father. Usually, autosomal alleles are expressed at similar levels from the 
maternally and paternally inherited chromosomes. This chapter is dedicated to an excep-
tion of this rule: the expression of genes that are regulated by genomic imprinting depends 
on the parental origin of the allele, leading to the non-equivalence of maternal and pater-
nal genomes. Genomic imprinting is a paradigm of epigenetic gene regulation as geneti-
cally identical alleles can exist in two expression states within the same nucleus. The 
imprints marking the parental alleles are established in the parental germline, maintained 
during the development of the offspring, but reset before they are passed on to the next 
generation. In mammals, the primary imprint is usually a differentially methylated region 
at the locus but there are also examples where histone modifications mark the parental 
alleles. Many imprinted genes play important roles for development and are associated 
with human disease. Interestingly, genomic imprinting evolved independently in mammals 
and seed plants and similar mechanisms have been recruited to regulate imprinted expres-
sion in the two kingdoms. We will discuss evolutionary constraints that could have led to 
the evolution of genomic imprinting in these seemingly disparate lineages.
5.1  Discovery of the Non-equivalence of Maternal and Paternal 
Genomes
In general, the genetic contributions from father and mother are equivalent (except 
for the sex chromosomes; see book 7 Chap. 4 of Wutz), each contributing a chromo-
some set to the progeny. Genetically, this manifests itself  by the recessive nature of 
the vast majority of loss-of-function mutations, i.e., if  a mutant allele is only inher-
ited from one of the parents, the offspring is phenotypically wild-type. Studies on 
traits that did show surprising parent-of-origin-specific effects suggested the non- 
equivalence of the parental genomes and led to the discovery of genomic imprinting.
5.1.1  Genome-Wide Imprinting in Insects
The first evidence that parental contributions may not be equivalent came from cyto-
genetic observations that Charles Metz made nearly 100 years ago. He found that, 
during the first meiotic division in the male germline of the fungus gnat Sciara cop-
rophila, an entire chromosome set was eliminated. Genetic studies using the autoso-
mal recessive truncate mutant, which affects wing shape, showed that only the maternal 
allele was transmitted by the sperm while the paternal chromosomes were lost. Metz 
concluded (Metz 1938): “… that the difference in behavior [of the chromosomes] is 
due to a general qualitative difference between maternal and paternal chromosomes 
…, and that this [difference] is impressed on the chromosomes in the preceding gen-
eration by the sex of the parent.” And he continued: “It should be emphasized that 
this qualitative difference or modification persists for only one generation and is 
reversible.” Although the term “imprint” was only introduced by Helen Crouse when 
studying the genetic determinants of paternal X-chromosome elimination in S. 
 coprophila, Metz’ conclusions set the foundations of the imprinting field, namely:
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 1. The differential behavior of the chromosomes implies the existence of differential 
modifications, i.e., imprints, on the chromosomes.
 2. Imprints may be on the maternal or paternal chromosomes, or both; the imprint 
represents a difference between them, not an absolute state.
 3. Imprints are established in the parents but persist during development of the 
progeny. Thus, they must be maintained during cell division as the genetic mate-
rial is replicated.
 4. Imprints are reversible and have to be reset in every generation: both maternal 
and paternal chromosome sets of a male are passed on to the progeny with pater-
nal imprints, those of a female with maternal imprints.
Parental imprints were later also postulated in coccids, scale insects where the pater-
nal genome is heterochromatinized and silenced or even eliminated early during 
embryogenesis. Although maternal and paternal chromosome sets in these embryos 
are distinctly marked (e.g., by differences in DNA methylation, H3K9me3, and 
H4ac), the mechanisms underlying the establishment, maintenance, and resetting of 
the imprints are not well understood (Sánchez 2014). While studies in insects pro-
vided a conceptual framework for imprints that distinguish maternal and paternal 
chromosomes, the focus of this chapter is not on genome-wide imprinting but rather 
on the imprints that distinguish individual genes or gene clusters and ultimately lead 
to the parent-of-origin-dependent expression of the corresponding alleles.
5.1.2  Discovery of Genomic Imprinting at an Individual Locus 
in Maize
Genomic imprinting regulating an individual gene rather than an entire chromosome 
set was first discovered when studying seed coloration in maize (Zea mays). In flower-
ing plants, seeds develop from ovules after double fertilization, involving the fusion 
of two pairs of gametes: one haploid sperm fuses with the haploid egg cell to form 
the diploid embryo whereas the second haploid sperm unites with the homo-diploid 
central cell and develops into the triploid endosperm. The endosperm is a placenta- 
like tissue supporting the development of the embryo by providing nutrients. Both 
fertilization products are surrounded by the protective seed coat, a maternal tissue 
derived from the integuments of the ovule. In the 1960s, Jerry Kermicle studied vari-
ous alleles of the colored1 (r1) locus in maize. The R-r:standard allele (hereafter 
referred to as R) controls the production of anthocyanin pigments in the aleurone, 
the outermost layer of the endosperm in maize seeds (kernels). If  crossed to the 
recessive null allele r-g (hereafter referred to as r), Kermicle obtained fully colored 
kernels if  R was inherited from the mother and mottled kernels with purple-brownish 
spots when R was inherited from the father (. Fig. 5.1).
Such a difference in phenotype depending on the direction of the cross indicates 
a parental effect. In this case, there is a maternal effect on R expression as most aleu-
rone cells do not express R if  it is inherited from the father. However, there are several 
fundamentally different mechanisms that could lead to such a maternal effect and 
Kermicle used an elegant series of genetic experiments to distinguish between them 
(Kermicle 1970).
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The maternal effect could be due to a dosage effect in the triploid endosperm 
as it contains two chromosome sets from the mother and only one from the father. 
Therefore, the copy number of  R differs in reciprocal crosses and it is possible 
that full pigmentation requires a threshold that is only reached if  two R copies are 
present. To test this hypothesis, Kermicle used B-A translocations (7 Box 5.1) to 
generate kernels with two paternal copies of  R. As the phenotype remained mot-




  . Fig. 5.1 Imprinting at the r1 locus. a Kernel with maternal (full pigmentation) and b with paternal 
inheritance of  the R allele (mottled pigmentation) after a cross with the recessive, colorless r allele. 
(From Evans and Grossniklaus 2008). c Schematic representation of  a maize kernel showing the com-
posite structure of  the seed with the purely maternal (2m) seed coat, the triploid endosperm including 
the pigmented aleurone with 2 maternal and 1 paternal genomes (2m:1p), and the diploid embryo 
(1m:1p). (From Encyclopedia Brittanica). d Results of  crosses involving R and r alleles as well as the TR 
translocation where the long arm of  A-chromosome 10 containing the R locus is translocated onto a 
non-essential B-chromosome. Such B-A translocation stocks can produce sperm cells with either two 
TRs or none, allowing the generation of  kernels with different R dosage. The maternal derepression of 
r1 (mdr1) mutation disrupts a trans-acting factor of  imprinting required for full expression of  the mater-
nally inherited R allele. (From Baroux et al. 2002)
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  . Box Fig. 5.1 In both maize and mice, genetic studies that were crucial for the demonstration 
of  genomic imprinting relied on translocation stocks. a Maize B- chromosomes do not carry any 
essential genes but can participate in translocations with the normal A-chromosomes. In the 
meiotic product (microspore) shown below, only the reciprocal A-B and B-A translocation 
chromosomes are shown. Microspores undergo two mitotic divisions to form the sperm. In 
mitosis I, the vegetative and generative lineage separate, while in mitosis II, the generative cell 
divides once more to form the two sperm cells that will participate in double fertilization. The 
B-chromosome can impart a peculiar behavior onto the translocated part of  the A-chromo-
some that does not contain a centromere: during mitosis II, non- disjunction produces one 
sperm with two and one without a B-A translocation chromosome, allowing the manipulation 
of  dosage for the genes present on the translocated part of  the A-chromosome. (From Walbot 
and Evans 2003). b In mice, balanced reciprocal translocation heterozygotes were used to map 
chromosomal regions that contain imprinted loci. Crossing such translocation stocks carrying 
appropriate markers (yellow segment in the example below) generates some progeny that have 
a fully balanced genome, i.e., all chromosomal regions are present in two copies, but the trans-
located segments (distal parts of  red and blue chromosomes) are of  the same parental origin. If  
such progeny shows phenotypic abnormalities, the corresponding segments must contain 
imprinted genes required for normal development or behavior. (From Oakey and Beechy 2002)
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Alternatively, the maternal effect could be of cytoplasmic nature, i.e., it depends on 
organelles, proteins, or RNAs produced prior to fertilization and deposited in the 
female gametes. If  full pigmentation depended on a product that is maternally stored 
in the central cell but required only later in endosperm development, the phenotype 
would be independent of the presence of the maternal R allele after fertilization. To 
test this, Kermicle used a genetic trick to induce the loss of the chromosome frag-
ment carrying the R locus shortly after fertilization and found that the sectors in 
which the maternal R copies had been lost were mottled. As R was present when the 
female gametes were formed, this experiment ruled out that a cytoplasmically stored 
product was responsible for the maternal effect.
Given that the maternal effect on R expression was neither due to dosage nor of a 
cytoplasmic nature, Kermicle concluded that it was of chromosomal nature, i.e., that 
the R locus itself was somehow modified during gamete formation and carried an 
imprint that was maintained during development and ultimately affected the expres-
sion of R later during aleurone formation. These findings were confirmed by the isola-
tion of the maternal derepression of r1 (mdr1) mutant, disrupting a factor required for 
the establishment of the active state of the maternal R allele. Even if a wild-type MDR1 
copy was present after fertilization, only mottled kernels were produced by mdr1 
mutant females. This indicates that the active state of R is set during female gameto-
genesis, even though the maternal R allele is only expressed much later in development.
In summary, through sophisticated genetic experiments, Kermicle clearly demon-
strated that the expression of the very same R allele differs depending on its parental 
origin. He thus identified the first case of genomic imprinting affecting an individual 
locus rather than an entire chromosome set, demonstrating that this type of epigenetic 
gene regulation can act on single genes. This is clearly different from the genome- wide 
effects first described in insects and also from chromosome-wide repression, such as 
imprinted or random X chromosome inactivation (see book 7 Chap. 4 of Wutz).
5.1.3  Demonstrating the Non-equivalence of Parental Genomes 
in Mammals
In mammals, chromosome-wide imprinting was also described in the 1970s when 
X-chromosome inactivation (see book 7 Chap. 4 of Wutz) was found to be paternal- 
specific in marsupials and in the extraembryonic tissues of the mouse (Cooper et al. 
1971). Furthermore, using translocation stocks (7 Box 5.1), mouse geneticists identi-
fied regions with parental-specific phenotypes and described a maternal effect in the 
“hairpin-tail” mouse. However, they did not conclude that this was due to genomic 
imprinting but favored the interpretation of a cytoplasmic maternal effect. This view 
only changed with the seminal nuclear transfer experiments performed in Davor Solter’s 
and Azim Surani’s groups, which unequivocally showed that maternal and paternal 
genomes of the mouse are not equivalent (McGrath and Solter 1984; Surani et al. 1984).
After fertilization, the nucleus contributed by the sperm decondenses and forms 
a pronucleus that is larger than the female pronucleus, making them easily distin-
guishable. As these pronuclei remain observable for more than 12 hours, the parental 
genomes in the zygote can be manipulated. Using micropipettes to remove and add 
pronuclei, Surani and Solter generated zygotes that had either two maternal, two 
paternal, or one maternal and paternal pronucleus each (. Fig. 5.2).
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Only embryos with a biparental constitution survived and produced viable pubs, 
while gynogenotic (two maternal genomes) and androgenotic (two paternal genomes) 
embryos died early during embryogenesis. These results clearly demonstrate that both, 
maternal and paternal genomes are required for normal embryogenesis and suggest 
that the two parental genomes are not equivalent. Unlike in genetic crosses, neither 
genome dosage nor the cytoplasm of the zygote differed in these experiments, pointing 
to the existence of imprinted genes with only the paternally or maternally inherited 
allele being expressed. Nevertheless, it was only with the cloning of three imprinted 
genes and the demonstration of their parental-specific expression in the early 1990s 
that the idea of genomic imprinting in mammals gained widespread acceptance.
Conceptuses that develop from zygotes with only paternal or maternal genomes also 
spontaneously occur in humans and lead to abnormal pregnancies. Hydatidiform moles 
are derived from androgenetic zygotes that were generated by fertilization of an anuclear 
egg cell either by one sperm followed by chromosome doubling or by two sperm cells. 
  . Fig. 5.2 Both maternal and paternal genomes are required for normal embryogenesis in the mouse. 
The zygote contains a maternal (pink) and paternal (purple) pronucleus that can be manipulated using 
a micropipette. By removing and adding different pronuclei, the following combinations were gener-
ated: gynogenetic and androgenetic embryos containing two maternal or two paternal pronuclei, respec-
tively, aborted during embryogenesis, while embryos, in which the wild-type situation with one paternal 
and maternal pronucleus was recreated, developed normally. (From Barlow and Bartolomei 2014)
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Hydatidiform moles do not contain differentiated embryonic tissues and are derived from 
trophoblast cells that would normally give rise to the embryonic parts of the placenta. In 
contrast, benign ovarian teratomas are tumors that contain various differentiated tissues, 
often including hair, muscle, and bone. Most mature ovarian teratomas contain two mater-
nal chromosome sets and are thus gynogenotes. They are derived from egg cells containing 
two maternal genomes because of an aberrant meiosis, spontaneous genome doubling, or 
the fusion of two egg cells, and develop without fertilization (parthenogenesis).
5.2  Characteristics of Imprinted Genes in Mammals
After the demonstration of the non-equivalence of the parental genomes by Solter 
and Surani, earlier genetic experiments using translocation stocks (7 Box 5.1) were 
revisited and extended, leading to the identification of imprinted regions on 8 of the 
19 mouse autosomes (Oakey and Beechy 2002). Most of these regions were found to 
be required from both the father and the mother, indicating that they contain pater-
nally as well as maternally expressed imprinted genes. The molecular isolation of 
imprinted genes confirmed that they typically occur in clusters with at least one 
maternally and one paternally expressed gene.
5.2.1  Molecular Characteristics of Imprinted Gene Clusters
The molecular isolation of imprinted genes allowed more detailed studies on the mecha-
nisms that lead to their unique regulation. The first three imprinted loci were described in 
the early 1990s and have since been studied intensely: the genes encoding the insulin-like 
growth factor type-2 receptor (Igf2r, Barlow et  al. 1991), the H19 non-coding RNA 
(Bartolomei et al. 1991), and the insulin-like growth factor 2 (Igf2; DeChiara et al. 1991). 
To date, about 150 genes are known to be imprinted in the mouse. Further characteriza-
tion has shown that not all imprinted genes are exclusively expressed from only one paren-
tal allele; rather, many show a consistent, biased expression of one parental allele. Thus, 
the definition of genomic imprinting should be broadened to include all genes that show 
non-equivalent expression from the parental alleles. Although many imprinted genes are 
expressed in the placenta, some show rather specific expression patterns, often restricted to 
adult tissues such as the brain. This emphasizes a key point initially made by Metz: while 
the imprints are established during gametogenesis, their readout, i.e., the biased or specific 
expression of one of the parental alleles, can manifest itself much later in development. 
Thus, the imprint itself and its effect on gene expression should not be confounded. Some 
genes show imprinted expression in some tissues but are biallelically expressed in others. 
Imprinted expression can also be stage-specific, whereby even the parental association of 
the active and silenced alleles can be reversed in different tissues. In other words, the effect 
of the imprint that has been established in the germline differs depending on developmen-
tal stage and tissue. These observations suggest complex mechanisms that translate the 
imprinting mark into a discernable effect on gene expression and ultimately the phenotype.
A typical imprinted gene cluster contains both maternally and paternally expressed 
genes and usually also biparentally expressed ones (. Fig. 5.3). The expression of 
the imprinted genes is controlled by an imprinting control element, also known as 
ICE. In most imprinted gene clusters, the ICE shows differential DNA methylation, 
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which was established in only one of the parents during gametogenesis (gametic or 
primary imprint) and then maintained exclusively on this allele throughout post-fer-
tilization development. Thus, the gametic imprint marks the maternal or paternal 
alleles differently in the respective zygote. Initially, all studied imprinted gene clusters 
in the mouse carried a gametic imprint based on 5-methyl-cytosine (see book 7 Chap. 
1 of Wutz), but this is not true in macaques where several ICEs do not show differen-
tial DNA methylation in the gametes. More recently, it was shown that primary 
imprints can also be based on the histone modification H3K27me3 (Inoue et  al. 
2017). Deletion of the ICE leads to parent-of-origin-specific effects. Such a deletion 
has usually no effect on the expression of the genes on the allele carrying the imprint-
ing mark. In contrast, deletion of the ICE on the allele without the gametic imprint-
ing mark leads to a switch, such that the expression of the imprinted genes in the 
cluster now resembles that of the allele that is normally carrying the imprinting mark.
5.2.2  Molecular Mechanisms Leading to Imprinted Expression
The majority of imprinted gene clusters contains at least one imprinted gene for a 
non-coding RNA (IG-NC). While several imprinted non-coding RNA genes are very 
long, ranging from about 100 kb for Airn to over 1000 kb for LNCAT, the H19 non- 
coding RNA is only 2.3 kb. Two observations suggest that the IG-NC plays a role in 
regulating imprinted expression. First, the IG-NC usually shows the opposite 
parental- specific expression of the protein-coding genes in the cluster, and second, 
the ICE of the cluster carrying the gametic imprint typically overlaps with the IG-NC 
promoter, controlling its expression (. Fig. 5.4). The role of the long non-coding 
RNA in regulating imprinted expression was tested in several clusters by truncating 
it through the insertion of a polyadenylation signal at the endogenous locus. 
Truncation of Airn, Kcqnt1ot1, and Nespas showed that expression of these long 
non- coding RNAs was necessary to silence the paternal alleles of the protein-coding 
genes in the cluster. How exactly they silence other genes in cis is currently not known, 
although models involving RNA-interference (see book 7 Chap. 6 of Grossniklaus), 
transcriptional interference, or coating of the local chromatin and recruitment of 
repressive marks similar to X-chromosome inactivation (see book 7 Chap. 4 of 
Wutz) have been proposed. In all three clusters, the maternal allele carries the gametic 
DNA methylation imprint that prevents transcription of the IG-NC (. Fig. 5.4a).
  . Fig. 5.3 A typical imprinted gene cluster with non-imprinted genes (NI) as well as paternally and 
maternally expressed imprinted genes (IG). Maternal (Mat) and paternal (Pat) chromosomes of  a typical 
imprinted gene cluster are shown with silenced (slashed circles) and expressed (arrows) alleles. Most 
clusters contain at least one imprinted, non-coding RNA gene (IG-NC). Imprinted expression is con-
trolled by an imprinting control element (ICE) that carries an epigenetic imprinting mark that was estab-
lished in and inherited from one parental gamete. The ICE often controls expression of  the imprinted 
IG-NC, which plays an important role in regulating the cluster. (From Barlow and Bartolomei 2014)
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In contrast, at the Igf2 cluster the gametic methylation imprint is on the paternal 
allele and deletion of the H19 non-coding RNA gene had no effect on silencing the 
maternal alleles of Igf2 and Ins2. The Igf2 cluster uses an insulator-based mechanism 
that results in parent-of-origin-dependent expression (. Fig. 5.4b). All genes in the 
cluster are regulated by the same enhancers located downstream of the H19 gene. As 
described in 7 Chap. 1, chromatin structure and topology contribute to the regula-
tion of gene expression (see book 7 Chap. 1 of Wutz). In particular, CTCF was 
implicated in the formation of insulators and chromatin loops. The unmethylated 
a
b
  . Fig. 5.4 Molecular mechanisms underlying parental-specific expression in imprinted gene clusters. 
a In the Igf2r cluster, the ICE carrying a DNA methylation imprint overlaps with the promoter of  the 
Airn non-coding RNA (Airn NC). Expression in the placenta is shown where Slc22a1 and Mas1 are not 
expressed (diamonds). On the maternal (Mat) chromosome, the Airn promoter is methylated and 
silenced (slashed circle), while Igf2r, Slc22a2, and Slc22a3 are expressed (arrows). On the paternal (Pat) 
chromosome, lacking the gametic methylation imprint, Airn is expressed and silences Igf2r, Slc22a2, 
and Slc22a3 in cis. b The genes of  the Igf2 cluster are regulated by the same enhancers (E) distal to the 
H19 non-coding RNA gene (H19-NC). On the maternal chromosome, the ICE is unmethylated, allow-
ing CTCF proteins to bind and form an insulator that blocks the enhancers from interacting with the 
promoters of  Igf2 and Ins2, while they can interact and activate H19. On the paternal chromosome, the 
ICE carries a gametic methylation imprint which prevents the binding of  CTCF and, thus, the forma-
tion of  an insulator. The enhancers now preferentially interact with and activate the Igf2 and Ins2 pro-
moters, while H19 is not expressed. (From Barlow and Bartolomei 2014)
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ICE, located upstream the H19 gene, serves as a binding site for CTCF proteins, 
which form an insulator that blocks the interaction of these enhancers with the Igf2 
and Ins2 promoters, while activating the H19 promoter. If  the ICE is methylated, 
CTCF proteins cannot bind and the insulator does not form, thus allowing the inter-
action of the enhancers with the more distant promoters of the protein-coding genes 
Igf2 and Ins2. CTCF binding sites were also identified at other imprinting clusters, 
where a similar mechanism may regulate imprinted expression.
5.2.3  The Life Cycle of a Genomic Imprint
As described above, essentially all imprinted gene clusters carry differentially methyl-
ated regions (DMRs) as well as regions that differ with respect to H3K27me3 on the 
maternal and paternal chromosomes. However, not all of these are necessarily the 
primary or gametic imprints that mark the parental chromosomes and are typically 
located at ICEs. As DNA methylation is associated with repression, DMRs can also 
simply coincide with the silenced alleles in a cluster, as can other repressive marks 
such as H3K27me3. To identify the primary imprint, whether it is differential DNA 
methylation or a chromatin modification, it is therefore important to determine when 
the imprinting mark is established during development. If  it forms during gameto-
genesis and is maintained throughout development, it is likely the primary imprint-
ing mark that confers a memory of its parent-of-origin. On the other hand, if  the 
mark is established after fertilization, when the two parental genomes are in the same 
nucleus, it might be considered a consequence of the silenced state of imprinted 
genes.
As imprints have to be reset in each generation, they undergo a life cycle of era-
sure and reestablishment in the germline. This occurs in primordial germ cells where 
DNA methylation is erased genome-wide and then reestablished, with DMRs getting 
methylated according to the sex of the individual (. Fig.  5.5a). There are many 
more DMRs that are methylated on the maternal allele (22 of 25 well-studied DMRs) 
than on the paternal one, and the timing of methylation differs between males and 
females. Maternal methylation imprints are established during oocyte maturation in 
meiotic prophase, which occurs after birth. Paternal methylation imprints are estab-
lished in the developing testes of the fetus in prospermatogonia long before the germ 
cells enter into meiosis. Despite this difference in timing, the acquisition of gametic 
methylation imprints depends on the de novo DNA methyltransferase 3A (Dnmt3A, 
see book 7 Chap. 1 of Wutz). In oocytes, Dnmt3A is aided by the non-catalytic 
Dnmt3L that directs DNA methylation to transcriptionally active regions, which are 
enriched in H3K36me3 but devoid of H3K4me2/3 (Stewart et al. 2016). In the male 
germline, de novo DNA methylation is linked to Piwi-interacting RNAS (piRNAs) 
that direct it to repeats and transposable elements (see book 7 Chap. 6 of 
Grossniklaus). This targeting mechanism includes the paternal gametic imprint in 
the Rasgrf1 cluster, which contains a retrotransposon. In addition to Dnmt3A/L, 
Dnmt3B is required for methylation at the Rasgrf1 DMR but it plays no role for the 
maternal methylome. In sperm, DNA methylation is more evenly distributed in both 
genic and intergenic regions. Why Dnmt3A/L appears to act rather unspecifically in 
sperm but is precisely targeted to transcribed genes in oocytes is currently not under-
stood.
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Once the gametic imprints are established, they are propagated over cell divisions 
by the maintenance DNA methyltransferase Dnmt1, which methylates hemimethyl-
ated CpG sites directly at the replication fork (see book 7 Chap. 1 of Wutz). However, 
imprinted loci are challenged by a second genome-wide reprogramming event imme-
diately following fertilization, involving demethylation during preimplantation devel-
opment and de novo methylation in the postimplantation embryo (. Fig. 5.5a). This 
wave of genome reprogramming is postulated to allow the resetting of the zygotic 
genome to a totipotent state. The parental genomes that contribute to the zygote are 
derived from highly differentiated gametes and, therefore, carry epigenetic markings 
that have to be removed in order to generate totipotent cells and, subsequently, all 
cell types of the organism (see also book 7 Chap. 7 of Paro).
While the paternal genome undergoes a rapid loss of DNA methylation even 
before the first division, the maternal genome is demethylated more slowly during 
a
b
  . Fig. 5.5 Reprogramming of  DNA methylation in the primordial germ cells and the embryo. a The 
schematic shows how the level of  methylation in non-methylated (grey) and methylated (black) DMRs 
of  imprinted genes and in non-imprinted sequences (red: maternal, blue: paternal genome) changes dur-
ing development. The x-axis indicating developmental timing and the y-axis showing relative methyla-
tion levels are not to scale. In germ cells, the methylation imprints are erased and reset according the sex 
of  the individual. In the zygote and early embryo, there is global demethylation that, however, does not 
affect the gametic imprints, which are maintained. The paternal genome loses DNA methylation in the 
zygote very rapidly, even before the first division. In contrast, the maternal genome loses DNA methyla-
tion gradually, possibly through passive demethylation by DNA replication. (From Reik and Walter 
2001). b The rapid loss of  5-methyl-cytosine (5mC) in the male pronucleus occurs concomitantly with 
oxidation, resulting in 5-hydroxymethyl-cytosine (5hmC). As revealed by antibody staining, the female 
pronucleus und polar body (pb) still show high levels of  5mC when the male pronucleus has completely 
lost this antigen but gained 5hmC. (From Iqbal et al. 2011)
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preimplantation development (. Fig. 5.5a). These kinetics indicate an active demeth-
ylation of the paternal genome whereas the maternal genome likely loses DNA meth-
ylation passively in a DNA replication-dependent manner (see book 7 Chap. 1 of 
Wutz). Active demethylation was proposed to be mediated by ten-eleven transloca-
tion methylcytosine dioxygenases (TETs), which can oxidize 5-methyl-cytosine 
(5mC) to 5-hydroxymethyl-cytosine (5hmC) and further to 5-formyl- and 5-carboxyl- 
cytosine (see book 7 Chap. 1 of Wutz). Indeed, TET3 expression coincides with loss 
of 5mC and the accumulation of 5hmC in the male pronucleus (. Fig. 5.5b), leading 
to the widely held view that demethylation occurs via oxidation by TET enzymes. 
However, recent studies have shed some doubt on this notion as demethylation 
seemed complete prior to the accumulation of 5hmC and still occurred in an oocyte-
specific Tet3 knock-out mouse (SanMiguel and Bartolomei 2018).
One of  the most intriguing questions is how gametic imprints escape demethyl-
ation in the embryo and unmethylated DMRs are protected from becoming methyl-
ated when the rest of  the genome regains DNA methylation. This is probably 
achieved by trans-acting factors that bind to specific cis-regulatory regions to pro-
tect gametic DMRs. One of  these proteins is DPPA3, which is responsible for the 
maintenance of  DNA methylation at some of  the gametic DMRs. Another protein 
that protects methylation imprints is ZFP57, a zinc finger protein with binding pref-
erence for TGCCGC, which occurs at most gametic DMRs involved in imprinting. 
ZFP57 binds only to methylated sites and interacts with the KAP1 protein that 
recruits various repressive histone modifying enzymes and, importantly, Dnmt1, 
which maintains methylation at the DMR.  In maternal-zygotic Zfp57 mutant 
embryos, there is a loss of  DNA methylation at many gametic DMRs accompanied 
by extensive changes in the expression of  imprinted genes, thus illustrating its 
importance in protecting the DMRs during reprogramming (SanMiguel and 
Bartolomei 2018).
5.3  Genomic Imprinting and Human Disease
Imprinted genes are expressed in diverse tissues and their functions are manifold. 
Consistent with the expression of many imprinted genes in the embryo and placenta, 
mutations often affect fetal growth and development. Other imprinted genes show 
preferential expression in the brain and mutations in the mouse can lead to the devel-
opment of behavioral phenotypes. Given that only one of the parental alleles of 
imprinted genes is active, it is not surprising that mutations in imprinted gene clusters 
are often linked to human disease (see book 7 Chap. 8 of Santoro). While some of 
these diseases are clearly linked to a specific imprinting cluster, others show disrup-
tions of imprinting at multiple loci across the genome. A selection of imprinting 
disorders is shown in . Table 5.1 (based on Monk et al. 2019):
As becomes obvious from the selection in . Table 5.1, many imprinting disorders 
affect the same genomic region but lead to distinct clinical features depending on 
which of the parental alleles is affected. For instance, in some patients with Silver- 
Russel Syndrome, the paternal copy of the Igf2/H19 imprinting cluster is missing or 
affected, while in Beckwith-Wiedemann Syndrome, it is the maternal copy. Likewise, 
in Temple Syndrome, the paternal allele of the Meg3-Dlk1 cluster is affected, while 
the maternal one is missing in most patients with Kagami-Ogata Syndrome.
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To illustrate the molecular basis of imprinting disorders, we focus on the Prader- 
Willi Syndrome (PWS) and Angelman Syndrome (AS), both affecting the 
Snrpn/Ube3A imprinted gene cluster. Among other clinical features, PWS is charac-
terized by a lower birth weight, neonatal hypotonia, postnatal growth restriction fol-
lowed by hyperphagia and obesity, short stature, hypogonadism, and mild intellectual 
disability. In contrast, AS patients can have an above-average birth weight (depend-
ing on the exact lesion), severe delay in postnatal development, ataxia, scoliosis, 
microcephaly, seizures, severe intellectual disability, minimal verbal skills, and a 
happy affect with frequent bouts of laughter.
The majority of patients with either disorder carry a deletion of about 5–6 Mb in 
15q11. While the deletion is inherited paternally in PWS patients, it is derived from 
the mother in AS children. This difference explains the distinct clinical features in 
PWS and AS patients, as only the maternal or paternal alleles of the Snrpn/Ube3A 
cluster, respectively, are expressed. Apart from deletions, other genetic lesions lead-
ing to loss-of-function mutations of genes in the Snrpn/Ube3A cluster can cause the 
syndromes (. Fig. 5.6). For AS, about 10–15% of the cases carry a mutation in the 
  . Fig. 5.6 The Snrpn/Ube3A imprinted gene cluster associated with Prader-Willi Syndrome (PWS) 
and Angelman Syndrome (AS). The ICE controls imprinted expression of  the genes in the cluster. The 
SNURF-SNRPN gene encodes not only two protein products, Snurf  and Snrpn, but also a paternally 
expressed long non-coding antisense transcript (LNCAT) that overlaps with the promoter of  the mater-
nally expressed UBE3A gene responsible for AS. (From Zoghbi and Beaudet 2016)
  . Table 5.1 Selected human disorders related to defects in imprinting clusters







Beckwith-Wiedemann Syndrome 11p15.5 Kcnq1, Igf2/H19
Temple Syndrome 14q32 Dlk1-Dlo3
Kagami-Ogata Syndrome 14q32 Dlk1-Dlo3
Prader-Willi Syndrome 15q11-q13 Snrpn/Ube3A
Angelman Syndrome 15q11-q13 Snrpn/Ube3A
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maternally expressed UBE3A gene, identifying UBE3A as gene likely responsible for 
AS. It is not yet fully clear which of the genes in the PWS region of the imprinting 
cluster is responsible for PWS, although recent evidence points to the SNORD116 
locus encoding a set of small nucleolar RNAs.
Apart from genetic causes of these syndromes, there are also cases where the 
Snrpn/Ube3A cluster is intact but its genes are epigenetically misregulated. This is for 
instance the case if  both homologs of chromosome 15 originate from the same par-
ent, a condition called uniparental disomy (UPD). Maternal UPD is responsible for 
PWS, whereas AS is caused by paternal UPD.  The origin of UPDs lies in 
 non- disjunction during female meiosis that, after fertilization, leads to zygotes that 
either have only one paternal (monosomy) or two maternal and one paternal (tri-
somy) chromosome 15  in the case of PWS and AS.  These aberrant zygotes can 
develop normally if  they spontaneously loose or duplicate chromosome 15. Loss of 
the paternal copy from trisomic zygotes leads to maternal UPD, while duplication of 
the single paternal chromosome in monosomic zygotes to paternal UPD. As in indi-
viduals with UPD the two homologs stem from the same parent, they lack expression 
of imprinted genes specific to the other parent, resulting in imprinting disorders.
Importantly, PWS and AS can also stem from imprinting defects. Imprinted 
expression at the Snrpn/Ube3A cluster is controlled by an ICE upstream of the 
SNURF-SNRPN gene. If  a mutation affects the function of the ICE, the genes in the 
cluster lose their parent-of-origin-specific expression. The same can result from a 
failure to reprogram the gametic imprint in primordial germ cells. For instance, if  the 
methylation mark on the maternal ICE is not erased in prospermatogonia, a male 
will transmit it with a maternal rather than a paternal gametic mark. This will lead to 
the formation of a zygote with two “maternal” Snrpn/Ube3A clusters causing 
PWS. Although such imprinting defects are responsible for only a minority of the 
PWS and AS cases, they contributed important insights into the resetting of imprints 
and the regulation of imprinted expression at the Snrpn/Ube3A cluster.
5.4  Genomic Imprinting in Flowering Plants
Although imprinting of individual genes was originally discovered in plants and the 
parent-of-origin-dependent expression of a few genes was documented in the maize 
endosperm, the mechanisms underlying genomic imprinting were not well studied 
until the discovery of imprinted genes in the model plant Arabidopsis thaliana in the 
late 1990s. Plant imprinting studies were reinvigorated by the discovery of MEDEA 
(MEA) (Grossniklaus et al. 1998), a maternally expressed imprinted gene encoding a 
homolog of Drosophila melanogaster Enhancer of zeste, the histone methyltransfer-
ase in the conserved Polycomb Repressive Complex 2 (PRC2; see book 7 Chap. 3 of 
Paro). The mea mutant was identified in a screen for maternal effect mutants, with 
the genotype of the female gametes determining the phenotype of the developing 
seeds. Because the gametes of plants are produced by haploid multicellular organ-
isms (gametophytes) that form through mitotic divisions after meiosis, such mutants 
show a peculiar genetic behavior. In a heterozygous mea/MEA plant, half  the meiotic 
products will carry the mutant mea allele and half  the wild-type MEA allele. 
Correspondingly, also half  of the gametophytes and the gametes they contain (egg 
and central cell in the female gametophyte; two sperm cells in pollen, the male game-
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tophyte) will carry the mutant allele. Thus, if  a mea/MEA heterozygous female plant 
is crossed with a wild-type male, half  of the seeds abort while, in the reciprocal cross, 
all seeds develop normally (. Fig. 5.7).
Of course, similar to kernel pigmentation regulated by the R allele in maize, 
maternal effect seed abortion observed in mea mutants could be caused by (i) a dos-
age effect in the endosperm, (ii) a missing cytoplasmically stored product, or (iii) 
genomic imprinting. As A. thaliana does not offer the sophisticated genetic tools 
available in maize, a dosage effect was excluded by generating tetraploid plants that 
produce endosperm with mea:MEA allelic ratios ranging from 6:0 to 0:6. Distinction 
of  the remaining two possibilities required the cloning of  MEA and analysis of  its 
allelic expression using parental-specific polymorphisms. This showed that only 
maternal transcripts could be detected in developing seeds. However, MEA was 
already expressed in the female gametes, such that these maternal transcripts could 
have either been produced exclusively before fertilization and stored in the egg cell 
or, in addition, also be derived from the maternal allele after fertilization. RNA in 
situ hybridization to detect nascent transcripts in triploid endosperm nuclei showed 
that only two of  the three MEA alleles were transcribed. Nascent transcripts tem-
porarily remain at their chromosomal site of  transcription forming “nuclear dots” 
of  high transcript concentration (. Fig. 5.7). Thus, while MEA is already expressed 
in the female gametes, it is also regulated by genomic imprinting leading to the 
transcription of  only the maternal MEA alleles in the endosperm (Vielle-Calzada 
et al. 1999). The discovery of  genomic imprinting in A. thaliana stimulated many 
studies both at the genome-wide level as well as on the molecular mechanisms 
underlying parental-specific expression at specific loci in plants.
a b c
  . Fig. 5.7 Genomic imprinting is responsible for maternal effect seed abortion observed in the mea 
mutant. a and b show opened siliques with developing seeds from reciprocal crosses. If  the mutant mea 
allele is inherited from the mother, seeds abort (red and brown seeds in a but if  it is inherited from the 
father, it has no effect on seed development b. (From Grossniklaus et al. 1998). c Detection of  nascent 
transcripts at the MEA locus (arrows) show that only two of  the three alleles in the endosperm are 
actively transcribed, i.e., the two maternal copies as illustrated schematically. (From Vielle- Calzada 
et al. 1999)
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5.4.1  Genomic Imprinting Occurs Predominantly 
in the Endosperm But Also Exists in the Embryo
As all imprinted genes initially studied in maize were expressed in the endosperm 
(Messing and Grossniklaus 1999) and the DNA of the maternal genome was found 
to be hypomethylated in this tissue (Hsieh et al. 2009), imprinting is often referred to 
as endosperm-specific. Despite imprinted genes also having been identified in the 
plant embryo, most studies to date focused on endosperm. Over the last years, many 
genome-wide studies identified candidate imprinted genes in several species, includ-
ing A. thaliana, maize, and rice (Oryza sativa). These studies relied on sequencing 
RNA isolated from dissected endosperm tissue or sorted endosperm nuclei, and sub-
sequent searching for transcripts with parentally biased expression based on nucleo-
tide polymorphisms between the parents.
All studies looked at steady-state levels of mRNA transcripts, which does not 
distinguish between mRNAs that were exclusively produced prior to fertilization and 
stored in the gametes and those that were differentially transcribed from the parental 
alleles after fertilization. Although endosperm was isolated several days after fertil-
ization, the half-life of mRNAs is unknown and they could potentially be very stable. 
Thus, to conclude that a gene is regulated by genomic imprinting requires the dem-
onstration of its active transcription after fertilization. Only in the zygote or fertil-
ized central cell, both parental alleles will be present in the same nucleus and 
transcribed based on their gametic imprint. This would be the case if  no transcripts 
were detected in the gametes, although cases like MEA, which is expressed in the 
female gametes as well as imprinted, would be missed by this strategy. Alternatively, 
active transcription can be shown by looking at nascent transcripts (. Fig.  5.7). 
While, in plants, this analysis has so far only been done for MEA, fluorescent in situ 
hybridization to detect RNAs (RNA-FISH) is a standard technique in mammals. In 
summary, while RNA sequencing experiments have identified hundreds of candidate 
imprinted genes in diverse species, regulation by genomic imprinting has unequivo-
cally been demonstrated for only a few of them.
Moreover, the overlap of presumptive imprinted genes between genome-wide 
studies performed in different laboratories is very small (Wyder et al. 2019). It is pos-
sible that the hypomethylation of the maternal genome in the endosperm leads to 
stochastic changes in expression, which differ between individuals and are influenced 
by the environment, explaining the poor overlap between studies. This would mean 
that the parent-of-origin-dependent expression of these genes would be accidental 
and not play a crucial role in development. Consistent with this idea, the function of 
only a handful of imprinted genes is known, including A. thaliana MEA and 
FERTILIZATION INDEPENDENT SEED2 (FIS2), which encodes a homolog of 
Drosophila Su(z)12. MEA and FIS2 are subunits of FIS-PRC2, a PRC2 variant (see 
book 7 Chap. 3 by Paro) that is required for normal seed development.
Although most imprinting studies in plants focused on the endosperm, genomic 
imprinting has also been reported in the embryo. In A. thaliana, about a dozen can-
didate genes were identified, ten of which were not expressed in the gametes, indicat-
ing active expression after fertilization and thus bona fide imprinting. A recent study 
in maize identified several dozen candidate imprinted genes. As in mammals, gametic 
imprints of genes expressed in plant embryos would have to be reset in every genera-
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tion. This is not true for imprints in the endosperm, which is a terminal tissue that 
does not contribute to the next generation. As in mammals, the primary imprints 
have to be established during gametogenesis when the parental genomes are sepa-
rated. In both maize and A. thaliana, genes with parental allele-specific expression in 
young embryos become biallelically expressed later during embryogenesis. Whether 
this represents erasure of the gametic imprint or an alternative transcriptional regu-
lation is currently unknown.
5.4.2  Mechanisms Underlying Imprinting Show Similarities 
Between Mammals and Plants
Both, the dissection of imprinting regulation at specific loci as well as genome-wide 
profiling studies of DNA methylation and histone modifications have shed light onto 
the mechanisms underlying genomic imprinting in plants. Again, studies on the regu-
lation of the MEA locus paved the way to show that, as in mammals, DNA methyla-
tion plays a prominent role in genomic imprinting in plants. Unlike in mammals, 
where only CGs are methylated (see book 7 Chap. 1 of Wutz), in plants, DNA meth-
ylation can occur in the CG, CHG, and CHH context (with H ≠ G). While DOMAINS 
REARRANGED METHYLTRANSFERASE2 (DRM2) is the major de novo meth-
yltransferase for all Cs, distinct DNA methyltransferases are responsible to maintain 
methylation in the different contexts: the Dnmt1 homolog MET1 for CG, the 
CHROMOMETHYLTRANSFERASE3 (CMT3) for CHG, and DRM2 together 
with CMT2 for CHH.
Mutants affecting MET1 indicated an involvement of DNA methylation in 
silencing the paternal MEA allele. This was confirmed by the identification of 
DEMETER (DME), a DNA glycosylase that can excise methylated cytosines 
through base excision repair (Choi et al. 2002). DME is preferentially expressed in 
the central cell, where it leads to demethylation that then results in the hypomethyl-
ation of the maternal chromosomes in the endosperm after fertilization. In the dme 
mutant, the maternal MEA allele fails to be expressed, indicating that demethylation 
is required to set its active state. Regulation of imprinting by the maintenance meth-
yltransferase MET1 and DME, which removes this epigenetic mark, has also been 
demonstrated for several other loci.
In addition to DNA methylation, H3K27me3 mediated by PRC2 was shown to 
regulate many imprinted genes. This was first shown for PHERES1 (PHE1), a direct 
target of  FIS-PRC2. The paternal allele of  PHE1 is expressed at a much higher level 
than the maternal one, which is specifically repressed by FIS-PRC2 during seed 
development (Köhler et al. 2005). The repression of the maternal PHE1 allele also 
depends on a DMR at tandem repeats downstream of the gene. It has been pro-
posed that the unmethylated DMR allows the formation of a repressive chromatin 
loop through interaction with FIS-PRC2 at the PHE1 promoter (. Fig. 5.8). In its 
methylated form, the DMR prevents the binding of  yet unknown factors involved in 
loop formation, resulting in an active paternal allele. While loops involved in 
imprinting await experimental confirmation in plants, the existence of  such loops 
has been shown in mice. As discussed earlier, at the Igf2/H19 imprinting cluster, 
CTCF binds to the unmethylated ICE and, together with PRC2, forms a chromatin 
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loop that represses Igf2 (. Fig. 5.8). PRC2 does not only play an essential role in 
seed development but also regulates some paternally repressed genes in the mouse 
placenta. Moreover, PRC2-mediated H3K27me3 can serve as gametic imprint, but 
relative to DNA methylation, the role of  PRC2 is relatively minor (Barlow and 
Bartolomei 2014). Nevertheless, DNA methylation and PRC2 are involved in 
genomic imprinting in both mammals and plants, highlighting the independent 
recruitment of  these two repressive modules in both lineages in the evolution of 
parental-specific expression.
Genome-wide profiling studies of DNA methylation, repressive chromatin 
marks, and gene expression in the endosperm have shown that a major determinant 
for maternally expressed imprinted plant genes is DNA methylation (Batista and 
Köhler 2020). In many cases, these genes are silenced by DNA methylation in most 
tissues and their demethylation by DME in the central cell leads to the expression 
of the maternal alleles in the endosperm. In other cases, de novo methylation of 
the paternal allele in sperm may lead to their imprinted maternal-specific expres-
sion (. Fig. 5.9). For paternally expressed genes, histone modifications mediated by 
PRC2 (H3K27me3) or CHROMOMETHYLASE3 (CMT3) and plant SU(VAR)3-9 
homologs (H3K9me2) play a major role in regulating imprinted expression. This can 
occur through demethylation of the maternal allele by DME followed by the deposi-
tion of repressive histone marks in combination with DNA methylation of the pater-
nal allele, preventing the binding of PRC2 as it was shown for PHE1 (. Fig. 5.8). 
Alternatively, the maternal allele may be specifically targeted by recruiting PRC2 via 
selected transcription factors, or by removal of repressive histone marks of broadly 
silenced genes specifically in the sperm cell (. Fig. 5.9).
While these mechanisms may explain the regulation of  up to 30% and 90% of 
maternally and paternally expressed genes in the endosperm of  A. thaliana (Batista 
and Köhler 2020), respectively, the regulation of  many other imprinted genes does 
  . Fig. 5.8 Chromatin loops as part of  the imprinting mechanism. On the left, the active paternal 
PHE1 allele has methylated tandem repeats (DMR), while on the maternal allele, the DMR is unmeth-
ylated, which is proposed to allow the formation of  a chromatin loop on the two maternal chromosomes 
in the endosperm. On the right, the Igf2/H19 cluster is shown for which loop formation on the maternal 
chromosome, mediated by CTCF and PRC2, has been demonstrated. (From Loppin and Oakey 2009)
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neither involve DNA nor histone methylation. This is particularly true for 
imprinted genes in the embryo, where none of  12 tested genes appears to be regu-
lated by DNA methylation and only three were affected by mutants affecting PRC2 
(Raissig et al. 2013).
There are also several cases of imprinted genes expressed in maize or A. thaliana 
endosperm carrying a DMR that, however, is not inherited from the parents but only 
established after fertilization. Differential DNA methylation does, therefore, not act 
as a gametic imprint in these cases.
That imprinting can be very complex was also shown through more detailed stud-
ies of the MEA locus. The expression of the maternal MEA allele depends on 
demethylation by DME and, after fertilization, the paternal allele is repressed by the 
maternally produced FIS-PRC2. The latter was concluded from several studies in 
which a paternal reporter gene driven by the MEA promoter became active in crosses 
to mea mothers. However, the analysis of the endogenous gene subsequently showed 
that the derepression of the paternal allele was minimal and MEA still showed a 
strongly biased allelic expression. Furthermore, imprinting could be conferred to a 
reporter gene using only 200 bp of the MEA promoter, which is completely free of 
any DNA methylation in the gametes. This was the first report of a DNA methylation- 
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  . Fig. 5.9 Different models for the regulation of  genomic imprinting in the endosperm. The events 
proposed to set gametic imprints in central cell and sperm are shown. For maternally expressed genes, 
the establishment of  differential DNA methylation imprints, through demethylation or specific de novo 
methylation, is important. For paternally expressed genes, three scenarios involving PRC2 are shown. 
See text for details. (From Batista and Köhler 2020)
 Chapter 5 · Genomic Imprinting
111 5
nor DNA methylation is required for imprinted MEA expression, the primary 
imprints remain elusive (Wöhrmann et  al. 2012). It was proposed that, similar to 
PHE1, chromatin loops may form depending on the DNA methylation status of 
flanking regions, thereby preventing access of imprinting factors that would establish 
the yet unknown gametic imprint.
Finally, the identification of PHE1 as a target of FIS-PRC2 revealed the existence 
of an extensive regulatory cascade controlling seed development that is based on 
genomic imprinting. The maternally expressed imprinted genes MEA and FIS2 con-
trol the paternal expression of PHE1, a transcription factor that, in turn, regulates a 
large number of paternally expressed imprinted genes in the endosperm. Thus, epi-
genetic gene regulation plays a major role in seed development.
5.5  Evolution of Genomic Imprinting
Several hypotheses have been proposed to explain the evolution of genomic imprint-
ing. Among these, David Haig’s parental conflict theory by far attracted the most 
attention from biologists working on imprinting. Haig tried to find an explanation 
why imprinting evolved in such different organisms as mammals and seed plants 
(Haig and Westoby 1989). He realized that both share a “placental habit”, i.e., the 
development of seeds and fetuses depends solely on resources provided by the 
mother. Indeed, both the mammalian placenta and the endosperm of seed plants are 
major tissues with imprinted gene expression and play a central role in providing 
nutrients to the next generation. In contrast, the father contributes little to support 
the developing offspring. In polygamous species, this leads to a parental conflict 
between the paternal and maternal genomes in the progeny because of different kin-
ship relationships. The mother is equally related to all her offspring and (epi)geno-
types are favored that lead to a uniform distribution of resources to all her offspring 
over her lifetime. In contrast, the paternal genome is not the same in all the progeny, 
such that (epi)genotypes are favored that lead to an increased acquisition of nutrients 
at the expense of non-related siblings. This parental conflict will lead to the biased 
expression of genes involved in the acquisition of nutrients from the mother, and 
thus the growth of the seed or fetus. This theory makes clear evolutionary predic-
tions: First, paternally expressed genes should promote growth of the offspring and 
second, maternally expressed genes should reduce it.
There is substantial evidence in support of  the parental conflict theory (Pires 
and Grossniklaus 2014). For instance, the endosperm overproliferates in crosses of 
parents with different ploidy that increase the number of  paternal genomes, while 
it proliferates less and differentiates earlier in seeds with an excess of  maternal 
genomes (Haig and Westoby 1989). Similarly, androgenetic mouse embryos form a 
large trophoblast, from which the embryonic part of  the placenta forms, while 
gynogenetic embryos produce an underdeveloped trophoblast. The parental con-
flict theory is also supported by its phylogenetic distribution in vertebrates. Genes 
that are imprinted in mammals are biallelically expressed in fish and birds, in which 
the amount of  resources deposited in the egg is determined by the mother prior to 
fertilization, such that the paternal genome in zygotic tissues cannot influence 
nutrient acquisition from the mother. This is also true for egg-laying mammals like 
the platypus and echidna but not for marsupials. In the latter, much of  the off-
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spring’s development occurs in the pouch, which from the point-of-view of  the 
parental conflict theory is equivalent to the uterus in eutherian mammals or the 
seed in plants.
Intriguingly, the predictions of the parental conflict theory also play out at the 
level of individual genes. For instance, MEA is a maternally expressed gene and is 
predicted to restrict growth. Indeed, seeds developing from mea mutant gametes 
show overproliferation in both the embryo and endosperm before they abort 
(Grossniklaus et al. 1998). Similarly, the paternally expressed Igf2 gene is expected to 
promote fetal growth in the mouse and, consistent with the theory, mutant pubs have 
a 40% reduction in birth weight compared to their wild-type siblings. In contrast, 
embryos lacking the maternally expressed Igf2r gene, encoding the receptor for Igf2, 
show overgrowth before they die. Most interestingly, double mutants are normal in 
size and are viable. In fact, Igf2r is a receptor that binds the growth factor Igf2 but 
targets it to the lysosome, preventing its growth-promoting action. Thus, Igf2r is a 
kind of decoy receptor expressed from the maternal genome to remove the paternally 
produced Igf2 growth factor: a molecular reflection of the tug-of-war between mater-
nal and paternal genomes.
The parental conflict theory is very attractive as it explains the evolution of 
imprinting in both mammals and plants. To my knowledge, the phenotypes of all 
imprinted genes that have a function related to growth, either during embryogenesis 
or, in mice, also postnatally, e.g., by controlling feeding behavior, are consistent with 
the parental conflict theory. This includes some of the clinical features of patients 
with syndromes associated with imprinted gene clusters, which often affect birth 
weight or postnatal feeding behavior. However, not all imprinted genes regulate 
growth and for these, the parent conflict theory does not apply in an obvious manner. 
More than a dozen other theories for the evolution of imprinting have been proposed 
(Spencer and Clark 2014). Depending on the organism and the function of the 
imprinted gene, distinct selective forces may have driven the evolution of genomic 
imprinting. However, most alternative theories do not explain the peculiar phyloge-
netic distribution of genomic imprinting, i.e., its evolution in mammals and seed 
plants.
Take-Home Messages
 5 Genomic imprinting is a paradigm of epigenetic gene regulation that evolved inde-
pendently in seed plants and mammals.
 5 Genomic imprinting leads to parent-of-origin dependent gene expression, render-
ing parental genomes non-equivalent, and is not related to the sex of the individ-
ual.
 5 Gametic or primary imprints are differential epigenetic marks that are acquired 
during gametogenesis and lead to allelically biased gene expression after fertiliza-
tion.
 5 Gametic imprints have to be reset every generation in the germline according to 
the sex of the individual. In mammals, they withstand genome-wide reprogram-
ming in the zygote, associated with a wave of DNA demethylation and remethyl-
ation.
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What You Will Learn in This Chapter
Although epigenetic states are typically associated with DNA-methylation and posttrans-
lational histone modifications, RNAs often play an important role in their regulation. 
Specific examples have already been discussed in the context of dosage compensation (see 
book 7 Chap. 4 of Wutz) and genomic imprinting (see book 7 Chap. 5 of Grossniklaus). 
In this Chapter, we will take a closer look at a particular class of RNAs implicated in gene 
silencing. Although the focus will lie on RNA-based silencing mechanisms in plants, many 
of its components, such as RNase III-related DICERLIKE endonucleases or small RNA-
binding ARGONAUTE proteins, are conserved in animals, plants, and fungi. On the one 
hand, small RNAs are involved in post-transcriptional silencing by targeting mRNAs for 
degradation or inhibiting their translation, a feature that has been exploited for large-scale 
genetic screens. On the other hand, they also play a central role in transcriptional gene 
silencing, for instance in the repression of transposable elements across a wide variety of 
organisms. In plants, this involves a complex system whereby small RNAs derived from 
transposons and repeats direct DNA-methylation and repressive histone modifications in 
a sequence-specific manner. Recent results link this so-called RNA-dependent DNA-
methylation to paramutation, a classical epigenetic phenomenon where one allele directs a 
heritable epigenetic change in another.
6.1  The Unusual Behavior of Transgenes Led to the Discovery 
of Novel RNA-Based Silencing Mechanisms
With the establishment of transformation technologies and their increasing use in 
plants in the late 1980s, it became apparent that the expression behavior of trans-
genes was hard to predict. While transgenics that did not show the expected expres-
sion of the transgene were initially discarded, they soon became an object of interest. 
One of the most striking examples was the characterization of transgenic petunia 
(Petunia hybrida) overexpressing the chalcone synthase (CHS) gene by Carolyn 
Napoli and Richard Jorgensen (Napoli et al. 1990). CHS encodes the rate-limiting 
enzyme of anthocyanin biosynthesis, which leads to the purple pigmentation of the 
flowers (. Fig. 6.1). Unexpectedly, instead of producing deep purple flowers due to 
CHS overexpression, many transgenics produced white flowers or flowers with a 
combination of purple and white tissues. Molecular analyses showed that the trans-
gene had an effect on the endogenous CHS gene in trans, and that the transgene and 
the endogenous CHS gene were coordinately repressed (. Fig. 6.1). This phenome-
non was termed “co-suppression”. Subsequently, a similar observation was reported 
in the fungus Neurospora crassa, where the introduction of two transgenes of the 
carotenoid biosynthesis pathway led to a reduction in the expression of the endoge-
nous gene, referred to as “quelling” (Romano and Macino 1992). RNA-based silenc-
ing was also discovered in animals, where the injection of RNA being either sense or 
antisense to the par-1 mRNA in the nematode Caenorhabditis elegans led to degrada-
tion of the par-1 transcripts (Guo and Kemphues 1995). Unlike the chromatin-based 
mechanisms described in earlier chapters, in these cases, gene silencing occurred at 
the post-transcriptional level (PTGS). Such cytoplasmic mechanisms can also con-
tribute to the establishment of heritable epigenetic states as the RNAs involved are 
sometimes amplified in a self-sustaining fashion. Other RNA-based gene silencing 
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phenomena in plants (Matzke et al. 1989) and animals (Bestor et al. 1994) occur in 
the nucleus and involve transcriptional gene silencing (TGS) by DNA methylation 
and chromatin modifications. It was soon clear that the various gene silencing phe-
nomena were based on homology, i.e., showed sequence-specificity, and models 
involving DNA-DNA, DNA-RNA, and RNA-RNA pairing were proposed.
The seminal experiments of Fire and Mello (Fire et al. 1998) in C. elegans showed 
that not single-stranded but rather double-stranded RNA (dsRNA) was responsible 
for silencing, providing a unifying explanation for co-suppression, quelling, and 
other PTGS phenomena, now referred to as RNA interference (RNAi). In both 
plants and nematodes, gene silencing was heritable, suggesting a stable silencing 
intermediate. Hamilton and Baulcombe (1999) showed that this was not the full-
length dsRNA but rather short fragments of roughly 25 nt in length, so-called short 
interfering RNAs (siRNAs). Similar 21–23 nt long siRNAs were then also found to 
be involved in RNAi in Drosophila melanogaster and C. elegans. The demonstration 
that chemically synthesized 21–22 nt dsRNAs can downregulate target mRNAs also 
a
b
  . Fig. 6.1 Discovery of  RNA-based gene silencing in petunia. a The wild type produces purple flow-
ers due to anthocyanin production requiring the CHS biosynthetic gene (left panel). Introduction of  a 
CHS transgene leads to a variety of  phenotypes, including completely white flowers (three panels on 
the right). (From Stam et al. 1997). b Some of  these phenotypes are unstable, producing revertant sec-
tors (left panel). RNAse protection assays showed that both transgene (TG) and endogenous CHS 
gene (EG) are expressed in the purple sectors but RNA levels of  both TG and EG are strongly reduced 
in the white sectors (right panels). Three flowers per sector were analyzed; M, marker lane. (From 
Napoli et al. 1990)
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in mammalian cells, opened completely new avenues for functional studies in cell 
culture. These discoveries did not only stimulate intensive research into the underly-
ing mechanisms but also led to a wide range of applications (Sen and Blau 2006).
6.1.1  Conserved Components of RNA-Based Silencing 
Mechanisms
Given that siRNAs are involved in diverse silencing mechanisms in animals and 
plants, it is not surprising that they also use similar proteins that mediate the function 
of siRNAs. As the mechanisms are diverse, only the two key components are intro-
duced here: the enzymes responsible for dicing the dsRNA into the siRNAs 
[DICERLIKE (DCL) proteins] and the ones involved in slicing the target mRNAs 
[ARGONAUTE (AGO) proteins]. DCL and AGO proteins are central to essentially 
all RNA-based silencing mechanisms.
DCL proteins, named after the founding member Dicer, were identified in D. 
melanogaster through a candidate gene approach testing different RNase III family 
members for the ability to cleave dsRNA into siRNAs (Bernstein et al. 2001). DCL 
proteins have a conserved structure, with two RNase III domains that cleave the 
dsRNA, a PAZ domain binding the 3’end of the dsRNA, and a helicase domain that 
unwinds the dsRNA duplexes (. Fig.  6.2). In some species, e.g., the model plant 
Arabidopsis thaliana, the family diversified and different members have specialized 
functions.
Another family of proteins involved in various silencing pathways are the 
ARGONAUTE (AGO) proteins, which are the catalytic subunit of an RNA-induced 
silencing complex (RISC) that slices the target mRNAs. Like DCL proteins, AGOs 
have a PAZ domain that binds the 3’end of dsRNAs, in this case the siRNAs pro-
duced by DCL proteins, which can base-pair with complementary target mRNAs. 
Through their PIWI domain, AGOs can slice the target mRNA complementary to 
the siRNA (. Fig. 6.3). However, cleaving the mRNA is not the only outcome of 
base-pairing with the siRNA; depending on the silencing pathway and type of RISC, 
translation of the mRNA can be blocked instead. AGO proteins can also be incorpo-
rated into another complex, called RNA-induced transcriptional silencing (RITS) 
complex, which is targeted to homologous DNA regions. The RITS complex then 
recruits enzymes that mediate DNA methylation and/or histone modifications which 
are associated with TGS.
6.2  Post-Transcriptional Gene Silencing (PTGS)
There is a wide variety of small RNAs that are involved in targeting mRNAs for 
degradation or inhibiting translation at the post-transcriptional level (PTGS). Others 
are involved in the sequence-specific silencing of genes at the transcriptional level 
(TGS) by establishing repressive chromatin (Pikaard and Mittelsten Scheid 2014). 
These small RNAs can be derived from transgenes or viruses (siRNAs) but many of 
them are endogenously produced during the life cycle of the plant, including microR-
NAs (miRNAs), hairpin siRNAs (hp-siRNA), trans-acting siRNAs (tasiRNAs), 
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phased siRNAs (phasi RNAs) produced during anther development, and epigeneti-
cally activated siRNA (easiRNA) that accumulate in the sperm cells (. Fig. 6.4). 
Here, we will look at the biogenesis and function of only a few selected types of small 
RNAs (Borges and Martienssen 2015).
6.2.1  The Biogenesis and Function of microRNAs
In both animals and plants, miRNAs play important roles in development by limit-
ing the function of their target mRNAs to specific cells or tissues through their deg-
radation or translational repression. Thus, they regulate gene expression at the 
















  . Fig. 6.2 Domain organization of  DICERLIKE (DCL) proteins from various eukaryotes. DCL pro-
teins are responsible for dicing dsRNAs of  diverse origin, e.g., derived from transgenes, endogenous 
genes, or viruses, into siRNAs. They are also crucial for the biosynthesis of  microRNAs (miRNAs), 
regulatory small RNAs produced from stem-loop structures formed by transcripts of  endogenous loci. 
The RNase III domains are responsible for dicing, while other domains are involved in binding the 
target dsRNA. (From Johanson et al. 2013)
6.2 · Post-Transcriptional Gene Silencing (PTGS)
122
6
cell as the target mRNA. Because they do not result in a heritable change of gene 
expression, they are often not considered epigenetic regulators. An epigenetic change 
in gene expression persists even if  the initial trigger, be it developmental or environ-
mental, is gone (see also book 7 Chap. 3 of Paro). Nevertheless, because their bio-
genesis and function are similar to epigenetically acting, short RNAs whose level is 
sustained, e.g. by RNA-dependent RNA polymerases (RDRs) that generate dsR-
NAs in a feed-forward loop, they are also discussed here.
miRNAs are derived from RNA polymerase II (Pol II) transcribed genes that do 
not encode proteins, but they can also originate from sequences in long non-coding 
RNAs or introns of protein-coding genes. These precursor RNAs have stretches of 
self-complementarity and can form imperfect RNA hairpins or stem-loop structures, 
which are then processed into the miRNAs. In mammals, these pri-miRNAs are 
cleaved by the RNase III-type endonuclease Drosha on one side of the loop in the 
nucleus. The resulting partially processed pre-miRNA is then transported to the 
cytoplasm where Dicer cuts the stem 22 nt away from the Drosha cleavage site to 
generate an RNA duplex consisting of the miRNA and its complementary strand. In 
plants, both cleavages are made by DCL1  in the nucleus and result in 21 nt long 
miRNA duplexes (. Fig. 6.4). Before these are exported to the cytoplasm, they are 
processed by HUA ENHANCER1 (HEN1), which methylates the 3′-terminal ribose 
of each RNA strand to protect the miRNA from degradation. The miRNA is then 
a b
c
  . Fig. 6.3 Phylogenetic tree and domain structure of  ARGONAUTE (AGO) proteins. a Unrooted 
phylogenetic tree of  135 AGO proteins. The AGO proteins fall into three major clades: AGO proteins 
from plants, animals, and fungi that bind miRNAs or siRNAs, PIWI proteins which bind to Piwi-inter-
acting RNAs (piRNAs) expressed in the germline of  animals only, and the worm-specific WAGO clade. 
In some species, this family is highly diversified, e.g., in A. thaliana with 10 and C. elegans with 25 mem-
bers, respectively. (From Wei et al. 2013). b Domain structure of  AGO proteins with a PAZ domain that 
binds siRNAs, the PIWI domain that cleaves the target mRNA, and the cap-binding-like domain MC 
that lies within the Mid-domain connecting the PAZ and PIWI domains. (From Hutvagner and Simard 
2008). c Crystal structure of  an AGO protein, showing the 3’end of  the siRNA in purple and part of  the 
mRNA in turquoise; active residues of  the PIWI domain are shown in red. (From Song et al. 2004)
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bound by A. thaliana AGO1 (sometimes AGO7/AGO10) to form a RISC complex 
that slices the target mRNA or blocks its translation. In plants, the miRNA typically 
shows near-perfect complementarity to the target mRNA, leading to slicing in the 
majority of cases. In contrast, animal miRNAs rarely have perfect complementarity 
to the mRNA and more often cause translational inhibition. Also in plants, some 
miRNA block translation in combination with slicing of the transcript. Many plant 
miRNAs target transcription factors and are often conserved during evolution, indi-
cating important regulatory roles during development. Although the coding 
sequences for these transcription factors have diverged considerably, the target sites 
on the mRNAs matching the miRNAs are nearly invariant. Other miRNAs are evo-
lutionary young and often specific to a cell lineage. In A. thaliana, these lineage-spe-
cific miRNAs are sometimes processed by DCL4, while DCL1 is required for the vast 
majority of miRNAs.
a b c
  . Fig. 6.4 Different small RNA biogenesis pathways in plants. a Pathways involved in PTGS: tran-
scripts from miRNA genes form hairpin-like structures (pri-miRNA) that are diced by DLC1 into 
shorter stem-loop structures (pre-miRNA) and then into mature miRNA duplexes. Longer hairpin 
structures can originate from inverted repeats and are processed by all DCL proteins into hp-siRNAs. 
They may represent an early stage in the evolution of  miRNAs. natsiRNAs are derived from dsRNA 
produced by overlapping transcription (cis-natsiRNAs) or from transcripts with regions of  high com-
plementary originating from distant loci (trans-natsiRNAs). RNA-dependent RNA polymerases 
(RDRs) are likely involved in extending the dsRNA, which is diced by various DCLs. b Secondary 
siRNAs act on transcripts distinct from those that generated them and are involved in both PTGS and 
TGS. The transcripts come from non-coding loci, protein-coding genes, or transposons and are con-
verted into dsRNA by RDR6 and processed by DCL2 and DCL4 into various classes of  siRNAs. The 
tasiRNAs, for instance, are derived from non-coding transcripts of  specific TAS genes (TAS1 to TAS4 
in A. thaliana), which are targeted by specific miRNAs that mediate their cleavage (e.g., miR173-AGO1 
for TAS1/TAS2; mir390-AGO7 for TAS3). The 3′ cleavage product is converted into dsRNA by RDR6, 
and then sequentially diced by DCL4 into 21 nt long tasiRNAs that are phased relative to the miRNA 
cleavage site. Thus, tasiRNAs have defined sequences and function like miRNAs to slice or inhibit their 
target mRNAs. c The heterochromatic siRNAs (hetsiRNAs) originate from transposons and repeats, 
often located in pericentromeric regions. They depend on transcription by RNA polymerase IV (Pol 
IV), dsRNA synthesis by RDR2, and dicing into 24 nt long siRNAs by DCL3. hetsiRNAs mediate 
RNA-dependent DNA methylation (RdDM). (From Borges and Martienssen 2015)
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6.2.2  Genome Defense by siRNA-Mediated Silencing
An important class of small RNAs are the siRNAs that induce PTGS to defend the 
genome against viruses and microbes (Pikaard and Mittelsten Scheid 2014). Most 
plant viruses have a ssRNA genome whose replication depends on an endogenous or 
virus-encoded RDR to produce dsRNA intermediates, which are substrates for DCL 
proteins. In addition, viruses with dsRNA genomes are direct substrates for dicing as 
are dsRNA intermediates formed during the life cycle of ssDNA viruses. The silenc-
ing of transgenes is likely observed due to the activity of similar genome defense 
pathways. Transgenes often integrate as multiple copies that can have opposite orien-
tations. Transcription through inverted transgenes can lead to hairpin-like RNA 
structures that are substrates for DCL proteins. Transgenes may also integrate next 
to strong promoters pointing in the opposite direction, leading to transcription of 
both strands and, thus, dsRNA formation. Finally, other aberrant types of trans-
gene-derived mRNAs can serve as a substrate for an RDR protein, generating 
dsRNA. PTGS of viruses and transgenes typically involves 21–22 nt long siRNAs 
generated primarily by DCL2 and DCL4 (. Fig. 6.4). The 21 nt long siRNAs guide 
the cleavage of the mRNA by AGO1, which generates a 3′ fragment of the mRNA 
that lacks a 7-methylguanosine cap at its 5’end. mRNAs without a cap are eliminated 
rapidly by exonuclease-mediated degradation. The association of 22 nt siRNAs with 
AGO1 couples target mRNA cleavage to the recruitment of RDR6, such that the 3′ 
cleavage fragment is transcribed into dsRNA, which is then diced again by DCL4 to 
make 21 nt long secondary siRNAs. DCL3 can also dice dsRNA derived from viruses 
or transgenes, generating 24 nt siRNAs (. Fig. 6.4). However, these lead to TGS 
through DNA and chromatin modifications at loci with complementarity to the siR-
NAs. Taken together, these diverse aspects induced by siRNAs mount a very power-
ful response to invading nucleic acids. Not surprisingly, viruses developed a variety 
of countermeasure and many encode suppressors of gene silencing in their genomes 
(Jiang et al. 2012).
The discovery of RNAi and its underlying mechanisms, many of which are con-
served across organisms, have opened unprecedented opportunities for applications. 
For instance, the discovery that synthetic dsDNA can be used in tissue culture cells 
to induce RNAi allowed genome-wide screens to address gene function in cultured 
cells. This has been instrumental not only for basic research but especially for drug 
discovery in the pharmaceutical industry (Hokaiwado et al. 2008). In plants, miR-
NAs have been used to address the function of genes or gene families by introducing 
artificial miRNAs that target transcripts derived from one or multiple loci. Also, 
siRNAs derived from transgenic hairpin constructs that target a specific gene of 
interest have been extensively used to study gene function. Moreover, viral genomes 
have been engineered to encode plant genes of interest. A viral infection thereby 
leads to the production of siRNAs against the endogenous plant gene, allowing func-
tional studies. This so-called virus-induced gene silencing (VIGS) is particularly use-
ful to study the function of genes in non-model organisms, where no efficient 
transgenesis methods are available but infections using such engineered viruses are 
possible.
Similar approaches have led to biotechnological applications. One of the most 
successful advancements was the development of virus-resistant plants by exploiting 
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the siRNA-based defense mechanism of the plant and targeting it specifically to the 
virus. For instance, the Hawaiian production of papaya was severely threatened by 
papaya ringspot virus, which devastated the plantations in the 1990s. The introduc-
tion of a genetically modified virus-resistant papaya variety in 1998 saved the papaya 
growers and is the basis of current papaya production in the USA (. Fig. 6.5). A 
similar approach has since been used to protect commercially grown summer squash 
(Gottula and Fuchs 2009).
6.3  Transcriptional Gene Silencing (TGS)
Transgene silencing does not only involve siRNAs at the post-transcriptional level 
but also comprises DNA methylation. The two phenomena were linked when it 
was discovered that homology-dependent DNA methylation also involved siRNAs 
(Mette et  al. 2000) and some mutants of  A. thaliana affected both PTGS and 
TGS. Furthermore, the silencing of  transposable elements and repeats is crucial 
for the maintenance of  genome integrity. A failure to keep transposons in check 
results in hybrid dysgenesis in D. melanogaster, where massive transposition in the 
germline leads to sterility, a high mutation rate, and chromosome breakage. In 
metazoans, transposons are silenced through the action of  Piwi-interacting RNAs 
(piRNAs), which are generated from long Pol II transcripts that are derived from 
piRNA clusters, loci composed of  transposons of  diverse families or fragments 
thereof. Thus, piRNAs are complementary to many dispersed transposons. Their 
production is independent of  DCL proteins but piRNAs bind to AGO-like pro-
teins of  the PIWI clade (. Fig.  6.3), which are essential to their biogenesis. 
Primary piRNAs can be amplified through a so-called ping-pong cycle and eventu-
ally lead to silencing of  the transposons by recruiting the machinery to establish 



























  . Fig. 6.5 Virus-resistant, transgenic papaya based on RNAi directed against the coat protein of 
papaya ringspot virus. a Field trial showing a block of  resistant papaya plants of  the transgenic Rain-
bow cultivar surrounded by susceptible non-transgenic plants of  the Sunrise cultivar. b All transgenic 
Rainbow plants were resistant to the virus while all non-transgenic Sunrise plants became infected 
within a few months of  the field trial. (From Gonsalves et al. 2004)
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The silencing of endogenous repeats, such as those present at centromeres, was 
also found to rely on RNA-based mechanisms, for instance in the formation of cen-
tromeric heterochromatin in A. thaliana or the yeast Schizosaccharomyces pombe 
(Martienssen and Moazed 2015). Here, however, we focus on RNA-dependent DNA-
methylation (RdDM), an RNA-based mechanism primarily targeting endogenous 
transposons and repeats, but also transgenes, in plants (Matzke and Mosher 2014).
RdDM was initially discovered in plants that were infected with a viroid 
(Wassenegger et  al. 1994). It was later shown to also occur at transcriptionally 
silenced transgenes and rely on siRNAs and proteins of the RNAi machinery. RdDM 
is a very complex mechanism, involving many factors that were identified in genetic 
screens for mutants that relieve transgene silencing. In addition, the biochemical iso-
lation of proteins interacting with known factors by co-immunoprecipitation con-
tributed to complete the picture. Taken together, these studies revealed that RdDM 
relies on two specialized RNA polymerase complexes that are derived from Pol II, 
called Pol IV and Pol V. Conceptually, the RdDM mechanism can be separated into 
three major phases (. Fig. 6.6) (Matzke and Mosher 2014).
First, Pol IV is recruited to target loci by SAWADEE HOMEODOMAIN 
HOMOLOGUE1 (SHH1), which binds to H3K9me. The transcripts produced by 
Pol IV are then copied by RDR2, which interacts with the chromatin remodeler 
CLASSY1, into dsRNA that is diced into 24 nt siRNAs by DCL3. The siRNAs 
are protected from degradation through methylation by HEN1 and incorporated 
into AGO4.
In a second phase, Pol V mediates de novo DNA methylation of the target loci by 
transcribing a scaffold RNA with complementarity to the AGO4-bound siRNAs. 
ChIP-sequencing experiments showed that Pol V is targeted to transposons and 
  . Fig. 6.6 Schematic representation of  the canonical RdDM pathway involving the plant-specific 
RNA polymerases Pol IV and Pol V. The three phases of  establishing silent chromatin at target loci, 
mostly transposable elements and repeats but also transgenes, are shown. In phase one, 24 nt siRNA are 
generated through a Pol IV-dependent process (left). In the second phase, the target loci get de novo 
methylated through a Pol V-mediated mechanism (middle) and in the last phase, heterochromatin is 
established through repressive histone modifications, nucleosome repositioning, and changes in higher 
order chromatin structure (right). For details, see main text. (From Matzke and Mosher 2014)
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genomic repeats that are associated with DNA methylation and 24  nt siRNAs. 
However, about 25% of the Pol V loci do not show these features, indicating that Pol 
V occupancy is not sufficient for RdDM. Pol V recruitment to target loci may involve 
interactions with SU(VAR)3-9 HOMOLOG2 (SUVH2) and SUVH9, which both 
bind to methylated DNA. Pol V transcription is likely facilitated through the unwind-
ing of DNA by the chromatin remodeler DEFECTIVE IN RNA-DIRECTED DNA 
METHYLATION1 (DRD1) and the single strand DNA-binding ability of RNA-
DIRECTED DNA METHYLATION1 (RDM1) that, together with DEFECTIVE 
IN MERISTEM SILENCING3 (DMS3) and MICROCHIDIA6 (MORC6), may 
establish and maintain the unwound state. AGO4 is recruited to the locus through 
interactions with KOW DOMAIN-CONTAINING TRANSCRIPTION FACTOR1 
(KTF1) and binding to Pol V itself. The RDM1 protein brings the DOMAINS 
REARRANGED METHYLTRANSFERASE2 (DRM2) together with AGO4, 
leading to de novo DNA methylation of regions with homology to the siRNAs.
Finally, in the third phase, a repressive chromatin state is established. This 
involves the repositioning of nucleosomes through a SWI/SNF chromatin remodel-
ing complex (see book 7 Chap. 2 of Paro) that interacts with a complex composed 
the Pol V scaffold RNA-binding proteins INVOLVED IN DE NOVO2 (IND2) 
and IND2 PARALOGUE (IDP). Active histone marks are removed by HISTONE 
DEACETYLASE6 (HDA6), histone demethylase JUMONJI14 (JMJ14), and 
UBIQUITIN-SPECIFIC PROTEASE26 (UNP26), followed by the deposition of 
repressive histone modifications, e.g., H3K9me, by SUVH4, SUVH5, and SUVH6. 
The silent state may be further reinforced through changes in higher order chromatin 
conformation mediated by the activity of MORC1 and MORC6.
Mutations affecting the RdDM machinery are viable and fertile and do typically 
not show gross developmental aberrations. However, the pathway is important for 
transposon repression and, thus, contributes to maintaining the integrity of the 
genome. Furthermore, it plays a role in various physiological and developmental pro-
cesses (Matzke and Mosher 2014). Thus, RdDM has been implicated in the defense 
against bacteria and viruses. Additionally, it may be involved in establishing some 
gametic imprints (see book 7 Chap. 5 of Grossniklaus). Moreover, siRNAs can be 
transported over short distances from cell to cell but also long-distance through the 
vasculature, potentially playing a role in intercellular communication. This has for 
instance been proposed to occur between cells in the female gametophyte and pollen, 
and may also occur between embryo and endosperm, although direct evidence for 
the transport of siRNAs in these tissues is missing. Finally, RdDM has been shown 
to occur in hybrids, where the production of siRNAs from one parental genome can 
affect previously non-methylated loci in the other genome in trans, either at allelic 
sites or at distant loci if  there is sufficient sequence homology.
6.4  Paramutation
Paramutation is a classical epigenetic phenomenon that is now understood to involve 
RdDM. It was simultaneously discovered by Alexander Brink and Edward Coe in 
maize as well as Robert Hagemann in tomato (Brink 1956; Coe Jr 1959; Hagemann 
1958). Paramutation describes a paradox of genetics where certain alleles do not 




found that a ‘genetic’ change or ‘conversion’ occurred in certain heterozygous combi-
nations. For instance, Coe worked with alleles of the booster1 (b1) locus responsible 
for anthocyanin pigmentation of the plant and reported “an effect on plant color in 
maize, interpreted as a regular conversion of one allele at the B locus by another […]. 
The effect is a continuing one in that the ‘converted’ B, termed B’, is also regularly 
able to ‘convert’ newly introduced B″. When Coe crossed intensely pigmented, purple 
plants homozygous for the booster1-Intense (B-I) allele to weakly pigmented, green 
plants homozygous for the B allele, all progeny was weakly pigmented. This could, in 
principle, be explained by dominance of B over B-I, but the progeny also remained 
weakly pigmented after repeated outcrossing to B-I plants. Thus, given there was no 
segregation, the B-I allele appeared to have changed its activity to that of the weakly 
pigmented B allele and was termed B′ (. Fig. 6.7). The non-Mendelian segregation 
was confirmed in test-crosses of B-I/B heterozygotes to unpigmented plants homozy-
gous for the loss-of-function b allele. Instead of the expected 1:1 segregation of 
intensely pigmented B-I/b and weakly pigmented B/b plants, all progeny was weakly 
pigmented, confirming the conversion of B-I to B′. Already in these early studies, 
Coe found that the B-I allele can spontaneously give rise to the B′ allele and Brink 
found the altered state of the R’ allele of the coloured1 (r1) locus to revert in some of 
the progeny. Such instability or metastability is now considered a hallmark of an 
epigenetic state, which is much less stable than genetic mutations.
Nowadays, the conversion of one allele into another is understood as a change in 
the epigenetic control of the expression state of the locus and is called paramutation. 
Paramutation is defined as a directed, heritable change in gene expression that is 
invoked by interactions between specific alleles. Paramutation can occur between 
genetically identical or distinct alleles. The alleles that incite paramutation are called 
paramutagenic, those that are susceptible to it are paramutable, and those that do 
a b c
  . Fig. 6.7 Paramutation illustrated by the genetic behavior of  the purple plant1-Rhoades (Pl-Rh) allele 
required for anthocyanin pigmentation of  the plant. a Pigmented anthers of  a Pl-Rh plant. b Unpig-
mented anthers of  a Pl’ plant. (a, b from Hollick 2017). c Schematic representation of  paramutation at 
the pl1 locus. Diploid genotypes and seedling coloration are shown on the left, anther color and haploid 
genotypes of  the gametes produced are shown on the right. In the middle, transcription from the pl1 
locus is represented: the strongly expressed Pl-Rh allele, the weekly expressed Pl’ allele with broken 
wavy lines representing unstable mRNAs, and the interaction between the paramutagenic Pl’ and the 
paramutable Pl-Rh (red arrow), leading to reduced expression of  Pl-Rh and conversion to Pl’. (From 
Hollick 2010)
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not participate in paramutation are neutral. As Coe described, the converted para-
mutable allele then becomes paramutagenic itself  and can incite secondary paramu-
tation. This interesting epigenetic phenomenon has been described for several 
endogenous loci in tomato and maize, including b1, r1, purple plant1 (pl1), and peri-
carp color1 (p1), all which are transcriptional regulators of flavonoid biosynthesis. 
But there is also an increasing number of transgenes that show a paramutation-like 
behavior, both in plants and animals, including D. melanogaster, C. elegans, and mice 
(Hollick 2017).
6.4.1  The cis-Regulatory Elements Controlling Paramutation 
and trans-Acting Factors Link Paramutation to RdDM
Most paramutation systems in maize are metastable and the expression state of an 
allele can spontaneously change in both directions at variable frequencies. At the b1 
locus, however, B′ alleles are formed spontaneously from B-I, while the B′ state is 
extremely stable. In genetic screens metastability can be problematic as it may gener-
ate false positives. The stability of the B′ state was one of the reasons to use this 
system in various genetic screens to identify cis-regulatory regions and trans-acting 
factors of paramutation.
For instance, the cis-regulatory regions required for high expression of B-I were 
localized by looking for recombinants where high expression was acquired by a neu-
tral allele. Likewise, the cis-elements required for paramutation were identified by 
isolating recombinants where a neutral allele had become paramutagenic. Mapping 
of the recombination breakpoints showed that the enhancer for high b1 expression 
and the region mediating paramutation coincided and were located about 100 kb 
upstream of the b1 transcriptional start site (Stam et al. 2002). Molecular character-
ization of this region showed that it was composed of seven tandem repeats of an 
853 bp sequence that is unique in the maize genome (. Fig. 6.8). These repeats were 
identical in the paramutagenic B′ and the paramutable B-I alleles, confirming the 
epigenetic nature of paramutation.
Paramutagenicity is related to how many copies of the repeat are present in an 
allele. With five repeats, an allele is still fully paramutagenic but with three, paramu-
tagenicity is reduced, and neutral alleles have only a single repeat (. Fig. 6.8). A 
relationship between the number of repeats and paramutagenicity was also observed 
at the r1 locus, where the paramutagenic alleles R-stippled and R-marbled both con-
sist of multiple copies of the r1 coding region and flanking sequences, while alleles 
with only one r1 gene are neutral. Deletion derivatives showed a direct correlation 
between paramutagenicity and the number of r1 genes (Hövel et al. 2015).
Given that both B-I and B′ have the same seven repeats, the difference between 
them must lie in their epigenetic state. Indeed, at several loci, the paramutable and 
paramutagenic alleles were shown to be differentially methylated (. Fig.  6.8). 
Importantly, upon paramutation, the paramutable allele gained DNA methylation, 
implying methylation is associated with and possibly even triggering the epigenetic 
switch underlying paramutation. Thus, during paramutation, the cis-regulatory 
regions mediate trans-homolog interactions between the two alleles, leading to a 




ated as compared to those of B-I but they also carry the repressive histone marks 
H3K9me2 and H3K27me3, similar to silenced transposons (. Fig. 6.8).
Using the powerful genetic tools in maize, screens for second-site mutations in 
factors required for the establishment and/or maintenance of paramutation were 
conducted (Hollick 2017). Looking for mutants that abolish the reduced pigmenta-
tion levels observed in Pl’/Pl’ and B′/B′ plants, parallel screens for required to main-
tain repression (rmr) and mediator of paramutation (mop) mutants were performed 
(. Fig. 6.8). The molecular cloning of some of these mutants provided a clear link 
to gene silencing by RdDM. The mop1 locus was found to encode a homolog of 
RDR2, which is required for the generation of Pol IV-dependent 24 nt siRNAs in A. 
thaliana. Moreover, the rmr6/mop3 locus encodes the largest subunit of Pol IV, and 
rmr7/mop2 the second largest subunit, which is part of both Pol IV and Pol V, fully 
establishing the link between paramutation and RdDM. Indeed, all known mop and 
rdr mutants do not only suppress the reduced pigmentation in Pl’/Pl’ plants but also 




  . Fig. 6.8 Features of  cis-elements required for paramutation at the b1 locus and genetic screen for 
trans-acting factors. a Repeat region ~100 kb upstream of  the b1 coding sequence. The paramutagenic 
B-I and paramutable B′ alleles have seven identical tandem repeats while the neutral b-N allele has only 
one. A reduction to five repeats maintains full paramutagenicity while, with three repeats, the allele is 
less paramutagenic. b Epigenetic features of  B′ and B-I, which show differential DNA methylation and 
carry distinct histone marks at the tandem repeats (only four repeats are show for simplicity) (a, b from 
Hövel et al. 2015). c Scheme of  the genetic screen for Mediator of paramutation (Mop) mutants using 
EMS pollen mutagenesis. The two parental lines carry wild-type or mutant alleles of  glossy2 (gl2) and 
white tip (wt), respectively, that flank the b1 locus. B′* indicates a B-I allele that was paramutated to B′ 
in wild-type plants, B-I* indicates a B-I allele exposed to B′ in the presence of  Mop2-1, which prevents 
paramutation. (From Sidorenko et al. 2009)
 Chapter 6 · RNA-Based Mechanisms of Gene Silencing
131 6
situation in maize is more complex than in A. thaliana as there are two non-redun-
dant Pol IV and three Pol V subtypes. Thus, the specific roles of the RdDM compo-
nents identified in maize through these screens are still not well understood. Clearly, 
there are some unique features of paramutation in comparison to transposon silenc-
ing by RdDM, namely the directed trans-homolog interactions and heritable changes 
occurring in meiosis that are a hallmark of paramutation. Future work will shed 
more light onto the similarities and differences of paramutation and RdDM.
Take-Home Message
 5 In diverse epigenetic phenomena, RNAs play a key role. These include long non-
coding RNAs in genomic imprinting and X chromosome inactivation, or short 
RNAs of different types in gene silencing mechanisms.
 5 Gene silencing can occur at the transcriptional or post-transcriptional level but 
both mechanisms rely on short RNAs. The mechanisms play important roles in the 
defense against viruses as well as in maintaining genome integrity.
 5 Many of the components of RNA-based silencing mechanisms are conserved in 
animals, plants, and fungi. These include some key players like the RNase III-
related DICERLIKE endonucleases and the ARGONAUTE proteins that bind to 
small RNAs and slice target mRNAs.
 5 Small RNAs are involved in post-transcriptional silencing, targeting mRNAs for 
degradation or inhibiting their translation. This mechanism is also referred to as 
RNA interference (RNAi) and has been instrumental for large-scale screens in 
cultured cells both in fundamental and applied research.
 5 Transcriptional gene silencing, for instance to repress transposable elements and 
repeats, is also based on small RNAs – siRNAs or piRNAs – across a wide variety 
of organisms. In plants, this is achieved by RNA-dependent DNA-methylation, a 
complex pathway involving the plant-specific RNA polymerases Pol IV and Pol V.
 5 Paramutation involves trans-homolog interactions that cause a heritable repres-
sion of the paramutable allele directed by the paramutagenic allele. Similar effects 
were observed in hybrids where bringing together divergent (epi)genomes can 
cause DNA methylation changes in trans.
 5 Paramutation relies on cis-regulatory sequences that can be far away from the cod-
ing sequence and consist of repeats. The epigenetic state of these repeats differs 
between paramutable and paramutagenic alleles and is established and/or main-
tained by the RNA-dependent DNA methylation pathway.
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What You Will Learn in This Chapter
During regenerative processes, cells are required to restructure parts of a damaged or 
worn-out organ and tissue. Here, you will become acquainted with the strategies that 
organisms developed to provide the material for tissue and organ repair. On the one hand, 
somatic cells can become dedifferentiated to increase their developmental potential and 
produce the plasticity required to replace the entire cellular complexity of a damaged part. 
On the other hand, organisms retain organ-specific stem cells with a restricted develop-
mental potency and use these to provide the “spare parts” for replacing damaged cells. In 
all cases, a substantial reprogramming of the epigenome of these cells accompanies the 
restructuring process. In vitro strategies have been developed to drive cells back to a plu-
ripotent state, allowing a better understanding of the underlying chromatin adjustments 
and providing a rich source for cellular therapies.
7.1  Types of Regenerative Phenomena
Epigenetic mechanisms mostly sustain long-term processes, like maintenance of gene 
expression patterns, keeping either the maternal or the paternal X chromosome 
repressed within a cell lineage, maintaining cellular memory over developmental 
time, or tightly silence transposon-riddled genome sections during the life of a cell 
and of its progenitors. Many of these mechanisms have evolved to be exceptionally 
stable, approaching sometimes the perseverance of the genetic system. Yet, organ-
isms also adapt to changing environments and physiological requirements and, 
therefore, have to adjust or reverse some of these long-term epigenetic commitments. 
A prime example requiring restructuring of the epigenomic landscape is the process 
of regeneration. Damaged body parts, organs, or tissues can be faithfully repaired 
contributing to the survival of the adult organism. In adults, development has been 
completed and cell types and the anatomy of tissues in the organs is maintained with 
minimal changes. Additionally, the process of ageing leads to a degradation of tissue 
function. Hence, new strategies to provide the materials necessary for the repair pro-
cess evolved. The body can carry a reservoir of stem cells from which replacement of 
parts can form through cell differentiation, by re-running developmental cascades to 
achieve the necessary structures and functions. Alternatively, differentiated cells in 
the neighborhood can change their own identity and attain the morphological struc-
tures and physiological functions required to replace the damaged parts. In low com-
plexity organs, hyperproliferation of the basic structural and functional constituents 
can often fill the gaps left by the damage. This chapter deals with the obstacles that 
regenerative processes encounter when epigenetically encoded, stable states have to 
be changed and reprogrammed.
While plants have extraordinary regenerative capacities and there is a large body 
of literature describing the underlying epigenetic processes (Ikeuchi et al. 2019), this 
chapter will focus on animal regenerative mechanisms (Tanaka and Reddien 2011; 
Carlson 2005). Different phenomena have been observed in animal phyla, like mor-
phallaxis in Planaria or Hydra, approaching the repair capacities observed in the 
plant world. Tissue fragments retain the ability to reconstitute an entire functional 
organism or organ. In general, compensatory growth restores the size of an organ by 
increasing cell size (compensatory hypertrophy) or by accelerating cell division 
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 (compensatory hyperplasia). Limited to the usage of the existing pool of differenti-
ated cells, such regulatory processes can be observed after damage of a number of 
human organs, like liver or kidney. Physiological regeneration describes the continu-
ing replacement of damaged or ageing cells or body parts. In humans, examples for 
this form of tissue homeostasis are the process of blood cell replacement, the renewal 
of the lining of the intestine, or the surface of the skin.
7.1.1  Regenerating from a Blastema
Reparative regeneration represents the most spectacular form of restoration observed 
in higher animals. The capability to regrow an entire limb structure after amputation, 
as observed in newts, is certainly such a remarkable process, regarded with envy by us 
humans. Not surprisingly, these reparative processes were studied for decades by sci-
entists in a number of model organisms, like the amphibian axolotl1 or newts. The 
repair and regenerative process after amputation of the limb can be described in the 
following series of key events (Carlson 2005):
 1. Wound Healing: Epidermal migration to cover the amputation surface and pre-
vent infections by pathogens.
 2. Demolition and Phagocytosis: Inflammatory response and enzymatic removal of 
matrix components just beneath the wound epithelium.
 3. Dedifferentiation: The loss of differentiated tissue types beneath the wound epi-
thelium and the appearance of embryonic-looking (dedifferentiated) cells in the 
same area.
 4. Blastema Formation: The aggregation of the dedifferentiated cells into a struc-
ture reminiscent of embryonic limb structure.
 5. Morphogenesis and Growth: Growth of the blastema and shaping and differen-
tiation of the blastemal cells into the cells and tissues comprising the normal limb. 
In larger appendages, after morphogenesis is completed, growth of the miniature 
regenerate continues until it is of the same size as the original limb structure that 
was lost.
Central to the process is the formation of a blastema containing the progenitor cells 
for the regrowth of the full appendage (epimorphic regeneration). Cells forming the 
blastema derive from tissues surrounding the wound. Though resembling the mor-
phology of embryonic cells, these precursors nevertheless appear not be fully dedif-
ferentiated to a pluripotent state (see below) but gain a multipotent condition required 
to rebuilt the resident organ or tissue. Lineage tracing experiments in axolotl reveal 
that the cells of the blastema retain certain developmental restrictions and only have a 
limited differentiation potential (Tanaka and Reddien 2011). By tracing cells from 
each major tissue during axolotl limb regeneration, dermal cells turned out to have the 
potency to form cartilages and tendons, but never switched the fate across embryonic 
1 Interestingly, axolotl does loose regenerative ability when it is hormonally forced to develop to the 
adult form. This is an interesting case how regenerative ability has been apparently selected along 
with a developmental arrest. This might add support to a view of  a re-running of  developmental 
programs to a restricted extent for regenerative purposes.
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germ layers. Other blastema cells derived from epidermal cells, muscles, Schwann cells, 
and cartilage cells, retained their original tissue identity during regeneration. Hence, a 
rather limited dedifferentiation and change in fate appears to occur at the blastema.
7.1.2  Changing Potency by Transdifferentiation
Other processes of regeneration, omitting the formation of a blastema but still utiliz-
ing partial dedifferentiation steps, have been observed. For example, zebrafish hearts 
can regenerate after amputation of up to 20% of the ventricle. During the process, 
the newly formed heart muscle cells are derived from the dedifferentiation and prolif-
eration of pre-existing cardiomyocytes. Dedifferentiation promotes proliferation and 
the activation of embryonic cardiogenesis genes. Conversely, a decrease in expression 
of sarcomeric components leads to the disassembly of sarcomeric structures (Barrero 
and Izpisua Belmonte 2011).
In other cases, a complete change in cellular fate has been described and termed “trans-
differentiation”. Glucagon-producing α-cells can transdifferentiate into pancreatic insulin-
producing β-cells after ablation of β-cells with diphtheria toxin. This transition process 
seems to be direct, not involving undifferentiated intermediates2. Transdifferentiation 
can also occur through an undifferentiated intermediate, however, as observed during 
the regeneration of the eye lens in newts. Lens regeneration takes place through transdif-
ferentiation of the pigmented epithelial cells (PECs) of the iris. After removal of the lens, 
the PECs re-enter the cell cycle, dedifferentiate, and lose their characteristic pigmentation. 
During this early stage, the expression of developmental regulators, such as the transcrip-
tion factors Pax6 and Sox2, is activated. Later, the dedifferentiated proliferating PECs 
start to express crystallins and differentiate into lens fibers.
Taken together, these results suggest that the process of dedifferentiation and 
transdifferentiation during regeneration involves the silencing of tissue-specific 
genes, as well as the induction of genes involved in embryonic programs and the 
control of the cell cycle. These changes in gene expression might facilitate the acqui-
sition of a limited extended plasticity that allows cells to proliferate and rearrange 
into the new structures by a limited iteration of developmental pathways. Potentially, 
embryonic genes involved in regeneration might remain poised for activation in 
regenerating animals, but irreversibly silenced in non-regenerating animals. The 
questions remaining are: what signaling mechanisms drive this change in potency 
and what mechanisms repattern the cells to reproduce a full organ?
7.1.3  Signaling in the Blastema
Despite substantial interest in understanding the basic mechanisms regulating regen-
erative capacity, in many of the classical model organisms it has been difficult to study 
the underlying molecular mechanisms. Conversely, Drosophila melanogaster offers sub-
stantial advantages for regenerative studies since it is less complex than amphibians and 
2 Also during normal development α and β-cells are derived from an initially bipotential progenitor. 
The potential of  the progenitor for making α is switched later in development to β-cells. Reflecting 
again a copy mechanism of  developmental steps in regeneration.
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humans and a wide palette of research tools is available. Drosophila, unlike some other 
arthropods, is not able to regenerate damaged legs or wings in adults. However, the 
larvae harbour regeneration abilities in the imaginal discs (see also book 7 Chap. 3 of 
Paro). Imaginal discs can regenerate to form normal adult appendages even after mas-
sive lesion of disc cells are caused by X-rays irradiation at larval stages or by local induc-
tion of cell death (Hariharan and Serras 2017;  Ahmed- de- Prado and Baonza 2018).
Regeneration of the imaginal discs is also observed under ex vivo conditions 
(. Fig. 7.1). When imaginal discs are manually fragmented, transplanted, and cul-
tured in the abdomen of an adult fly, the disc cells at the wound site regenerate the 
missing parts. Remember that the imaginal disc cells consist of already specifically 
determined but undifferentiated cells until metamorphosis, hence they are not uni-
form cells. Each imaginal disc established during embryogenesis is destined to follow 
a specific developmental pathway. The regional identities and specific cell fates in 













  . Fig. 7.1 Signaling in the blastema of  the regenerating imaginal disc. a Leg imaginal disc dissected 
from third instar larva at 100 h after egg deposition, wounded and cultured in adult abdomen (ex vivo). 
Activation of  JNK signaling in cells shown by a continuous labeling of  a GFP-reporter (bottom panel) 
in the blastema at different time points after wounding; (C0P) 0 hours (un-cultured), (C6P) 6 hours, 
(C12P) 12 hours, (C24P) 24 hours, and (C48P) 48 hours of  culturing. Yellow arrowheads indicate the 
fragmented positions. Scale bar = 100 μm. b JNK signaling at the wound site is required to downregu-
late PcG silencing and up-regulate ligands for Dpp, JAK-STAT, and Wg signaling cascades. Dpp signal-
ing initiates wound closure. The concerted action of  JAK-STAT and Wg signaling induces cell 
proliferation and tissue repatterning in the blastema
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At the time of damage, the expression of master regulatory genes shows already an 
intricate developmental pattern. The steps in the regeneration process of fragmented 
imaginal discs are, in principle, analogous to those of amphibian limb regeneration, 
consisting of wound healing (closure), localized cell proliferation (regeneration blas-
tema formation), and pattern formation. Collectively, the observations demonstrate 
that disc regeneration induces limited cellular reprogramming, enabling the reconsti-
tution of the lost tissue while disc identity is maintained independently of the local 
environment.
Studies of imaginal disc transplantation have uncovered the process of transde-
termination, i.e., neighbouring groups of cells in regeneration blastema sometimes 
become more plastic and acquire alternative organ identities from different imaginal 
discs (comparable to transdifferentiation; see book 7 Chap. 3 of Paro). This sug-
gested that the mechanism of cellular memory has to be changed and reprogrammed 
during the regenerative process. Indeed, disc regeneration and transdetermination 
are coupled to the regulation of Polycomb (PcG) function. Down-regulation of PcG 
function, as monitored by the derepression of a silent PcG regulated reporter gene, 
was observed in proliferating, regenerating cells of the blastema (Lee et al. 2005). 
Furthermore, only cells with compromised PcG function were found to transdeter-
mine more frequently, suggesting that PcG modulation is a prerequisite for cellular 
reprogramming.
The healing at wound sites involves the activation of the Jun N-terminal kinase 
(JNK) signalling pathway in several rows of cells at the edge of the wound (. Fig. 7.1). 
The blastema cells are derived from cells in which JNK has been activated. It was 
found that the JNK signalling pathway directly controls the down-regulation of PcG 
silencing (Lee et al. 2005). Clonal activation of the JNK pathway in imaginal discs 
was sufficient to reduce PcG-mediated silencing function, as can be visualized by 
ectopic expression of a Hox gene, a target of the PcG system. Hence, the down- 
regulation of PcG silencing by JNK signaling appears to result in a specific, yet, not 
global reactivation of PcG target genes. These appear to be driven into a poised state 
and only upon the activation by tissue-specific transcription factors, the cells are 
directed towards the required differentiated state (Beira et al. 2018).
An important finding shows that in epimorphic regenerative processes observed 
in many animals, the formation of a blastema provides the starting source of cells 
used for the repatterning. However, while changing their differentiation state to a 
more multipotent character, the cells of the blastema never acquire a fully pluripo-
tent capacity. Unlike the exogenous expression of reprogramming factors to induce 
pluripotent stem cells (see below), the natural regeneration signals are able to repro-
gram the chromatin state of the blastema cells to more lineage-restricted progenitor 
states, circumventing the problem of tumorigenic deregulation often observed in plu-
ripotent cells.
7.2  Stem Cells in the Adult
A different concept for providing cells to regenerating parts are stem cells. By defini-
tion, the division of a stem cell will produce another stem cell as well as a precursor 
for a particular lineage. Hence, on the one side, the constant availability of a stem cell 
pool is guaranteed. On the other side, the stem cell has to maintain the developmen-
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tal potential to produce all the cell types of the lineage(s) that is contributing to. In 
mammals at the early blastocyst stage, cells from epiblast of the inner cell mass can 
be maintained in culture. They have the capacity to develop and contribute to cell 
types of all three germ layers when subjected in vitro to a differentiation program or 
transplanted back into the corresponding developmental stage of the organism. As 
such, they are pluripotent since they have the potential to develop into any part of 
the organism, except the extraembryonic tissue giving rise to the placenta. Conversely, 
adult organisms maintain pools of stem cells with a more restricted developmental 
capacity (multipotent). Here, the classical example are hematopoietic stem cells. The 
“fluid” nature of the blood system allowed the study of the various cell types and 
their pedigrees in great detail. The original source is the multipotential hematopoietic 
stem cells in the bone marrow. The fact that we can use normal hematopoietic stem 
cells to repopulate the full blood system in a leukemic patient crippled with cancer-
ous blood cells is a clear indication that our body carries a pool of cells with highly 
specific regenerative capacities. Is this true for every organ? The search for an answer 
to this question has occupied generations of scientists. Hampered by their apparently 
limited cell number and the difficulty to isolate and cultivate them, for long time it 
has been challenging to identify molecular markers characteristic for adult stem cells. 
In particular, by analysing organs with a high cellular turnover like skin or gut, 
caused, for example, by mechanical or chemical strain, the corresponding source of 
adult stem cells could be localized and the differentiation path their progeny follows 
could be studied. The intestinal epithelium is composed at the basis of crypts encom-
passing the cradle of stem cells (expressing, among others, the marker Lgr5) (Tetteh 
et al. 2015). Progenitors of the stem cells leaving the cradle are subjected to intricate 
signalling cascades and start to differentiate along their path to the villus (the intes-
tinal surface exposed to the inside of the stomach). Lgr5- expressing cells can be cul-
tivated in vitro. Eventually, they will self-assemble into a mini-gut organoid, 
manifesting their developmental capability to structure a specific part of an organ. 
This example demonstrates that also the intestine harbours its own “spare parts” to 
counter the constant degradation and turnover of cells and thereby maintains tissue 
homeostasis. Other pools of adult stem cells have been identified in different organs 
(Clevers and Watt 2018), but their cultivation in vitro and molecular characterization 
has been exceedingly difficult. This is in part caused by the exclusive neighbourhood 
required by the stem cells. Stem cells clearly must have a different epigenetic status 
than most of their differentiated neighbours. They seem to only be able to maintain 
this status in a special environment, termed “niche”. A niche represents a highly pro-
tective microenvironment, located in a specific anatomic location where the stem cells 
are found. At these sites adult stem cells are maintained in a quiescent state by a 
combination of cell-cell or cell-matrix interactions, endocrine, paracrine, and auto-
crine signalling pathways, specific physical interactions, neuronal connections and 
particular physico-chemical conditions. However, after tissue injury or to maintain 
tissue homeostasis, the surrounding micro-environment actively signals to stem cells 
to induce either self-renewal or differentiation to form cells required for regeneration. 
As soon as stem cells leave the niche, they are subjected to differentiation signals, 
become first transient amplifying cells, and then start to develop fates similar to their 
neighbours. Recreating niche conditions in a dish to cultivate the multipotent stem 
cells has been a major challenge, though.
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7.3  Sources of Pluripotent Stem Cells
Why bother with finicky adult stem cells if  pluripotent embryonic stem cells can pro-
duce all the cell types of a mammalian organism? Indeed, already 40 years ago, 
mouse embryonic stem cells (mESC) from the inner cell mass of blastocysts could be 
established as an in vitro culture. Eventually, these cells could be induced in vitro by 
specific combinations of developmental factors to produce almost all cell types of a 
mouse, demonstrating their pluripotent capacity. Experiments with human embry-
onic stem cells demonstrated a similar capacity. The possibility to cultivate and drive 
theses pluripotent cells through specific differentiation paths to produce functionally 
and morphologically elaborate cell types, offered seemingly extraordinary opportu-
nities for regenerative medicine. In parallel, alternative methods to collect or produce 
pluripotent cells were developed (. Fig. 7.2). Besides the described cell mass from 
blastocysts before implantation, in vivo, two other sources of mouse pluripotent stem 
cells exist. Embryonic germ cells can be derived from primordial germ cells during 
mid-gestation (mouse embryonic day 8.5–12.5). Germline-derived pluripotent stem 
cells can be isolated from spermatogonial stem cells of neonatal and adult testes3.
The study of murine germ cell development allowed to observe the dramatic 
reshuffling of epigenetic information not only during germ cell maturation but also 
after fertilization (. Fig. 7.3) (Saitou et al. 2012). The massive changes of the epi-
genetic landscape detected over time reflect the substantial remodelling germ cells 
undertake to bring the epigenome back to the ground state (see also book 7 Chap. 3 
of Paro).
In primordial germ cells, different waves of DNA de- and re-methylation together 
with chromatin modifying mechanisms ensure that genomic imprints are reset, inac-
tive X chromosomes reactivated, and somatic epigenetic signatures eliminated (see 
also book 7 Chap. 5 of Grossniklaus). Similar mechanisms will apply to the somatic 
cell lineages. Hence, organisms have developed very elaborate mechanisms to repro-
gram, in a substantial and directional manner, the epigenetic landscape of some of 
their cell types.
In the past decades, three in vitro methods have been developed to generate cells 
with a pluripotent capacity (Gaspar-Maia et al. 2011). Fusions between a differenti-
ated somatic cell and an embryonic stem cell reprograms the nucleus restricted in 
developmental potential to a pluripotent state. Here, reprogramming processes could 
be studied in vitro and the ensuing changes of the epigenetic states could be pursued 
at the molecular level. The disadvantage, in particular for therapeutic purposes, was 
that the resulting cell contains both genomes of the fusion partners and, thus, a tet-
raploid state is obtained. Transferring a nucleus from a somatic cell to an enucleated 
oocyte also changes the epigenome to a pluripotent ground state. Somatic cell nuclear 
transfer was most spectacularly demonstrated with the birth of the cloned sheep 
Dolly, providing evidence that a transferred somatic cell nucleus from the mammary 
3 Primordial germ cells (PGCs) are specified from the epiblast and form the cell lineage that will 
develop into the gametes. EG cells are derived from PGCs before sex specific differentiation by 
inductive signals form the forming gonad from mesodermal genital ridges, which forms the somatic 
cells of  testis and ovary. Spermatogonial stem cells are precursors in the male germ line and give rise 
to the spermatocytes.
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epithelium of an ewe could be fully reprogrammed to restart development and pro-
duce an entire mammal. Reprogramming utilizing transcription factors is nowadays 
the most powerful technique to obtain large quantities of cells with a pluripotent 
developmental potential, however. Furthermore, this method is ethically also less 
controversial because it does not require access to mammalian oocytes.
Developmental biology studies identified many transcription factors that act as 
master regulators for defining cell fates (Graf and Enver 2009). Forced expression of 
these master regulators can override determined cell identities and respecify cells to 
a new cell type. An example is Myf5, whose expression in fibroblasts will induce the 
formation of contractile muscle cells. In parallel with the respecification, reprogram-
  . Fig. 7.2 Pluripotent stem cells can be derived from several sources. There are three sources of  plu-
ripotent stem cells in vivo (see the figure, top half). Embryonic stem (ES) cells are derived from the inner 
cell mass of  the blastocyst, before embryo implantation. Embryonic germ (EG) cells are derived from 
primordial germ cells (PGCs) during mid-gestation (embryonic days 8.5–12.5 in the mouse) and germ-
line-derived pluripotent stem (gPS) cells are derived from spermatogonial stem cells of  neonatal and 
adult testes. In addition, three major routes for somatic cell reprogramming to pluripotency have been 
described (see the figure, bottom half): fusion between a somatic cell and an ES cell giving rise to repro-
grammed hybrid cells; the generation of  nuclear transfer embryonic stem (NT-ES) cells, produced by 
reprogramming of  a somatic nucleus by an enucleated oocyte, which is then cultured to the blastocyst 
stage to allow derivation of  ES cells; and the production of  induced pluripotent stem (iPS) cells, derived 
by somatic cell overexpression of  reprogramming transcription factors, most commonly OCT4 (also 
known as POU5F1), Sry-box containing gene 2 (SOX2), myelocytomatosis oncogene (MYC) and Krüp-
pel-like factor 4 (KLF4). (From (Gaspar-Maia et al. 2011)
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ming of the cell’s epigenome can be observed using biochemical tools. Based on these 
same principles, Yamanaka and co-workers were able to change a fully differentiated 
mouse fibroblast back to a pluripotent stem cell (Takahashi and Yamanaka 2006). 
Mouse embryonic stem cells had been extensively characterized and their transcrip-
tome and underlying regulatory network carefully and comprehensively catalogued. 
Using this information, they selected a combination of four transcription factors 
which, when expressed artificially in fibroblasts, reversed the entire differentiation 
path back to the early pluripotent state. However, this process was very inefficient 
(less than 1% of the cells became pluripotent, termed induced pluripotent stem cells 
(iPSC)), already providing a hint that differentiated cellular states are very stable 
and, only under special circumstances and on rare occasions, revert to another state. 
The trick was to equip the fibroblast with a fluorescent reporter that was controlled 
by the Nanog promoter (Nanog + green fluorescent protein (GFP)) which would only 
become activated when the cell entered the pluripotent state. Subsequently, iPS cells 
were also derived from human fibroblasts. In the following years, this technique 
became standard in many laboratories, allowing the production of large quantities of 
iPS cells from different sources, thereby opening outstanding perspectives for regen-
erative medicine (see below). Interestingly, over these many years of research, the low 
efficiency of iPS cells reprogramming could not be substantially improved. This illus-
trates that the cellular memory encoded in the somatic state of the cell is remarkably 
stable and highly resistant to induced reprogramming (see book 7 Chap. 3 of Paro). 
Hence, the question is: what are the underlying epigenetic hurdles that need to be 
removed or remodelled for cell reprogramming?
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  . Fig. 7.3 A schematic of  mouse pre-implantation and germ cell development. (Top) A schematic of 
pre-implantation and germ-cell development in mice. a Pre-implantation development stages; b post-
implantation embryonic development, following blastocyst implantation at around E4.5; and c postna-
tal germ cell development and maturation. Primordial germ cell (PGC) precursors (E6.25) and PGCs 
are shown as green circles in embryos from E6.25 to E12.5. (Bottom) Key genetic and epigenetic events 
are shown that are associated with pre-implantation and germ cell development, together with relative 
levels of  5-methylcytosine (5mC) at different developmental stages. Al allantois, Epi epiblast, ExE 
extraembryonic ectoderm, ICM inner cell mass, PB polar body, PGCs primordial germ cells, Sm somite, 
TE trophectoderm, VE visceral endoderm, ZP zona pelucida. (From (Saitou et al. 2012)
 Chapter 7 · Regeneration and Reprogramming
145 7
7.4  Chromatin Dynamics During Reprogramming
Already at the microscopic level, the nuclei of ESC show a different morphology 
compared to nuclei from differentiated cells. In particular, heterochromatic regions 
are much more discernible and compact in somatic cells, indicating that one accom-
panying force of differentiation is the compaction of specific regions of chromatin. 
This suggests that reprogramming of fates need not only changes local chromatin 
landscapes to activate or repress different sets of genes, but also requires large scale 
reshuffling of chromatin domains and chromosomal territories. An example of this 
is the reactivation of the entire repressed X chromosome in female mammalian cells4 
(see book 7 Chap. 4 of Wutz). The availability of a technique inducing the repro-
gramming of somatic chromatin to a pluripotent state, hence, offered a great oppor-
tunity to study the underlying processes in substantial detail. The facility of growing 
cells in culture enabled biochemical studies, using classical transcriptome analysis 
methods, ChIP, and other chromatin mapping techniques to elucidate changes in the 
epigenetic landscape during the reprogramming process. The observed complexity of 
cellular transitions during iPSC induction provide a glimpse of why reprogramming 
takes a sizeable amount of time and why only few cells manage to reach the pluripo-
tent state. The entire process appears to be stochastic and the individual steps diffi-
cult to predict. It is thought that the four transcription factors [Oct4, Sox2, KLF4, 
and Myc (OSKM)] induce a cascade of changes in the transcription program of the 
starting cell population. Subsequently, the readjustment of gene expression profiles 
with the accompanying changes in chromatin and DNA modifications cause: (i) inhi-
bition of somatic regulators, (ii) induction of cellular proliferation, (iii) inhibition of 
senescence and apoptosis pathways, (iv) activation of pluripotency loci, (v) acquisi-
tion of factor independence, (vi) immortalization and finally reprogramming of telo-
mere structures, X chromosome reactivation, and cellular memory erasure (see 
. Fig. 7.4). The exogenously introduced transcription factors are capable of estab-
lishing a self-regulatory loop, eventually activating the corresponding endogenous 
loci and thereby sustaining a self-propagating stem cell identity. This is a crucial step 
as exogenously expressed factors become often silenced over time. Additionally, in 
order to differentiate, iPS cells, as for ESC, need to downregulate pluripotency fac-
tors and this can be done only when the endogenous genes are expressed.
OSKM acting as pioneer factors in the reprogramming process require the support 
from different epigenetic modifiers including histone post-translational modifying 
enzymes, nucleosome remodeling factors, histone chaperones, and DNA modifying 
enzymes (. Fig. 7.4).
Initially, OSKM bind to active somatic genes, eventually inducing the change 
of their active histone modifications like H3K4me1 and H3K27ac into repressive 
marks. Conversely, genes characteristic for embryonic stages lose their negative 
histone marks and, subsequently, become reactivated. During the entire process, a 
massive replacement of histone variants can be observed, either by reactivating the 
4 Interestingly, reactivation of  the inactive X chromosome is observed in mouse but not human iPS 
cells. This suggests that the developmental state of  ESC/iPSC from humans is likely very different 
from that of  mouse and corresponds to a more determined cell state with partially established chro-
matin patterns.
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quiescent part of the genome (i.e. H2A.X, TH2A/2B) or by removing repressing vari-
ants like macroH2A (see book 7 Chap. 1 of Wutz and book 7 Chap. 2 of Paro). 
Similarly, histone chaperones play an import role in the genome-wide realignment 
of histones and nucleosomes. Inhibition of CAF-1 can, for example, increase the 
reprogramming efficiency. Differentiation is inherently connected to a specific depo-
sition of CpG dinucleotide methylation (see book 7 Chap. 1 of Wutz). The entire 
DNA methylation and demethylation apparatus is heavily engaged over the length 
of the reprogramming process. DNA dioxygenases like TET1/2, which are involved 
in the demethylation process, can partly replace OSKM in chromatin remodeling. 
Not surprisingly, modulating the amount and activity of chromatin factors (writer, 
readers, and erasers) has a substantial impact on the efficiency of the reprogram-
ming process. For example, adding the DNA methylation inhibitor 5-aza-cytidine 
during reprogramming substantially increases the production of iPS cells more than 
30-fold. As expected, the reprogramming process does not only lead to a readjust-
ment of the somatic epigenetic landscape to an ESC-like state but also to a com-
plete re- organization of the 3D chromatin architecture and topology (Apostolou and 
Stadtfeld 2018).
  . Fig. 7.4 Dynamics of  key molecular events during direct reprogramming. A summary of  cellular, 
transcriptional and epigenetic changes (colored bars) that occur during induced pluripotent stem cell 
(iPSC) formation from fibroblasts and examples of  candidate regulators that have been associated with 
the depicted chromatin marks in the context of  direct reprogramming (right). Red arrows indicate the 
time points of  exogenous factor induction (+OKSM) and withdrawal (−OKSM). 5hmC 5-hydroxy-
methylcytosine, 5mC 5-methylcytosine, MET mesenchymal-to-epithelial- transition, OKSM Oct4, 
Klf4, Sox2, c-Myc. (From (Apostolou and Hochedlinger 2013))
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7.5  Regenerative Therapies
Stem cell technologies certainly represent a major breakthrough development in 
regenerative medicine (Cherry and Daley 2012). The availability of large quantities 
of cells with a pluripotent developmental capacity provide exceptional opportunities 
to establish novel cell therapies. Additionally, iPS cells can be derived from patients 
with specific syndromes and used as models for studying disease. In this way, specific 
drug screens and diagnostic tests for personalized medicine can be developed. A very 
exciting development based on stem cells in general and iPS cells in particular is the 
possibility to create organoid structures in vitro (Akkerman and Defize 2017). 
Originally, small three-dimensional (3D) tissue structures were produced in vitro 
using tissue culture cells. In most cases these cells are considered to have a tumori-
genic state as they can proliferate indefinitely in the dish and therefore the usefulness 
of these mini-organs was limited. The availability of self-renewing embryonic stem 
cells and eventually of iPS cells allowed the development of complex culturing and 
differentiation conditions, leading to organoid structures of remarkable morpholog-
ical and functional resemblance to the real organ. Here also, the availability of iPS 
cells from patients as a source for specific organoid construction allows researchers 
to study the effect of human syndromes on the early development of the correspond-
ing organ.
Despite the extraordinary enthusiasm accompanying iPSC technology, only few 
clinical trials have so far tested the medical usefulness of stem cell transplants. As 
mentioned, normal regenerative processes in almost all complex animals do not 
involve cells with a pluripotent developmental potential but organ- and tissue- specific 
multipotent stem and progenitor cells. For good reasons, organisms restrain and 
keep under strict control cells in a pluripotent state (see germ cell development). 
Cancer cells often attain and maintain their highly proliferative and destructive capa-
bility by dedifferentiation, thereby increasing their epigenetic resemblance to embry-
onic stem cells (see book 7 Chap. 3 of Paro and 7 Chap. 8 of Santoro). Incidentally, 
the first pluripotent cells to be cultivated in vitro were from teratocarcinomas (can-
cers of the germ line). Hence, there is only a fine line between normal development 
from a pluripotent state and degenerated development. Indeed, when transplanted 
into the skin of mice, iPS cells develop into carcinomas, but injection into blastocysts 
allows them to contribute to normal development. Additionally, it was found that 
iPS cells do not always erase all epigenetic marks from the somatic state from which 
they were derived, leaving, for example, distinctive somatic DNA methylation pat-
terns. This imposes on the starting cells an unwanted epigenetic history and may, in 
certain conditions, lead to aberrant differentiation behaviour, aging onset, or suscep-
tibility to degeneration. Using iPSC derived from the same person to install regen-
erative processes potentially circumvents the well-known problems of organ rejection. 
However, the delivery and integration of iPS cells to damaged parts in the organism 
is still a major challenge.
Second generation iPSC technology is attempting to reduce some of these prob-
lems by inducing the reprogramming process in vivo (Martinez-Redondo and Izpisua 
Belmonte 2020). CRISPR/Cas9 technology produced forms of the Cas9 enzyme 
which allows the alteration of histone modifications and other epigenetic marks in a 
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site-specific manner. Potentially, this approach could aid the entire reprogramming 
process to the pluripotent state but also partial reprogramming to intermediate or 
alternative differentiation states. After all, most known regenerative processes in 
complex organisms use the latter for repopulating damaged organs or tissues, either 
by using highly specialized stem cells with a restricted potential or by reassigning 
necessary new fates to cells at the injury site. Thus, regenerative biology and medicine 
will need to understand these processes in much better detail in order to be able to 
use cell therapies in a controllable and predictive fashion.
It is very clear that the epigenetic landscape of cells used in therapies is of crucial 
importance. Hence, an epigenetic profiling of stem cells used in clinical context 
appears as an obligatory requirement as is the sequencing of the genome to eliminate 
cell lineages with potential deleterious mutations. Indeed, technically we are 
approaching capabilities to comprehensively screen cells for genetic and epigenetic 
integrity. What we are still lacking is a better knowledge of how natural regenerative 
processes are able to reprogram the epigenome of somatic cells to the desired organ- 
specific multipotent state. This would permit to apply cellular therapies in a much 
more controlled fashion.
Take-Home Message
 5 Amphibians and many other animals can regenerate complex body structures 
through a blastema (epimorphic regeneration). In the blastema, ordered signaling 
events reprogram cells for patterning and regrowth processes.
 5 In regenerating Drosophila imaginal discs, JNK is activated at the wound site and 
in the blastema, resulting in downregulation of PcG silencing and, as a conse-
quence, re-activation of many silenced PcG target genes, like the homeotic master 
regulators.
 5 Dedifferentiation and transdifferentiation of cells/tissues is also utilized in verte-
brates to produce cells with structures and functions necessary to regenerate a 
wound or an organ damage in their neighborhood.
 5 Organ-specific adult stem cells contribute to physiological regeneration required 
for tissue and organs, like gut or skin, subjected to constant mechanical and chem-
ical stress. They undergo specific differentiation programs and extended epigenetic 
reprogramming to maintain tissue homeostasis.
 5 Hematopoietic stem cells are used in the clinic to treat leukemia patients. Stem 
cells from other organs are difficult to isolate and cultivate, requiring specific con-
ditions found in stem cell niches.
 5 Pluripotent stem cells can be induced to differentiate into any other cell type. iPSC 
technology reprograms differentiated cells to induced pluripotent stem cells. Tran-
scription factor-driven reprogramming encompasses numerous pathways requir-
ing reversal of many epigenetic processes.
 5 Some of the inefficiency of iPSC reprogramming can be explained by the need to 
change the cellular memory system of differentiated cells to the embryonic state. A 
highly coordinated and sequential erasure of chromatin marks and DNA methyla-
tion patterns must occur during reprogramming.
 5 iPS cells can be used for cell therapies. Patient-derived iPS cells can be used to 
study disease or for the development of new drugs. A promising new path is the 
engineering of self-organizing organoid structures using iPS cell cultures.
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What You Will Learn in This Chapter
Alterations in chromatin function and epigenetic mechanisms are a hallmark of cancer. 
The disruption of epigenetic processes has been linked to altered gene expression and to 
cancer initiation and progression. Recent cancer genome sequencing projects revealed that 
numerous epigenetic regulators are frequently mutated in various cancers. This informa-
tion has not only started to be utilized as prognostic and predictive markers to guide treat-
ment decisions but also provided important information for the understanding of the 
molecular mechanisms of epigenetic regulation in both physiological and pathological 
conditions. Furthermore, the reversible nature of epigenetic aberrations has led to the 
emergence of the promising field of epigenetic therapy that has already provided new ther-
apeutic options for patients with malignancies characterized by epigenetic alterations, lay-
ing the basis for new and personalized medicine.
8.1  Epigenetics and Cancer
Cancer is a group of more than 100 different and distinct diseases in which abnormal 
cells divide without control and can invade nearby tissues. Cancer is the second lead-
ing cause of death globally. In the recent years, there have been tremendous efforts 
and remarkable advances to understand and treat this disease. In particular, the new-
est sequencing technologies have made possible to obtain a complete DNA sequence 
of large numbers of cancer genomes. These analyses identified genetic alterations not 
only between normal and cancer genomes but also between genomes of tumors from 
patients affected by the same type of cancer. This tremendous effort had provided 
relevant information for the history of tumor development at molecular level and led 
the basis for a personalized treatment approach that allows doctors to select treat-
ments based on a molecular understanding of their disease.
The earliest indications of an epigenetic link to cancer originated from gene 
expression and DNA methylation studies. The past decade has seen a remarkable 
acceleration in the validation of the concept that cancer is not only a genetic disease 
but also one of epigenetic abnormalities. This view has been significantly strength-
ened by whole-genome sequencing results showing that numerous epigenetic regula-
tors are frequently the target of mutations and epimutations in cancer cells, with an 
intriguing interplay between the two. The abundance of cancer mutations involving 
these genes practically affects all levels of epigenetic regulation, including key play-
ers in DNA methylation, histone modifications, and chromatin organization but also 
substrates for these modifications, such as histones. The identification of mutations 
in writers, readers, and erasers, as well as alterations in the epigenetic landscape in 
cancers, do not only imply a causative role for these factors in cancer initiation and 
progression but also provide potential targets for therapeutic intervention.
In this chapter, we describe the best studied epigenetic and chromatin alterations 
found in cancers (DNA methylation, histone H3K27 trimethylation, histone acetyla-
tion, and chromatin remodeling factors), how these alterations occur, and how they 
contribute to cancer initiation and progression. We also provide examples of the 
development of epigenetic inhibitors and strategies for their therapeutic application.
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8.2  DNA Methylation and Cancer
Aberrant DNA methylation was the first epigenetic abnormality to be identified in 
human cancers (Feinberg and Vogelstein 1983). DNA methylation provides a stable 
gene silencing mechanism that plays an important role in regulating gene expres-
sion and chromatin architecture in association with histone modifications and other 
chromatin associated proteins (see book 7 Chap. 1 of Wutz). Alterations detected 
in cancers can be promoter hypermethylation and the consequent silencing of tumor 
suppressor genes (7 Sect. 8.2.1), global hypomethylation that has been associated 
with genomic instability (7 Sect. 8.2.2), and alterations of DNA methylation at 
imprinting control regions (see book 7 Chap. 5 of Grossniklaus) with a consequent 
loss of imprinting (7 Sect. 8.2.3). Regions of low-density methylation near CpG 
islands, known as ‘shores’, exhibit great variation in DNA methylation, including 
hypomethylation and hypermethylation, across different types of cancers.
8.2.1  DNA Hypermethylation in Cancer
Many genes associated with CpG islands undergo de novo methylation in cancer. The 
“CpG island methylator phenotype (CIMP)” is defined as frequent methylation of 
multiple CpG islands and has been found in many types of cancers (. Fig. 8.1). The 
CIMP status is uniquely associated with specific clinicopathological characteristics 
in individual cancer types and has the potential to provide information for cancer 
diagnosis and the stratification of patients for specific therapeutic treatments.
Since DNA methylation is associated with gene repression, it has been suggested 
that new/aberrant acquisition of DNA methylation contributes to the repression of 
genes that are active in normal tissue and probably involved in tumor suppression 
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  . Fig. 8.1 Normal and cancer genomes exhibit distinct DNA methylation profiles. Schematic showing 
the difference in DNA methylation at defined gene regulatory elements and repeats between normal and 
cancer cells. These alterations include hypermethylation of  CpG islands and hypomethylation at trans-
posable elements and pericentromeric heterochromatin. These changes cause transcriptional silencing 
of  tumor suppressor genes, the increase in the expression of  oncogenes, and genome and chromosome 
instability. White circle, unmethylated CpG; black circle, methylated CpG
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activities1. Accordingly, hypermethylation in cancers has been associated with the 
suppression of genes involved in cancer-related pathways, such as cell cycle control, 
DNA repair, apoptosis, and angiogenesis. The profiles of hypermethylation of the 
CpG islands in tumor suppressor genes are specific to the cancer type. Examples of 
this are the methylation at the promoter of the tumor suppressor gene VHL (asso-
ciated with von Hippel-Lindau disease) in renal cancer, the cell cycle control gene 
p16 in many types of cancer, the DNA mismatch repair MutL Homolog 1 (MLH1) 
gene in colorectal cancer, and breast-cancer susceptibility 1 (BRCA1) gene in breast 
and ovarian cancers. Although these are important examples of DNA methylation- 
mediated gene repression, it was also shown that a large fraction of genes acquiring 
DNA methylation in cancer were already transcriptionally repressed in the normal 
tissue. It was proposed that the repression of these genes was mainly acting through 
PcG proteins that establish H3K27me3 (see book 7 Chap. 3 of Paro). It was also 
shown that genes targeted by DNA methylation in cancer have a low, poised tran-
scription state in embryonic stem cells and are implicated in the maintenance of 
stemness and self-renewal in normal stem cells. Their reactivation occurs at defined 
stages of development through the removal of the repressive PcG-complexes. Thus, 
the acquisition of DNA methylation at genes that are already in a repressed state 
might serve to either further downregulate and/or establish a stable repression that 
prevents activation, thereby contributing to a stem cell-like state of cancer. However, 
mechanisms that target de novo methylation at genes critical to cancer remain yet 
elusive.
8.2.2  DNA Hypomethylation in Cancer
Loss of 5-methylcytosine (5mC) was the first epigenetic abnormality to be identified 
in human cancer. The loss of DNA methylation is mainly occurring at repetitive 
DNA sequences, coding regions, and introns (. Fig. 8.1). The extensive demethyl-
ation of DNA observed in tumor progression was suggested to be a source of the 
continually generated cellular diversity associated with cancers. During the develop-
ment of a neoplasm2, the degree of hypomethylation of genomic DNA increases as 
the lesion progresses from a benign proliferation of cells (hyperplasia)3 to an invasive 
and potentially metastatic cancer4 (Fraga et al. 2004).
1 Tumor-suppressor activities are mediated by tumor-suppressor genes, class of  genes that regulate 
cell proliferation and their inactivation can play a profound role in the development of  malignan-
cies.
2 Neoplasm is an abnormal mass of  tissue that forms when cells grow and divide more than they 
should or do not die when they should. Neoplasms may be benign (not cancer) or malignant (can-
cer). Benign neoplasms may grow large but do not spread into, or invade, nearby tissues or other 
parts of  the body. Malignant neoplasms can spread into, or invade, nearby tissues. They can also 
spread to other parts of  the body through the blood and lymph systems.
3 Hyperplasia refers to the increase in the number of  cells in an organ or tissue due to loss of  prolif-
eration control. These cells appear normal under a microscope. They are not cancer but may become 
cancer.
4 Metastatic cancer is a cancer that has spread from the part of  the body where it started (the primary 
site, primary cancer) to other parts of  the body.
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Hypomethylation of DNA in cancer has several implications, including gene 
activation, loss of imprinting, reactivation of transposable elements, and genome 
instability. DNA methylation is particularly concentrated at repetitive elements and 
may limit their genomic activity. Loss of DNA methylation can favor mitotic recom-
bination, leading to deletions, translocations, and chromosomal rearrangements. 
Furthermore, hypomethylation of DNA in malignant cells can reactivate transpos-
able elements, such as the long interspersed nuclear element LINE 1, which accounts 
for 17% of the human genome (. Fig. 8.1). The large number of these repeats can, 
when reactivated, promote translocations to other genomic regions, thereby affecting 
genome integrity. Hypomethylation can also occur at pericentromeric regions of the 
chromosome (near the site of attachment of the mitotic spindle) and rearrangements 
in the pericentromeric heterochromatin of chromosomes 1 or 16 are found in many 
types of cancers.
8.2.3  Loss of Imprinting Through Alterations of DNA Methylation
The Beckwith-Wiedemann syndrome (BWS) is an important example of disruption 
of genome imprinting through alteration in DNA methylation (see book 7 Chap. 
5 of Grossniklaus). BWS is characterized by macrosomia, macroglossia, and 
abdominal wall defects, and exhibits a predisposition to tumorigenesis (Soejima and 
Higashimoto 2013). In particular, the development of embryonal tumors (i.e. Wilms’ 
tumor, hepatoblastoma, and rhabdomyosarcoma) is a recurring feature of BWS. The 
relevant imprinted chromosomal region in BWS that is epigenetically altered is 
11p15.5, which consists of two imprinting domains, CDKN1C/KCNQ1OT1 and 
IGF2/H19 (. Fig. 8.2) (see also book 7 Chap. 5 of Grossniklaus).
In the imprinting domain CDKN1C/KCNQ1OT1, CDKN1C (Cyclin Dependent 
Kinase Inhibitor 1C) is maternally expressed, whereas the long non-coding RNA 
KCNQ1OT1 is paternally expressed. The imprinting control region (ICR) of 
CDKN1C/KCNQ1OT1 domain is the differentially methylated region (DMR) 
KvDMR1, which overlaps with the promoter of KCNQ1OT1. KvDMR1 is methyl-
ated on the maternal allele and unmethylated on the paternal allele. Fifty percent 
of BWS patients display a loss of DNA methylation on KvDMR1 at the maternal 
allele, which leads to the expression of KCNQ1OT1 and repression of the cell cycle 
inhibitor CDKN1C. Representative phenotypes of this epigenetic alteration include 
omphalocele and hemihyperplasia5. Of note is that downregulation of CDKN1C has 
been reported in several other cancers. It has been proposed that the repression of 
CDKN1C on the paternal chromosome is mediated by the long non-coding RNA 
(lncRNA) KCNQ1OT1, which coats the surrounding locus. KCNQ1OT1, through 
the interaction with H3K9- and H3K27-specific histone methyltransferases G9a 
and EZH1/2, the latter part of Polycomb Repressive Complex 2 (PRC2) (see book 
7 Chap. 3 of Paro), leads to the repression of CDKN1C in cis.
5 Omphalocele is a birth defect in which an infant’s intestine or other abdominal organs are outside 
of  the body because of  a hole in the belly button area. The intestines are covered only by a thin layer 
of  tissue. Hemihyperplesia refers to asymmetric body overgrowth of  one or more body parts.
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In about 5% of BWS patients, gain of DNA methylation occurs on the nor-
mally unmethylated maternal H19-DMR, which is the ICR of IGF2/H19 domain 
(. Fig.  8.2). H19-DMR is located 2 kb upstream of H19. In normal cells, differ-
ential parental methylation of H19-DMR leads to paternal expression of IGF2 
(the insulin- like growth factor gene), and maternal expression of the non-coding 
RNA gene H19. On the maternal allele, IGF2 is repressed due to CTCF binding the 
unmethylated H19DMR. The insulator formed by CTCF blocks enhancers down-
stream of H19 from accessing IGF2 promoters (see also 7 Chap. 5 of Grossniklaus). 
On the paternal allele, IGF2 is expressed since H19-DMR is methylated, which 
Normal cell
































  . Fig. 8.2 Loss of  imprinting through alteration of  DNA methylation in cancer. Schema representing 
aberrant imprinting patterns at the chromosome 11p15 imprinting cluster found in Beckwith- 
Wiedemann Syndrome (BWS) patients. Loss of  methylation at the differentially methylated regions 
(DMRs) KvDMR1 or H19-DMR and the resulting changes in the expression of  imprinted genes are 
shown. Pink boxes represent maternally genes. Blue boxes are paternally expressed genes. White circle, 
unmethylated CpG; black circle, methylated CpG
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impairs CTCF binding and results in the contact of enhancers with IGF2 promot-
ers (Bell and Felsenfeld 2000). Gain of methylation of H19-DMR on the mater-
nal allele induces loss of imprinting in BWS, leading to biallelic expression of IGF2 
and reduced expression of H19. Loss of imprinting of IGF2 is also a risk factor for 
colorectal cancer and disrupted genomic imprinting contributes to the development 
of Wilms’ tumor. The mechanism by which gain of methylation at H19-DMR occurs 
is still unknown.
8.2.4  Mutations in the DNA Methylation Machinery in Cancers
High-resolution cancer genome sequencing efforts have discovered mutations in 
genes encoding epigenetic regulators that have roles as writers, readers, or erasers 
of DNA methylation and/or chromatin states (see also book 7 Chap.1 of Wutz). 
In this section, we describe the mutations at the de novo DNA methyltransferase 3a 
(DNMT3A) and the methylcytosine dioxygenase Ten-eleven translocation 2 (TET2) 
and their roles in cancer.
8.2.4.1  Mutations of de novo DNA Methyltransferase 3a
The de novo DNA methyltransferase 3a (DNMT3A) is one of the most frequently 
mutated genes across a range of haematological malignancies6, especially in acute 
myeloid leukaemia (AML) and T cell lymphoma. DNMT3A mutations in AML 
were found with frequencies of up to 22%, indicating that DNMT3A acts as critical 
tumor suppressor (Yang et al. 2015). Patients with DNMT3A mutations had signifi-
cantly worse survival than patient with DNMT3A wild-type. Arginine 882 (R882) is 
located within the catalytic domain of the methyltransferase and represents a muta-
tional hotspot that accounts for around 60% of DNMT3A mutations in AML. The 
R882 mutation results in a hypomorphic protein (i.e. partial loss of enzymatic activ-
ity) that inhibits wild-type DNMT3A by blocking its ability to form active tetramers, 
which represent the most active form of the DNA methyltransferase.
DNMT3A was found to be essential for the differentiation of hematopoietic stem 
cells (HSCs). Conditional deletion of Dnmt3a in mouse HSCs promoted self-renewal 
over differentiation and HSCs with a complete knock-out of the Dnmt3a gene 
(Dnmt3a-KO) dramatically outcompete their wild-type counterparts and accumulate 
in the bone marrow (. Fig. 8.3). Dnmt3a-KO HSCs display significant genome-wide 
hypomethylation. In particular, HSC-associated enhancers display dominant hypo-
methylation in Dnmt3a-KO HSCs. Accordingly, Dnmt3a-KO HSCs show upregula-
tion of HSC multipotency genes and downregulation of differentiation factors, and 
their progeny exhibit global DNA hypomethylation and incomplete repression of 
HSC-specific genes.
It has been proposed that DNMT3A mutations serve as a pre-leukaemic lesion 
since somatic DNMT3A mutations arise in HSCs many years before malignan-
cies develop. It has also been suggested that the enhanced self-renewal capacity of 
HSCs with DNMT3A mutations would be advantageous for second pro-oncogenic 
hits that drive tumor development (Brunetti et al. 2017). DNM3A mutations were 
6 Hematologic malignancies are classified according to which type of  blood cell is affected.
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found to negatively correlate with other known AML alterations, such as chro-
mosomal translocations t(15;17), t(8;21) and inversion inv(16), rearrangements 
involving the histone lysine N-methyltransferase KMT2A (MLL), and mutations 
affecting TET2, the enzyme responsible for DNA hydroxymethylation (see book 
7 Chap. 1 of  Wutz and 7 Chap. 3 of  Paro). The mutual exclusion of  DNMT3A 
mutations and these genomic alterations suggests a role in similar epigenetic 
pathways. In contrast, mutations of  DNMT3A in AML co-occur with mutations 
of  nucleophosmin (NPM1) and the internal tandem duplication in the receptor 
tyrosine kinase FLT3 gene (FLT3ITD). Sixty percent of  patients with DNMT3A 
mutations carry an NPM1 mutation, whereas only 13% of  patients with wild-
type DNMT3A harbor an NPM1 mutation (Yang et al. 2015). Similarly, FLT3ITD 
mutations are specifically enriched in patients with DNMT3A mutations. When 
patients with FLT3ITD mutations were classified according to DNMT3A status, 
those carrying a DNMT3A mutation had a significantly worse outcome, and a 
high relapse rate. Recent extensive genomic and  epigenomic sequencing data 
suggested that the occurrence of  all three mutations is non-random, and that 
NPM1mut/FLT3ITD/DNMT3Amut AML is a distinct entity (Cancer Genome Atlas 
Research et al. 2013). However, how these mutations act together to cause leukae-
mia remains elusive. HSCs with DNMT3A mutations persist even after chemother-
apy and during relapse, indicating that mutant HSCs might represent a reservoir 




HSC - DNMT3A-KO HSC - DNMT3A-wt 
Self-renewal genes, negative regulators of differentiation genes 
  . Fig. 8.3 DNMT3A controls hematopoietic stem cell fate. DNMT3A is a critical factor for the epi-
genetic silencing of  hematopoietic stem cell (HSC) regulatory genes. Dnmt3a-KO HSCs show substan-
tial CpG island hypermethylation, upregulate HSC multipotency genes, and downregulate differentiation 
factors. DNMT3A loss progressively impairs HSC differentiation and expands HSC numbers in the 
bone marrow
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8.2.4.2  Mutations of Ten-Eleven Translocation 2 (TET2)
Somatic mutations at the Ten-eleven translocation 2 (TET2) gene have frequently 
been identified in a wide variety of hematologic malignancies, including AML, 
myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia (CMML), and 
myeloproliferative neoplasms (MPN). In particular, somatic deletions and inactivat-
ing mutations in TET2 were identified in 10–20% of the MPN and MDS cases and 
in 7–23% of the AML cases. TET2 belongs to a family of three proteins (TET1, 
TET2, and TET3) that catalyze the successive oxidation of 5-methylcytosine (5meC) 
to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine 
(5caC), finally resulting in the replacement of 5meC by an unmodified cytosine (see 
book 7 Chap. 1 of Wutz). TET2 mutations associated with the disease are largely 
loss-of-function mutations that impair the enzymatic activity, resulting in the fail-
ure of the 5mC-to-5hmC conversion, and eventually impairment of DNA demeth-
ylation. Studies in mice have shown that Tet2 loss leads to increased hematopoietic 
stem cell self-renewal and progressive myeloproliferation (the expansion of a mul-
tipotent hematopoietic progenitor stem cell), with features characteristic of human 
CMML.  Thus, it appears that impaired 5meC-to-5hmC conversion confers clonal 
dominance to HSCs and exerts differentiation pressure toward the myeloid lineage. 
As in the case of DNMT3A, mutations in TET2 are considered pre-leukaemic as the 
mutation per se does not induce haematologic malignancies but rather does so in 
conjunction with other driver mutations. The pool of pre-leukaemic HSCs containing 
mutations at epigenetic regulators, such as TET2 or DNMT3A, has been considered a 
cellular reservoir that should be targeted therapeutically for more durable remissions.
Genome-wide methylation analyses revealed CpG hypermethylation of many 
active enhancer elements in human AML patients with TET2 mutations and similar 
results were obtained using a Tet2-dependent leukemia mouse model. The loss of 
5hmC and gain of methylation at these enhancer elements lead to decreased H3K27ac 
and downregulation of neighboring genes, including tumor suppressor genes.
TET enzymes are Fe(II)/α-ketoglutarate (αKG)-dependent dioxygenases. Isocitrate 
dehydrogenases IDH1, IDH2, IDH3 are the enzymes that generate αKG. Genome-
wide sequencing studies identified mutations in IDH1 and IDH2 in several cancers, 
including AML. IDH1/2 mutations gain the function to generate the novel oncome-
tabolite D-2-hydroxyglutarate (D2HG) from αKG. D2HG inhibits αKG-dependent 
enzymes such as TET2. In AML, TET2 and IDH1/2 mutations are mutually exclu-
sive, suggesting that the IDH1/2-TET2 pathway acts to suppress AML. The role and 
function of αKG and IDH in physiological and pathological conditions is described 
in book 7 Chap. 9 of Santoro.
8.2.5  Epigenetic Inhibitors of DNA Methyltransferases  
in Cancer Therapy
Two inhibitors of DNA methyltransferases, 5-azacytidine (azacitidine) and 5-aza-
2′-deoxycytidine (decitabine), have been approved for clinical use in haematologi-
cal malignancies such as MDS, AML, and CMML (. Fig.  8.4). Azacitidine and 
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decitabine are nucleotide analogues. Azacitidine can be incorporated into RNA and 
DNA whereas decitabine only into DNA. In particular, these nucleotide analogues 
can be incorporated during DNA replication instead of cytosine.
Maintenance of DNA methylation occurs after the passage of the replication 
fork where hemi-methylated DNA is generated that is then methylated at the oppo-
site strand by DNMT1 (see book 7 Chap. 1 of Wutz). The reaction of DNMTs com-
prises the attack at the C6 position of the pyrimidine ring of cytosine, leading to the 
intermediate formation of a covalent DNMT-DNA complex, followed by formation 
of 5mC (. Fig. 8.5). In the case of azacitidine or decitabine, however, the replace-
ment of the carbon with an aza-group impairs the transfer of the methyl-group to 
the C-5 position (. Fig. 8.5). Consequently, the reaction arrests, the DNMT remains 
covalently trapped on the DNA, and the restoration and maintenance of methylation 
after the passage of the replication fork is impaired. Thus, treatment with DNMT 
inhibitors leads to a passive DNA demethylation process (see book 7 Chap. 1 of 
Wutz).
Azacitidine is the first therapy to have demonstrated a survival benefit for patients 
with MDS (Fenaux et al. 2009). However, the molecular mechanisms governing the 
impressive responses seen in MDS are largely unknown. It is important to note that, 
in addition to the demethylating effect of these compounds, also the trapping of 
DNMT proteins on the DNA might indirectly contribute to an anti-cancer effect. 
Recently, it has also been shown that treatment with DNMT inhibitors induces 
immune signaling in cancer cells through the upregulation of a wide range of genes 
implicated in immune signaling and increased numbers of immune cells in the tumor 
microenvironment. Transcriptional silencing mediated by DNA methylation is also 
related to the recruitment of co-repressors and deacetylation or methylation of 
histone marks at promoters and enhancers. Accordingly, the combinatorial use of 
DNMT and histone deacetylases (HDAC) inhibitors (described in the next para-
graph) was shown to enhance reactivation of aberrantly silenced genes in tumor cells 
and cause reductions in tumor burden.
  . Fig. 8.4 DNA methyltransferase inhibitors. Chemical structure of  cytidine nucleoside and DNA 
methyltransferases inhibitors azanucleosides
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8.3  Polycomb Group Proteins and Cancer
In 7 Chap. 3 “cellular memory”, you have learnt that Polycomb group (PcG) pro-
teins mainly function as members of two large multisubunit complexes, Polycomb 
Repressive Complex 1 and 2 (PRC1 and PRC2). PRC1 catalyzes the monoubiqui-
tination of histone H2A at lysine 119 (H2AK119ub1) whereas PRC2 catalyzes the 
trimethylation of histone H3 at lysine 27 (H3K27me3) (see book 7 Chap. 3 of Paro). 
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  . Fig. 8.5 Scheme showing the action of  DNMT inhibitors. a The reaction of  DNMTs comprises the 
attack at the C6 position of  the pyrimidine ring of  cytosine, leading to the intermediate formation of  a 
covalent DNMT-DNA complex followed by formation of  5mC. Methylation of  the C5 position induces 
a shift of  electrons and releases the enzyme. b In the case of  azacitidine or decitabine, the replacement 
of  the carbon with an aza-group impairs the transfer of  the methyl-group to the C-5 position. Conse-
quently, the reaction arrests and the DNMT remains covalently trapped on the DNA. c Because of  the 
semiconservative nature of  DNA replication, a DNA sequence carrying symmetrical methylation marks 
on both strands gives rise to two hemi-methylated double strands, which can be restored to fully a meth-
ylated status by the maintenance DNA methyltransferase DNMT1. Azacitidine and decitabine can be 
incorporated into DNA during replication. Treatment with these compounds leads to loss of  DNMT 
activity because the enzyme becomes irreversibly bound to the aza-residues in DNA and is no longer 
available for further catalysis. Loss of  DNA methylation is the result of  the dilution of  DNA methyla-
tion during several rounds of  DNA replication (passive DNA demethylation), resulting in transcrip-
tional activation of  genes previously silenced by DNA methylation
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scriptional silencing. PcG proteins have been shown to regulate diverse biological 
processes during embryonic development, such as cell fate and lineage decisions, cel-
lular memory, stem cell function, tissue homeostasis and regeneration. Because of 
the involvement of PcG proteins in so many key cellular processes, it should not be 
now surprising that alterations in the PcG machinery have frequently been found in 
several cancers. These changes include mutations and differential expression of the 
writers and erasers of H3K27me3 (8.3.1) and mutations in genes encoding histone 
H3 (8.3.2).
8.3.1  Alterations of PcG Activity in Cancer
Several PcG proteins are differentially expressed in tumors compared to the cor-
responding normal tissue (. Fig. 8.6). PRC2 components EZH2 and SUZ12 and 
PRC2 component BMI1 (see book 7 Chap.3 of Paro) are often found overex-
pressed in several malignancies with an aggressive phenotype. In particular, more 
than half  of the hormone-refractory prostate cancers, representing the late-stage 
cancer, exhibit amplification of the EZH2 gene, which encodes the catalytic subunit 
of PRC2 responsible for H3K27me3. This amplification results in increased EZH2 
protein expression that consequently alters the H3K27me3 genomic landscape. High 
levels of BMI1 and EZH2 predict advanced disease and a poor prognosis in several 
human cancer types. In particular, EZH2 level is an important factor for assessing 
the progression and prognosis of prostate cancers.
Cancers also exhibit several PcG missense mutations and chromosomal trans-
locations. For example, heterozygous mutations replacing a single tyrosine in the 
catalytic SET domain of the EZH2 protein (Tyr641) occur in 21.7% of patients with 
diffuse large B-cell lymphoma and 7.2% with follicular lymphoma. This mutation 
alters the catalytic activity of EZH2 by inhibiting the monomethylation of H3K27 
and increasing the catalytic efficiency for subsequent di- and di- to trimethylation 
reactions (hyperactivated EZH2 mutants). Furthermore, PcG proteins can physically 
interact with a number of fusion transcription factors originating from transloca-
Decreased H3K27me3 
Derepression of genes that promote  
cell growth and invasion 
EED











Silencing of tumor suppressor genes 
Subversion of developmental programs 
  . Fig. 8.6 Alterations of  PcG activity in cancer. EZH2 is the catalytic subunit of  PRC2 that also 
contains SUZ12 and EED. Loss-of-function mutations in EZH2 gene decrease H3K27me3 levels and 
activate the expression of  genes implicated in cancer growth and invasion, conferring a poor prognosis. 
Amplification of  EZH2 or mutations leading to its hyperactivation increase H3K27me3, thereby silenc-
ing tumor suppressor genes and promoting a cancer stem cell-like state. Similarly, inactivating muta-
tions in the histone demethylase gene UTX cause an increase in H3K27me3
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tions, such as the promyelocytic leukemia zinc finger-retinoic acid receptor α (PLZF- 
RARα) that, together with PRC2, induces the transcriptional silencing of target 
genes, thereby mediating leukemic transformation. Consistent with the critical role 
of H3K27me3 regulation in cancers, inactivating somatic mutations in the histone 
lysine demethylase gene UTX (KDM6A) have also been found in several cancers that 
consequently showed high H3K27me3 levels.
Although the role of PRC2 in cancer is mainly linked to H3K27me3 and transcrip-
tional repression, there are cases of additional, non-classical functions. For example, 
in castration-resistant prostate cancers (CRPCs, i.e. cancers that do not respond to 
androgen deprivation therapy and hence representing the final and most aggressive 
stage of the disease), EZH2 acts as a coactivator for critical transcription factors. 
This functional switch is dependent on the phosphorylation of EZH2 at Ser21, which 
promotes the interaction with the Androgen Receptor (AR) and the activation of 
AR-target genes that are critical for disease progression (Xu et al. 2012).
Since PcG proteins are critical for maintaining stem cell-like characteristics of 
adult as well as embryonic stem cells (ESCs), it has been proposed that abnormally 
elevated levels of PcG proteins may lead to the generation and maintenance of can-
cer stem cells. Tumors are composed of heterogeneous populations of cells, which 
differ in their phenotypic and genetic features. It has been suggested that cellular 
heterogeneity within a tumor is organized in a hierarchical manner. In particular, 
evidence indicates the presence of a small subpopulation of cancer stem cells with 
stem cell-like characteristics that give rise to heterogeneous cancer cell lineages and 
undergo self-renewal to maintain their reservoir7. Cancer stem cells were shown to 
have an enhanced capacity for therapeutic resistance, immune evasion, invasion, and 
metastasis (Prager et al. 2019). In pluripotent ESCs, PRC1 and PRC2 bind to pro-
moters of genes encoding regulators of developmental processes that must remain 
silenced to maintain ESC self-renewal. During ESC differentiation, PcG factors are 
removed from these genes that consequently become de-repressed, thereby setting 
new transcriptional programs to ensure proper differentiation. Furthermore, PcG 
proteins are required for cell fate determination since they restrict alternative fates 
once cells differentiate towards a specific cell lineage. Since PRC2 is important for 
balancing proliferation versus differentiation, PRC2 has been shown to promote a 
de-differentiated phenotype of several cancers (see also book 7 Chap. 3 of Paro). 
Increased PRC2 activity in stem or progenitor cells might promote self-renewal over 
differentiation by repressing differentiation genes or genes controlling cell prolifera-
tion, such as CDKN2A (Laugesen et al. 2016). For example, elevated EZH2 levels led 
to growth of Ewing tumors and a consequential inhibition of endothelial and neu-
roectodermal differentiation. The important role of PcG proteins in cancer makes 
them attractive targets for cancer therapy.
7 Stem cells in normal tissues are generally defined as undifferentiated cells that have the capacity to 
produce the specialized end cells of  a tissue as well as to self-renew to maintain their reservoir (see 
haematopoietic stem cells). By analogy, cancer stem cells have the ability to self-renew and to gener-
ate and re-populate a malignant cell population.
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8.3.2  Mutations of Affecting Lysine 27 of Histone H3 Occur 
in Multiple Cancers
Consistent with the critical role of altered PRC2 activity, mutations in the substrate, 
lysine 27 of histone H3, have also been reported in cancers. Whole-genome sequenc-
ing of paediatric high-grade gliomas have identified gain-of-function mutations in 
histone H3 genes, specifically histone 3A (H3F3A) and histone H3B (HIST1H3B), 
encoding histone H3 variants H3.3 and H3.1, respectively (Schwartzentruber et al. 
2012; Wu et al. 2012). In 78% of paediatric diffuse intrinsic pontine gliomas (DIPGs) 
and in 22% of non-brainstem paediatric glioblastomas (non-BS-PGs), the H3F3A 
or HIST1H3B genes contained a mutation leading to the substitution of lysine 27 
to methionine (H3K27M). Somatic mutations at H3F3A that replace glycine 34 with 
arginine (H3G34R) were also found in 14% of non-BS-PGs.
H3K27M mutant tumors are frequently found in the thalamus, pons, and spi-
nal cord and show poor prognosis whereas H3G34R mutations are seen in tumors 
of the cerebral hemispheres, suggesting a different cellular origin for these tumors. 
At molecular level, H3K27M inhibits the enzymatic activity of PRC2 through 
interaction with the EZH2 subunit and causes a profound reduction of wild-type 
H3K27me3 levels (Lewis et al. 2013) (. Fig. 8.7).
The alteration in H3K27me3 levels has been thought to drive a transcriptional 
program that promotes tumor initiation and progression. The strong reduction of 
H3K27me3 in H3K27M tumors is quite remarkable since the human genome contains 
16 distinct histone H3 encoding genes and only one of the two H3F3A genes contains 
the H3K27M mutation. Thus, the K27M mutation of only one histone H3 gene causes 
a drastic reduction of H3K27me3 at all the other wild-type histone H3s that, in diploid 
cells, are encoded by 31 genes. Importantly, concomitant with H3K27me3 reduction, 
the levels of the active H3K27ac mark increase, suggesting a switch in the epigenetic 
landscape of H3K27M tumors and the activation of genes linked to proliferation.
There have been several hypotheses to explain how H3K27M impairs PRC2 
activity. It has been suggested that H3K27M might sequester PRC2 to chromatin 








  . Fig. 8.7 H3K27M mutations in genes encoding the histone variants H3.3 and H3.1. H3K27M 
mutations are recurrently found in pediatric high-grade glioma (HGG) and diffuse intrinsic pontine 
glioma (DIPG). K27M mutations in genes coding for histone variants H3.3 and H3.1 result in a global 
reduction of  H3K27me3 levels, leading to derepression of  PRC2 target genes
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PRC2 has high binding affinity for mutant H3K27M histones, leading to the stall-
ing of PRC2 and preventing propagation of the H3K27me3 mark. Furthermore, in 
vitro biochemical analyses revealed that PRC2 activity is inhibited by di-nucleosomes 
composed of H3K27M-H3K27me3. On the other hand, it has also been proposed 
that H3K27M might exclude PRC2 from chromatin. Indeed, H3K27M associates 
with chromatin regions enriched in H3K27ac whereas PRC2 is excluded from these 
regions. These results support a model in which H3K27M excludes PRC2 binding, 
which thus induces aberrant accumulation of H3K27ac at nucleosomes containing 
the wild-type H3 and the mutated H3K27M.
The majority of the heterotypic H3K27M-H3K27ac nucleosomes were found at 
actively transcribed genes and colocalized with BRD2 and BRD4, which are part of 
the Bromodomain (BRD) and Extra-Terminal motif (BET) protein family. BRD- 
containing proteins regulate gene expression primarily through recognition of histone 
acetyl residues, leading to the recruitment of protein complexes that modulate gene 
expression (see also 8.4.2). The development of inhibitors of epigenetic readers as anti-
cancer agents is now an intense area of research. In particular, the selective small-mol-
ecule inhibitor JQ1 binds competitively to bromodomains and impairs their binding 
to acetylated histones (Qi 2014). The association of BRD2 and BRD4 proteins with 
chromatin regions enriched in H3K27M-H3K27ac heterotypic nucleosomes suggested 
a potential role of BRD proteins in DIPG pathogenesis. Accordingly, treatment with 
JQ1 strongly inhibits the proliferation of H3K27M-DIPG cells in vivo and DIPG xeno-
graft mice8 show substantially improved survival, identifying BET proteins as poten-
tial therapeutic targets of H3K27M-DIPG. It has also been suggested that increasing 
H3K27me3  in H3K27M-DIPG might be an effective therapeutic strategy. This can 
be achieved either by enhancing PRC2 methyltransferase activity or inhibiting H3K27 
demethylase activity. H3K27me3 can be demethylated by the KDM6 subfamily K27 
demethylases JMJD3 and/or UTX. Accordingly, treatment with the JMJD3 K27 his-
tone demethylase inhibitor GSKJ4 increased cellular H3K27 methylation in patient-
derived H3K27M-DIPG tumor cells and showed potent antitumor activity both in vitro 
against H3K27M cells and in vivo against H3K27M-DIPG xenografts (. Fig. 8.8).
8.3.3  EZH2 Inhibitors in Cancer Therapy
Since PcG proteins have been proven to be bona fide and cancer stem cell mark-
ers, PcG proteins became attractive targets for both cancer prevention and therapy. 
Inhibitors targeting EZH2 activity have been developed. Three of these inhibitors 
(GSK126, Tazemetostat, and CPI-1205) are now undergoing phase I or II clinical 
trials. GSK126 is an S-adenosylmethionine (SAM) competitor and a highly selective 
EZH2 inhibitor. However, these inhibitors are not selective for hyperactive EZH2 
mutants that contain mutations in the substrate-binding pocket (Laugesen et  al. 
2016). Thus, targeting EZH2 might be a relevant therapeutic strategy in cancers not 
expressing hyperactivated EZH2 mutant variants.
8 Mouse xenograft is one of  the most widely used models in cancer biology. In this model, human 
tumor cells are transplanted, either under the skin or into the organ type in which the tumor origi-
nated, into immunocompromised mice that do not reject human cells.
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8.4  Histone Acetylation and Deacetylation in Cancers
Histone acetyltransferases (HATs) are a class of enzymes that transfer acetyl groups 
from acetyl-CoA cofactors to lysine residues at histones (see book 7 Chap. 1 by 
Wutz and 7 Chap. 9 by Santoro). Histone acetylation is a highly reversible pro-
cess since histone deacetylases (HDACs) act as erasers by removing the acetyl group. 
Histone acetylation is associated with active transcription, especially at promoters 
and enhancers, and facilitates the recruitment of co-regulators and RNA polymerase 
II complexes. In contrast, HDACs usually establish gene repression. As discussed 
in the previous section, the acetyl group can be recognized by proteins containing 
bromodomains (BRD) that, in turn, often recruit factors linked to transcriptional 
activation.
The impairment of the balance between acetylation and deacetylation can affect 
gene expression. This situation is often found in cancers with altered acetylation 
patterns. Alterations in the acetylation/deacetylation balance can originate because 
of the abnormal recruitment of HDACs or the reduced activity of HATs, leading 
to repression of tumor suppressor genes. On the other hand, it can also occur an 
increased HAT activity with consequent activation of oncogenes (. Fig. 8.9). These 
mechanisms can alter the normal cell cycle, block or revert differentiation, impair 
apoptosis, and facilitate proliferation.
8.4.1  Alterations of Histone Acetyltransferases in Cancer
HATs are divided into three families, depending on their structural homology. Gcn5- 
related N-acetyltransferases (GNAT) include GCN5 and PCAF. MYST acetyltrans-
ferases include MOZ, MOF, TIP60, and HBO1. The last class consists of p300/
cAMP-responsive element-binding proteins that include CBP and p300.
  . Fig. 8.8 Methylation and demethylation of  H3K27. Left panel. EZH2, the catalytic component of 
PRC2, methylates H3K27 and promotes a transcriptionally repressed chromatin state. In contrast, 
JMDJD3 or UTX are demethylases that remove methyl groups from H327K, inducing an open and 
transcriptionally active chromatin state. Right panel. H3K27M inactivates EZH2 activity with a conse-
quent decrease of  H3K27me3 levels and transcriptional activation. Pharmacological inhibition of 
JMJD3 demethylase by GSKJ4 increases methylation at wild-type H3K27 and inhibits gene expression. 
Treatment with GSKJ4 showed potent antitumor activity in H3K27M tumor cells
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Appropriate acetylation within cells is important since upregulation or downreg-
ulation of HATs is associated with tumorigenesis and poor prognosis (Di Cerbo and 
Schneider 2013). For example, aberrant lysine acetylation mediated by CBP/p300 has 
been implicated in the genesis of multiple haematologic cancers. A high frequency 
of alterations in HAT genes has been reported in small-cell lung cancers, an aggres-
sive lung tumor subtype with poor prognosis, and non-Hodgkin B-cell lymphomas. 
These mutations are most often point mutations in proximity to the HAT catalytic 
domain, resulting in loss of enzymatic activity. In acute lymphoid leukemia (ALL), 
a significant percentage of patients (18.3%) have mutations in the HAT domain of 
CBP. These mutations were shown to impair histone acetylation and transcriptional 
regulation of CBP targets. Since several of these mutations acquired at relapse were 
detected in subclones at diagnosis, it was suggested that they may confer resistance 
to therapy.
  . Fig. 8.9 Alterations of  HATs and HDACs in cancers. Alterations in the acetylation/deacetylation 
balance can influence the expression of  tumor suppressor genes and oncogenes, favoring the tumori-
genic process. High expression or the abnormal recruitment of  HDACs or the reduced expression or 
activity of  HATs can lead to the repression of  tumor suppressor genes. In contrast, mutation or low 
expression of  HDACs or high expression, oncogenic fusion, or aberrant recruitment of  HATs can lead 
to the activation of  oncogenes
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Genes encoding HATs can also act as oncogenes. Although less frequent, it has 
been reported that chromosomal translocations involving HAT genes can gener-
ate chimeric proteins that retain HAT catalytic activity and bromodomains. Beside 
these cases, HATs can also be involved in the regulation of oncogenic fusions. For 
example, AML1-ETO, the most frequent fusion protein in AMLs, is acetylated by 
p300. This acetylation is essential to promote self-renewal and induce leukemogen-
esis. These examples indicate that because of the various cellular functions linked to 
HATs and their specific substrates (histones but also non-histone proteins), they can 
act as either tumor suppressors or oncogenes, depending on the cellular or molecular 
context and cancer type.
8.4.2  Acetyl-Lysine Recognition Proteins and Cancer
The bromodomain (BRD) is a conserved protein module (reader) that recognizes 
acetyl-lysine. Depending on the structure, each BRD has preference for different 
acetylated histones. BRD-containing proteins are often implicated in the regulation 
of transcription by the recruitment of different molecular partners. HATs, such as 
PCAF, GCN5, p300, and CBP also contain a BRD.
As discussed earlier, an important class of BRD-containing proteins is the BET 
protein family, including BRD2, BRD3, BRD4, and BRDt. BET proteins are critical 
mediators of transcriptional activity through the recognition of acetylated histones 
and the recruitment of cofactors for gene activation (. Fig. 8.10).
BRD4 and BRD2 play an important role in transcription elongation of genes 
controlling cell proliferation by recruiting the positive transcription elongation fac-
tor complex (P-TEFb) to acetylated chromatin through their BRDs. BET proteins 
were shown to play important roles in tumorigenesis, for instance BRD4, which is 
required for the maintenance of AML with sustained expression of Myc. In breast 
cancer, BRD3/4 interacts with the histone H3K36 methyltransferase WHSC1 and 







  . Fig. 8.10 Targeting readers of  histone acetylation to modify gene expression. The bromodomain 
(BRD) is a conserved protein module that recognizes acetyl-lysine (reader). BRD-containing proteins 
are often implicated in the activation of  transcription by the recruitment of  different molecular part-
ners. BRD inhibitors prevent the interaction between the BRD and the acetyl group, causing the down-
regulation of  genes including some that may play critical roles in cancer
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tamoxifen9 resistance in ER-positive breast cancers. The fact that BRDs are a poten-
tially druggable target has encouraged the discovery and development of several 
small-molecule inhibitors in recent years (. Fig. 8.10).
JQ1 and I-BET762 are two representative inhibitors of BET family proteins that 
competitively bind to BRD4 (Filippakopoulos et al. 2010). The efficacy of JQ1 was 
initially tested in NUT midline carcinoma (NMC) cells that express BRD4 fused to 
the nuclear protein in testis (NUT). The BRD4-NUT oncoprotein contributes to 
carcinogenesis by interfering with epithelial differentiation. Treatment of NMC cell 
lines and xenograft models with JQ1 was shown to displace BRD4-NUT from chro-
matin, inducing differentiation and specific anti-proliferative effects. To date, the effi-
cacy of JQ1 was demonstrated in many other malignancies, including hematological 
malignancies and a variety of solid tumors, such as glioblastoma, medulloblastoma, 
hepatocellular carcinoma, colon cancer, pancreatic cancer, prostate cancer, lung can-
cer, and breast cancer (Perez-Salvia and Esteller 2017). Currently, there is a lot of 
effort in generating inhibitors targeting BRDs of non-BET proteins, including the 
BRD of CBP and p300. To date, many inhibitors targeting BRD proteins have been 
investigated in clinical trials.
8.4.3  Alterations of Histone Deacetylases in Cancer
In humans, the genome encodes 18 histone deacetylases (HDACs). HDACs can be 
divided into four classes, based on their primary homology to yeast HDACs. Class I 
HDACs include HDAC1, HDAC2, HDAC3, and HDAC8. Class II HDACs are rep-
resented by HDAC4, HDAC5, HDAC6, HDAC7, HDAC9, and HDAC10. Class III 
HDACs belong to the Sirtuin 2 (Sir2) family, which is composed of SIRT1, SIRT2, 
SIRT3, SIRT4, SIRT5, SIRT6, and SIRT7. Class IV contains only HDAC11. Classes 
I, II, and IV are Zn2+-dependent HDACs whereas Sir2-like proteins (sirtuins) are nic-
otinamide adenine dinucleotide (NAD+)-dependent HDACs (see also book 7 Chap. 
9 by Santoro). HDACs can also deacetylate non-histone proteins. Some HDACs are 
subunits of complexes, such as Sin3 and NuRD. The association with these com-
plexes was shown to increase they catalytic activity.
Alterations of HDAC activity in cancers is generally associated with aberrant 
deacetylation and the inactivation of tumor suppressor genes. Altered expression and 
mutations in genes encoding HDACs have been linked to tumor development due to 
inactivation of tumor suppressor genes (Ropero and Esteller 2007). Overexpression 
of HDAC1 has been found in gastric, breast, pancreatic, hepatocellular, lung, and 
prostate carcinomas and, in most of the cases, HDAC1 up-regulation is associ-
ated with poor prognosis. HDAC1, HDAC2, and HDAC3 were shown to be highly 
expressed in renal cell, colorectal, and gastric cancers as well as in classical Hodgkin’s 
lymphoma. Mutations affecting HDACs were also reported in several cancers. Loss 
9 Tamoxifen is a hormone therapy drug used to treat breast cancer that are estrogen sensitive or 
estrogen receptor positive. Tamoxifen blocks the binding of  estrogen receptors to estrogen, thereby 
the cells cannot be stimulated to divide and grow.
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of HDAC2 protein expression in sporadic carcinoma was associated microsatellite 
instability. The best-known mechanism showing the contribution of HDACs in can-
cer is their interaction with oncogenic fusion proteins. In acute promyelocytic leuke-
mia (APL), fusion proteins containing RAR-PML and RAR-PLZF bind to retinoic 
acid-responsive elements (RAREs) and recruit HDAC-containing complexes. This 
action prevents the binding of the retinoic acid receptor and represses the expression 
of genes implicated in the differentiation of myeloid cells. Furthermore, the fusion 
of ETO or TEL to AML1 converts a transcriptional activator to a constitutive tran-
scriptional repressor through recruitment of a HDAC complex, thereby repressing 
the expression of genes critical to differentiation and promoting acute myeloid leu-
kemia.
8.4.4  HAT and HDAC Inhibitors in Cancer Therapy
Aberrant HAT activity in cancers can be targeted by using HAT inhibitors. 
An example is provided by bi-substrate inhibitors for PCAF, p300, and TIP60 
that mimic two substrates of  HATs: the cofactor acetyl coenzyme A (Ac-CoA) 
and a peptide resembling the lysine substrate. However, these molecules are not 
membrane- permeable. Several synthetic compounds have been designed to selec-
tively target HATs, such as A-485, a potent, selective, and drug-like catalytic 
inhibitor of  p300 and CBP (Lasko et al. 2017). As described in 8.4.3, targeting 
of  the histone acetylation readout through inhibition of  the readers of  histone 
acetylation (i.e. inhibitors targeting BRD proteins) is an attractive strategy for the 
pharmacological treatment of  malignancies. Accordingly, BRD inhibitors have 
been investigated in clinical trials, whereas there currently are no clinical trials 
with HAT inhibitors.
HDAC family members are attractive targets for drug design and a variety of 
HDAC-based combination strategies have been developed for the treatment of can-
cers (Ropero and Esteller 2007). The inhibition of HDACs has shown promising anti-
tumor effects. Several classes of natural and synthetic HDAC inhibitors have been 
identified, such as butyrates, hydroxamic acid, benzamides, and cyclic tetrapeptides. 
Trichostatin A (TSA) is a natural compound that inhibits the activity of HDACs 
and induces cancer cell differentiation and apoptosis. SAHA (vorinostat) is a pan-
HDAC competitive inhibitor that structurally belongs to the group of hydroxamic 
acids. SAHA was the first FDA-approved HDAC inhibitor and is clinically effective 
in the treatment of refractory, primary cutaneous T-cell lymphomas. Specific HDAC 
inhibitors have also successfully been generated. SHI-1:2 is a benzamide inhibitor 
that shows HDAC1/HDAC2-specific inhibitory activity. Several HDAC inhibitors 
are currently in clinical trials and some of them have already been approved for dis-
ease treatment. As described above, mutations affecting HDACs were reported in 
several cancers. Mutations causing loss of HDAC2 protein  expression and/or enzy-
matic activity rendered cells more resistant to the usual antiproliferative and pro-
apoptotic effects of histone deacetylase inhibitors. Thus, the mutational status of 
HDAC encoding genes in individual cancers should be taken into consideration for 
pharmacogenetic treatments.
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8.5  Chromatin Remodeling Factors and Cancer
Chromatin remodeling factors are multi-subunit complexes that use the energy of 
ATP hydrolysis to reposition, eject, slide, or alter the composition of nucleosomes. 
These processes play key roles in transcription by enabling access of DNA-binding 
proteins and the transcriptional machinery to DNA in order to facilitate expres-
sion. In eukaryotes, four families of chromatin remodeling complexes have been 
characterized: the switching defective/sucrose non-fermenting (SWI/SNF) family, 
the imitation- switch (ISWI) family, the nucleosome remodeling and histone deacety-
lase complex (NuRD), and the inositol 80 (INO80) family. These complexes contain 
distinct types of catalytic ATPases and associate with several factors that specify tar-
gets and contribute to diverse biological processes, including the regulation of gene 
expression. An extensive description of the activities of these chromatin remodeling 
factors can be found in book 7 Chap. 3 of Paro. Here, the alterations of these com-
plexes in cancer and their functional consequences are described.
8.5.1  SWI/SNF Complexes and Cancer
In mammalian cells, the SWI/SNF complexes are generally grouped into two types of 
complexes: BAF complexes containing the ATPase BRG1 or BRM and several alter-
nate core subunits, such as ARID1A or ARID1B, and PBAF (polybromo- associated 
BAF) complexes containing the BRG1 ATPase associated with factors like PBRM1 
and ARID2. Cancer genome sequencing studies have revealed that >20% of all can-
cers harbor mutations in SWI/SNF-encoding genes (Valencia and Kadoch 2019). 
Evidence for a driving role of BAF complex alterations in cancer first came from the 
identification of mutations at the SMARCB1 locus encoding a subunit shared by 
both SWI/SNF BAF and PBAF complexes. The SMARCB1 gene undergoes bial-
lelic inactivation in ∼98% of malignant rhabdoid tumors (MRTs), a highly aggressive 
paediatric cancer. Loss of ARID1A represents a commonly mutated gene in ovarian, 
endometrial, gastric, pancreas, breast, brain, prostate, lung, and liver cancers. The 
large majority of ARID1A mutations are frameshift indels or nonsense point muta-
tions resulting in loss of the protein.
SWI/SNF complexes were suggested to oppose epigenetic silencing by PcG pro-
teins. For example, in Drosophila, PcG proteins were shown to maintain repression of 
Hox genes during embryogenesis, while the SWI/SNF complex promotes Hox gene 
activation. Studies in MRT showed that loss of SMARCB1 destabilizes SWI/SNF 
complexes on chromatin, so they are unable to oppose PcG-mediated repression at 
bivalent promoters required for differentiation (Nakayama et al. 2017). Intriguingly, 
while core components of the SWI/SNF complex are frequently inactivated, PcG 
proteins are frequently overexpressed in cancers. For example, EZH2 is often over-
expressed in ovarian clear cell carcinomas (OCCCs) whereas ARID1A is mutated in 
∼57% of OCCCs. The link between PcG and SWI/SNF complexes is further sup-
ported by studies showing that the inhibition of EZH2 acts in a synthetic lethal 
manner in ARID1A-mutated ovarian cancer cells and the ARID1A mutational status 
correlates with the response to EZH2 inhibitors (Bitler et al. 2015).
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Gain-of-function perturbations of  SWI/SNF subunits have also recently been 
discovered. Human synovial sarcoma show a recurrent chromosomal translocation, 
t(X;18)(p11.2;q11.2), that fuses the SS18 gene on chromosome 18 to one of  three 
closely related genes on the X chromosome, SSX1, SSX2, and, rarely, SSX4, result-
ing in in-frame fusion proteins. SS18 is a subunit of  BAF complexes. When SS18 is 
fused to SSX, a protein is produced that alters the SWI/SNF complex by evicting 
the SWI/SNF subunit SMARCB1. This altered SWI/SNF complex is redirected to 
other genomic loci, relieving H3K27me3 repression at genes critical to cancer. One 
of these genes encodes the transcription factor Sox2 that is essential for prolifera-
tion in synovial sarcoma. Because of  the important role of  SWI/SNF complexes 
in cancer, several compounds targeting SWI/SNF subunits have been developed. 
For example, the bromodomain of the SWI/SNF subunit BRD7 and BRD9 has 
been targeted by specific chemicals and ligand base degrader compounds, which 
were shown to attenuate the proliferation of tumor cells with SWI/SNF mutations 
(Remillard et al. 2017).
8.5.2  ISWI Complexes and Cancer
Mammals have two homologs of ISWI, SNF2L (encoded by the SMARCA1 gene) 
and SNF2H (encoded by the SMARCA5 gene). In mammals, five ISWI complexes 
have been identified: ACF, CHRAC, WICH, RSF, and NoRC. ISWI complexes are 
typically heterodimers and composed of an ISWI protein (SNF2H or SNF2L) and 
another subunit that provides additional specificity through targeting and recruit-
ment of additional chromatin regulators.
RSF1 is an ISWI complex composed of SNF2H and the remodeling and spac-
ing factor 1 (RSF1). This complex can reposition the nucleosome for transcriptional 
regulation. RSF1 is overexpressed in multiple types of tumors, including breast 
cancer, and correlates with their aggressiveness in terms of tumor size and stage. 
Overexpression of RSF1 was associated with the amplification of the 11q13.5 chro-
mosomal region. Elevated expression of RSF1 was shown to promote the expression 
of genes regulated by NF-kB, including some involved in the evasion of apoptosis 
and inflammation, which is necessary for the development of chemoresistance in 
ovarian cancer cells (Yang et al. 2014).
BAZ2A (also known as TIP5) interacts with SNF2H to form the nucleolar remod-
eling complex NoRC (Bersaglieri and Santoro 2019). BAZ2A was initially identified 
as the repressor of ribosomal rRNA genes in healthy and differentiated cells. In pros-
tate cancer, BAZ2A is highly expressed. Alterations in BAZ2A levels are not caused 
by somatic structural or sequence variations but more likely by post- transcriptional 
misregulation involving loss of microRNA miR-133a. In prostate cancer, BAZ2A 
silences the expression of numerous genes that are frequently repressed in metastatic 
prostate cancers. Data have also shown that BAZ2A is required for the initiation of 
prostate cancer driven by the loss of PTEN, the most commonly lost tumor suppres-
sor gene in primary prostate cancer (Pietrzak et al. 2020). BAZ2A overexpression 
was shown to be tightly associated with a prostate cancer subtype displaying CIMP 
and prostate cancer recurrence. Thus, BAZ2A might serve as a useful marker for 
metastatic potential in prostate cancer.
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8.5.3  The NuRD Complex and Cancer
NuRD (Mi-2) is macromolecular protein complex that combines chromatin remod-
eling with protein deacetylase activity (Hoffmann and Spengler 2019). The remod-
eling subcomplex consists of an ATPase (chromodomain helicase DNA-binding 
protein 3/4/5; CHD3/4/5) whereas the histone deacetylase activity is attributed to 
HDAC1/2. NuRD also encompasses several non-enzymatic components including 
methyl-CpG-binding domain 2/3 (MBD2/3), retinoblastoma-binding proteins 4/7 
(RBBP4/7), metastasis-associated proteins 1/2/3 (MTA1/2/3) and GATA zinc finger 
domain containing proteins 2A/B (GATAD2A/B) (Allen et al. 2013).
Multiple subunits belonging to NuRD complex protein families are overexpressed 
in a variety of human cancers. These include MTA1/2/3, HDAC1, and HDAC2. The 
elevated expression of these factors was associated with gene repression and impli-
cated in processes such as DNA damage repair and the maintenance of genomic 
integrity. MTA1 is overexpressed in various cancers, correlating with cancer progres-
sion and poor outcome. MTA3 has been shown to directly interact with BCL-6, a 
master regulator of B cell differentiation that plays a crucial role in diffuse large B 
cell lymphoma. The MBD3 subunit was shown to directly interact with JUN, an 
oncoprotein important in many malignancies. Recently, CHD4, one of the catalytic 
subunits of NuRD, was shown to be essential in fusion-positive rhabdomyosarcoma 
(FP-RMS), a rare paediatric sarcoma with a low mutational burden that exhibits 
features of skeletal myogenesis. The most common chromosomal translocation 
observed in FP-RMS is PAX3-FOXO1, both encoding transcription factors. This 
fusion generates a novel transcription factor with altered transcriptional power and 
target genes. Surprisingly, although CHD4 is classically defined as a repressor, in FP- 
RMS it acts as co-activator by interacting with super-enhancers where it generates 
a chromatin architecture permissive for binding of PAX3-FOXO1 and activating its 
downstream oncogenic program (Marques et al. 2020). These examples further indi-
cate that because of the various cellular functions mediated by chromatin remodeling 
activities, their readout depend on the cellular or molecular context and cancer type.
8.5.4  The INO80 Complex and Cancer
The INO80 family of remodeling enzymes is currently composed of two classes 
of enzymes, Ino80 and Swr1 (Watanabe and Peterson 2010). In mammals, the 
chromatin- remodeling complexes of the INO80 subfamily are INO80, Snf2-related 
CBP activator protein (SRCAP), and p400. The mammalian INO80 complex is 
composed of at least 13 subunits. INO80 has been implicated in many crucial cel-
lular functions, including transcriptional regulation, DNA replication and repair, 
telomere maintenance, and chromosome segregation. Subunits of the INO80 com-
plex are frequently amplified in cancers, including lung squamous carcinoma, 50% 
of pancreatic cancers, and 45% of bladder cancers. Increased expression of INO80 
has been  functionally associated with tumor progression. INO80 is overexpressed in 
BRAF- and NRAS-mutated melanoma cancer cells. Mechanistically, INO80 inter-
acts with super- enhancers through transcription factors such as MITF and Sox9. 
INO80 binding reduces nucleosome occupancy and facilitates Mediator recruit-
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ment (see also book 7 Chap. 3 of Paro), thus promoting oncogenic transcription. 
Expression of INO80 was also found upregulated in anaplastic thyroid carcinoma, 
an aggressive and lethal cancer with extrathyroidal invasion, distant metastasis, and 
resistance to conventional therapies. Interestingly, downregulation of INO80 was 
shown to decrease the expression of stem cell marker genes as well as to attenuate 
stem cell-specific properties including the ability to form tumors. These results sug-
gest that the role of INO80 in cancer cells is linked to its stem cell-promoting func-
tion. Accordingly, INO80 has been found to selectively activate pluripotency genes in 
ESCs (Wang et al. 2014), supporting the notion that genes and pathways important 
for ESC maintenance are often reactivated in cancer.
Take-Home Message
 5 Alterations of epigenetic processes affect gene expression and promote cancer ini-
tiation and progression
 5 Epigenetic regulators are frequently mutated in cancer
 5 The reversible nature of epigenetic aberrations has led to the emergence of the 
promising field of epigenetic therapy
 5 Alterations of DNA methylation are frequently observed in cancers. Tumor sup-
pressor genes can be silenced through promoter hypermethylation. Global hypo-
methylation has been associated with genomic instability. Alterations of DNA 
methylation at imprinting control regions, with a consequent loss of imprinting, 
have also been linked to cancer.
 5 Component of the DNA methylation/demethylation machinery, DNMT3A and 
TET2, are frequently mutated in haematological malignancies. Alterations in the 
DNA methylation profile have been linked to enhanced self-renewal capacity of 
HSCs.
 5 Azacitidine and decitabine are nucleotide analogues that are used as inhibitors of 
DNA methyltransferases. These nucleotide analogues can be incorporated during 
DNA replication instead of cytosine and covalently bind DNMT1, impairing the 
inheritance of DNA methylation during DNA replication (passive DNA demeth-
ylation).
 5 Component of the PcG machinery are frequently mutated in cancers. These 
changes include mutations (loss of function or hyperactivation) and differential 
expression of the writers and erasers of H3K27me3 and mutations in genes encod-
ing histone H3 (H3K27M). Increased PRC2 activity has been shown to promote a 
de-differentiated phenotype of several cancers by promote self-renewal over dif-
ferentiation through the repression of differentiation genes or genes controlling 
cell proliferation.
 5 The mutation one histone H3 gene (H3K27M), identified in paediatric high-grade 
gliomas, exerts a dominant negative effect on H3K27me3.
 5 Expression of HATs and HDACs are frequently altered in cancers, leading to an 
acetylation/deacetylation imbalance that can influence the expression of tumor 
suppressor genes and oncogenes, favoring the tumorigenic process.
 5 BRD is a conserved protein module (reader) that recognizes acetyl-lysine. BRD- 
containing proteins are often implicated in the regulation of transcription by the 
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What You Will Learn in This Chapter
Most chromatin-modifying enzymes use metabolites as cofactors. Consequently, the cel-
lular metabolism can influence the capacity of the cell to write or erase chromatin marks. 
This points to an intimate relationship between metabolic and epigenetic regulation. In 
this chapter, we describe the biosynthetic pathways of cofactors that are implicated in 
epigenetic and chromatin regulation and provide examples of how metabolic pathways can 
influence chromatin and epigenetic processes as well as their interplay in developmental 
and cancer biology.
9.1  Epigenetics and Metabolism
Cellular metabolism involves a set of complex and highly coordinated biochemical 
reactions that convert or use energy to maintain the living state of a cell. This process 
engages regulatory mechanisms that enable cells to sense nutrient availability and 
transmit the information through signaling networks. Metabolism impacts every cel-
lular process. Nowadays, the study of metabolism is influencing all fields of biological 
research. Most chromatin-modifying enzymes use as cofactors important intermedi-
ates of cellular metabolism. Depending on dietary intake, metabolite concentrations 
can vary, and, in turn, can affect gene expression by modulating the activity of epi-
genetic pathways and associated chromatin modifying enzymes. Considering that the 
methylation of DNA and each post-translational modification (PTM) of proteins 
can be affected by many metabolic pathways, it is clear that the epigenome might act 
as a sensor of the whole metabolic network.
9.2  Acetyl-Coenzyme A (Acetyl-CoA)
Acetyl-coenzyme A (acetyl-CoA) is the cofactor of histone acetyltransferases 
(HATs) (. Fig.  9.1). The abundance of acetyl-CoA reflects the general energetic 
state of the cell. Biosynthesis, compartmentalization, and fluctuation of acetyl-CoA 
concentration change considerably in response to a series of physiological or patho-
logical conditions. Thus, acetyl-CoA acts as metabolic sensor by signaling changes in 
metabolism that are then converted into gene expression states.
9.2.1  Biosynthesis of Acetyl-CoA
Acetyl-CoA comprises an acetyl moiety linked to coenzyme A, a derivative of vita-
min B5 and cysteine (. Fig. 9.1). Acetyl-CoA is a central metabolite that intercon-
nects multiple metabolic pathways. It can be found in two separate pools in the cell: 
the mitochondrial pool and the nuclear/cytosolic pool (. Fig.  9.2). This distinc-
tion is due to the fact that the inner mitochondrial membrane is impermeable to 
the highly charged acetyl-CoA molecule whereas nuclear pores allow acetyl-CoA to 
freely  distribute between the cytosol and the nucleus.
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The majority of acetyl-CoA is produced and consumed in mitochondria where it 
allows glycolytic1 pyruvate to enter the citric acid cycles, also known or tricarboxylic 
acid (TCA) cycle. In the cytosolic compartment, acetyl-CoA supports several ana-
bolic reactions including synthesis of fatty acids and steroid and protein acetylation. 
In mitochondria, acetyl-CoA is produced through carboxylation of pyruvate to form 
acetyl-CoA, CO2, and NADH, a reaction catalyzed by the mitochondrial pyruvate 
dehydrogenase complex (PDC) (. Fig. 9.2). At high glucose levels, acetyl-CoA is 
prevalently produced during the oxidation of glucose whereas at low glucose levels, 
it is generated as the end-product of the ß-oxidation of fatty acids. Acetyl-CoA can 
also be produced by branched-chain amino acids, i.e., valine, leucine, and isoleucine, 
through cytosolic transamination to branched-chain α-ketoacids followed by import 
into mitochondria. There, a reaction catalyzed by the mitochondrial branched-
chain α-ketoacid dehydrogenase generates NADH, acetyl-CoA, and other acyl-CoA 
thioesters. In addition to these nearly ubiquitous metabolic networks, mitochondrial 
acetyl-CoA can be produced by organ-specific pathways.
The nuclear-cytoplasmic level of  acetyl-CoA in mammalian cells is established 
primarily by the combined action of  two enzymes: ATP-citrate lyase (ACL) and 
acetyl- CoA synthetase (ACS) (. Fig. 9.2). ACL converts citrate into acetyl-CoA 
and oxaloacetate. This cytoplasmic pool of  acetyl-CoA can originate from the 
1 Glycolysis is a cytoplasmatic pathway that breaks down glucose into three carbon compounds and 
generates pyruvate and energy in form of  ATP and NADH.
  . Fig. 9.1 Acetyl-coenzyme A is the cofactor of  histone acetyltransferases. Acetyl-coenzyme A 
(acetyl- CoA) comprises an acetyl moiety linked to coenzyme A, a derivative of  vitamin B5 and cysteine. 
The schematic shows the acetylation of  the ε-amino group of  lysine mediated by histone acetyltransfer-
ases (HATs), whereby the acetyl group of  acetyl-CoA is transferred to the lysine
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reductive carboxylation of  glutamine. Cytosolic glutamine is transformed into 
glutamate, transported into mitochondria, and converted into α-ketoglutarate, 
which generates citrate within the TCA cycle. Finally, citrate can be exported back 
to the cytosol where is converted into oxaloacetate and acetyl-CoA by ACL. ACS 
utilizes acetate as a substrate for acetyl-CoA synthesis. Production of  acetyl-CoA 
within the nucleus is also possible due to the presence, in the nucleus, of  ACL 
and ACS. In Saccharomyces cerevisiae, inactivation of  ACS leads to rapid histone 
deacetylation and transcriptional defects, underscoring a direct link between ace-
tyl-CoA producing enzymes, chromatin regulation, and gene expression. A novel 
pathway for nuclear acetyl-CoA synthesis has recently been suggested by showing 







































  . Fig. 9.2 Metabolism of  acetyl-CoA in mammalian cells. Acetyl-CoA can be found in two distinct 
pools in the cell: the mitochondrial pool and the nuclear/cytosolic pool. The majority of  cellular acetyl- 
CoA in mitochondria is generated and consumed in reactions involving the oxidative metabolism of 
glycolytic pyruvate, free fatty acids, branched-chain amino acids (BCAAs), or ketone bodies, which all 
converge on the citric acid cycle (TCA). In the cytosolic and nuclear compartment, acetyl-CoA is pro-
duced by ATP-citrate lyase (ACL) and acetyl-CoA synthetase (ACS). ACL converts citrate into oxalo-
acetate and acetyl-CoA. ACS utilizes acetate as a substrate for acetyl-CoA synthesis. These reactions 
support several anabolic reactions, including lipogenesis, steroidogenesis, and the synthesis of  specific 
amino acids. PDC, ACL, and ACS are also found in the nucleus and produce acetyl-CoA therein. Their 
role in the nucleus mainly serves to produce acetyl-CoA for the acetylation of  histones and non- histone 
proteins, thereby regulating gene expression
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9.2.2  Acetyl-CoA as Cofactor of Histone Acetyltransferases
Acetyl-CoA is the cofactor required by histone acetyltransferases (HATs), which 
attach an acetyl group to the ε-amino group of specific lysine residues (. Fig. 9.1). 
Type B HATs are cytoplasmic enzymes, which modify free histones in the cytoplasm 
just after their synthesis2. Type A HATs are mainly nuclear enzymes and they are 
responsible for acetylation of histones and non-histone proteins in the nucleus and 
implicated in the epigenetic regulation of gene expression (see also book 7 Chap. 1 
of Wutz). In response to a series of physiological or pathological conditions, com-
partmentalization and fluctuation of acetyl-CoA concentration changes consider-
ably and has a major impact in protein acetylation.
An important example of how acetyl-CoA synthesis responds to stimuli and 
affects histone acetylation and gene expression is provided by experiments study-
ing growth of prototrophic3 strains of yeast under a nutrient-limiting environment. 
Under these conditions, cells enter into synchronous and highly robust oscillations 
of oxygen consumption, termed yeast metabolic cycles (YMCs). During YMCs, 
cells go through a synchronized transition between three metabolic phases, termed 
oxidative (OX), reductive and building (RB), and reductive and charging (RC). 
Acetyl- CoA levels strongly fluctuate as a function of the YMC. In the OX phase, 
mitochondrial respiration peaks and is associated with the rapid induction of genes 
involved in growth. In the RB phase, the rate of oxygen consumption begins to 
decrease and cell division initiates. In the RC phase, cells enter into a stationary and 
quiescent phase and express many genes that are negatively correlated with increas-
ing growth rate. In the transition from the RC to the OX phase, cells re-enter into 
growth. This time point is characterized by a substantial increase in intracellular 
acetyl-CoA levels that trigger a series of histone acetylation events catalyzed by Spt- 
Ada- Gcn5-acetyltransferase (SAGA, see also 7 Chap. 2 of Paro) at genes important 
for growth, thereby enabling their rapid transcription and commitment to growth. 
The peak of acetyl-CoA at the OX/RB boundary is likely coordinated by induction 
of all enzymes required to convert ethanol (fermented via the consumption of glu-
cose during the RB phase) into acetylaldehyde, into acetate, and, finally, into acetyl- 
CoA (Kaelin Jr. and McKnight 2013). Moreover, the link of this metabolic pathway 
with histone acetylation and gene expression is supported by the fact that acetyl- 
CoA synthase, which produces acetyl-CoA from acetate, is localized in the nucleus. 
In mammals, high acetyl-CoA concentrations also favor cell growth and replication 
at the expense of differentiation. The metabolism of embryonic stem cell (ESCs) 
shows the Warburg effect, a shift from oxidative phosphorylation to aerobic glycoly-
sis that is also utilized by cancer cells4. Thus, ESCs produce acetyl-CoA and acetate 
2 Note that the cytoplasmatic acetylation of  newly synthesized histones plays a critical role in their 
transport and assembly into chromatin. Once incorporated into chromatin, the cytoplasmatic acet-
ylation at these newly synthesized histone is removed by histone deacetylases.
3 Prototroph refers to an organisms or cell capable of  synthesizing all its metabolites from inorganic 
material, without requiring organic nutrients.
4 When oxygen is limiting, cells can redirect the pyruvate generated by glycolysis away from mito-
chondrial oxidative phosphorylation by producing lactate (Warburg effect). This generation of  lac-
tate during anaerobic glycolysis allows glycolysis to continue, with consequent increase of 
Acetyl-CoA levels.
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through glycolysis, however, this processing step is rapidly downregulated during 
differentiation. This metabolic switch causes a loss of histone acetylation during the 
first hours of differentiation. The link of acetyl-CoA levels and pluripotency state is 
supported by experiments showing that an increase of acetate, a precursor of acetyl- 
CoA, delays ESC differentiation and blocks early histone deacetylation whereas gly-
colysis inhibition leads to deacetylation and differentiation of ESCs (Moussaieff  
et al. 2015). Acetyl-CoA fluctuations during ESC differentiation have also been cor-
related with changes in the expression of threonine dehydrogenase (TDH), which 
converts threonine into glycine and acetyl-CoA in mitochondria, with glycine facili-
tating one-carbon metabolism and the synthesis of  S-adenosylmethionine (SAM) 
for DNA and histone methylation (see 7 Sect. 9.4) and acetyl-CoA feeding the TCA 
cycle. Another example of the link between metabolism and epigenetic gene regu-
lation are adipocytes, cells that are the primary constituent of adipose tissue and 
specialized in storing energy as fat. In adipocytes, ACL, the enzyme that converts 
glucose-derived citrate into acetyl-CoA, is required to increase histone acetylation in 
response to growth factor stimulation and during differentiation, indicating that glu-
cose availability can affect histone acetylation in an ACL-dependent manner (Wellen 
et al. 2009).
The local abundance of acetyl-CoA within the nucleus might also affect HAT cat-
alytic activity and regulate gene expression by controlling the levels of histone acety-
lation at specific genes. HATs display a relatively high dissociation constant (KD) 
for acetyl-CoA and consequently local changes in acetyl-CoA concentration might 
affect HAT activity. Studies in yeast have shown that acetyl-CoA levels (3–30 μM) 
may fluctuate within a range to limit the activity of the HAT GCN5, which has a KD 
for acetyl-CoA of 8.5 mM. This is not the case for kinases, which use ATP as cofac-
tor to phosphorylate, due to the elevated concentration of cellular ATP (roughly mM 
in cells) and their relatively high affinity for ATP (KD roughly μM). It is also worth 
to mention that many HATs are subject to product inhibition by free CoA, indicat-
ing that the acetyl-CoA/CoA ratio might be the relevant regulator of HAT activity 
instead of the absolute levels of acetyl-CoA.
The concentration of acetyl-CoA can also alter the substrate specificity of HATs. 
The lysine acetyltransferases CBP and p300 acetylate many common lysine residues 
on histones H3 and H4. However, under limiting acetyl-CoA concentrations, CBP 
and p300 display distinct specificity and selectivity, with p300 showing the highest 
specificity for H4K16, that is 1018-fold higher than CBP.
9.3  Nicotinamide Adenine Dinucleotide (NAD)
Nicotinamide adenine dinucleotide (NAD) serves both as a critical cofactor for 
enzymes that catalyze reduction-oxidation reactions and as a co-substrate for three 
classes of enzymes: (i) the sirtuins (SIRTs), (ii) the adenosine diphosphate (ADP)-
ribose transferases (ARTs) and poly(ADP-ribose) polymerases (PARPs), and (iii) the 
cyclic ADP-ribose (cADPR) synthases (. Fig. 9.3) (Verdin 2015).
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9.3.1  Biosynthesis of NAD
NAD can be synthesized from diverse dietary sources, including nicotinic acid (also 
known as Vitamin B3, an essential human nutrient) and nicotinamide, tryptophan, 
and nicotinamide riboside (NR). The major dietary source of NAD is nicotinic acid. 
NAD levels are maintained by three independent pathways: the Preiss-Handler path-
way, the kinurenine pathway, and the NAD salvage pathway (. Fig. 9.4).
In the Preiss-Handler pathway, dietary nicotinic acid and the enzyme nicotinic 
acid phosphoribosyltransferase (NAPRT) generate nicotinic acid mononucleotide 
(NAMN), which is in turn converted by the nicotinamide mononucleotide adeny-
lyltransferase (NMNAT) into nicotinic acid adenine dinucleotide (NAAD) in the 
presence of  adenosine triphosphate (ATP). NMNAT has three forms with distinct 
subcellular localizations: NMNAT1  in the nucleus, NMNAT2  in the cytosol and 
Golgi, and NMNAT3  in the cytosol and mitochondria. The kinurenine pathway 
  . Fig. 9.3 Nicotinamide adenine dinucleotide (NAD) is a co-substrate for histone deacetylation and 
ADP-ribosylation. The structure of  NAD in its oxidized form (NAD+) is shown. Sirtuins remove acetyl 
groups from target proteins. In this reaction, NAD is cleaved into nicotinamide, and the ADP-ribose 
serves as the acceptor for the removed acetyl group. Adenosine diphosphate (ADP)-ribose transferases 
(ARTs) and poly(ADP-ribose) polymerases (PARPs) transfer the ADP-ribose moiety from NAD to a 
target protein, releasing nicotinamide. Nicotinamide also serves as an inhibitory factor of  SIRTs, ARTs, 
and PARPs
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produces NAD from tryptophan and converges into the Preiss-Handler pathway 
since 2-amino-3-carboxymuconate semialdehyde (ACMS) undergoes spontane-
ous condensation and rearranges into quinolinic acid, which is transformed into 
NAMN.
The NAD salvage pathway is a key pathway for maintaining cellular NAD levels 
since it recycles the nicotinamide generated as a by-product of the enzymatic activities 
of NAD-consuming enzymes, the SIRTs, ARTs, and PARPs. Nicotinamide phospho-
ribosyltransferase (NAMPT) recycles nicotinamide into nicotinamide mononucleo-
tide (NMN), which is then converted into NAD via the different NMNATs as in the 
Preiss-Handler pathway. As it will be discussed in 7 Sect. 9.3.2, nicotinamide also 
serves as an inhibitory factor of SIRTs, ARTs, and PARPs (. Fig. 9.3). Consequently, 
the NAD salvage pathway leads not only to recycling of nicotinamide into NAD but 




































  . Fig. 9.4 NAD biosynthetic pathways. Three independent pathways (Preiss-Handler, kinurenine and 
salvage pathways) maintain NAD levels. In the Preiss-Handler pathway, NAPRT enzyme transforms 
nicotinic acid into NAMN, which is then converted into NAAD by NMNAT1-3. NAD is generated 
from NAMN by the reaction catalyzed by NAD synthase (NADS). In the kinurenine pathway, NAD is 
 produced from tryptophan. Spontaneous condensation ACMS and rearrangement into quinolinic acid 
make the kinurenine pathway to converge into the Preiss-Handler pathway for the production of 
NAD. The NAD salvage pathway recycles the nicotinamide generated as a by-product of  the enzymatic 
activities of  NAD-consuming enzymes SIRTs, ARTs, and PARPs. NAMPT uses nicotinamide to pro-
duce NMN, which is then converted into NAD via the different NMNATs as in the Preiss-Handler 
pathway. Nicotinic acid phosphoribosyltransferase (NAPRT), Nicotinic acid mononucleotide (NAMN), 
Nicotinic acid adenine dinucleotide (NAAD), Nicotinamide mononucleotide adenylyltransferase 
(NMNAT1-3), 2-amino-3-carboxymuconate semialdehyde (ACMS), Nicotinamide phosphoribosyl-
transferase (NAMPT), Nicotinamide mononucleotide (NMN)
 Chapter 9 · Epigenetics and Metabolism
187 9
Cellular NAD levels decline during the process of chronological aging and in 
progeroid5 states. NAD levels decrease in animals kept under a high fat diet whereas 
NAD increases under exercise and caloric restriction. The relationship between 
NAD levels and the nutritional state of the organism has also been confirmed in 
studies of the circadian clock, which is encoded by a transcription-translation feed-
back loop that synchronizes behavior and metabolism with the light-dark cycle. Both 
the expression of NAMPT, the rate-limiting enzyme in the NAD salvage pathway, 
and the levels of NAD cycle with a 24-hour rhythm are regulated by the core clock 
machinery in mice.
NAMPT has been implicated in the decline of cellular NAD levels associated with 
aging. NAMPT expression decreases during age and forced expression of NAMPT 
delays senescence and substantially lengthens cell lifespan. In addition, lifelong mus-
cle-specific Nampt transgene expression preserved muscle NAD levels and exercise 
capacity in aged mice (Frederick et al. 2016). The link between NAD levels and aging 
has initiated considerable efforts to manipulate NAD concentrations in therapies 
aimed at disease prevention and life-span extension. Pharmacological approaches 
able to improve NAD availability have been investigated as potential therapeutic 
treatments for different human disorders. NR is a NAD precursor that has the abil-
ity to cross the plasma membrane and does not inhibit the activity of sirtuins and 
PARPs. Diet supplementation with NR was shown to induce the  mitochondrial 
unfolded protein response and synthesis of prohibitin proteins, rejuvenate muscle 
stem cells in aged mice and in a mouse model of muscular dystrophy (Zhang et al. 
2016). Similarly, administration of the NAD intermediate NMN, a product of the 
NAMPT reaction, has been shown to enhance NAD biosynthesis and to mitigate 
age-associated physiological decline in mice. Supplementation of NMN was shown 
to suppress age-associated body weight gain, enhance energy metabolism, promote 
physical activity, improve insulin sensitivity and the plasma lipid profile, and amelio-
rate reduced eye function and other pathophysiologies (Mills et al. 2016).
9.3.2  NAD as Cofactor of Sirtuins and PARPs
NAD is a critical cofactor for SIRTs, ARTs, and PARPs. Although these three classes 
of enzymes use NAD, they have distinct functional roles. In the next sections, the role 
of SIRT and PARP enzymes will be discussed and their regulation, which is mediated 
by NAD levels.
9.3.2.1  Sirtuins
Sirtuins are class III histone deacylases that remove acyl groups from lysine resi-
dues on proteins in a NAD-dependent manner (. Fig. 9.3). NAD is cleaved between 
nicotinamide and ADP-ribose, and the latter serves as an acyl acceptor, generating 
acyl- ADP- ribose.
In mammalian cells, there are seven sirtuins, SIRT1-7, which are located in 
distinct cellular compartments and can, therefore, coordinate cellular responses to 
5 Progeroid syndromes are a group of  rare genetic disorders that showed accelerating physiological 
ageing, such as hair loss, short stature, skin tightness, cardiovascular diseases and osteoporosis.
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caloric restriction. SIRT1, SIRT6, and SIRT7 are localized in the nucleus where 
they function to deacetylate histones, thereby affecting gene expression. SIRT2 
is both a cytosolic and nuclear sirtuin and modulates cell cycle control. SIRT3, 
SIRT4, and SIRT5 are mitochondrial sirtuins and respond to caloric restric-
tion by switching cells to favor mitochondrial oxidative metabolism (Chang and 
Guarente 2014).
Sirtuin function is intrinsically linked to cellular metabolism. Over the past two 
decades, accumulating evidence indicates that sirtuins are conserved, diet-sensitive, 
anti-aging proteins. Caloric restriction, a decrease in calorie intake (by 10 to 40%) 
without malnutrition, has been shown to increase lifespan and healthspan in all 
organisms in which it has been tested. Moreover, as discussed above, NAD levels 
decline with aging, which would lead to a reduction in sirtuin activity. Initial studies 
in S. cerevisiae showed that the increased longevity induced by caloric restriction 
requires the activation of  the sirtuin protein silent information regulator 2 (SIR2) 
by NAD (Lin et al. 2000). Since then, several other studies in flies and worms have 
confirmed the lifespan-extending effects of  SIR2 homologs, underscoring the evo-
lutionary significance of  SIR2 in extending life span. Studies in mice also revealed 
a role of  sirtuins in the regulation of  aging and longevity in mammals. Transgenic 
mice overexpressing SIRT1 and SIRT6 exhibit phenotypes consistent with a delay 
in aging.
SIRT1 functions as a chromatin regulator by deacetylating specific histone- 
acetylated residues (e.g., H3K9ac, H3K14ac, and H4K16ac) but also transcription 
factors such as TP53, NF-kB, PGC-1a, and FOXO3a. SIRT1 protein abundance 
is relatively stable, but its deacetylase activity depends on NAMPT to generate 
NAD. An important example is provided by the regulation of  SIRT1 activity in 
circadian clock regulation. SIRT1 is recruited to the Nampt promoter inhibiting 
the expression of  NAMPT, which is a key enzyme of  the NAD salvage pathway, 
and thus contributes to the circadian synthesis of  its own coenzyme. Inhibition of 
Nampt promotes oscillation of  the clock gene Per2 by releasing CLOCK:BMAL1 
from suppression by SIRT1. In turn, the circadian transcription factor CLOCK 
binds to and up-regulates Nampt, thus completing a feedback loop involving 
NAMPT/NAD and SIRT1/CLOCK: BMAL1. Caloric restriction increases SIRT1 
protein levels and induces neural activation in the dorsomedial and lateral hypo-
thalamic nuclei. Increasing SIRT1 in the brain of  transgenic mice enhances neu-
ral activity specifically in hypothalamic nuclei and promotes physical activity in 
response to different diet- restricting paradigms. However, moderate overexpres-
sion of  SIRT1 in the whole organism was not sufficiently potent to affect longevity 
although old mice presented lower levels of  DNA damage, decreased expression 
of  the ageing-associated and cell cycle regulator gene p16Ink4a6, a better gen-
eral health, and fewer spontaneous carcinomas and sarcomas. Pharmacological 
interventions directed to increase SIRT1 activity have been found to slow the 
onset of  aging and delay age-associated disease. This concept has been validated 
in mice treated with the natural polyphenol resveratrol, which activates SIRT1 
and produces changes associated with longer lifespan, including increased insulin 
6 Note that p16Ink4a is frequently silenced in cancer through DNA methylation (see 7 Chap. 8 of 
Santoro)
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sensitivity, reduced insulin-like growth factor-1 (IGF-I) levels, increased AMP-
activated protein kinase (AMPK) and peroxisome proliferator- activated receptor 
gamma coactivator 1-alpha (PGC-1α) activity, increased mitochondrial number, 
and improved motor function (Baur et al. 2006).
Like SIRT1, SIRT6 expression is also correlated with longevity. SIRT6 modu-
lates telomeric chromatin through its association with telomeres and deacetylation 
of H3K9ac, which is required for the stable association of WRN, a factor that is 
mutated in the premature ageing disorder Werner syndrome. Accordingly, SIRT6-
depleted cells show premature cellular senescence and exhibit abnormal telomere 
structures that resemble defects observed in Werner syndrome.
The seven members of sirtuin family are considered potential targets for the treat-
ment of human pathologies including neurodegenerative diseases, cardiovascular 
diseases, and cancer. The action of sirtuins as epigenetic players in the regulation of 
fundamental biological pathways has prompted increased efforts to discover small 
molecules able to modify sirtuin activity.
9.3.2.2  PARPs
Another group of enzymes that uses NAD as a substrate and regulates cellular NAD 
levels are the PARP enzymes (. Fig.  9.3). There are 17 PARP-related enzymes. 
PARP1 and PARP2 catalyze the polymerization of ADP-ribose units from NAD, 
resulting in the attachment of either linear or branched poly-(ADP-ribose) (PAR) 
polymers to itself  or other target proteins.
Many early studies on PARPs and ADP-ribosylation were carried out with 
PARP1, the most ubiquitous and abundant PARP family member. PARP1 has been 
implicated in epigenetic and chromatin regulation. PARP1 can modulate chroma-
tin structure and act as a transcriptional coregulator. Initial evidence of a role of 
PARP1  in the regulation of chromatin structure derives from pioneering studies 
reporting that PARylation of nucleosomes causes chromatin decondensation in vitro 
(Poirier et al. 1982). In Drosophila, activation of PARP1 promotes decondensation of 
chromatin in response to heat shock or other cellular signaling pathways (Tulin and 
Spradling 2003). Accordingly, histone H1 and PARP1 exhibit a reciprocal  pattern 
of chromatin binding at many RNA polymerase II transcribed promoters. PARP1 
was enriched whereas H1 was depleted at these promoters. Furthermore, PARP1 
can act as coregulator by altering the function of components of the transcriptional 
machinery.
PARP1 is strongly activated by DNA damage and, through the production of 
long PAR chains, leads to consumption of a large amount of cellular NAD. PARP1 
and SIRT1 have a similar Km for NAD (PARP1 50–97 μM; SIRT1 94–96 μM). 
Consequentially, upon PARP1 activation, the decrease of NAD concentration 
should lead to a decrease in SIRT1 activity. PARP1 KO mice phenocopied many 
aspects of SIRT1 activity, such as a higher mitochondrial content, increased energy 
expenditure, and protection against metabolic diseases. The pharmacologic inhibi-
tion of PARP increases NAD content and SIRT1 activity and enhances oxidative 
metabolism. Interestingly, the NAD boosting effects of PARP inhibition enhance the 
activity of SIRT1 in the nucleus, but not that of SIRT2 in the cytoplasm or SIRT3 in 
mitochondria. This finding suggests that NAD is independently regulated within dif-
ferent cellular compartments. However, the role of PARP1 in aging and longevity is 
still not clear.
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PARP inhibitors7 are currently used in the management of tumors with absent or 
dysfunctional BRCA genes such as breast and ovarian cancers.
9.4  S-adenosylmethionine (SAM)
S-adenosylmethionine (SAM) is the cofactor of DNA and histone methyltransfer-
ases and is the second most common enzymatic cofactor after ATP (. Fig. 9.5).
9.4.1  Biosynthesis of SAM
SAM plays major roles in epigenetics, biosynthetic processes including phosphati-
dylcholine, creatine, and polyamine synthesis, as well as sulfur metabolism (Ducker 
and Rabinowitz 2017). The methyl group of SAM serves as donor for trans- 
methyltransferase reactions and is then converted into S-adenosylhomocysteine 
(SAH), which is a potent inhibitor of all methyltransferases (. Fig. 9.5).
The production of SAM and its control in the methylation of DNA and his-
tones is a prominent example of how diet and nutrition can impact the epigenome. 
SAM is produced by one-carbon metabolism, which combines the folate cycle and 
the methionine cycle (. Fig. 9.6). One-carbon metabolism is an integrator of the 
nutrient status based on amino acids, glucose, and vitamins The products generated 
in these pathways are implicated in diverse cellular processes that include cellular 
biosynthesis, regulation of redox status, regulation of epigenetics through nucleic 
acid and protein methylation, and genome maintenance through the regulation of 
nucleotide pools.
Nutrients that fuel one-carbon metabolism are folate, serine, and glycine. Serine 
and glycine can be synthesized de novo. In contrast, folate can be synthesized by plants 
and most microorganisms whereas animals require dietary folate intake. In cells, 
folate is reduced into tetrahydrofolate (THF) by dihydrofolate reductase (DHFR). 
THF enters into the folate cycle and serves as scaffold that carries 1-carbon groups in 
a variety of reactions, including the production of methyl-THF (mTHF). The folate 
cycle is coupled to the methionine cycle through the demethylation of mTHF, which 
regenerate THF and allows methylation of homocysteine (hCYS) to produce methi-
onine by methionine synthase and its cofactor vitamin B12. Methionine adenyltrans-
ferase (MAT) with ATP as cofactor converts methionine into SAM, which is then 
7 The use of  a PARP inhibitor in a BRCA-deficient cancers is the first example of  the clinical applica-
tion of  the concept of  synthetic lethality. BRCA1/2 genes produce proteins with an important role 
in repair of  double strand DNA breaks (DSB) by homologous recombination (HR). While normal 
cells can repair DSBs through HR that is error free, loss of  BRCA function forces cells to repair 
DSBs via non-homologous end joining NHEJ or the single-strand annealing sub-pathway of  HR, 
both mechanisms being prone to error and genomic instability.
Ftnote_PARP1 and 2 are implicated in the repair of  single-strand DNA break (SSB). PARP 
inhibitors trap the PARP complex and DNA replication stalls, converting SSBs into DSBs. When 
PARP inhibitors are given to cells with wild type BRCA1/2, the cells manage to repair DSBs by HR 
and survive. However, after administration of  PARP inhibitors, tumor cells with mutated BRCA1/2 
genes are unable to repair and undergo cell death.
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demethylated to form SAH.  Deadenylation of SAH by S-adenosyl homocysteine 
hydrolase (SAHH) generates hCYS, resulting in a full turn of the methionine cycle.
9.4.2  SAM as Cofactor of DNA and Histone Methyltransferases
Enzymes that use SAM as cofactor are DNA methyltransferases (DNMTs), lysine 
methyltrasferases (KMTs), and peptidylarginine methyltransferases (PRMTs). The 
crosstalk between metabolism and chromatin is regulated by the kinetic properties of 
each enzyme and the physiological concentrations of the metabolites. This is particu-
larly important for methyltransferases and acetyltransferases (see also Sect. 9.2.2), 
which respond to changes in metabolism due to low physiological concentrations of 
metabolic substrates that limit their enzymatic activities.
  . Fig. 9.5 S-adenosylmethionine (SAM) is the cofactor of  DNA and histone methyltransferases. 
SAM and S-adenosylhomocystein (SAH) are shown. SAM is the cofactor for DNA methyltransferase 
and histone methyltransferase. The methyl group of  SAM serves as donor for trans-methyltransferase 
reactions. SAM is then converted into SAH, which is a potent inhibitor of  all methyltransferases
9.4 · S-adenosylmethionine (SAM)
192
9
Competition for available SAM may regulate the contrasting methylation events, 
such as methylation of histone H3K4 that is associated with transcription activity 
and methylation of DNA and histone H3K9 that are associated with transcriptional 
silencing. Thus, changes in one-carbon metabolism, and, hence, alterations in the 
levels of SAM, can have an impact on gene expression. For instance, low amounts 
of external methyl donor groups from dietary sources can reduce the concentrations 
of SAM and affect gene expression. An important example of how nutrients affect 
the epigenome is the agouti mouse model where the maternal methyl dietary content 
affects the coat color of the offspring (. Fig. 9.7 and 9.8). The murine agouti gene 
encodes a paracrine signaling molecule that signals follicular melanocytes to switch 
from producing black eumelanin to yellow phaeomelanin. The agouti (a) gene is tran-
siently expressed in hair follicles resulting in a sub-apical yellow band on each black 
hair that causes the brown (agouti) coat color of wild-type mice. The Agouti viable 
yellow (Avy) allele was first described in the early 1960s and resulted from the inser-
tion of an intracisternal A particle (IAP) retrotransposon upstream of the transcrip-
tion start site of the agouti gene. In mice carrying the Avy allele, a cryptic promoter 
in the proximal end of the IAP promotes constitutive, ectopic agouti transcription, 
resulting in the expression not only in hair follicles but in all cells. This leads to a 
yellow fur, as well as adult-onset obesity, diabetes, and tumorigenesis (. Fig.9.7). 






































  . Fig. 9.6 One-carbon metabolism. SAM is produced by one-carbon metabolism, which combines the 
folate cycle and the methionine cycle. Nutrients that fuel one-carbon metabolism are folate, serine, and 
glycine. DHFR reduces folate to THF, which enters into the folate cycle and serves as scaffold that car-
ries 1-carbon groups in a variety of  reactions, including the production of  mTHF. The folate cycle is 
coupled to the methionine cycle through Vitamin B12 that serves as cofactor for the demethylation of 
mTHF and the production of  methionine by methionine synthase. MAT enzyme converts methionine 
into SAM, which is then demethylated to form SAH.  Deadenylation of  SAH by SAHH generates 
hCYS, resulting in a full turn of  the methionine cycle. Dihydrofolate reductase (DHFR); tetrahydrofo-
late (THF); methyl-THF (mTHF); homocysteine (hCYS); methionine adenyltransferase (MAT); S-ade-
nosyl homocysteine hydrolase (SAHH)
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of hypermethylation, the allele is silent and produces a wild-type, agouti-colored 
coat (termed pseudoagouti), whereas hypomethylation characterizes a transcription-
ally active state that produces a completely yellow coat and increases the tendency 
towards obesity and cancer (Morgan et al. 1999) (. Fig. 9.7).
Thus, agouti and pseudoagouti mice are genetically identical but they differ in 
epigenetic state and phenotype. Remarkably, if  a pregnant Avy mouse receives dietary 
supplements such as vitamin B12, folic acid, choline, and betaine, fueling the one-
carbon metabolism and leading to an increase in SAM production, the IAP in off-
spring will be methylated and agouti shows wild-type expression (. Fig. 9.8). These 
pups have a brown fur and no increased tendency towards obesity and cancer. Thus, 
environmental exposure or nutritional status can alter gene expression, especially 
during embryonic development, when the epigenome is established.
Chromatin-localized biosynthesis of metabolites has emerged as a process that 

















  . Fig. 9.7 Regulation of  Agouti viable yellow (Avy) by DNA methylation. The Avy allele results from 
the insertion of  an intracisternal A particle (IAP) retrotransposon upstream of  the transcription start 
site of  the agouti gene. DNA methylation at the IAP represses the ectopic expression of  the agouti gene, 
resulting in healthy mice with brown coat color
Agouti pregnant mom 
Fed with dietary supplemental:
folic acid, Vitamin B12,
choline, betaine 










  . Fig. 9.8 Effect of  maternal dietary supplementation on the phenotype and epigenotype of  Avy off-
spring. Maternal supplementation of  Avy mice with methyl donors (folate, betaine, vitamin B12, and 
choline) results in litters with a higher proportion of  offspring with brown coats, whereas the offspring 
of  mothers fed with a regular diet have a predominantly yellow coat color
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enzymes. This is of particular interest for methyltransferase reactions where interac-
tions between SAM producers (metabolic enzymes) and SAM consumers (epigenetic 
enzymes) result in efficient chromatin modifications and an increased specificity for 
the correct modifications by limiting the use of SAM by enzymes with opposing out-
comes (i.e. methylation of H3K4 versus methylation of H3K9). An example of this 
regulation is methionine adenosyltransferase (MAT), the enzyme that catalyzes the 
formation of SAM from methionine and ATP in one-carbon metabolism, which is a 
mitochondrial/cytosolic pathway. In mammals, MATII, one of the three distinct forms 
of MAT, localizes also to nuclei and interacts with the transcription factor MafK and 
H3K9 methyltransferases. The catalytic activity of MATII, which serves to supply 
SAM for methyltransferases, was necessary for H3K9 methylation and transcriptional 
repression of the heme oxygenase-1 gene (Katoh et al. 2011). The presence of microdo-
mains for chromatin modifications, where SAM moieties for histone or DNA methyl-
transferases are immediately replenished after the modification, was also described for 
other epigenetic enzymes using, e.g., acetyl-CoA and NAD (see 7 Sects. 9.2 and 9.3). 
Understanding how localized fluctuations in the levels of metabolites regulate chroma-
tin states in space and time is a challenging question in the field of epigenetic research.
9.5  Flavin Adenine Dinucleotide (FAD)
Flavin adenine dinucleotide (FAD) is a cofactor of lysine demethylase 1 (KDM1 or 
LSD1) (. Fig. 9.9).
9.5.1  Biosynthesis of FAD
FAD is produced in mitochondria and the cytoplasm from riboflavin (vitamin B2), 
which can be found in many vegetables and meat. Riboflavin is phosphorylated 











































  . Fig. 9.9 Flavin adenine dinucleotide (FAD) is a cofactor of  lysine demethylase 1 (LSD1). The struc-
ture of  FAD and its involvement in the histone demethylation mediated by LSD1 are shown. The reac-
tion mediated by LSD1 requires protonation of the nitrogen to be demethylated, which limits LSD1 
demethylating abilities to mono- and dimethylated lysines. LSD1-mediated demethylation generates 
formaldehyde and FADH2. Recycling of  FAD occurs via oxidation of FADH2, which produces peroxide
 Chapter 9 · Epigenetics and Metabolism
195 9
monucleotide (FMN), which is further converted to FAD by FMN adenyltransfer-
ase and ATP. Enzymes involved in FAD synthesis (FAD synthase) and hydrolysis 
(FAD pyrophosphatase) can also be found in the nucleus, providing a dynamic pool 
of nuclear FAD by balancing the ratio between its oxidized (FAD+) and reduced 
(FADH2) forms. The reduction of FAD to FADH2 is an essential reaction in the 
TCA cycle, where succinate dehydrogenase requires covalently bound FAD to cata-
lyze the oxidation of succinate to fumarate. Finally, FADH2 can be re-oxidized by 
oxygen producing FAD and peroxide.
FAD acts as cofactor of flavoenzymes, which have dehydrogenase, oxidase, 
monooxygenase, or reductase activities. Flavoenzymes play crucial roles in bioener-
getics, photochemistry, bioluminescence, redox homeostasis, chromatin remodeling, 
DNA repair, protein folding, apoptosis, and other physiologically relevant pro-
cesses (Joosten and van Berkel 2007). Deficiency in FAD-dependent enzymes and/or 
impairment of flavin homeostasis in humans and animal models have been linked to 
several diseases, including cancer and neurological disorders.
9.5.2  FAD as Cofactor of Lysine Demethylase 1 (LSD1)
The majority of  reported flavoenzymes localize to the mitochondria or cytoplasm. 
LSD1 is one of  a few flavoproteins in the nucleus and is the only epigenetic enzyme 
that utilizes FAD as an essential cofactor for catalytic activity. LSD1 is a mem-
ber of  the flavin-containing amine oxidase family and represses transcription by 
removing the methyl group from mono-methylated and di-methylated H3K4 (Shi 
et  al. 2004) (. Fig.  9.9). LSD1, in association with a nuclear receptor, is also 
involved in the demethylation of  H3K9. Furthermore, demethylation by LSD1 was 
also reported for non- histone proteins such as p53. FAD-dependent monoamine 
oxidases typically catalyze the oxidation of  amine-containing substrates, utilizing 
molecular oxygen as electron acceptor. The reaction mediated by LSD1 requires 
protonation of  the nitrogen to be demethylated, which limits LSD1 demethylat-
ing abilities to mono- and dimethylated lysines. Of  note is that LSD1-mediated 
demethylation generates formaldehyde and FADH2. Moreover, recycling of  FAD 
occurs via oxidation of  FADH2, which  produces peroxide. The generation of 
formaldehyde and peroxide might potentially have deleterious effects when pres-
ent near promoters. However, how cells deal with these products remains yet to be 
investigated.
The important function of LSD1 is evident by the embryonic lethality in null- 
mutant Kdm1KO mice and LSD1-deficient ESCs displaying global DNA hypometh-
ylation (Wang et  al. 2009). The biological significance of FAD-dependent LSD1 
activities in metabolic regulation have recently been supported by studies showing a 
crosstalk between energy metabolism and epigenetic gene regulation, e.g., by LSD1 
repressing energy-expenditure genes such as PGC1α through H3K4 demethylation 
in adipocytes where excess energy is stored as triglycerides. Cellular FAD content 
remarkably increased during adipogenic differentiation while a reduction in FAD 
levels by downregulation of riboflavin kinase induced expression of most LSD1- 
target genes. Moreover, transgenic overexpression of LSD1 in adipose tissue leads 
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to increased browning8 by promoting mitochondrial activity, thus protecting against 
diet-induced obesity. Finally, LSD1 inhibitors lead to a shift from oxidative to gly-
colytic metabolism in brown adipose tissue, resulting in weight gain but improved 
glucose tolerance (Duteil et al. 2016). LSD1 inhibitors have entered in clinical trials 
to treat mixed lineage leukemia.
9.6  α-Ketoglutarate (αKG)
α-ketoglutarate (αKG) is an intermediate of the TCA cycle and is a required cosub-
strate for Jumonji domain-containing histone lysine demethylases (KDMs) and TET 
enzymes, which participate in a multi-step DNA demethylation process (. Fig.9.10).
9.6.1  Biosynthesis of α-Ketoglutarate
Isocitrate dehydrogenases (IDH1, IDH2, IDH3) and glutamate dehydrogenase 
(GDH) are the enzymes producing αKG (. Fig. 9.11).
IDH1 and IDH2 are nicotinamide adenine dinucleotide phosphate (NADP+)-
dependent enzymes whereas IDH3 is a NAD-dependent enzyme. IDH1 is localized 
to the cytoplasm and peroxisomes. IDH2 and IDH3 are localized to the mitochon-
8 Brown adipose tissue that has the function to dissipates energy to produce heat and has the poten-
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  . Fig. 9.10 α-ketoglutarate (αKG) is a co-substrate for dioxygenases. αKG is a required cosubstrate 
for Jumonji C-family histone demethylases (KDMs) and TET enzymes, which participate in a multi-
step DNA demethylation process. TETs and KDMs require Fe(II) as a cofactor metal and α-KG as a 
cosubstrate to catalyze the reactions in which one oxygen atom from molecular oxygen (O2) is attached 
to a hydroxyl group in the substrate (hydroxylation) while the other is taken up by αKG, leading to the 
decarboxylation of  αKG and subsequent release of  carbon dioxide (CO2) and succinate
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dria and play a key role in the regulation of the TCA cycle. IDH1 and IDH2 are 
bidirectional enzymes that can both produce and consume αKG to meet cellular 
demands. αKG is used for four separate pathways: TCA cycle, anaplerosis9, fatty 
acid synthesis, and protein and nucleic acid hydroxylation. αKG is a rate-determining 
intermediate in the TCA cycle and has a crucial role in cellular energy metabolism. In 
the TCA cycle, αKG is decarboxylated to succinyl-CoA and CO2 by the oxoglutarate 
dehydrogenase complex (OGDC), a key control point of the TCA cycle. αKG also 
plays a major role in anaplerosis of the TCA cycle, a pathway that replenishes TCA 
intermediates from other biosynthetic pathways. In this case, αKG serves as entry 
point into TCA cycle for several 5-carbon amino acids (Arg, Glu, Gln, His, and Pro) 
that, after the conversion into glutamate, undergo oxidative deamination catalyzed 
by GDH to form αKG and NH3. αKG can also be reduced by IDH1 and IDH2 to 
isocitrate and then citrate. As discussed below, αKG is used as a cosubstrate for mul-
tiple αKG-dependent dioxygenases that are involved in the hydroxylation of various 
proteins and nucleic acids.































  . Fig. 9.11 Biosynthesis of  α-ketoglutarate. Isocitrate dehydrogenases (IDH1, IDH2, IDH3) and glu-
tamate dehydrogenase (GDH) are the enzymes producing αKG from isocitrate. IDH1 is localized to the 
cytoplasm whereas IDH2 and IDH3 are localized to the mitochondria. IDH1 and IDH2 are NADP+-
dependent enzymes whereas IDH3 is a NAD-dependent enzyme
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9.6.2  αKG as Cofactor of TET-Family DNA Demethylases 
and Jumonji C-Family Histone Demethylases
αKG is used by several dioxygenases, which catalyze hydroxylation reactions on 
diverse substrates, including proteins and nucleic acids. TET-family DNA demeth-
ylases (TETs) and Jumonji C-family (JmjC) histone demethylases are Fe(II)/αKG- 
dependent dioxygenases that facilitate the removal of methyl groups from cytosine 
bases and histone residues, respectively (. Fig.  9.10). TET proteins mediate oxi-
dation of 5mC to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 
5- carboxylcytosine (5caC), a reaction implicated in DNA demethylation (see book 
7 Chap. 1 of Wutz). JmJC demethylases are a group of the histone lysine demethyl-
ases (KDMs). There are several different subfamilies of the JmjC KDMs that have 
been identified, including KDM2, KDM3, KDM4, KDM5, and KDM6. TETs and 
JmjC KDMs require Fe(II) as a cofactor metal and αKG as a co-substrate to cata-
lyze the reactions in which one oxygen atom from molecular oxygen (O2) is attached 
to form a hydroxyl group in the substrate (hydroxylation) while the other is taken up 
by αKG, leading to the decarboxylation of αKG and subsequent release of carbon 
dioxide (CO2) and succinate (Hausinger 2004). The activity of TETs and JmjCs is 
competitively inhibited by TCA cycle intermediates such as succinate and fumarate.
Naive ESCs utilize both glucose and glutamine catabolism to maintain a high 
level of αKG. The elevated αKG to succinate ratio in naive ESCs promotes histone 
and DNA demethylation and maintains pluripotency. Direct manipulation of the 
intracellular αKG/succinate ratio is sufficient to regulate multiple chromatin modifi-
cations, including H3K27me3 and TET-dependent DNA demethylation, which con-
tribute to the regulation of pluripotency-associated gene expression.
Initial genome-wide sequencing studies in patients with glioblastoma identified 
somatic mutations in IDH1 and tumors without IDH1 mutations often have muta-
tions affecting IDH2 (. Fig. 9.12) (Parsons et al. 2008; Yan et al. 2009). Later, a 
similar mutation was also found in acute myelogenous leukemia (AML) and chon-
drosarcomas. Mutations in IDH1 and IDH2 are almost always in the binding site 
for isocitrate (Arg 132 for IDH1, Arg 172 for IDH2). However, mutant IDH1 and 
IDH2 are not simply inactive enzymes but, instead, possess a novel enzymatic activ-
ity that leads to the production of 2-hydroxyglutarate (2HG) (Dang et  al. 2009). 
Accordingly, human malignant gliomas and AMLs harboring IDH1 mutations con-
tained elevated levels of 2HG.
Evidence indicates that 2HG may act as an oncometabolite by competitive 
inhibition of αKG-dependent enzymes, including both JmjC KDMs and TETs 
(. Fig. 9.12). The structure of 2HG and αKG is similar with the exception of the 
2-ketone group in αKG is replaced by a hydroxyl group in 2HG. Structural analysis 
showed that 2HG occupies the same space as αKG does in the active site of histone 
demethylases and adopted a nearly identical orientation as αKG, thereby preventing 
the binding of αKG to the active site of the enzymes.
In vitro studies revealed that 2HG strongly inhibits histone demethylases. The 
strongest inhibition was observed with KDM4A, which demethylates H3K9 and 
H3K36, followed by the H3K9/H3K36 demethylase KDM4C and the H3K36 
demethylase KDM2A. These finding were supported by in vivo studies showing that 
human tumors expressing IDH1 and IDH2 mutants had increased histone methyla-
tion at H3K4, H3K9, H3K27, and H3K79 (Lu et al. 2012).
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The second major target of IDH1 and IDH2 mutations is the TET family. 2-HG 
inhibits TET activity and this inhibition could be overcome by the addition of αKG (Xu 
et al. 2011). Furthermore, glioblastomas expressing mutant IDH1 display hypermeth-
ylation at a large number of loci, leading to what is known as the glioma-CpG island 
methylator phenotype. Remarkably, mutations affecting TET2 and IDH1 in AML (see 
7 Chap. 8 of Santoro) occur in a mutually exclusive manner, suggesting that their bio-
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  . Fig. 9.12 Chemical reactions catalyzed by IDH enzymes and IDH1/2 mutants. IDH1 and IDH2 
mutants possess a novel enzymatic activity that leads to the production of  2-hydroxyglutarate (2HG). 
2HG acts as competitive inhibitor of  αKG-dependent enzymes, including both KDMs and TETs, 
thereby causing hypermethylation at DNA and histones
Take-Home Message
 5 Most chromatin-modifying enzymes use metabolites that are central to cellular 
metabolism as cofactor
 5 The epigenome acts a sensor of the whole metabolic network and regulates gene 
expression accordingly.
 5 Environmental and physiological stimuli can alter metabolite concentration, which 
in turn might affect gene expression by modulating the activity of epigenetic and 
chromatin enzymes.
 5 Chromatin-localized biosynthesis of metabolites has emerged as a process that 
modulates the expression of nearby genes by providing metabolites that, as cofac-
tors, activate epigenetic enzymes.
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A/B compartment On a large scale, chromosomes are organized into two distinct 
compartments A and B, whereby A refers to active and B to inactive regions with 
reference to gene expression. A/B compartments were observed in chromatin con-
formation capture (Hi-C) studies. Researchers observed that contacts of DNA 
sequences of individual chromosomes indicated two spatial compartments. Regions 
in compartment A interacted preferentially with A compartment-associated regions. 
Similarly, interactions within B compartments were observed but not between A and 
B compartments. A/B compartment-associated regions are several mega base pairs 
long. Whereas A compartments contain active genes, B compartments are consid-
ered largely inactive.
Aleurone The aleurone is the outermost cell layer of the endosperm in cereals, which 
surrounds the inner, starchy endosperm. In maize, the aleurone produces anthocy-
anin pigments that lead to the purple-brownish color of wild-type kernels.
Allelic/biallelic/monoallelic expression A diploid genome comprises two copies 
of each chromosome. A gene can be expressed from both chromosomes (biallelic 
expression), or from only one (monoallelic expression). In case of genomic imprint-
ing a gene is expressed only from either the maternally or the paternally inherited 
chromosome. An analysis that takes into account from which allele transcripts origi-
nate is referred to an analysis of allelic expression.
Anabolism The process by which the body utilizes energy to synthesize complex mol-
ecules.
Anaplerosis Metabolic pathways that replenish the citric acid (TCA) cycle intermedi-
ates, which are essential to energy metabolism.
Angiogenesis The process of developing new blood vessels. Angiogenesis is critically 
important during the normal development of the embryo and fetus. It also appears 
to be important during tumor formation.
Anther The anther is the male reproductive organ of flowering plants and the site of 
meiosis and male gametogenesis. After meiosis, all four meiotic products, the micro-
spores, survive to form multicellular pollen grain through two mitotic divisions. The 
pollen contains two sperm cells that participate in double fertilization.
Bivalent promoter Bivalent promoters are characterized by both repressing and acti-
vating epigenetic regulators, which is most commonly observed as dual- modified 
chromatin with H3K27me3 and H3K4me3  in the same region. Associated genes 
are expressed at low levels and often developmentally regulated. Bivalent chromatin 
is observed in stem cells or progenitor cells and is resolved to either repressed and 
H3K27me3 marked chromatin or active and H3K4me3 marked chromatin, when 
these cells differentiate into different lineages.
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Blastema A blastema is a mass of proliferating, undifferentiated cells that has the 
capability to regenerate organs and tissues. Cells appear not to be pluripotent, but to 
retain the restricted developmental potential of the tissue of origin.
Blastocyst The blastocyst represents an early mammalian embryonic developmen-
tal stage. It consists of the inner cell mass (ICM) which upon further development 
contribute to the formation of the embryo. The outer layer of the blastocyst is called 
the trophoblast which gives rise to the placenta. A cavity inside, termed blastocoel, 
is filled with fluid. The cells of the ICM are pluripotent and can be maintained in 
culture as embryonic stem cells.
Bromodomain The bromodomain was identified by sequence homology in the 
Drosophila gene Brahma, from which its name is derived, and genes involved in tran-
scriptional activation. Bromodomains are approximately 110 amino acids in length 
and recognize acetylated lysines in the N-terminal tails of histones. Among bromo-
domain-containing proteins are histone acetyltransferases and the histone methyl-
transferase ASH1L.
Central cell The central cell is the second female gamete of flowering plants that par-
ticipates in double fertilization. In most species, it is genetically identical to the egg 
cell as both female gametes are derived from the same meiotic product (functional 
megaspore) through mitotic divisions. However, in the majority of cases, it carries 
two copies of the maternal genome and is, thus, homo-diploid as compared to the 
haploid egg cell.
Chemoresistance The resistance of a tumor to chemotherapy.
Chromodomain The chromodomain is defined by sequence homology and is 
found as domain of about 40–50 amino acids in proteins associated with chroma-
tin. Chromodomain containing proteins include binders of methylated histones. 
The chromodomain of HP1 has affinity for H3K9me3, and the chromodomain of 
Polycomb has affinity for H3K27me3.
Chromosome territory A chromosome territory refers to the volume that a particular 
chromosome occupies in the cell nucleus. Chromosome territories have a globular 
shape and a diameter of a few micrometers. The chromosomal DNA in interphase 
adopts a loosely folded configuration. Although defined borders between chromo-
some territories have not been observed, chromosomes occupy discrete regions.
CIMP CpG island methylator phenotype defined as frequent methylation of multiple 
CpG islands that were found in many types of cancer.
Circadian clocks Endogenous oscillators that control 24-hour physiological and 
behavioral processes in organisms. These cell-autonomous clocks are composed of a 
transcription/translation-based autoregulatory feedback loop.
CpG island They are short interspersed DNA sequences (500–1500  bp long) with 
elevated CG density compared to the majority of the genome. Approximately 70% 
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of annotated gene promoters in the human and mouse genome are associated with a 
CGI, making this the most common promoter type in the vertebrate genome. CpG 
islands are normally devoid of any methylation at cytosines. The “p” represents the 
phosphor- ribose linkage and serves to clarify that CpG islands refer to CG dinucleo-
tides and not GC.
Crypt In general, crypts are anatomical structures that are narrow but deep invagina-
tions into a larger structure. In this context, the intestinal epithelium is organized in 
a basal crypt and a villus. Crypts of the small intestine contain replicating stem cells, 
Paneth cells of the innate immune system and goblet cell producing mucus. After 
stem cell division, one of the two daughter cells remain in the crypt as a stem cell, 
while the other differentiates and migrates up the side of the crypt and eventually 
forms specifically differentiated cells in the villus.
Cuticular structure Insects are protected by a rigid exoskeleton made out of chitin. 
The segmental structure of the insect body is particularly well reflected in the organi-
zation the thorax and abdomen.
Double fertilization Double fertilization is typical of flowering plants, where repro-
duction involves two fertilization events: one sperm cell fuses with the egg cell to 
form the zygote while a second sperm fuses with the central cell that develops into 
the endosperm. These two fertilization products develop coordinately into a seed, 
surrounded by maternal tissues that form the seed coat. In the majority of species, 
each pair of male and female gametes are genetically identical, respectively, i.e., they 
are derived from the same meiotic product.
Genomic repeat Genomic repeats are DNA sequences that occur in multiple copies 
throughout the genome. Repeats can be subdivided into tandem repeats and inter-
spersed repeats, the latter reflecting different types of transposable elements. Tandem 
repeats are adjacent to each other in the same or opposite orientation, e.g., satellite 
repeats typical of centromeres, minisatellites (10–60 bp) found in many places in the 
genome including centromeres, and microsatellites (<10 bp) found throughout the 
genome and typical of telomeres.
Glycolysis Metabolic pathway that breaks down glucose into two three-carbon com-
pounds and generates energy through the synthesis of ATP and NADH.
Hemolymph Insects have an open circulatory system. The hemolymph, like the blood 
system in vertebrates, among other tasks is responsible for carrying nutrients to organs 
and transport of cells of the innate immune system to damaged or infected parts.
Heterochromatin The two forms of chromatin were distinguished by cytological 
staining of cells. Heterochromatin stained darker than euchromatin due to a denser 
packing and is generally localized to the periphery of the nucleus. However, it has 
become clear that there are distinct forms of heterochromatin that can be molecu-
larly distinguished. Constitutive heterochromatin at the pericentric repeats is charac-
terized by H3K9me3 and HP1 binding, whereas facultative heterochromatin of the 
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inactive X chromosome in female mammals is characterized by H3K27me3 and PcG 
binding.
Histolyzed In flies like Drosophila, during embryogenesis cell lineages forming the 
adult structures (like the imaginal discs) are developed separately from the larval 
organs and tissues. During metamorphosis the molting hormone ecdysone induces 
the formation of a puparium. During this period the imaginal structures form the 
organ and appendages of the adult fly. Conversely the larval structures are decaying 
(they become histolyzed).
Histone code The histone code has been a hypothesis stating that chemical modifi-
cations to histone proteins would regulate the transcription of genetic information 
in a combinatorial manner. Together with DNA methylation this concept has been 
extended to an epigenetic code. Although such a code is far from the clarity and com-
pleteness of the codons for amino acids that are used by the ribosome for translation, 
the concepts still remains useful for discussing combinatorial interactions between 
histone modifications and their effect on gene regulation. The present view has aban-
doned with the generality of the histone code and adopted a biochemical and molec-
ular view of processes that work on chromatin and involve histone modifications.
Homeotic Homeosis describes the transformation of one organ into the identity of 
another. This can be the result of mutations or miss-expression of homeotic genes; 
master regulators involved in the patterning of body and organ structures.
Homo-diploid A homo-diploid cell carries two identical copies of the genome. In the 
majority of species, the central cell is homo-diploid because it contains two nuclei 
that are derived from the same meiotic product through mitotic divisions. These two 
nuclei fuse prior to or at fertilization with a haploid sperm to form the triploid endo-
sperm.
Hybrid A hybrid is an offspring resulting from sexual reproduction between two par-
ents belonging to different varieties, species, or even genera. In plants, hybridization 
is very common and an important driver of evolutionary change. Hybridization can 
lead to changes at the genomic and epigenomic scale, e.g., the activation of transposi-
tion or changes in DNA methylation, respectively.
Hyperplasia Increase in the number of cells in an organ or tissue due to loss of prolif-
eration control. These cells appear normal under a microscope. They are not cancer 
but may become cancerous.
Hypomorphic It is a mutation that causes a partial loss of gene function. A hypo-
morph is a reduction in gene function through reduced expression at RNA or protein 
levels or reduced functional activity, but not a complete loss.
Imaginal disc Imaginal cells are tissue-specific progenitors determined during fly 
embryogenesis. They increase in size by proliferation during embryonic and larval 
life, but cells do not differentiate. At metamorphosis the hormone Ecdysone triggers 
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the formation of pupal and adult structures, while the larval tissues are eliminated. 
The imaginal discs start differentiating giving rise to the external cuticle and append-
ages, like wing, leg or antennae.
Indels It refers to insertion and/or deletion of nucleotides into genomic DNA and 
include events less than 1 kb in length.
Insulator Insulators are a class of DNA elements having the ability to protect genes 
from inappropriate regulatory signals radiating from their neighboring environment. 
Insulators can control the interaction of enhancers with the promoter. Insulators can 
also protect genes by acting as barriers preventing the advance of nearby condensed 
chromatin that might otherwise silence expression (see also PEV).
Interchromatin compartment The interchromatin compartment (IC) refers to the 
space in the nucleus that is not occupied by chromatin. It consists of channels into 
chromatin territories that are thought to facilitate the diffusion of transcription fac-
tors and messenger RNA processing and transport.
LINE1 Active and autonomous transposable element that propagates in the genome 
through retrotransposition.
Metastatic cancer It is a cancer that has spread from the part of the body where it 
started (the primary site) to other parts of the body. When cancer cells break away 
from a tumor, they can travel to other parts of the body through the bloodstream or 
the lymph system.
Methylome The methylome describes the entirety of methylated cytosines in the 
genome of an organism, tissue, or cell type.
Microspore The microspore is the product of meiosis in the male reproductive organs 
of flowering plants. All four microspores survive and form mature pollen through 
two mitotic divisions. Each pollen contains two sperm cells that are delivered by the 
pollen tube to the female gametes to effect double fertilization.
Myeloproliferation It is the abnormal proliferation of myelopoietic cells from bone 
marrow. Myeloproliferative disorders refer to a type of disease in which the bone 
marrow produces too many red blood cells, platelets, or granulocytes (a type of white 
blood cells).
Neoplasm An abnormal mass of tissue that forms when cells grow and divide more 
than they should or do not die when they should. Neoplasms may be benign (not 
cancer) or malignant (cancer). Benign neoplasms may grow large but do not spread 
into, or invade, nearby tissues or other parts of the body. Malignant neoplasms can 
spread into, or invade, nearby tissues. They can also spread to other parts of the body 
through the blood and lymph systems.
Nonsense mutations It is a point mutation in a sequence of DNA that results in a 
premature stop codon, causing a protein to terminate or end its translation earlier 
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than required. In contrast, missense mutation is a point mutation that results in the 
substitution of one amino acid for another in the protein.
Nucleosome free region Nucleosome free regions refer to a single missing nucleosome 
at the transcription start site of active genes. It is a consequence of the  establishment 
of DNA accessibility at the promoter, which mediates the binding of transcription 
factors and assembly of the transcriptional machinery. Nucleosomes in the vicinity 
of the nucleosome free region are strongly positioned. The +1 and −1 nucleosome 
are located downstream and upstream of the transcription start site, respectively. The 
histone variant H2A.Z is found to be incorporated specifically at the +1 nucleosome 
and several downstream nucleosomes.
Oncogenes Genes that have the potential to become dominant oncogenic determi-
nants in tumorigenesis.
Oncometabolites Metabolites whose quantity increase in tumors compared to nor-
mal cells.
Ontogeny This refers to the developmental life-time history of a single organism in 
comparison to phylogeny which refers to the evolutionary history of a species.
Ovule The ovule is the female reproductive organ of flowering plants and the site of 
meiosis and female gametogenesis. After meiosis, only one of the meiotic products 
survives, the functional megaspore, which forms a multicellular organism through 
several mitotic divisions. Two of the formed cells are the female gametes, the egg and 
central cells. After fertilization, the ovule develops into the seed.
Paracrine signaling The transfer of information from one cell to another, where the 
signal molecule travels from the signal-producing cell to the receiving cell by passive 
diffusion or bulk flow in intercellular fluid. The signaling cell and the receiving cell 
are usually in the vicinity of each other.
Paused polymerase Pol II pausing or stalling is caused by different incidences; block-
age by nucleosomes, need for proofreading, and others. In this context, promoter-
proximal pausing is considered an important regulatory stage during transcriptional 
initiation. At the promoter, stalled Pol II produces short characteristic RNA tran-
scripts. Upon an additional activating cascade of factors (see text) the polymerase 
is released and produces the productive transcript. Pausing could be required for a 
better synchrony in gene activation, as a checkpoint for assembly of transcriptional 
components, a requirement of additional signal integration and others.
Pericentric chromatin/regions/repeats The centromeres of mammalian chromo-
somes are flanked by repeated sequences that consist of the minor and major satellite 
repeat sequences. These pericentric repeats are distinct from the centromeres and 
contribute to a heterochromatic environment that supports centromere function. The 




Phagocytosis Describes the process by which a cell (termed phagocyte) uses its 
plasma membrane to engulf  large particles or other cells giving rise to an internal 
compartment called phagosome. It is a particular form of endocytosis. Phagocytosis 
is a major mechanism of the immune system to remove pathogens and cell debris.
Phyla Phyla (singular: phylum) represent the level of classification or taxonomic 
rank below kingdom and above class.
Pioneer TF Pioneer transcription factor can recognize and bind to their cognate 
sequence even when the DNA is wrapped in a nucleosomal structure. Pioneer TFs 
attract nucleosome remodeling complexes and histone modifying enzymes to further 
loosen and open condensed chromatin for access to additional factors required for 
example to assemble a transcription initiation complex on free DNA.
Position effect variegation (PEV) Position effect variegation (PEV) causes a gene to be sto-
chastically silenced in regions where it should normally be expressed. This occurs when 
the gene becomes juxtaposed to heterochromatin in a genome translocation or insertion 
event. Repressive heterochromatin spreads, un-inhibited by insulator elements, into the 
regulatory part of the gene. An example is variegated eye color in Drosophila caused by 
a translocation of the white gene into the vicinity of heterochromatin.
Protamines Protamines are small, arginine-rich proteins replacing the histones in 
chromatin during late spermatogenesis. They allow a denser packaging of the DNA 
and are considered crucial for sperm head condensation and genome stabilization.
Prototrophic organism An organism or cell capable of synthesizing all its metabolites 
from inorganic material, requiring no organic nutrients.
Pseudoautosomal region In heteromorphic sex chromosome systems pairing is 
restricted to specific regions that share homology. For example, the mammalian X 
and Y chromosomes have diverged but share small regions of homology at the ends 
of the chromosomes. Through these regions pairing and exchange of sequences by 
crossing over occurs during meiosis in the male germline. These pairing regions on 
the X and Y, thus, behave like autosomes and are referred to as pseudo autosomal 
regions (PAR) of the sex chromosomes.
Retrovirus element A retrovirus inserts a copy of its RNA genome into the DNA 
of the host cell it invades. The RNA is copied into DNA by reverse transcriptase 
encoded by the viral genome. The viral DNA is then integrated and become part of 
the host genome. There it can be transcribed again, reactivating the process of new 
viral production. Genomes are full of such retroelements which in most cases repre-
sent dead, defective viral genomes.
Sciara/Fungus gnat Sciara (gnat), a genus of fungus gnats; insects that have been 
studied for the process of genome elimination. Analysis of genetics and chromatin in 
Sciara have also revealed insights into the evolution of epigenetic processes. Fungus 
gnats are harmless and feed on soil-grown fungi. Larvae in some species are plant 
pathogens and can damage particularly seedlings and young plants.
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Sex combs A set of dark bristles found on the first leg pair of Drosophila males and 
used for mating. Conspicuous morphological marker used by geneticists to identify 
homeotic transformations of the second and third leg pairs into the identity of the 
first leg pair.
Synthetic lethality It is the setting in which inactivation of either of two genes indi-
vidually has little effect on cell viability whereas loss of function of both genes simul-
taneously leads to cell death. In cancer, the concept of synthetic lethality has been 
applied to therapy against cancer cells in which one gene is inactivated by deletion or 
mutation present and the other is pharmacologically inhibited, leading to death of 
cancer cells. Normal or cancer cells not containing these mutations survive.
Teratocarcinoma Teratocarcinoma is a form of malignant germ cell tumor found in 
animals and humans. These tumors contain an undifferentiated embryonal carci-
noma component and differentiated derivatives that can include all three germ layers.
Transdetermination Transdetermination is defined as a switch in lineage commit-
ment in progenitor cells (i.e. leg imaginal discs) to a developmentally closely related 
cell type (i.e. wing imaginal disc). This change of fate can occur for example in long-
term transplantation experiments of Drosophila larval imaginal discs.
Transdifferentiation Transdifferentiation occurs when a differentiated somatic cell 
switches to another differentiated lineage without an intermediate stage of dediffer-
entiation (like a pluripotent or progenitor state).
Transposable element A transposable element (TE) is a DNA sequence capable of 
changing its position in the genome. The TE codes for enzymes necessary for its 
own excision and integration. Insertions of TEs can cause mutations and large-scale 
genome aberrations.
Tumor suppressor gene Class of genes that regulate cell proliferation and their inac-
tivation can play a profound role in the development of malignancies.
X inactivation center The X inactivation center (Xic) refers to a genetic locus on the 
mouse and human X chromosome that contains regulatory elements for X chromo-
some inactivation. The Xic includes the Xist gene as well as elements that allow to 
sense the cell how many X chromosomes are present. All but one X chromosome are 
inactivated, which results in balanced gene expression of a single X chromosome in 
both male and female cells.
Xenograft It is one of the most widely used models in cancer research. Typically, 
human tumor cells are transplanted, either under the skin or into the organ type 
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